data_2dwv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dwv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.36 161.55 45.43 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 121.914 1.743 . . . . 0.0 109.566 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.44 108.7 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.316 2.678 . . . . 0.0 108.653 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.28 -16.42 6.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.684 1.611 . . . . 0.0 111.704 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.0 m95 -95.38 142.68 27.48 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.261 -1.141 . . . . 0.0 109.429 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.525 ' HG2' ' HH ' ' B' ' 29' ' ' TYR . 4.1 tp10 -125.32 140.73 52.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.273 0.629 . . . . 0.0 110.818 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -104.13 134.8 46.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 t -115.0 138.65 44.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.78 131.01 40.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.262 1.025 . . . . 0.0 110.729 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.82 170.9 18.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.01 1.724 . . . . 0.0 111.283 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -86.76 -29.36 22.41 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.446 1.098 . . . . 0.0 112.534 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.82 -44.38 27.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.97 1.259 . . . . 0.0 110.952 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.84 -24.73 14.58 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -94.75 1.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.55 130.35 10.07 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.216 -0.579 . . . . 0.0 110.752 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.474 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 52.8 p90 -135.29 173.48 11.67 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -125.76 146.07 49.93 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.22 -0.925 . . . . 0.0 108.559 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 143.44 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.614 0.721 . . . . 0.0 109.546 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 64.6 t0 -108.2 109.75 21.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.709 2.003 . . . . 0.0 109.829 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' CE1' ' HH ' ' B' ' 40' ' ' TYR . 1.5 m-70 -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.086 0.857 . . . . 0.0 111.092 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 m -68.12 -33.43 74.49 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.615 1.166 . . . . 0.0 111.603 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -122.38 1.05 9.57 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 38' ' ' ALA . 22.2 mmmt 50.31 51.48 16.69 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.584 1.953 . . . . 0.0 110.023 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.34 166.91 16.94 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 123.809 0.844 . . . . 0.0 110.227 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.417 ' O ' ' HE3' ' B' ' 36' ' ' LYS . . . -122.78 149.91 43.5 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -150.55 171.39 17.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.406 1.482 . . . . 0.0 107.988 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -112.89 -8.15 13.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -100.74 167.49 10.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.972 1.309 . . . . 0.0 110.865 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 149.48 82.82 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 110.059 178.011 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 119.727 -0.178 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 160.97 46.84 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.338 2.025 . . . . 0.0 111.009 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.73 115.43 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.249 2.632 . . . . 0.0 108.696 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.23 -21.31 13.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.661 1.124 . . . . 0.0 112.514 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -87.56 164.06 16.3 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 119.229 1.514 . . . . 0.0 108.144 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.474 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 3.7 tp10 -144.82 152.65 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.943 -0.473 . . . . 0.0 110.797 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -112.75 133.88 54.55 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.341 1.857 . . . . 0.0 107.005 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.32 128.51 75.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -109.93 141.56 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 10.1 t -153.07 -169.81 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.9 m -130.32 -38.29 1.38 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.564 1.946 . . . . 0.0 107.093 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.41 -27.22 66.9 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -121.36 -26.21 5.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.67 -91.48 1.04 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.06 1.315 . . . . 0.0 110.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.4 m -154.93 137.07 14.75 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.491 -1.594 . . . . 0.0 109.3 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.525 ' HH ' ' HG2' ' A' ' 19' ' ' GLU . 53.1 p90 -146.14 179.21 7.65 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -131.65 154.44 48.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.46 0.704 . . . . 0.0 109.424 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.96 142.01 41.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.38 0.672 . . . . 0.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -102.9 125.69 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.478 2.711 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -85.17 -19.81 31.19 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.924 -0.485 . . . . 0.0 110.657 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 46.7 m -73.06 -32.69 65.21 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.82 1.248 . . . . 0.0 110.247 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -123.54 -2.94 8.37 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 38' ' ' ALA . 25.8 mmmt 54.88 40.38 31.95 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.802 1.241 . . . . 0.0 110.71 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -115.27 158.6 22.11 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.427 ' O ' ' HE3' ' A' ' 36' ' ' LYS . . . -116.89 147.48 42.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.51 1.124 . . . . 0.0 108.482 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -152.51 162.54 41.06 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.393 1.477 . . . . 0.0 108.745 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.413 ' HH ' ' CE1' ' A' ' 33' ' ' HIS . 66.2 m-85 -103.33 -4.68 23.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.116 0.966 . . . . 0.0 113.023 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 163.28 13.46 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.18 0.992 . . . . 0.0 110.615 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -79.58 143.43 59.09 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.535 0.545 0 C-N-CA 121.627 1.551 . . . . 0.0 113.278 -178.651 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.236 0.393 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.92 159.66 50.7 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.533 0.822 . . . . 0.0 110.314 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.1 110.68 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.493 2.795 . . . . 0.0 108.872 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.17 -14.48 16.1 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-O 117.942 -1.477 . . . . 0.0 114.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 11.5 m95 -96.22 150.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.447 1.623 . . . . 0.0 107.036 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -135.08 148.31 49.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.488 0.185 . . . . 0.0 110.917 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -103.83 130.06 51.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.57 144.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.3 147.01 50.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 p -158.08 164.34 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.288 1.435 . . . . 0.0 110.701 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -92.06 -29.16 16.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.926 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -17.99 35.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.46 -46.87 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.83 -104.35 0.87 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -138.34 124.01 19.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -135.93 176.61 8.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.826 0.45 . . . . 0.0 111.043 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.39 151.88 51.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.541 0.737 . . . . 0.0 110.767 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.61 137.79 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.061 0.544 . . . . 0.0 111.146 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 34.3 t0 -101.26 107.97 19.49 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 127.946 2.498 . . . . 0.0 105.447 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -74.77 -19.71 60.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.0 m -80.75 -47.42 13.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.303 0.956 . . . . 0.0 110.276 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.91 -10.14 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.937 1.295 . . . . 0.0 112.213 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm 55.58 45.06 25.63 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.73 2.012 . . . . 0.0 110.868 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -114.46 164.29 14.17 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.096 0.959 . . . . 0.0 109.411 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.42 150.37 48.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.365 1.466 . . . . 0.0 109.102 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -160.23 151.97 19.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.015 1.326 . . . . 0.0 109.968 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -93.14 11.12 28.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.028 0.931 . . . . 0.0 111.388 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 160.24 34.64 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.522 -1.361 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -63.22 138.66 97.4 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.449 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 CA--C 1.532 0.421 1 C-N-CA 125.928 4.418 . . . . 0.0 115.305 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -72.09 164.72 34.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.365 2.044 . . . . 0.0 111.686 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.09 121.36 9.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.7 58.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.288 -1.285 . . . . 0.0 115.063 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -94.04 161.29 14.34 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 119.521 1.66 . . . . 0.0 108.525 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.84 169.15 20.43 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -128.5 121.94 30.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 109.355 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.58 123.74 49.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.96 137.92 50.62 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -150.93 -154.51 0.55 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.71 1.604 . . . . 0.0 108.96 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.1 m -127.31 -55.58 1.34 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.604 1.962 . . . . 0.0 107.101 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -60.83 -26.29 67.23 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.752 1.221 . . . . 0.0 113.312 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -113.93 -41.98 3.47 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.75 -96.72 1.02 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.068 0.842 . . . . 0.0 112.339 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -149.28 108.35 3.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.609 0.705 . . . . 0.0 109.567 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -125.22 176.77 6.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 109.726 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.25 156.9 44.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 110.239 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.34 142.59 32.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.506 1.122 . . . . 0.0 108.783 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -106.19 115.04 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.548 2.339 . . . . 0.0 105.096 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -79.55 -17.1 54.74 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 112.773 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -79.98 -45.11 19.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.214 1.405 . . . . 0.0 109.33 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -95.32 -15.12 23.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.188 0.995 . . . . 0.0 111.54 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 58.48 53.41 6.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.454 2.302 . . . . 0.0 109.312 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -134.66 153.61 51.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.967 0.507 . . . . 0.0 111.291 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.08 145.78 36.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.831 1.253 . . . . 0.0 110.524 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -147.23 150.87 35.7 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.682 0.793 . . . . 0.0 109.277 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.54 19.2 11.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.815 1.646 . . . . 0.0 112.613 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 159.69 41.67 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.41 -1.431 . . . . 0.0 109.037 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.63 152.09 76.06 Favored Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 123.956 0.902 . . . . 0.0 112.588 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 CA--C 1.535 0.556 0 C-N-CA 123.32 2.68 . . . . 0.0 116.047 -178.428 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 mt . . . . . 0 C--O 1.235 0.301 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.05 163.7 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.458 2.105 . . . . 0.0 110.614 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 140.49 64.31 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.954 1.77 . . . . 0.0 108.747 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.12 -12.6 63.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.057 -1.413 . . . . 0.0 113.23 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 5.9 m95 -90.59 164.14 14.31 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 120.657 2.229 . . . . 0.0 109.112 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -147.43 155.27 41.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.804 0.812 . . . . 0.0 109.847 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -124.87 140.81 52.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.99 139.19 50.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.8 121.53 37.43 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.212 1.805 . . . . 0.0 106.474 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 p -131.53 172.25 12.44 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.012 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -95.64 -28.21 14.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.791 1.236 . . . . 0.0 110.674 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -95.93 -28.14 14.82 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -107.97 -34.79 6.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 -98.23 0.98 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.33 0.968 . . . . 0.0 112.762 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 m -148.16 121.83 9.23 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.521 0.728 . . . . 0.0 109.202 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -140.14 176.44 8.75 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.206 -0.934 . . . . 0.0 109.67 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -129.42 150.09 50.92 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.814 0.734 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.5 131.85 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.747 0.819 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.3 t0 -98.78 116.98 32.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -86.84 -20.46 27.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.115 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m -76.97 -31.71 56.75 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.591 1.087 . . . . 0.0 110.118 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -109.96 -12.01 14.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.893 1.677 . . . . 0.0 111.959 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HE2' ' CE2' ' B' ' 40' ' ' TYR . 42.5 mmtm 54.11 56.91 6.44 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.476 1.51 . . . . 0.0 110.782 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -130.58 169.6 15.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.24 1.016 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.37 142.74 51.42 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.896 1.679 . . . . 0.0 108.923 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.77 161.01 43.37 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.432 1.493 . . . . 0.0 110.522 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.57 25.78 11.06 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.906 1.282 . . . . 0.0 112.142 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 160.03 40.81 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.704 -1.248 . . . . 0.0 110.059 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 153.41 55.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.913 . . . . 0.0 110.481 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 C-N-CA 123.636 2.891 . . . . 0.0 114.509 -178.552 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.78 160.51 49.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.108 1.872 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.62 99.21 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.797 2.998 . . . . 0.0 109.769 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.59 -1.62 5.22 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.645 1.593 . . . . 0.0 112.235 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -117.37 153.75 32.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.651 1.225 . . . . 0.0 109.479 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.01 168.47 19.64 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -130.8 125.54 33.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.643 2.377 . . . . 0.0 105.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.54 145.73 15.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -124.5 138.9 54.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.477 1.111 . . . . 0.0 108.276 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.7 p -154.66 177.66 10.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.363 1.865 . . . . 0.0 111.479 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -105.52 -33.47 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.62 -35.57 81.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.908 1.683 . . . . 0.0 110.865 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.05 -35.96 3.22 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.811 0.844 . . . . 0.0 113.006 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.05 -100.37 1.3 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 22.9 m -147.36 127.56 13.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 120.225 -1.75 . . . . 0.0 108.818 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -142.37 173.99 11.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.641 0.776 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -122.62 148.04 45.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.168 0.987 . . . . 0.0 112.944 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.49 140.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 108.66 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -107.94 115.61 30.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 127.862 2.465 . . . . 0.0 108.418 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -77.27 -30.31 54.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 87.3 m -67.61 -39.07 84.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.55 1.14 . . . . 0.0 110.783 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -106.9 -6.77 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.094 0.558 . . . . 0.0 112.441 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp 51.74 52.94 13.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.854 1.662 . . . . 0.0 110.633 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -126.48 166.46 17.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.846 1.258 . . . . 0.0 109.954 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.47 140.63 52.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.351 1.461 . . . . 0.0 107.727 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -147.06 171.67 14.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.607 1.163 . . . . 0.0 108.743 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.472 ' CE2' ' HE2' ' A' ' 36' ' ' LYS . 84.3 m-85 -112.79 -2.08 14.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.66 0.664 . . . . 0.0 112.429 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 160.89 14.84 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.964 0.906 . . . . 0.0 109.37 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -71.72 143.72 87.49 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.51 2.14 . . . . 0.0 114.155 -179.143 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.595 -0.24 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.91 163.56 35.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.058 1.172 . . . . 0.0 110.949 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.27 133.11 36.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.042 1.828 . . . . 0.0 109.006 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.1 -14.96 61.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.72 1.629 . . . . 0.0 111.644 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -105.9 142.54 35.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.394 1.097 . . . . 0.0 108.884 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.94 160.19 39.36 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.475 1.51 . . . . 0.0 107.705 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -120.26 120.7 36.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.16 149.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.43 148.38 52.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.72 1.208 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 t -160.82 153.88 21.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.784 1.634 . . . . 0.0 112.819 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -80.44 -29.75 37.57 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -80.58 -27.1 37.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.918 1.687 . . . . 0.0 112.41 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -117.26 -38.13 3.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.95 -109.83 2.3 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.25 126.98 20.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -138.48 170.04 16.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.508 0.67 . . . . 0.0 109.665 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.27 148.45 52.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.225 1.01 . . . . 0.0 109.0 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.42 139.68 47.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 109.355 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -103.34 116.1 31.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.734 2.014 . . . . 0.0 108.319 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -72.23 -17.55 61.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.581 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -71.21 -51.22 25.92 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.877 0.871 . . . . 0.0 111.665 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -110.4 4.75 20.92 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.516 0.727 . . . . 0.0 112.776 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 51.87 41.69 29.59 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.97 1.308 . . . . 0.0 111.387 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -105.74 156.34 18.39 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.21 49.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.942 1.297 . . . . 0.0 107.952 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.44 168.31 25.43 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.865 -1.147 . . . . 0.0 110.647 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.85 15.73 27.28 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 112.302 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.22 153.95 31.99 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.047 -1.033 . . . . 0.0 109.977 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -71.18 136.63 84.42 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 121.781 1.654 . . . . 0.0 108.197 -179.845 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--O 1.236 0.378 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.78 160.21 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.786 1.657 . . . . 0.0 111.368 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.86 91.05 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.534 3.489 . . . . 0.0 110.149 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.49 -3.28 2.93 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.477 1.513 . . . . 0.0 111.734 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -110.36 156.73 20.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.487 1.144 . . . . 0.0 108.195 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -148.95 158.56 44.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.21 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -112.04 144.95 40.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.787 1.635 . . . . 0.0 106.949 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.44 118.82 54.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -110.28 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 t -154.77 148.72 25.7 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.745 1.218 . . . . 0.0 110.804 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -76.16 -23.34 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.494 1.043 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -81.22 -22.67 38.63 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -120.69 -43.97 2.46 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.52 -113.29 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -141.05 111.99 7.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -131.71 -179.96 5.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -131.35 155.9 46.43 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.89 0.876 . . . . 0.0 111.345 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.66 138.7 52.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.795 1.238 . . . . 0.0 109.301 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -106.68 118.96 38.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.474 1.91 . . . . 0.0 109.258 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -77.88 -20.9 52.15 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -69.28 -49.98 51.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.5 1.046 . . . . 0.0 110.49 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -105.85 -0.06 25.55 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt 53.87 53.49 11.21 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.008 1.323 . . . . 0.0 109.919 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -119.27 162.48 18.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.466 0.706 . . . . 0.0 109.578 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.93 142.68 50.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.861 1.264 . . . . 0.0 108.856 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -154.9 164.81 38.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.349 1.059 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -103.71 -6.56 21.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 142.5 34.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . 0.426 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.0 t-80 -56.12 146.69 49.42 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.807 1.243 . . . . 0.0 110.572 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 56.4 Cg_endo . . . . . 0 C--N 1.348 0.515 0 C-N-CA 122.469 2.113 . . . . 0.0 112.492 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 163.27 39.2 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.863 2.375 . . . . 0.0 110.921 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.52 123.92 11.02 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.391 2.061 . . . . 0.0 107.991 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.71 -17.75 22.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.176 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 24.5 m95 -100.77 164.07 12.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -143.52 151.33 40.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.883 0.373 . . . . 0.0 111.851 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -112.82 121.16 43.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.79 146.28 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.8 111.83 11.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.98 1.712 . . . . 0.0 106.902 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.11 174.68 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.43 1.492 . . . . 0.0 111.427 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -106.85 -22.13 12.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 112.205 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.39 -12.96 47.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.724 0.693 . . . . 0.0 111.314 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.59 -63.41 0.71 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.192 0.997 . . . . 0.0 109.673 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.36 -109.47 0.71 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.627 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.1 m -131.37 112.05 12.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.757 1.279 . . . . 0.0 109.257 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -134.07 146.1 50.01 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.496 1.518 . . . . 0.0 108.255 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.11 146.87 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.859 1.264 . . . . 0.0 111.204 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.08 138.34 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.303 1.041 . . . . 0.0 110.15 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.421 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 36.3 t70 -105.92 110.48 22.77 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 127.044 2.137 . . . . 0.0 108.032 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -75.81 -18.08 59.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.2 m -71.72 -28.98 64.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.751 1.614 . . . . 0.0 111.807 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -126.18 -7.75 6.5 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 124.555 1.142 . . . . 0.0 112.536 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 mtmm 58.66 60.03 2.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.472 1.909 . . . . 0.0 109.047 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -124.33 168.79 12.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.54 1.136 . . . . 0.0 108.974 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.92 52.08 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -155.1 167.82 29.07 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.09 -1.006 . . . . 0.0 110.978 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.15 10.9 27.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.041 0.937 . . . . 0.0 112.927 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 153.27 46.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.327 1.051 . . . . 0.0 110.39 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.58 136.74 89.49 Favored Pre-proline 0 N--CA 1.451 -0.415 0 O-C-N 124.398 1.061 . . . . 0.0 109.946 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 N--CA 1.451 -0.992 0 C-N-CA 123.312 2.675 . . . . 0.0 110.564 179.686 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--O 1.233 0.2 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 42.6 Cg_endo -67.44 165.49 26.91 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.51 2.14 . . . . 0.0 109.841 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.81 128.05 22.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.273 1.982 . . . . 0.0 108.367 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.41 58.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.15 1.357 . . . . 0.0 114.28 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.415 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 6.8 m95 -83.96 153.79 23.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.955 1.877 . . . . 0.0 109.498 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.25 151.54 47.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.51 134.54 54.62 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.94 134.24 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.802 0.841 . . . . 0.0 109.055 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.18 140.71 52.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -159.9 133.52 7.11 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.222 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -60.06 -14.95 19.14 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -89.3 -20.73 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.011 0.823 . . . . 0.0 112.128 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.33 -16.4 3.95 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.03 -99.1 2.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 25.4 m -152.03 142.49 22.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.466 0.706 . . . . 0.0 109.497 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.09 -179.42 7.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 109.017 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -131.66 151.9 51.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.623 1.569 . . . . 0.0 106.898 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.93 145.97 34.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 123.556 0.743 . . . . 0.0 109.108 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -107.34 102.54 11.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 128.975 2.91 . . . . 0.0 105.918 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -23.84 61.65 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -74.95 -16.89 60.63 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.762 2.025 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.84 -12.45 2.94 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.253 1.421 . . . . 0.0 112.35 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 57.61 56.78 4.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.346 2.258 . . . . 0.0 109.095 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -133.22 155.7 48.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.525 1.13 . . . . 0.0 109.589 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.49 153.7 29.51 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.497 1.119 . . . . 0.0 110.865 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -153.78 147.82 25.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.34 10.62 12.13 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.78 23.83 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.207 1.367 . . . . 0.0 112.983 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -55.81 144.7 55.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.406 1.882 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 C-N-CA 124.791 3.66 . . . . 0.0 113.866 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.238 0.448 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.41 163.43 38.61 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 N-CA-C 107.409 -1.804 . . . . 0.0 107.409 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.29 151.39 82.7 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.72 4.95 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.593 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.5 m95 -86.06 157.99 19.93 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.956 1.878 . . . . 0.0 109.124 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -143.14 152.48 41.85 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.091 -0.38 . . . . 0.0 110.092 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -117.73 121.87 41.97 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.338 1.855 . . . . 0.0 108.939 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.34 138.78 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.65 105.08 8.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.411 1.484 . . . . 0.0 109.023 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.0 m -137.83 128.15 26.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 127.681 2.392 . . . . 0.0 108.491 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -63.79 -21.54 66.47 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.095 1.316 . . . . 0.0 112.045 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.88 -21.29 66.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.913 1.685 . . . . 0.0 112.651 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -134.24 -29.28 1.26 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.63 -108.21 2.15 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 127.351 2.405 . . . . 0.0 107.432 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -145.13 125.12 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.442 0.697 . . . . 0.0 110.274 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.32 176.92 8.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -128.39 153.4 47.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.894 1.278 . . . . 0.0 110.64 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.64 135.03 61.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.216 1.006 . . . . 0.0 108.985 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 62.1 t0 -99.8 102.71 14.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 126.578 1.951 . . . . 0.0 108.582 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -70.4 -20.36 62.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.245 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.8 m -75.81 -31.44 59.42 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 120.806 -1.184 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -117.79 -2.6 11.34 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 53.56 46.24 26.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.549 2.339 . . . . 0.0 110.252 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -119.49 167.45 11.94 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.78 51.89 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.089 1.355 . . . . 0.0 108.571 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.78 152.94 27.56 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 110.526 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.23 0.07 54.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -118.23 162.92 17.45 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.287 0.949 . . . . 0.0 112.314 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -65.11 143.94 98.96 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 124.557 1.161 . . . . 0.0 109.09 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 CA--C 1.535 0.565 0 C-N-CA 124.021 3.147 . . . . 0.0 113.462 179.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.65 165.17 33.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.86 1.707 . . . . 0.0 109.029 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.16 146.03 93.95 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.286 1.991 . . . . 0.0 110.518 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.1 -17.7 9.2 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.886 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.59 156.53 22.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 120.159 1.98 . . . . 0.0 109.414 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -140.54 153.44 46.16 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.947 -0.471 . . . . 0.0 110.651 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -121.35 121.43 37.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.8 112.42 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -110.58 130.99 55.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.673 1.189 . . . . 0.0 107.812 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -153.44 -162.61 1.49 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.175 2.59 . . . . 0.0 107.95 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -124.95 -24.09 4.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.948 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -69.83 -25.31 63.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.334 0.97 . . . . 0.0 109.895 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -127.89 -15.62 4.81 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.151 1.78 . . . . 0.0 111.873 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.95 -83.64 1.59 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.424 0.556 . . . . 0.0 113.436 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 87.6 m -156.63 129.12 7.58 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.159 -1.2 . . . . 0.0 110.665 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -142.44 171.15 14.45 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.83 149.46 48.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.378 1.471 . . . . 0.0 107.748 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.68 131.93 59.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.608 0.763 . . . . 0.0 108.956 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -94.73 107.41 19.42 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.095 1.358 . . . . 0.0 109.307 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -65.05 -19.03 65.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -76.02 -38.39 57.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.333 1.453 . . . . 0.0 113.414 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -121.0 2.07 10.43 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp 49.92 39.92 19.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.898 2.079 . . . . 0.0 112.316 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -105.86 156.98 17.81 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.23 143.07 48.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.68 1.192 . . . . 0.0 109.031 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -155.08 161.55 41.27 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.656 -0.652 . . . . 0.0 110.967 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.66 19.16 18.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.626 1.17 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.63 152.41 45.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 119.889 -1.757 . . . . 0.0 109.821 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.84 147.7 98.52 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.065 0.946 . . . . 0.0 109.612 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.461 -0.437 0 C-N-CA 123.5 2.8 . . . . 0.0 115.05 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.7 mt . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.38 166.34 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.894 . . . . 0.0 110.214 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 140.63 82.54 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 106.966 -1.974 . . . . 0.0 106.966 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.82 -9.63 73.41 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.291 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -104.11 156.17 18.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 121.196 2.498 . . . . 0.0 110.161 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -145.2 157.69 44.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.033 0.933 . . . . 0.0 108.958 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -127.23 121.56 31.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.727 2.411 . . . . 0.0 106.534 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.33 149.21 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 125.789 1.636 . . . . 0.0 109.116 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.28 130.44 38.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 0.0 110.036 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -147.88 170.45 17.63 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.091 1.356 . . . . 0.0 110.56 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.1 m -91.15 -42.58 10.37 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.315 -1.49 . . . . 0.0 107.027 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -64.54 -23.84 67.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.984 1.714 . . . . 0.0 112.374 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -129.07 -12.18 4.66 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 -86.4 1.21 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.58 136.78 13.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.461 0.704 . . . . 0.0 110.678 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.81 161.59 41.51 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.604 1.093 . . . . 0.0 109.571 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -116.34 148.09 40.93 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.575 0.75 . . . . 0.0 109.109 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.35 102.48 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.042 1.737 . . . . 0.0 110.342 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -66.04 -18.05 65.09 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.93 -0.481 . . . . 0.0 111.658 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.3 m -73.28 -29.75 62.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.284 0.947 . . . . 0.0 111.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -127.32 -0.96 6.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.63 0.772 . . . . 0.0 112.832 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm 56.75 45.32 22.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.683 1.993 . . . . 0.0 109.899 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -121.79 153.41 38.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.846 0.858 . . . . 0.0 110.684 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.6 143.79 44.44 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.946 1.299 . . . . 0.0 108.881 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -140.01 170.85 15.1 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.909 1.684 . . . . 0.0 109.778 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.6 6.88 20.3 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 161.03 34.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.586 0.63 . . . . 0.0 109.723 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.45 138.91 89.09 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.372 2.715 . . . . 0.0 114.902 -178.413 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.73 168.3 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.939 1.759 . . . . 0.0 109.441 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.26 151.11 86.75 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 -8.11 45.13 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.259 -1.3 . . . . 0.0 112.659 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 20.4 m95 -106.42 153.56 22.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 121.375 2.587 . . . . 0.0 110.039 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.07 157.87 45.2 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.513 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -118.32 131.83 56.31 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.976 2.11 . . . . 0.0 105.676 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.22 144.0 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.86 147.49 52.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m -158.57 158.49 34.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.898 2.079 . . . . 0.0 109.949 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -76.78 -43.41 37.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.685 1.13 . . . . 0.0 111.509 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . 0.433 ' HG3' ' CE1' ' B' ' 26' ' ' PHE . 9.8 pt-20 -67.36 -34.66 77.77 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' B' ' 25' ' ' GLU . 15.1 m-85 -98.71 -34.38 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.93 -98.32 1.98 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -147.32 132.09 17.96 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.627 -0.925 . . . . 0.0 110.892 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -140.97 158.03 44.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.546 0.689 . . . . 0.0 109.212 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.21 145.43 42.43 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.21 137.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 122.662 1.22 . . . . 0.0 110.342 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 26.2 t0 -103.08 102.37 12.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.088 2.955 . . . . 0.0 109.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -75.68 -22.95 56.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.62 0.768 . . . . 0.0 109.643 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 71.6 m -67.24 -18.14 65.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.871 1.269 . . . . 0.0 113.101 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.58 -12.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.537 1.135 . . . . 0.0 111.59 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm 65.07 60.42 0.8 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.826 2.05 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -128.61 164.5 22.74 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.468 1.507 . . . . 0.0 108.036 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.21 146.36 50.75 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -150.55 136.96 18.76 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.545 0.738 . . . . 0.0 109.313 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -80.08 20.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.757 1.623 . . . . 0.0 112.501 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 169.79 17.02 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.207 1.403 . . . . 0.0 110.282 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.23 149.59 97.46 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 0.0 110.461 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.073 179.237 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--O 1.234 0.279 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 14.9 Cg_endo -71.32 155.08 60.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 N-CA-C 109.908 -0.843 . . . . 0.0 109.908 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.48 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 103.789 -3.197 . . . . 0.0 103.789 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.36 -0.41 8.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.391 1.472 . . . . 0.0 110.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.1 m95 -121.08 144.15 48.7 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 119.293 1.546 . . . . 0.0 109.69 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -116.68 150.69 37.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.153 0.981 . . . . 0.0 109.391 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -111.03 136.73 49.6 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.0 t -119.24 124.37 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -117.49 110.91 18.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.637 1.975 . . . . 0.0 108.554 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 p -125.76 171.52 10.59 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.856 1.663 . . . . 0.0 109.958 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -108.47 -23.09 12.01 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.991 -0.443 . . . . 0.0 110.948 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -83.51 -18.74 37.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.056 0.389 . . . . 0.0 111.327 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.82 -61.35 1.51 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.935 1.294 . . . . 0.0 109.078 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.05 -95.4 0.25 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -152.31 132.68 13.71 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 117.933 0.866 . . . . 0.0 111.735 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.77 169.54 19.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.11 152.37 36.63 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.95 131.76 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.082 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.503 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 27.9 t0 -98.0 103.6 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.017 1.727 . . . . 0.0 109.976 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -18.4 65.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -77.84 -35.65 50.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.194 0.906 . . . . 0.0 112.788 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -118.86 4.4 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.033 0.833 . . . . 0.0 113.177 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 53.72 47.31 24.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.642 1.177 . . . . 0.0 110.854 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -120.2 142.59 48.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.493 1.117 . . . . 0.0 111.365 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.72 138.88 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -149.33 146.49 27.55 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 120.063 1.301 . . . . 0.0 113.547 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.85 3.21 46.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.833 1.653 . . . . 0.0 112.098 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.03 143.57 48.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.327 1.451 . . . . 0.0 108.319 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -62.08 142.13 95.57 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 125.71 1.604 . . . . 0.0 110.7 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.907 2.405 . . . . 0.0 111.434 179.016 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.7 mt . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 119.747 -0.168 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.29 168.15 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.944 1.763 . . . . 0.0 110.334 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.72 133.21 35.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.899 2.399 . . . . 0.0 108.768 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.63 -18.91 56.19 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.628 1.109 . . . . 0.0 111.96 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 21.9 m95 -93.06 132.55 37.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.199 1.5 . . . . 0.0 108.39 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.8 159.77 35.51 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.54 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -121.16 120.96 36.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.04 133.68 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.62 150.08 46.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -149.29 175.52 11.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 59.2 m -108.1 -12.85 15.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -93.9 -19.65 20.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.99 -53.16 0.8 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.14 -134.81 5.38 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 105.993 -2.843 . . . . 0.0 105.993 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.7 m -130.78 138.28 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.299 1.04 . . . . 0.0 110.19 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -147.18 178.75 8.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.131 0.972 . . . . 0.0 110.022 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -118.19 155.39 30.58 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.102 0.961 . . . . 0.0 110.371 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.53 135.26 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.002 0.921 . . . . 0.0 108.566 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.2 t0 -103.98 105.52 15.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.67 -20.21 64.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.892 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 39.9 m -74.31 -34.89 63.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.629 0.772 . . . . 0.0 111.793 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.87 -9.92 11.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm 60.72 49.93 5.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.177 1.791 . . . . 0.0 109.195 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -121.65 160.7 23.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.81 1.244 . . . . 0.0 109.109 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.95 139.98 50.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -149.73 137.78 20.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -77.97 -2.83 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -108.65 156.62 19.35 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.458 1.103 . . . . 0.0 109.78 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . 0.427 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 52.2 t-80 -69.76 149.33 96.7 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.931 0.893 . . . . 0.0 108.751 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 72.4 Cg_endo . . . . . 0 CA--C 1.54 0.822 0 C-N-CA 124.709 3.606 . . . . 0.0 115.813 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 C--O 1.233 0.235 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.24 157.98 59.49 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.437 1.425 . . . . 0.0 109.91 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.86 116.52 4.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.347 2.698 . . . . 0.0 107.359 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.18 -9.75 10.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.592 1.567 . . . . 0.0 111.582 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 23.1 m95 -107.36 163.8 12.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.531 1.166 . . . . 0.0 109.878 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -147.49 153.28 39.32 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.07 0.948 . . . . 0.0 109.775 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -118.43 121.01 39.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.15 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.15 92.12 3.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -127.87 151.96 48.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.788 1.235 . . . . 0.0 110.304 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 m -89.34 -29.53 19.06 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.769 0.827 . . . . 0.0 111.225 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.01 -38.45 88.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.289 0.636 . . . . 0.0 111.74 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -117.27 -40.61 3.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 -170.74 15.47 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.8 m -84.48 117.48 23.7 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.191 1.796 . . . . 0.0 107.892 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.439 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 50.6 p90 -136.36 -179.91 5.97 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 109.976 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -131.51 156.15 46.19 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.181 -0.95 . . . . 0.0 111.322 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.96 143.5 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.622 1.169 . . . . 0.0 109.106 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 23.8 t0 -106.17 118.78 37.51 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 127.39 2.276 . . . . 0.0 110.064 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -74.68 -21.73 59.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.915 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -65.24 -41.56 94.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 112.579 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.97 -1.87 8.78 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.278 1.431 . . . . 0.0 113.971 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 57.78 46.78 16.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 110.453 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -116.2 139.7 50.07 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.92 152.17 23.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.74 163.38 39.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.018 -1.051 . . . . 0.0 110.981 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -105.39 18.95 21.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.458 1.903 . . . . 0.0 111.846 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 154.12 51.84 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.246 -1.533 . . . . 0.0 110.948 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.65 136.67 96.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 123.918 3.079 . . . . 0.0 114.289 -179.13 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 C--O 1.235 0.301 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.54 155.76 58.95 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.627 2.218 . . . . 0.0 109.084 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.13 94.53 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.379 3.386 . . . . 0.0 109.356 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.57 -7.56 1.53 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.334 1.445 . . . . 0.0 111.509 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -108.56 156.46 19.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.895 0.878 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 5.5 tp10 -129.91 155.74 45.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.595 0.758 . . . . 0.0 109.641 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -129.39 121.66 27.83 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.92 142.76 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.16 111.3 10.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 57.7 m -134.01 141.82 47.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.462 1.505 . . . . 0.0 111.407 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -70.01 -25.5 63.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.536 1.062 . . . . 0.0 111.104 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.41 -26.72 63.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.199 -0.905 . . . . 0.0 113.176 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.18 -23.68 2.41 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -107.74 1.66 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.383 1.944 . . . . 0.0 111.82 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 54.5 m -141.85 132.43 25.41 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.488 1.915 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -150.83 174.82 12.64 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.95 0.795 . . . . 0.0 109.771 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -124.93 154.34 41.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.06 0.944 . . . . 0.0 110.511 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.94 143.08 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.601 1.16 . . . . 0.0 109.446 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -106.91 143.21 35.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.951 1.7 . . . . 0.0 108.256 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -105.87 2.21 27.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.136 1.374 . . . . 0.0 111.26 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -91.62 -38.5 12.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.04 1.736 . . . . 0.0 112.658 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -132.25 6.06 4.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.945 2.098 . . . . 0.0 113.145 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt 51.03 52.05 15.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.703 1.601 . . . . 0.0 111.822 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -110.57 150.51 28.85 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.46 146.85 49.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -155.49 172.42 18.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.725 1.148 . . . . 0.0 112.084 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -113.54 13.23 18.75 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 0.0 111.589 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 161.11 23.35 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -70.06 150.84 96.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.102 0.864 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.541 0.844 0 C-N-CA 122.874 2.383 . . . . 0.0 111.827 179.537 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--O 1.234 0.25 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.94 164.11 31.06 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.696 2.264 . . . . 0.0 110.894 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.02 127.97 19.65 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.119 1.879 . . . . 0.0 108.057 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.38 -20.98 31.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.294 0.949 . . . . 0.0 111.567 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.416 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 17.9 m95 -91.98 154.97 18.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.278 1.539 . . . . 0.0 108.171 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -142.07 146.24 35.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -107.25 126.86 52.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.303 1.841 . . . . 0.0 107.293 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.71 117.19 54.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -102.3 137.45 40.54 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.457 1.503 . . . . 0.0 107.829 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -149.44 178.96 8.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.911 0.884 . . . . 0.0 111.688 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.9 m -106.0 -11.05 16.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 0.0 111.412 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -104.41 -47.45 4.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.35 0.595 . . . . 0.0 110.669 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -91.93 -8.27 46.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.078 1.351 . . . . 0.0 113.108 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.17 -88.56 1.19 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.74 134.27 10.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.33 176.48 9.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -134.56 159.79 40.08 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.85 133.41 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.331 0.652 . . . . 0.0 110.284 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 14.9 t0 -92.56 108.37 19.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.893 2.477 . . . . 0.0 107.275 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -68.98 -28.15 66.36 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 122.12 -0.362 . . . . 0.0 111.948 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.5 m -69.6 -44.76 70.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.113 0.965 . . . . 0.0 111.892 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -103.45 -8.2 20.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.389 1.076 . . . . 0.0 113.696 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 55.74 60.81 3.09 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.653 1.581 . . . . 0.0 108.901 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -136.44 154.65 50.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.842 1.257 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.46 149.51 36.2 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -153.29 160.1 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.652 0.781 . . . . 0.0 111.413 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -108.0 13.66 25.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 0.0 113.219 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 160.38 29.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.931 1.292 . . . . 0.0 108.753 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.7 139.93 91.58 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.349 0.591 0 C-N-CA 124.964 3.776 . . . . 0.0 114.858 -178.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--O 1.234 0.247 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.37 158.06 51.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.235 1.956 . . . . 0.0 109.764 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.13 103.64 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.376 3.384 . . . . 0.0 109.983 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.99 3.52 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.004 1.764 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.181 -1.188 . . . . 0.0 109.151 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.24 155.07 44.42 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.233 0.54 . . . . 0.0 110.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -116.99 136.82 52.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 128.071 2.549 . . . . 0.0 105.365 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.38 143.95 27.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -128.16 137.18 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 m -154.44 -172.64 4.28 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.111 1.764 . . . . 0.0 110.508 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -105.21 -59.22 1.78 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -60.69 -18.04 51.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 114.192 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.72 -12.77 5.98 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.584 1.154 . . . . 0.0 114.06 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.64 -92.02 0.78 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.463 1.982 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.19 127.5 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.133 -0.627 . . . . 0.0 111.61 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -141.85 174.07 10.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.616 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.82 146.87 50.8 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.383 -1.448 . . . . 0.0 110.768 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.86 136.79 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.024 1.329 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -97.44 112.82 24.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.471 1.908 . . . . 0.0 106.328 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -22.57 53.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.899 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -67.08 -53.18 33.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.01 1.277 . . . . 0.0 111.746 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.78 -4.04 31.44 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.353 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm 56.55 58.14 4.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.533 1.533 . . . . 0.0 107.072 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -119.66 169.6 9.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.175 1.39 . . . . 0.0 109.693 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.65 146.39 50.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.245 1.018 . . . . 0.0 110.43 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.45 167.67 21.64 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.937 1.295 . . . . 0.0 109.487 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.7 4.88 18.85 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.045 0.938 . . . . 0.0 113.153 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.08 176.36 8.14 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.96 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -71.54 141.54 85.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 CA--C 1.538 0.682 0 C-N-CA 123.16 2.573 . . . . 0.0 114.733 -178.706 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.67 159.51 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.066 2.511 . . . . 0.0 110.773 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.79 117.6 5.12 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.971 2.448 . . . . 0.0 107.038 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.58 -20.76 8.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.317 1.437 . . . . 0.0 112.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.5 m95 -90.99 157.43 17.29 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 119.793 1.796 . . . . 0.0 110.005 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -135.03 145.15 47.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -118.53 130.53 55.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.57 139.4 47.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 140.29 49.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.594 1.958 . . . . 0.0 106.761 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.45 150.87 20.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.26 1.024 . . . . 0.0 108.374 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -74.27 -24.1 59.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.743 1.156 . . . . 0.0 110.35 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.43 -39.03 28.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.418 1.087 . . . . 0.0 113.732 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -109.55 -9.23 14.91 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.106 . . . . 0.0 113.528 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.32 -88.82 1.1 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 126.404 1.954 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 m -152.98 119.77 5.71 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.54 168.13 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.948 0.899 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -125.48 139.54 53.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.364 1.066 . . . . 0.0 109.695 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.12 131.87 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.02 0.928 . . . . 0.0 110.08 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.6 t0 -91.24 121.85 33.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 127.144 2.178 . . . . 0.0 108.836 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -85.97 -9.87 56.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.988 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -73.07 -43.56 61.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.794 1.179 . . . . 0.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -120.49 2.92 10.76 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.96 1.304 . . . . 0.0 112.871 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 56.59 45.84 21.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 110.973 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -117.21 138.6 51.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.28 20.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -151.91 164.95 36.04 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.322 1.058 . . . . 0.0 110.482 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.427 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 51.7 m-85 -107.76 26.4 10.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.8 1.64 . . . . 0.0 111.204 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -140.55 160.96 38.86 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -74.61 141.5 76.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.586 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 N--CA 1.458 -0.593 0 C-N-CA 122.438 2.092 . . . . 0.0 112.444 -179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.04 157.53 57.6 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.234 1.29 . . . . 0.0 110.373 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.12 125.25 13.78 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.648 2.232 . . . . 0.0 106.349 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.92 -10.84 27.34 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.779 1.657 . . . . 0.0 110.75 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.434 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 27.7 m95 -113.04 148.98 34.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.897 1.349 . . . . 0.0 109.695 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -139.3 155.83 47.46 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.927 0.767 . . . . 0.0 109.779 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -116.15 138.69 51.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.731 1.612 . . . . 0.0 108.257 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.59 139.58 42.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.43 133.26 46.21 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -149.02 172.03 15.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.885 1.274 . . . . 0.0 113.685 -175.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m -84.93 -32.48 23.07 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.541 1.137 . . . . 0.0 113.921 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -100.89 -12.03 19.31 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.464 1.106 . . . . 0.0 112.667 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -116.86 -21.08 9.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.315 1.046 . . . . 0.0 111.57 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.61 -89.97 1.34 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 24.1 m -156.74 129.16 7.52 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.082 -1.246 . . . . 0.0 109.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -138.45 174.75 10.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -130.53 143.03 50.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 22.2 t -119.19 131.78 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 12.2 t0 -92.66 109.32 20.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.57 -11.83 60.3 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.662 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.7 m -66.84 -41.25 87.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.498 1.499 . . . . 0.0 110.572 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.02 1.73 8.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.427 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 46.1 mmtm 59.39 51.75 6.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.756 1.222 . . . . 0.0 109.466 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -122.68 146.05 47.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.57 131.36 54.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -134.68 157.89 45.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.492 1.117 . . . . 0.0 108.291 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -104.26 3.21 32.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -105.04 156.04 18.42 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.826 1.65 . . . . 0.0 109.107 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -69.13 149.61 97.6 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-O 117.541 -1.219 . . . . 0.0 107.966 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.456 -0.695 0 CA-C-N 121.352 1.519 . . . . 0.0 110.276 -179.765 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 C--O 1.236 0.344 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.21 164.97 31.95 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.601 1.534 . . . . 0.0 109.982 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.69 149.03 78.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 N-CA-C 105.698 -2.462 . . . . 0.0 105.698 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.72 -11.43 70.32 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -111.7 136.18 51.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.431 1.615 . . . . 0.0 107.405 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.6 152.09 37.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 0.0 110.388 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -115.68 120.51 39.6 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.1 t -104.53 138.53 28.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.98 129.09 50.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.965 1.306 . . . . 0.0 107.816 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -147.76 169.22 20.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.812 2.045 . . . . 0.0 108.213 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -105.7 -23.89 12.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -78.16 -35.1 49.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -96.5 -69.65 0.75 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.978 1.311 . . . . 0.0 108.851 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.97 -132.75 6.27 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 104.316 -3.514 . . . . 0.0 104.316 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.97 132.14 54.46 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 109.421 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -141.71 166.51 24.52 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.512 0.725 . . . . 0.0 109.682 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -122.55 139.64 53.68 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 111.035 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.61 148.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -108.08 113.03 25.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.214 1.806 . . . . 0.0 111.963 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -21.08 64.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.695 0.679 . . . . 0.0 111.748 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -73.63 -30.85 63.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.17 0.988 . . . . 0.0 113.045 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -129.13 -1.09 5.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' CE ' ' CE2' ' B' ' 40' ' ' TYR . 17.6 mmtp 59.06 46.7 12.99 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.679 1.192 . . . . 0.0 110.616 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -125.35 146.41 49.59 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.635 -0.665 . . . . 0.0 110.78 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.19 142.11 36.42 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 107.858 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -148.83 161.48 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 108.833 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -106.99 14.17 26.74 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.948 0.899 . . . . 0.0 111.002 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -118.51 160.29 22.01 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 120.97 -1.081 . . . . 0.0 110.744 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.88 133.83 88.09 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.947 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.54 0.799 0 C-N-CA 124.362 3.374 . . . . 0.0 115.398 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 74.8 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.2 157.19 62.94 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.042 1.828 . . . . 0.0 109.407 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.18 93.34 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.573 3.515 . . . . 0.0 111.64 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.36 -19.65 2.26 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.279 1.419 . . . . 0.0 111.153 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 18.6 m95 -94.43 149.89 20.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -131.74 141.09 49.43 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.07 0.548 . . . . 0.0 109.788 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -107.48 121.83 45.41 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.0 t -110.91 141.53 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -130.18 150.23 51.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 m -154.87 -165.63 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.115 1.366 . . . . 0.0 109.435 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.0 m -115.43 -45.16 2.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.07 0.948 . . . . 0.0 108.957 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.79 -14.73 62.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.989 0.516 . . . . 0.0 110.559 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.61 -25.63 4.32 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.69 1.596 . . . . 0.0 113.192 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.79 -86.61 1.55 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.9 m -159.61 140.06 12.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.121 1.46 . . . . 0.0 110.577 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.64 176.34 9.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.414 -0.804 . . . . 0.0 109.689 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.34 151.9 50.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 108.931 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.5 t -128.32 136.6 59.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.217 1.007 . . . . 0.0 109.136 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.414 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.3 t0 -101.53 104.08 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.978 1.311 . . . . 0.0 108.879 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.24 -19.89 66.18 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.795 -0.565 . . . . 0.0 111.26 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.45 -33.16 69.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.682 1.593 . . . . 0.0 112.661 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -126.78 0.75 6.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 54.57 36.99 27.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -111.75 161.16 16.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.37 148.44 48.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.986 0.914 . . . . 0.0 108.587 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.42 168.51 26.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.82 1.248 . . . . 0.0 110.118 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.502 ' CE2' ' CE ' ' A' ' 36' ' ' LYS . 69.2 m-85 -105.36 -1.02 25.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.8 167.88 9.5 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.064 -1.023 . . . . 0.0 111.233 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.29 149.89 89.35 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 C-N-CA 123.447 2.765 . . . . 0.0 115.436 -178.216 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.6 mt . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.56 162.39 42.36 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.119 1.879 . . . . 0.0 110.705 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 121.22 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.12 2.546 . . . . 0.0 110.41 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.42 47.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.315 1.435 . . . . 0.0 112.904 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.2 m95 -92.2 151.09 20.54 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.454 1.627 . . . . 0.0 108.151 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.02 154.74 47.87 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.557 1.143 . . . . 0.0 109.919 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -125.87 124.86 41.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t -108.33 115.03 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 108.426 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.67 128.27 44.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.5 m -139.94 -173.72 3.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.575 1.15 . . . . 0.0 109.885 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -116.45 -43.96 2.9 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.853 1.261 . . . . 0.0 108.801 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.55 -18.81 62.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.928 0.891 . . . . 0.0 112.695 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -128.17 -19.28 3.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.3 -100.24 1.79 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -157.95 139.58 13.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.493 0.717 . . . . 0.0 109.641 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -146.31 170.57 16.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -119.33 152.79 36.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.576 1.55 . . . . 0.0 107.59 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.44 135.33 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.204 0.601 . . . . 0.0 110.321 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 20.4 t0 -101.53 106.19 17.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.248 1.419 . . . . 0.0 108.176 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.94 -13.87 61.76 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.561 -0.712 . . . . 0.0 111.233 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.5 m -75.11 -39.12 60.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.88 1.218 . . . . 0.0 112.528 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -124.25 8.12 8.5 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm 54.18 53.72 10.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.421 1.488 . . . . 0.0 109.414 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -121.97 134.93 54.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.792 1.637 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 135.35 39.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.318 1.447 . . . . 0.0 107.621 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -139.07 153.63 48.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.848 1.204 . . . . 0.0 113.227 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -96.96 15.81 21.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.891 1.276 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 158.44 43.99 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 119.955 -1.716 . . . . 0.0 109.742 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -58.37 141.71 82.71 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 124.391 1.057 . . . . 0.0 110.726 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.451 -0.999 0 C-N-CA 122.743 2.295 . . . . 0.0 109.306 178.624 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.238 0.475 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -69.06 163.35 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.914 1.742 . . . . 0.0 109.336 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.0 137.79 49.99 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.31 74.24 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.635 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -114.3 142.03 46.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 121.171 2.486 . . . . 0.0 109.094 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -125.32 157.68 36.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.647 0.779 . . . . 0.0 110.553 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -128.05 125.04 38.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.469 2.308 . . . . 0.0 106.906 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.51 133.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.96 119.06 35.94 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 65.1 m -138.51 158.46 44.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.462 1.105 . . . . 0.0 109.738 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -84.81 -39.55 18.22 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.695 -1.253 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.26 -16.24 59.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -124.83 -13.04 7.01 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.91 -94.66 1.99 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.998 1.761 . . . . 0.0 110.543 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -151.91 135.83 16.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.037 -0.684 . . . . 0.0 110.47 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -148.54 167.79 24.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.22 155.05 37.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 108.337 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.9 139.31 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.889 0.852 . . . . 0.0 109.236 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -100.61 102.47 13.62 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 128.533 2.733 . . . . 0.0 106.938 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -20.19 64.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.535 0.607 . . . . 0.0 112.413 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -71.86 -36.88 70.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.375 0.989 . . . . 0.0 110.7 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -116.82 -1.47 12.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 58.02 53.52 6.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.027 1.331 . . . . 0.0 108.285 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -123.41 147.38 47.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.702 0.401 . . . . 0.0 110.016 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.85 136.23 48.76 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 150.41 40.74 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.856 0.753 . . . . 0.0 110.376 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -88.73 1.32 55.35 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 156.5 33.61 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.583 1.153 . . . . 0.0 110.169 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -64.48 146.42 98.09 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 -179.074 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.62 168.66 23.27 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.575 2.184 . . . . 0.0 109.105 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.9 149.88 72.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 -11.44 44.51 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.554 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -99.68 151.8 20.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.475 1.638 . . . . 0.0 106.619 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -135.63 151.98 50.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.922 0.489 . . . . 0.0 110.004 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -111.14 129.72 55.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.31 143.97 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.33 149.88 51.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -155.31 148.96 25.28 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.401 1.08 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -76.23 -19.48 58.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -85.37 -20.09 30.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.337 1.055 . . . . 0.0 113.209 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.53 -46.0 1.77 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.67 -109.39 1.1 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -138.56 129.23 26.37 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -144.69 163.21 34.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.75 149.03 39.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 111.444 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.14 142.49 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.492 0.717 . . . . 0.0 109.744 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 119.44 39.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 127.907 2.483 . . . . 0.0 108.844 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -84.61 -20.97 30.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -76.84 -31.98 57.25 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.284 1.034 . . . . 0.0 110.085 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -117.38 -9.42 10.9 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp 56.86 50.46 12.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.07 1.348 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -126.05 160.19 30.74 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.661 0.785 . . . . 0.0 110.287 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.77 139.5 53.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.376 1.471 . . . . 0.0 109.37 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -153.9 144.68 22.57 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.631 1.173 . . . . 0.0 108.688 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -91.25 24.41 2.92 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.46 0.704 . . . . 0.0 109.845 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 154.28 47.99 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.573 -1.329 . . . . 0.0 111.036 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.95 143.99 98.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 C-N-CA 122.845 2.364 . . . . 0.0 116.658 -178.896 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--O 1.233 0.186 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.48 166.91 27.89 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.923 2.415 . . . . 0.0 110.291 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.67 118.63 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.703 2.268 . . . . 0.0 109.975 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.5 -11.96 33.12 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.181 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 32.2 m95 -100.54 150.43 22.68 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 119.303 1.551 . . . . 0.0 108.373 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.02 168.03 19.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 108.669 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -133.06 121.34 22.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.116 1.366 . . . . 0.0 108.585 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.76 107.98 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 124.168 0.917 . . . . 0.0 109.221 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -95.48 133.36 39.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.3 m -155.78 -177.64 6.71 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.006 -1.684 . . . . 0.0 110.833 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -102.68 -44.75 5.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.806 0.843 . . . . 0.0 111.896 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.74 -11.85 59.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.69 -19.86 3.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.17 -105.33 3.26 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -144.96 124.19 12.95 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.909 0.484 . . . . 0.0 110.905 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.45 178.51 7.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.373 1.069 . . . . 0.0 108.838 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.35 155.57 47.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.557 1.143 . . . . 0.0 109.767 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.4 131.58 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.473 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 51.7 t0 -98.82 104.66 16.72 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -70.06 -21.95 63.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.843 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 90.3 m -67.7 -45.19 75.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.837 1.653 . . . . 0.0 110.823 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -106.63 1.11 24.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.81 0.844 . . . . 0.0 112.424 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp 49.85 54.73 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.756 2.022 . . . . 0.0 110.611 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -119.62 167.39 12.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.089 0.956 . . . . 0.0 109.168 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 143.32 50.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -155.05 149.43 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.896 0.878 . . . . 0.0 108.968 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -90.98 -8.76 48.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.226 1.01 . . . . 0.0 110.14 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -93.56 152.4 19.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 124.539 1.136 . . . . 0.0 108.584 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . 0.405 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 42.5 t-80 -67.26 151.33 97.26 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.61 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 92.0 Cg_endo . . . . . 0 C--N 1.348 0.542 0 N-CA-C 117.357 2.022 . . . . 0.0 117.357 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 40.5 Cg_endo -72.09 164.55 35.31 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.405 1.403 . . . . 0.0 109.304 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.18 134.65 40.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.57 1.513 . . . . 0.0 108.919 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.68 -10.8 72.19 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 117.615 -1.659 . . . . 0.0 114.216 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.42 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.2 m95 -93.91 168.18 11.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.147 1.973 . . . . 0.0 109.181 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -140.95 156.27 46.1 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.608 0.763 . . . . 0.0 109.986 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -125.04 129.99 51.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.68 132.74 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.32 139.61 41.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -142.84 -172.41 3.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.8 2.44 . . . . 0.0 109.819 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -126.28 -38.86 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.535 1.934 . . . . 0.0 107.594 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -34.8 71.24 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -113.33 -17.11 12.37 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.76 -85.7 1.51 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -157.63 146.03 19.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.343 1.072 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -154.63 166.99 31.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.296 0.638 . . . . 0.0 109.606 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.0 144.98 45.09 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.78 142.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.823 0.849 . . . . 0.0 110.261 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -107.43 112.55 25.4 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 127.255 2.222 . . . . 0.0 109.498 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -74.22 -22.37 59.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.767 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.4 m -69.53 -34.1 73.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.59 1.086 . . . . 0.0 112.148 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -121.92 1.84 9.9 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.341 0.656 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HE3' ' CE1' ' B' ' 40' ' ' TYR . 34.9 mmtm 51.15 52.5 14.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.983 1.713 . . . . 0.0 108.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -121.75 154.84 36.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.664 0.786 . . . . 0.0 108.984 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.83 140.95 51.03 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.67 1.188 . . . . 0.0 108.371 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -150.22 147.28 27.51 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.522 -0.736 . . . . 0.0 110.527 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.31 -13.28 52.87 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.365 1.466 . . . . 0.0 112.965 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.69 144.01 27.1 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.481 1.912 . . . . 0.0 107.158 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -68.05 142.14 94.91 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 CA--C 1.536 0.612 0 C-N-CA 123.822 3.015 . . . . 0.0 112.591 179.543 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt . . . . . 0 C--O 1.237 0.41 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.25 164.0 35.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.59 2.194 . . . . 0.0 112.773 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.74 130.69 26.95 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 105.282 -2.622 . . . . 0.0 105.282 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.2 -1.83 56.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.532 -1.705 . . . . 0.0 113.283 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.431 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 16.0 m95 -117.18 165.98 12.79 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.226 2.013 . . . . 0.0 111.467 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -152.1 150.89 30.41 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.116 0.966 . . . . 0.0 109.153 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -104.59 149.46 25.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.04 114.43 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -105.9 145.94 30.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -156.22 -168.14 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.639 1.175 . . . . 0.0 109.364 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -120.6 -44.07 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.478 1.911 . . . . 0.0 107.954 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -63.88 -25.12 68.01 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.325 1.05 . . . . 0.0 113.263 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.01 -33.15 3.38 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.2 -104.51 1.35 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -150.24 136.47 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -151.09 -175.3 5.1 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -132.35 155.77 47.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.093 1.357 . . . . 0.0 109.43 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.61 133.63 61.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.431 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 57.2 t0 -97.06 111.51 23.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.166 1.787 . . . . 0.0 110.587 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -70.75 -18.75 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.436 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -67.52 -37.03 82.16 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.947 1.699 . . . . 0.0 112.377 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -127.13 3.96 6.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.585 0.754 . . . . 0.0 112.724 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 53.4 42.85 31.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.216 1.806 . . . . 0.0 110.878 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -113.97 161.37 17.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.03 146.92 46.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -158.06 155.6 29.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.321 1.048 . . . . 0.0 109.126 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . 0.41 ' CE1' ' HE3' ' A' ' 36' ' ' LYS . 75.5 m-85 -95.04 -4.2 46.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.568 1.147 . . . . 0.0 112.574 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.85 140.5 37.05 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . 0.469 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 61.1 t-80 -59.24 151.89 55.77 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 124.411 1.085 . . . . 0.0 109.672 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 87.0 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 C-N-CA 122.121 1.88 . . . . 0.0 110.283 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.65 163.54 36.59 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 107.965 -1.59 . . . . 0.0 107.965 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.1 149.99 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.23 -21.47 10.18 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.83 1.205 . . . . 0.0 112.64 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -88.12 143.54 27.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.759 1.78 . . . . 0.0 107.74 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HG2' ' HH ' ' B' ' 29' ' ' TYR . 8.4 tp10 -117.33 151.6 36.66 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.609 0.764 . . . . 0.0 111.011 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -117.71 119.42 34.89 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.32 145.12 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.15 139.79 52.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -157.48 132.27 8.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.216 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -59.64 -33.74 71.91 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.166 1.348 . . . . 0.0 112.512 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -16.5 61.64 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.96 -30.72 1.35 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.05 -94.15 0.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 126.647 2.07 . . . . 0.0 108.575 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.64 133.78 16.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -143.5 143.65 31.65 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.659 1.118 . . . . 0.0 109.739 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -96.87 156.48 16.33 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.261 -0.899 . . . . 0.0 109.806 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.16 142.17 44.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -105.2 108.69 20.34 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 127.344 2.258 . . . . 0.0 107.426 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -25.54 62.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.7 m -70.8 -41.43 71.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.235 1.014 . . . . 0.0 110.815 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -105.97 -10.01 16.8 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.935 0.894 . . . . 0.0 113.003 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 56.24 59.4 3.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.26 1.824 . . . . 0.0 107.198 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -126.4 166.69 16.72 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.895 1.678 . . . . 0.0 109.238 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.13 145.66 50.89 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.1 1.36 . . . . 0.0 107.414 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.14 163.79 36.57 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.268 -0.895 . . . . 0.0 112.448 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.6 19.07 20.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.915 1.686 . . . . 0.0 112.878 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 152.28 43.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.737 -1.227 . . . . 0.0 109.911 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.37 140.63 91.7 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.843 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 N--CA 1.453 -0.862 0 C-N-CA 123.629 2.886 . . . . 0.0 111.852 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.238 0.473 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.89 162.32 42.59 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.204 1.936 . . . . 0.0 109.131 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.53 139.77 72.06 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.574 -1.741 . . . . 0.0 107.574 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.14 73.05 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.413 -1.77 . . . . 0.0 112.588 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.434 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 11.4 m95 -101.62 157.49 16.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 120.434 2.117 . . . . 0.0 108.396 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -146.01 147.39 31.6 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.83 -0.544 . . . . 0.0 110.296 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.67 135.95 44.28 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.5 120.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.302 1.041 . . . . 0.0 109.1 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -111.76 136.93 50.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -143.44 135.65 26.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.606 1.562 . . . . 0.0 108.901 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.9 m -66.8 -28.52 68.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 120.61 1.55 . . . . 0.0 111.422 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.69 -21.5 57.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.76 -22.6 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.13 -98.37 1.22 Allowed Glycine 0 CA--C 1.519 0.339 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.2 m -158.17 145.55 18.11 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.232 1.013 . . . . 0.0 108.501 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.472 ' HH ' ' HG2' ' A' ' 19' ' ' GLU . 54.7 p90 -152.51 178.28 9.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.16 1.784 . . . . 0.0 106.623 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -128.26 158.08 39.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 66.1 t -132.08 131.43 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 59.7 t0 -91.61 103.86 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 127.435 2.294 . . . . 0.0 107.669 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -27.14 67.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.87 0.759 . . . . 0.0 111.877 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 63.1 m -69.13 -24.48 64.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.113 0.965 . . . . 0.0 112.535 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -126.72 -2.47 6.65 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.53 0.732 . . . . 0.0 112.752 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 51.06 52.22 15.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.946 2.098 . . . . 0.0 110.301 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -127.5 160.72 30.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.66 -0.65 . . . . 0.0 109.724 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.36 139.93 50.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.352 1.061 . . . . 0.0 110.179 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.15 159.78 42.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.459 1.104 . . . . 0.0 109.977 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -100.25 15.15 28.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.085 1.354 . . . . 0.0 114.071 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.07 151.7 51.52 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.21 -1.556 . . . . 0.0 110.829 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -60.41 143.73 89.2 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.883 0.873 . . . . 0.0 109.891 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 122.809 2.339 . . . . 0.0 112.55 179.813 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 C--O 1.235 0.311 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.2 164.42 35.69 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.794 1.663 . . . . 0.0 109.727 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.02 117.26 4.93 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.175 2.583 . . . . 0.0 109.906 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.81 7.92 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.158 1.837 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -88.95 136.66 32.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.397 -1.06 . . . . 0.0 109.705 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -119.68 139.95 51.42 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.284 1.033 . . . . 0.0 110.19 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -108.75 120.75 43.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.9 140.12 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -125.97 118.17 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.114 -2.551 . . . . 0.0 104.114 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m -140.86 170.62 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.526 1.131 . . . . 0.0 111.176 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -85.03 -65.14 1.04 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -60.43 -16.51 36.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.508 1.923 . . . . 0.0 114.911 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.15 -14.59 7.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.509 1.124 . . . . 0.0 112.45 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.38 -85.66 0.93 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 125.242 1.401 . . . . 0.0 111.759 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.83 136.43 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.249 -1.148 . . . . 0.0 109.497 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -149.03 175.21 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.565 1.075 . . . . 0.0 110.057 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -123.99 149.21 46.27 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.878 0.871 . . . . 0.0 109.82 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.79 143.06 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.683 1.193 . . . . 0.0 109.073 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.71 112.95 26.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.862 2.065 . . . . 0.0 105.599 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' ND1' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -74.17 -23.67 59.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -68.66 -36.83 79.06 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.854 0.862 . . . . 0.0 112.307 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.73 -3.57 11.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.121 . . . . 0.0 112.317 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HE3' ' ND1' ' A' ' 33' ' ' HIS . 6.9 mmtp 58.17 51.99 8.0 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.943 1.697 . . . . 0.0 109.78 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -118.23 161.86 19.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.463 0.705 . . . . 0.0 110.497 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.62 148.72 46.17 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.45 155.86 37.09 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.216 0.607 . . . . 0.0 111.223 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -95.58 27.28 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.594 1.558 . . . . 0.0 111.538 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -142.78 146.69 34.49 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 119.799 -1.813 . . . . 0.0 109.682 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.72 141.75 94.92 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.453 -0.903 0 C-N-CA 122.956 2.437 . . . . 0.0 116.476 -178.029 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 57.0 mt . . . . . 0 C--O 1.232 0.159 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.68 160.09 50.96 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.304 2.003 . . . . 0.0 112.553 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 84.95 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.784 3.656 . . . . 0.0 110.07 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.7 4.73 0.28 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.837 2.16 . . . . 0.0 112.162 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -124.71 157.78 34.84 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.27 155.9 44.05 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 122.047 -0.408 . . . . 0.0 109.933 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.17 121.84 46.01 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.538 1.535 . . . . 0.0 107.547 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.83 131.71 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.84 126.5 47.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.1 m -147.88 -176.0 5.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 110.767 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m -112.55 -29.88 7.32 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 110.004 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -79.07 -14.57 59.07 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.793 -0.567 . . . . 0.0 109.669 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -130.71 -19.5 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.97 -92.74 1.71 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.613 1.101 . . . . 0.0 111.093 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -151.41 131.2 13.22 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.811 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -148.75 172.57 14.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -120.73 156.6 31.46 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.919 -0.488 . . . . 0.0 110.606 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.51 140.04 49.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -101.37 112.75 25.37 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.572 2.349 . . . . 0.0 108.733 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -76.54 -13.09 60.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -88.96 -22.88 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 111.66 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -123.79 -5.62 8.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.505 0.722 . . . . 0.0 111.461 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp 51.76 52.73 13.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.23 1.812 . . . . 0.0 111.724 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -132.75 153.55 51.09 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.504 0.722 . . . . 0.0 109.459 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.91 153.97 21.22 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 108.584 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -158.96 151.91 22.16 Favored 'General case' 0 C--N 1.334 -0.071 0 O-C-N 121.608 -0.682 . . . . 0.0 111.107 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -95.45 27.63 3.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.002 1.321 . . . . 0.0 112.082 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 147.05 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 119.891 -1.755 . . . . 0.0 108.432 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -64.95 142.19 98.58 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 119.036 -0.507 . . . . 0.0 109.765 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 123.256 2.638 . . . . 0.0 114.056 -179.671 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.83 164.86 34.34 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.282 1.988 . . . . 0.0 110.205 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.98 124.04 11.36 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.543 2.162 . . . . 0.0 108.457 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.17 -12.08 33.96 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.723 1.154 . . . . 0.0 111.736 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -104.13 150.93 23.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.646 1.223 . . . . 0.0 108.608 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -144.09 156.8 44.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.105 0.962 . . . . 0.0 108.613 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -116.04 122.0 43.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.561 1.545 . . . . 0.0 107.055 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.78 127.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.03 116.03 22.16 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.9 m -140.46 155.23 46.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 111.709 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.5 m -76.71 -20.25 56.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.85 -1.157 . . . . 0.0 112.937 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -83.09 -53.63 5.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.8 0.727 . . . . 0.0 111.405 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.74 -11.85 30.5 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.74 -91.34 1.62 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -155.68 147.99 23.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.213 0.506 . . . . 0.0 111.851 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.506 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 38.1 p90 -161.16 179.64 8.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.74 1.616 . . . . 0.0 108.099 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.67 158.91 33.57 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.085 -1.009 . . . . 0.0 110.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.25 140.86 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 108.027 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -109.7 117.59 34.29 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.239 2.216 . . . . 0.0 109.512 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -82.35 -14.13 55.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.584 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.7 m -70.82 -47.83 57.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 120.217 1.371 . . . . 0.0 110.277 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -108.08 -3.41 18.69 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.25 1.42 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp 56.89 53.15 8.45 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.525 1.53 . . . . 0.0 110.073 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -120.86 165.64 14.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.41 138.34 53.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.99 151.64 32.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.19 0.905 . . . . 0.0 110.6 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CZ ' ' HE2' ' B' ' 36' ' ' LYS . 54.6 m-85 -83.06 8.2 13.6 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.25 153.26 44.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.295 1.407 . . . . 0.0 113.221 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -62.31 139.93 96.37 Favored Pre-proline 0 C--O 1.24 0.57 0 O-C-N 124.99 1.431 . . . . 0.0 109.345 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.456 -0.68 0 C-N-CA 123.308 2.672 . . . . 0.0 114.572 -179.616 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt . . . . . 0 C--O 1.233 0.222 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.24 155.96 63.2 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.38 140.07 62.2 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 105.385 -2.583 . . . . 0.0 105.385 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.81 70.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.639 -1.089 . . . . 0.0 112.071 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -107.01 167.62 9.76 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.954 1.877 . . . . 0.0 106.58 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.506 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 7.5 tp10 -144.43 154.45 42.97 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -119.06 133.34 55.87 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -124.87 136.96 59.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -127.17 134.94 50.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -150.94 179.1 8.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.522 2.329 . . . . 0.0 110.281 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 69.4 m -110.77 -25.05 10.11 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.099 -1.001 . . . . 0.0 111.7 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.08 -23.13 57.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 110.527 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.46 -53.65 1.9 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.243 1.417 . . . . 0.0 112.036 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.21 -104.36 0.64 Allowed Glycine 0 N--CA 1.469 0.84 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.7 m -144.13 131.01 20.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.506 1.653 . . . . 0.0 108.536 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.54 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.211 1.004 . . . . 0.0 109.829 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -127.18 142.94 51.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.035 1.334 . . . . 0.0 108.086 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.53 135.22 59.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.81 0.814 . . . . 0.0 110.11 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -100.63 104.26 15.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -72.94 -24.94 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 119.158 -0.448 . . . . 0.0 111.826 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -71.0 -37.21 72.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.363 1.465 . . . . 0.0 111.615 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -115.25 1.89 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.575 1.15 . . . . 0.0 112.574 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.422 ' HE2' ' CZ ' ' A' ' 40' ' ' TYR . 4.9 mmtp 48.19 62.17 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.554 1.942 . . . . 0.0 109.901 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -128.62 160.17 33.27 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.821 0.848 . . . . 0.0 110.018 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.8 131.41 47.76 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.356 1.462 . . . . 0.0 108.447 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -146.34 148.93 32.89 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.227 0.467 . . . . 0.0 110.538 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -91.44 25.7 2.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.04 1.736 . . . . 0.0 111.055 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -137.77 153.5 49.69 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . 0.424 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 4.7 t-80 -68.71 147.0 97.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 111.799 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 73.2 Cg_endo . . . . . 0 CA--C 1.539 0.742 0 C-N-CA 124.122 3.215 . . . . 0.0 113.449 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.81 161.73 40.96 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.536 2.157 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.36 123.71 11.18 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.851 2.368 . . . . 0.0 108.545 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.45 5.58 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.673 1.13 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 24.2 m95 -81.33 151.82 27.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.397 1.098 . . . . 0.0 108.993 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -135.43 140.87 45.24 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.468 0.707 . . . . 0.0 109.534 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -103.11 132.24 49.52 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.6 136.02 55.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.23 142.55 49.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -154.24 146.36 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.4 m -74.82 -12.82 60.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.559 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.27 -45.71 5.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 110.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -93.85 -18.1 22.36 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.11 -92.54 1.79 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.704 1.621 . . . . 0.0 111.544 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -153.75 124.44 7.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.41 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 53.5 p90 -139.43 177.15 8.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.806 0.442 . . . . 0.0 109.995 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.14 148.04 51.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 108.923 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.46 137.12 57.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.226 0.61 . . . . 0.0 110.271 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 9.2 t0 -99.14 115.74 29.74 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.597 2.759 . . . . 0.0 108.941 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -82.94 -10.04 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.598 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -75.45 -43.43 49.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 120.747 1.612 . . . . 0.0 110.164 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -117.74 0.41 11.99 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.157 0.983 . . . . 0.0 112.176 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 57.17 60.71 2.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.595 1.558 . . . . 0.0 108.509 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -129.47 143.63 50.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.789 0.835 . . . . 0.0 109.441 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.79 145.84 33.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 109.288 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.86 162.86 38.99 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.461 1.104 . . . . 0.0 110.276 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.78 8.91 41.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 160.56 32.15 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.819 1.19 . . . . 0.0 111.007 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -61.88 134.83 94.29 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 C--O 1.236 0.396 0 C-N-CA 124.29 3.327 . . . . 0.0 116.028 -179.107 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.9 158.53 52.61 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.283 1.989 . . . . 0.0 110.567 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.8 123.61 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.558 2.172 . . . . 0.0 106.87 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.96 -26.41 6.8 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.643 1.592 . . . . 0.0 110.789 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 25.6 m95 -90.0 157.01 18.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.381 1.091 . . . . 0.0 110.172 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.41 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 8.5 tp10 -141.19 150.5 42.8 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.802 0.841 . . . . 0.0 108.761 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -115.48 128.55 56.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -117.77 120.3 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.879 0.872 . . . . 0.0 109.509 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -107.31 146.28 31.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -150.11 170.77 18.14 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.754 1.622 . . . . 0.0 110.914 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -96.24 -34.23 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -74.87 -27.01 60.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.133 0.973 . . . . 0.0 110.756 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.93 -19.42 5.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.65 -86.5 1.28 Allowed Glycine 0 N--CA 1.461 0.331 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -159.67 134.23 7.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.902 1.351 . . . . 0.0 111.307 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -143.76 158.11 43.91 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 107.417 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -110.87 159.58 17.55 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.821 -1.174 . . . . 0.0 108.587 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.11 135.23 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 122.817 0.447 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 42.9 t0 -99.06 113.18 25.25 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.912 1.285 . . . . 0.0 108.689 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -72.92 -16.89 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.687 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 79.4 m -79.78 -28.91 40.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.996 0.919 . . . . 0.0 112.857 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -121.76 -4.79 9.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.893 0.769 . . . . 0.0 111.537 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp 56.21 47.66 18.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.829 1.652 . . . . 0.0 109.7 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.81 160.85 21.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.153 0.981 . . . . 0.0 111.175 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.61 140.59 51.32 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.972 1.309 . . . . 0.0 109.111 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -150.9 156.05 40.4 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.438 1.095 . . . . 0.0 110.169 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -97.47 -7.63 31.11 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.917 0.887 . . . . 0.0 111.67 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -100.1 142.43 31.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.06 1.344 . . . . 0.0 108.825 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -58.66 143.57 81.7 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.458 -0.563 0 C-N-CA 122.575 2.183 . . . . 0.0 116.734 -179.123 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.9 158.87 54.43 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.43 1.42 . . . . 0.0 110.454 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 95.55 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.528 2.819 . . . . 0.0 107.589 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 139.98 -2.04 2.33 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.347 0.975 . . . . 0.0 112.982 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -118.24 151.47 37.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -137.18 153.53 50.42 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.265 0.626 . . . . 0.0 109.964 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -114.49 127.62 55.91 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.23 1.812 . . . . 0.0 107.789 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.25 117.76 56.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.83 152.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -151.2 177.39 10.27 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 120.647 -1.283 . . . . 0.0 111.622 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -114.07 -18.08 11.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.81 -10.97 12.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.701 0.801 . . . . 0.0 110.087 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -123.69 -12.36 7.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.466 1.906 . . . . 0.0 112.563 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.87 -77.04 1.15 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 126.11 1.814 . . . . 0.0 110.329 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -161.24 138.43 8.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.628 1.714 . . . . 0.0 110.357 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -143.17 171.74 13.67 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.93 153.1 43.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.911 0.885 . . . . 0.0 109.686 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.92 141.5 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.885 0.874 . . . . 0.0 110.846 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.55 111.07 23.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 129.729 3.212 . . . . 0.0 108.477 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -76.56 -18.53 58.63 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -78.26 -32.45 49.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.98 0.809 . . . . 0.0 110.313 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -116.44 -4.97 11.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm 55.29 52.52 11.33 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.989 2.116 . . . . 0.0 109.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -124.52 165.69 17.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.454 1.102 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.68 151.52 47.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.158 1.383 . . . . 0.0 108.57 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.43 159.98 43.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.828 0.823 . . . . 0.0 111.643 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.572 ' CE1' ' HE2' ' B' ' 36' ' ' LYS . 14.2 m-30 -93.8 17.28 12.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.411 1.484 . . . . 0.0 113.837 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.36 150.84 38.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.464 -1.398 . . . . 0.0 110.072 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -59.92 142.33 88.87 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo . . . . . 0 CA--C 1.542 0.899 1 C-N-CA 125.747 4.298 . . . . 0.0 116.083 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.234 0.255 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.28 162.57 35.55 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.12 1.88 . . . . 0.0 110.336 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.95 108.62 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.423 2.749 . . . . 0.0 110.17 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.41 -26.19 6.73 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.674 1.131 . . . . 0.0 112.706 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 9.6 m95 -80.85 148.99 29.7 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 119.428 1.614 . . . . 0.0 108.867 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -131.24 152.19 50.76 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -111.65 138.84 47.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.6 136.15 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -124.58 141.19 52.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.0 p -154.25 -166.57 2.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.657 2.383 . . . . 0.0 109.209 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -121.15 -47.69 2.26 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.71 -50.99 70.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -80.61 -59.02 2.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.83 -98.49 0.53 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -150.96 136.34 17.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.446 1.623 . . . . 0.0 107.673 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -150.52 178.08 9.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.07 152.75 43.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.397 0.679 . . . . 0.0 109.409 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.66 139.0 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.455 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 55.0 t0 -100.01 104.91 16.54 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.051 1.74 . . . . 0.0 107.753 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -27.77 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.89 0.768 . . . . 0.0 112.386 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -64.2 -39.37 93.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 111.573 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -118.57 -1.33 11.19 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 40' ' ' TYR . 34.5 mmtm 52.63 50.71 17.57 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 125.019 1.328 . . . . 0.0 111.069 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -125.41 164.77 19.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.2 151.52 40.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.717 0.807 . . . . 0.0 109.104 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -146.14 152.25 38.97 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.271 0.941 . . . . 0.0 111.419 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.2 26.21 3.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.61 1.564 . . . . 0.0 112.622 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.86 167.52 28.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.15 -1.594 . . . . 0.0 109.011 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.11 154.84 91.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.159 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 0 CA--C 1.533 0.456 0 C-N-CA 123.651 2.901 . . . . 0.0 110.605 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.2 t -58.64 150.07 24.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.61 1.164 . . . . 0.0 111.803 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 p -112.16 12.91 20.51 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.829 2.452 . . . . 0.0 108.912 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.81 -11.75 5.66 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 126.181 1.848 . . . . 0.0 113.143 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 m -149.4 89.79 1.67 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.829 1.815 . . . . 0.0 109.674 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -61.59 153.28 28.19 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 160.68 47.42 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.38 0.434 . . . . 0.0 112.976 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.1 -16.81 6.0 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.368 2.712 . . . . 0.0 111.861 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.0 159.57 44.09 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.45 3.9 . . . . 0.0 106.293 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.3 0.76 5.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.018 1.327 . . . . 0.0 112.864 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 80.64 -21.15 0.34 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.388 3.475 . . . . 0.0 111.869 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.52 171.81 7.01 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.898 2.479 . . . . 0.0 112.258 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.91 166.22 53.92 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.31 162.14 62.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.642 1.177 . . . . 0.0 110.705 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.36 161.55 45.43 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 121.914 1.743 . . . . 0.0 109.566 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.44 108.7 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.316 2.678 . . . . 0.0 108.653 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.28 -16.42 6.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.684 1.611 . . . . 0.0 111.704 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.0 m95 -95.38 142.68 27.48 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.261 -1.141 . . . . 0.0 109.429 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.525 ' HG2' ' HH ' ' B' ' 29' ' ' TYR . 4.1 tp10 -125.32 140.73 52.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.273 0.629 . . . . 0.0 110.818 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -104.13 134.8 46.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 t -115.0 138.65 44.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.78 131.01 40.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.262 1.025 . . . . 0.0 110.729 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.82 170.9 18.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.01 1.724 . . . . 0.0 111.283 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -86.76 -29.36 22.41 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.446 1.098 . . . . 0.0 112.534 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.82 -44.38 27.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.97 1.259 . . . . 0.0 110.952 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.84 -24.73 14.58 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -94.75 1.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.55 130.35 10.07 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.216 -0.579 . . . . 0.0 110.752 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.474 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 52.8 p90 -135.29 173.48 11.67 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -125.76 146.07 49.93 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.22 -0.925 . . . . 0.0 108.559 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 143.44 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.614 0.721 . . . . 0.0 109.546 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 64.6 t0 -108.2 109.75 21.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.709 2.003 . . . . 0.0 109.829 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' CE1' ' HH ' ' B' ' 40' ' ' TYR . 1.5 m-70 -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.086 0.857 . . . . 0.0 111.092 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 m -68.12 -33.43 74.49 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.615 1.166 . . . . 0.0 111.603 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -122.38 1.05 9.57 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 38' ' ' ALA . 22.2 mmmt 50.31 51.48 16.69 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.584 1.953 . . . . 0.0 110.023 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.34 166.91 16.94 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 123.809 0.844 . . . . 0.0 110.227 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.417 ' O ' ' HE3' ' B' ' 36' ' ' LYS . . . -122.78 149.91 43.5 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -150.55 171.39 17.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.406 1.482 . . . . 0.0 107.988 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -112.89 -8.15 13.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -100.74 167.49 10.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.972 1.309 . . . . 0.0 110.865 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 149.48 82.82 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.05 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 110.059 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -152.27 118.6 5.59 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.465 -0.772 . . . . 0.0 111.238 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.94 167.98 25.2 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -84.45 79.25 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.062 3.842 . . . . 0.0 109.759 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 m -53.6 -29.43 37.64 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.8 m -128.2 137.02 51.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.6 t -62.6 148.03 47.39 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.365 1.082 . . . . 0.0 108.946 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 18.2 p -138.79 28.19 2.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.317 1.847 . . . . 0.0 109.195 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.7 -81.99 0.07 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.4 m -131.6 145.05 51.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.237 1.015 . . . . 0.0 109.642 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 135.83 53.07 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.92 168.73 9.61 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 123.665 0.65 . . . . 0.0 112.114 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.88 -35.32 9.52 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.034 1.822 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.99 157.19 25.9 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.854 1.262 . . . . 0.0 108.579 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.31 4.64 20.98 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.799 1.64 . . . . 0.0 110.058 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 71.48 -2.5 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.087 2.555 . . . . 0.0 113.107 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -69.07 173.76 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.488 1.915 . . . . 0.0 110.492 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.99 -175.69 47.15 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.26 158.07 32.9 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 121.514 -0.992 . . . . 0.0 110.951 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.56 160.97 46.84 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.338 2.025 . . . . 0.0 111.009 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.73 115.43 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.249 2.632 . . . . 0.0 108.696 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.23 -21.31 13.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.661 1.124 . . . . 0.0 112.514 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -87.56 164.06 16.3 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 119.229 1.514 . . . . 0.0 108.144 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.474 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 3.7 tp10 -144.82 152.65 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.943 -0.473 . . . . 0.0 110.797 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -112.75 133.88 54.55 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.341 1.857 . . . . 0.0 107.005 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.32 128.51 75.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -109.93 141.56 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 10.1 t -153.07 -169.81 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.9 m -130.32 -38.29 1.38 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.564 1.946 . . . . 0.0 107.093 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.41 -27.22 66.9 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -121.36 -26.21 5.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.67 -91.48 1.04 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.06 1.315 . . . . 0.0 110.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.4 m -154.93 137.07 14.75 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.491 -1.594 . . . . 0.0 109.3 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.525 ' HH ' ' HG2' ' A' ' 19' ' ' GLU . 53.1 p90 -146.14 179.21 7.65 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 177.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -131.65 154.44 48.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.46 0.704 . . . . 0.0 109.424 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.96 142.01 41.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.38 0.672 . . . . 0.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -102.9 125.69 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.478 2.711 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -85.17 -19.81 31.19 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.924 -0.485 . . . . 0.0 110.657 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 46.7 m -73.06 -32.69 65.21 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.82 1.248 . . . . 0.0 110.247 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -123.54 -2.94 8.37 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 38' ' ' ALA . 25.8 mmmt 54.88 40.38 31.95 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.802 1.241 . . . . 0.0 110.71 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -115.27 158.6 22.11 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.427 ' O ' ' HE3' ' A' ' 36' ' ' LYS . . . -116.89 147.48 42.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.51 1.124 . . . . 0.0 108.482 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -152.51 162.54 41.06 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.393 1.477 . . . . 0.0 108.745 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.413 ' HH ' ' CE1' ' A' ' 33' ' ' HIS . 66.2 m-85 -103.33 -4.68 23.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.116 0.966 . . . . 0.0 113.023 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 163.28 13.46 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.18 0.992 . . . . 0.0 110.615 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -79.58 143.43 59.09 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.45 168.6 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.627 1.551 . . . . 0.0 113.278 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.0 p -148.96 178.23 8.87 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.92 1.288 . . . . 0.0 111.397 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.87 -173.47 18.83 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.708 2.099 . . . . 0.0 111.105 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.79 165.8 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.072 3.182 . . . . 0.0 110.124 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -136.3 -8.98 1.98 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.299 1.039 . . . . 0.0 113.256 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.2 m -142.14 -176.22 4.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.035 1.334 . . . . 0.0 109.662 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.814 0 N-CA-C 106.564 -2.615 . . . . 0.0 106.564 -179.741 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -119.55 -28.54 5.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.54 1.936 . . . . 0.0 109.118 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p -65.01 142.43 58.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.81 1.244 . . . . 0.0 108.528 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.39 -90.99 0.13 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.5 p -137.4 167.89 20.72 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.494 1.118 . . . . 0.0 109.321 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t 155.54 -168.63 0.0 OUTLIER 'General case' 0 C--O 1.241 0.644 1 C-N-CA 132.126 4.17 . . . . 0.0 104.809 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.9 169.68 54.69 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.6 -51.54 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.576 2.184 . . . . 0.0 109.091 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.21 179.12 9.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 130.508 3.523 . . . . 0.0 106.665 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.25 -161.56 0.52 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.288 1.435 . . . . 0.0 112.956 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.29 11.55 3.53 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.936 1.694 . . . . 0.0 112.249 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -129.85 62.09 1.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.058 1.343 . . . . 0.0 107.997 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.79 5.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.805 -0.997 . . . . 0.0 114.818 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.77 161.89 51.85 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 119.104 1.452 . . . . 0.0 107.353 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.92 159.66 50.7 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.533 0.822 . . . . 0.0 110.314 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.1 110.68 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.493 2.795 . . . . 0.0 108.872 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.17 -14.48 16.1 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-O 117.942 -1.477 . . . . 0.0 114.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 11.5 m95 -96.22 150.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.447 1.623 . . . . 0.0 107.036 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -135.08 148.31 49.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.488 0.185 . . . . 0.0 110.917 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -103.83 130.06 51.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.57 144.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.3 147.01 50.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 p -158.08 164.34 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.288 1.435 . . . . 0.0 110.701 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -92.06 -29.16 16.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.926 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -17.99 35.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.46 -46.87 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.83 -104.35 0.87 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -138.34 124.01 19.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -135.93 176.61 8.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.826 0.45 . . . . 0.0 111.043 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.39 151.88 51.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.541 0.737 . . . . 0.0 110.767 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.61 137.79 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.061 0.544 . . . . 0.0 111.146 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 34.3 t0 -101.26 107.97 19.49 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 127.946 2.498 . . . . 0.0 105.447 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -74.77 -19.71 60.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.0 m -80.75 -47.42 13.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.303 0.956 . . . . 0.0 110.276 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.91 -10.14 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.937 1.295 . . . . 0.0 112.213 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm 55.58 45.06 25.63 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.73 2.012 . . . . 0.0 110.868 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -114.46 164.29 14.17 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.096 0.959 . . . . 0.0 109.411 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.42 150.37 48.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.365 1.466 . . . . 0.0 109.102 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -160.23 151.97 19.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.015 1.326 . . . . 0.0 109.968 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -93.14 11.12 28.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.028 0.931 . . . . 0.0 111.388 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 160.24 34.64 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.522 -1.361 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -63.22 138.66 97.4 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.449 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.5 53.1 3.01 Favored 'Trans proline' 0 CA--C 1.532 0.421 1 C-N-CA 125.928 4.418 . . . . 0.0 115.305 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -60.49 138.04 58.07 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.757 -0.589 . . . . 0.0 109.874 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.1 178.67 48.85 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.42 160.85 25.66 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.396 2.064 . . . . 0.0 109.61 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -143.26 77.46 1.56 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -82.73 -56.4 3.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.173 -0.441 . . . . 0.0 109.89 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 119.005 -0.886 . . . . 0.0 110.89 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 118.609 -1.106 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -128.31 -7.31 5.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.139 0.97 . . . . 0.0 112.84 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -76.29 160.72 29.37 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.668 1.122 . . . . 0.0 108.242 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.68 -83.58 0.86 Allowed Glycine 0 C--N 1.332 0.325 0 N-CA-C 103.614 -3.794 . . . . 0.0 103.614 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -156.16 125.24 6.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -166.07 179.0 6.02 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.466 1.106 . . . . 0.0 109.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.53 171.57 49.7 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 -51.94 0.75 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.929 2.419 . . . . 0.0 114.89 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.27 179.26 9.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.163 1.785 . . . . 0.0 109.868 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -85.94 -177.81 6.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.98 2.112 . . . . 0.0 110.771 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -107.0 -54.62 2.44 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.012 0.925 . . . . 0.0 111.318 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 -3.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.085 2.954 . . . . 0.0 116.876 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.43 -2.57 61.76 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 119.782 1.174 . . . . 0.0 114.67 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -78.31 157.86 77.44 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.085 1.442 . . . . 0.0 112.444 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -72.09 164.72 34.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.365 2.044 . . . . 0.0 111.686 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.09 121.36 9.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.7 58.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.288 -1.285 . . . . 0.0 115.063 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -94.04 161.29 14.34 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 119.521 1.66 . . . . 0.0 108.525 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.84 169.15 20.43 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -128.5 121.94 30.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 109.355 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.58 123.74 49.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.96 137.92 50.62 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -150.93 -154.51 0.55 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.71 1.604 . . . . 0.0 108.96 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.1 m -127.31 -55.58 1.34 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.604 1.962 . . . . 0.0 107.101 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -60.83 -26.29 67.23 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.752 1.221 . . . . 0.0 113.312 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -113.93 -41.98 3.47 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.75 -96.72 1.02 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.068 0.842 . . . . 0.0 112.339 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -149.28 108.35 3.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.609 0.705 . . . . 0.0 109.567 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -125.22 176.77 6.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 109.726 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.25 156.9 44.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 110.239 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.34 142.59 32.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.506 1.122 . . . . 0.0 108.783 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -106.19 115.04 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.548 2.339 . . . . 0.0 105.096 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -79.55 -17.1 54.74 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 112.773 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -79.98 -45.11 19.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.214 1.405 . . . . 0.0 109.33 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -95.32 -15.12 23.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.188 0.995 . . . . 0.0 111.54 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 58.48 53.41 6.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.454 2.302 . . . . 0.0 109.312 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -134.66 153.61 51.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.967 0.507 . . . . 0.0 111.291 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.08 145.78 36.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.831 1.253 . . . . 0.0 110.524 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -147.23 150.87 35.7 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.682 0.793 . . . . 0.0 109.277 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.54 19.2 11.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.815 1.646 . . . . 0.0 112.613 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 159.69 41.67 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.41 -1.431 . . . . 0.0 109.037 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.63 152.09 76.06 Favored Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 123.956 0.902 . . . . 0.0 112.588 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.11 77.31 3.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.32 2.68 . . . . 0.0 116.047 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.9 162.03 26.31 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.579 -0.701 . . . . 0.0 109.227 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.91 164.52 10.9 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.91 0.767 . . . . 0.0 113.739 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 150.75 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 106.451 -2.173 . . . . 0.0 106.451 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -141.53 63.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.764 0.792 . . . . 0.0 109.177 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -73.42 -13.01 61.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.642 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 p -132.65 155.55 48.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.502 1.151 . . . . 0.0 109.967 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -133.3 149.01 51.94 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.991 2.117 . . . . 0.0 108.313 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.64 -19.92 2.99 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.073 0.844 . . . . 0.0 112.5 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m -79.09 175.31 10.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.546 1.173 . . . . 0.0 110.985 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -37.96 109.15 0.09 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 126.419 1.888 . . . . 0.0 110.865 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.63 30.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -61.4 -38.88 60.76 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.918 2.412 . . . . 0.0 113.534 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.84 -171.0 2.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.268 1.827 . . . . 0.0 109.639 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.0 158.23 2.2 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.84 1.656 . . . . 0.0 112.628 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -130.43 68.12 1.47 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.371 1.468 . . . . 0.0 107.075 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -139.02 165.95 25.77 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.248 1.019 . . . . 0.0 108.963 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.77 -10.39 0.11 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.25 -1.305 . . . . 0.0 114.203 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 mt -123.38 160.17 51.64 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.747 1.619 . . . . 0.0 110.568 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.05 163.7 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.458 2.105 . . . . 0.0 110.614 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 140.49 64.31 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.954 1.77 . . . . 0.0 108.747 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.12 -12.6 63.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.057 -1.413 . . . . 0.0 113.23 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 5.9 m95 -90.59 164.14 14.31 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 120.657 2.229 . . . . 0.0 109.112 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -147.43 155.27 41.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.804 0.812 . . . . 0.0 109.847 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -124.87 140.81 52.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.99 139.19 50.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.8 121.53 37.43 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.212 1.805 . . . . 0.0 106.474 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 p -131.53 172.25 12.44 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.012 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -95.64 -28.21 14.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.791 1.236 . . . . 0.0 110.674 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -95.93 -28.14 14.82 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -107.97 -34.79 6.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 -98.23 0.98 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.33 0.968 . . . . 0.0 112.762 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 m -148.16 121.83 9.23 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.521 0.728 . . . . 0.0 109.202 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -140.14 176.44 8.75 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.206 -0.934 . . . . 0.0 109.67 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -129.42 150.09 50.92 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.814 0.734 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.5 131.85 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.747 0.819 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.3 t0 -98.78 116.98 32.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -86.84 -20.46 27.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.115 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m -76.97 -31.71 56.75 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.591 1.087 . . . . 0.0 110.118 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -109.96 -12.01 14.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.893 1.677 . . . . 0.0 111.959 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HE2' ' CE2' ' B' ' 40' ' ' TYR . 42.5 mmtm 54.11 56.91 6.44 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.476 1.51 . . . . 0.0 110.782 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -130.58 169.6 15.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.24 1.016 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.37 142.74 51.42 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.896 1.679 . . . . 0.0 108.923 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.77 161.01 43.37 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.432 1.493 . . . . 0.0 110.522 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.57 25.78 11.06 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.906 1.282 . . . . 0.0 112.142 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 160.03 40.81 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.704 -1.248 . . . . 0.0 110.059 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 153.41 55.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.913 . . . . 0.0 110.481 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.49 83.8 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.636 2.891 . . . . 0.0 114.509 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 p -50.95 -55.41 17.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.332 1.453 . . . . 0.0 112.786 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -175.44 32.98 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.96 -16.28 16.1 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.512 2.808 . . . . 0.0 113.949 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 p -139.34 175.87 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.518 1.127 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 p -147.87 -176.44 5.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.415 2.286 . . . . 0.0 106.385 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.699 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.603 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -145.43 179.14 7.6 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.773 1.229 . . . . 0.0 109.102 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -157.74 179.37 9.28 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.639 1.576 . . . . 0.0 108.343 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.2 -13.27 0.59 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.529 1.061 . . . . 0.0 113.274 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.7 m -82.79 166.58 18.9 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 119.007 1.403 . . . . 0.0 110.257 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -47.98 137.7 9.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.146 1.378 . . . . 0.0 111.922 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.22 166.51 35.11 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.776 0.703 . . . . 0.0 112.568 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.41 -39.14 10.19 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.814 2.343 . . . . 0.0 110.102 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.67 178.97 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.263 2.625 . . . . 0.0 107.069 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.17 168.92 2.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.985 0.898 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -130.16 12.88 5.64 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.086 1.354 . . . . 0.0 112.479 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -83.5 141.9 31.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.99 0.916 . . . . 0.0 109.66 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.83 -86.97 1.34 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 123.036 0.351 . . . . 0.0 113.294 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -50.5 153.26 2.77 Favored Pre-proline 0 N--CA 1.465 0.294 0 C-N-CA 126.15 1.78 . . . . 0.0 114.302 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.78 160.51 49.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.108 1.872 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.62 99.21 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.797 2.998 . . . . 0.0 109.769 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.59 -1.62 5.22 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.645 1.593 . . . . 0.0 112.235 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -117.37 153.75 32.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.651 1.225 . . . . 0.0 109.479 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.01 168.47 19.64 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -130.8 125.54 33.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.643 2.377 . . . . 0.0 105.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.54 145.73 15.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -124.5 138.9 54.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.477 1.111 . . . . 0.0 108.276 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.7 p -154.66 177.66 10.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.363 1.865 . . . . 0.0 111.479 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -105.52 -33.47 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.62 -35.57 81.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.908 1.683 . . . . 0.0 110.865 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.05 -35.96 3.22 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.811 0.844 . . . . 0.0 113.006 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.05 -100.37 1.3 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 22.9 m -147.36 127.56 13.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 120.225 -1.75 . . . . 0.0 108.818 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -142.37 173.99 11.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.641 0.776 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -122.62 148.04 45.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.168 0.987 . . . . 0.0 112.944 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.49 140.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 108.66 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -107.94 115.61 30.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 127.862 2.465 . . . . 0.0 108.418 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -77.27 -30.31 54.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 87.3 m -67.61 -39.07 84.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.55 1.14 . . . . 0.0 110.783 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -106.9 -6.77 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.094 0.558 . . . . 0.0 112.441 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp 51.74 52.94 13.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.854 1.662 . . . . 0.0 110.633 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -126.48 166.46 17.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.846 1.258 . . . . 0.0 109.954 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.47 140.63 52.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.351 1.461 . . . . 0.0 107.727 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -147.06 171.67 14.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.607 1.163 . . . . 0.0 108.743 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.472 ' CE2' ' HE2' ' A' ' 36' ' ' LYS . 84.3 m-85 -112.79 -2.08 14.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.66 0.664 . . . . 0.0 112.429 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 160.89 14.84 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.964 0.906 . . . . 0.0 109.37 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -71.72 143.72 87.49 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.81 147.68 50.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.51 2.14 . . . . 0.0 114.155 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -114.12 -89.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.117 1.767 . . . . 0.0 107.534 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.94 -177.37 20.03 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.457 1.98 . . . . 0.0 109.519 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.6 -8.43 19.36 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.778 2.986 . . . . 0.0 112.836 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.8 p -151.73 168.48 24.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.104 1.362 . . . . 0.0 109.226 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 p -172.75 160.52 4.51 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.897 1.679 . . . . 0.0 108.127 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.756 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -68.02 168.8 11.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.043 0.921 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.59 143.24 32.35 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.6 135.25 8.78 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 p -165.91 170.43 13.76 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.7 t -153.72 172.39 17.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.857 1.663 . . . . 0.0 107.01 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.7 -176.54 14.46 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.839 2.161 . . . . 0.0 109.142 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.2 -47.02 6.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.79 1.66 . . . . 0.0 109.626 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.17 177.84 11.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.953 2.501 . . . . 0.0 107.482 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -125.97 169.56 12.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.699 1.2 . . . . 0.0 108.545 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -130.17 44.42 2.97 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.557 1.543 . . . . 0.0 110.522 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -105.92 171.83 7.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.797 0.839 . . . . 0.0 110.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.47 -164.58 10.82 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.196 2.808 . . . . 0.0 108.834 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt -138.56 157.89 71.34 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 118.977 1.389 . . . . 0.0 111.438 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.91 163.56 35.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.058 1.172 . . . . 0.0 110.949 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.27 133.11 36.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.042 1.828 . . . . 0.0 109.006 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.1 -14.96 61.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.72 1.629 . . . . 0.0 111.644 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -105.9 142.54 35.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.394 1.097 . . . . 0.0 108.884 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.94 160.19 39.36 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.475 1.51 . . . . 0.0 107.705 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -120.26 120.7 36.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.16 149.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.43 148.38 52.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.72 1.208 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 t -160.82 153.88 21.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.784 1.634 . . . . 0.0 112.819 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -80.44 -29.75 37.57 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -80.58 -27.1 37.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.918 1.687 . . . . 0.0 112.41 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -117.26 -38.13 3.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.95 -109.83 2.3 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.25 126.98 20.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -138.48 170.04 16.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.508 0.67 . . . . 0.0 109.665 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.27 148.45 52.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.225 1.01 . . . . 0.0 109.0 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.42 139.68 47.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 109.355 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -103.34 116.1 31.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.734 2.014 . . . . 0.0 108.319 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -72.23 -17.55 61.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.581 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -71.21 -51.22 25.92 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.877 0.871 . . . . 0.0 111.665 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -110.4 4.75 20.92 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.516 0.727 . . . . 0.0 112.776 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 51.87 41.69 29.59 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.97 1.308 . . . . 0.0 111.387 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -105.74 156.34 18.39 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.21 49.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.942 1.297 . . . . 0.0 107.952 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.44 168.31 25.43 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.865 -1.147 . . . . 0.0 110.647 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.85 15.73 27.28 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 112.302 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.22 153.95 31.99 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.047 -1.033 . . . . 0.0 109.977 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -71.18 136.63 84.42 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.88 118.0 5.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.781 1.654 . . . . 0.0 108.197 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -116.58 54.15 0.86 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.559 1.544 . . . . 0.0 111.511 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.85 26.1 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.822 -1.174 . . . . 0.0 114.396 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 160.75 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.099 3.2 . . . . 0.0 111.473 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 m -86.09 114.51 23.01 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.806 0.843 . . . . 0.0 108.822 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.73 -45.83 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.865 0.866 . . . . 0.0 109.352 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.641 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -71.09 168.58 16.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -128.83 173.61 10.21 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 128.069 2.548 . . . . 0.0 107.048 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.26 165.28 12.16 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p -173.9 169.52 4.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.14 1.776 . . . . 0.0 108.51 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.7 t -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.17 169.62 40.17 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.97 -31.32 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.557 2.171 . . . . 0.0 111.423 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 pp -170.76 173.82 5.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.523 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -147.9 178.99 8.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.31 1.044 . . . . 0.0 110.989 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -126.37 17.09 7.68 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.933 2.493 . . . . 0.0 110.681 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.55 173.83 11.07 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.475 -0.765 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.9 -163.92 13.31 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 49.1 mt -130.32 156.12 79.93 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.627 1.571 . . . . 0.0 109.766 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.78 160.21 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.786 1.657 . . . . 0.0 111.368 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.86 91.05 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.534 3.489 . . . . 0.0 110.149 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.49 -3.28 2.93 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.477 1.513 . . . . 0.0 111.734 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -110.36 156.73 20.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.487 1.144 . . . . 0.0 108.195 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -148.95 158.56 44.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.21 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -112.04 144.95 40.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.787 1.635 . . . . 0.0 106.949 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.44 118.82 54.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -110.28 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 t -154.77 148.72 25.7 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.745 1.218 . . . . 0.0 110.804 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -76.16 -23.34 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.494 1.043 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -81.22 -22.67 38.63 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -120.69 -43.97 2.46 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.52 -113.29 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -141.05 111.99 7.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -131.71 -179.96 5.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -131.35 155.9 46.43 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.89 0.876 . . . . 0.0 111.345 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.66 138.7 52.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.795 1.238 . . . . 0.0 109.301 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -106.68 118.96 38.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.474 1.91 . . . . 0.0 109.258 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -77.88 -20.9 52.15 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -69.28 -49.98 51.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.5 1.046 . . . . 0.0 110.49 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -105.85 -0.06 25.55 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt 53.87 53.49 11.21 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.008 1.323 . . . . 0.0 109.919 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -119.27 162.48 18.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.466 0.706 . . . . 0.0 109.578 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.93 142.68 50.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.861 1.264 . . . . 0.0 108.856 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -154.9 164.81 38.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.349 1.059 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -103.71 -6.56 21.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 142.5 34.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . 0.426 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.0 t-80 -56.12 146.69 49.42 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.807 1.243 . . . . 0.0 110.572 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 56.4 Cg_endo -67.73 158.53 56.8 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.469 2.113 . . . . 0.0 112.492 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.37 125.21 3.81 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.785 1.234 . . . . 0.0 108.531 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -177.64 21.98 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.918 1.247 . . . . 0.0 111.688 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -83.03 -169.88 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 124.996 3.797 . . . . 0.0 109.858 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -109.65 112.44 24.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.607 1.163 . . . . 0.0 109.357 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -145.73 -81.53 0.15 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.145 1.378 . . . . 0.0 107.514 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.505 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -70.86 146.47 49.61 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.849 1.325 . . . . 0.0 108.932 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.9 m -149.22 170.74 17.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.688 1.995 . . . . 0.0 109.152 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.39 167.5 20.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p -161.45 178.34 9.23 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.08 0.552 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -164.31 -163.82 0.79 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.303 1.841 . . . . 0.0 106.787 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.66 176.34 44.48 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.16 -39.18 2.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.291 1.994 . . . . 0.0 112.057 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.6 mt -148.47 145.04 27.78 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 128.014 2.526 . . . . 0.0 107.994 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -121.74 168.64 11.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.187 1.395 . . . . 0.0 108.497 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.33 21.32 1.71 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.933 1.293 . . . . 0.0 113.038 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -82.21 -177.18 6.54 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.567 1.147 . . . . 0.0 112.752 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.65 122.66 27.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.41 157.64 63.13 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 163.27 39.2 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.863 2.375 . . . . 0.0 110.921 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.52 123.92 11.02 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.391 2.061 . . . . 0.0 107.991 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.71 -17.75 22.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.176 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 24.5 m95 -100.77 164.07 12.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -143.52 151.33 40.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.883 0.373 . . . . 0.0 111.851 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -112.82 121.16 43.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.79 146.28 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.8 111.83 11.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.98 1.712 . . . . 0.0 106.902 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.11 174.68 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.43 1.492 . . . . 0.0 111.427 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -106.85 -22.13 12.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 112.205 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.39 -12.96 47.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.724 0.693 . . . . 0.0 111.314 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.59 -63.41 0.71 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.192 0.997 . . . . 0.0 109.673 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.36 -109.47 0.71 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.627 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.1 m -131.37 112.05 12.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.757 1.279 . . . . 0.0 109.257 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -134.07 146.1 50.01 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.496 1.518 . . . . 0.0 108.255 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.11 146.87 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.859 1.264 . . . . 0.0 111.204 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.08 138.34 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.303 1.041 . . . . 0.0 110.15 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.421 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 36.3 t70 -105.92 110.48 22.77 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 127.044 2.137 . . . . 0.0 108.032 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -75.81 -18.08 59.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.2 m -71.72 -28.98 64.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.751 1.614 . . . . 0.0 111.807 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -126.18 -7.75 6.5 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 124.555 1.142 . . . . 0.0 112.536 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 mtmm 58.66 60.03 2.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.472 1.909 . . . . 0.0 109.047 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -124.33 168.79 12.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.54 1.136 . . . . 0.0 108.974 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.92 52.08 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -155.1 167.82 29.07 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.09 -1.006 . . . . 0.0 110.978 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.15 10.9 27.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.041 0.937 . . . . 0.0 112.927 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 153.27 46.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.327 1.051 . . . . 0.0 110.39 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.58 136.74 89.49 Favored Pre-proline 0 N--CA 1.451 -0.415 0 O-C-N 124.398 1.061 . . . . 0.0 109.946 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.5 92.12 1.03 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.312 2.675 . . . . 0.0 110.564 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.0 m -143.02 140.22 30.91 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 109.149 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.28 173.13 22.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.264 0.935 . . . . 0.0 111.351 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.36 125.21 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.286 2.657 . . . . 0.0 108.701 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.4 m -125.67 98.06 5.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.127 1.371 . . . . 0.0 108.641 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 t -70.7 -62.1 1.52 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.803 0.841 . . . . 0.0 109.124 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.205 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -65.35 157.51 28.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.545 1.172 . . . . 0.0 108.898 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.1 m -147.68 161.37 41.31 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.859 1.264 . . . . 0.0 109.118 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.5 -175.85 31.26 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.421 1.486 . . . . 0.0 110.571 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -162.77 133.49 4.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.09 0.445 . . . . 0.0 111.037 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m -155.95 139.03 15.48 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 129.201 3.0 . . . . 0.0 107.198 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 174.62 40.91 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.3 -49.2 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.148 2.565 . . . . 0.0 116.941 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -147.67 79.89 1.49 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.403 1.881 . . . . 0.0 110.922 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.05 165.59 15.46 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -142.3 67.44 1.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 125.299 1.44 . . . . 0.0 107.554 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -128.0 -170.03 2.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.99 167.67 10.98 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -115.27 157.23 44.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 121.341 -1.093 . . . . 0.0 112.038 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 42.6 Cg_endo -67.44 165.49 26.91 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.51 2.14 . . . . 0.0 109.841 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.81 128.05 22.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.273 1.982 . . . . 0.0 108.367 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.41 58.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.15 1.357 . . . . 0.0 114.28 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.415 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 6.8 m95 -83.96 153.79 23.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.955 1.877 . . . . 0.0 109.498 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.25 151.54 47.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.51 134.54 54.62 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.94 134.24 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.802 0.841 . . . . 0.0 109.055 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.18 140.71 52.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -159.9 133.52 7.11 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.222 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -60.06 -14.95 19.14 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -89.3 -20.73 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.011 0.823 . . . . 0.0 112.128 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.33 -16.4 3.95 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.03 -99.1 2.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 25.4 m -152.03 142.49 22.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.466 0.706 . . . . 0.0 109.497 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.09 -179.42 7.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 109.017 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -131.66 151.9 51.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.623 1.569 . . . . 0.0 106.898 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.93 145.97 34.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 123.556 0.743 . . . . 0.0 109.108 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -107.34 102.54 11.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 128.975 2.91 . . . . 0.0 105.918 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -23.84 61.65 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -74.95 -16.89 60.63 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.762 2.025 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.84 -12.45 2.94 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.253 1.421 . . . . 0.0 112.35 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 57.61 56.78 4.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.346 2.258 . . . . 0.0 109.095 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -133.22 155.7 48.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.525 1.13 . . . . 0.0 109.589 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.49 153.7 29.51 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.497 1.119 . . . . 0.0 110.865 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -153.78 147.82 25.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.34 10.62 12.13 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.78 23.83 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.207 1.367 . . . . 0.0 112.983 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -55.81 144.7 55.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.406 1.882 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.91 68.89 3.83 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.791 3.66 . . . . 0.0 113.866 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -81.91 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.835 1.254 . . . . 0.0 110.847 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.19 158.71 17.64 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.129 1.347 . . . . 0.0 113.093 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.99 167.35 22.11 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.335 3.357 . . . . 0.0 112.287 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -138.35 167.02 22.76 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.591 1.956 . . . . 0.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.2 t -134.31 -63.56 0.72 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.567 1.947 . . . . 0.0 108.232 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.666 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p -86.39 169.36 12.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.273 1.037 . . . . 0.0 110.589 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -77.51 31.45 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.482 1.913 . . . . 0.0 112.734 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.45 -87.78 0.18 Allowed Glycine 0 C--N 1.338 0.677 0 O-C-N 120.837 -1.164 . . . . 0.0 112.616 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m -103.22 -172.25 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.561 1.145 . . . . 0.0 110.379 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m -59.06 131.56 51.4 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.234 0.614 . . . . 0.0 109.384 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.91 -174.95 40.98 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.13 -54.33 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.302 2.668 . . . . 0.0 112.677 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -176.33 165.01 2.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.578 2.351 . . . . 0.0 109.024 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.53 175.81 9.04 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.057 1.343 . . . . 0.0 111.81 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -121.63 -8.1 9.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.796 1.238 . . . . 0.0 114.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.97 180.0 4.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.235 1.014 . . . . 0.0 112.605 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 174.8 51.0 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.522 1.058 . . . . 0.0 110.834 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.42 154.55 63.27 Favored Pre-proline 0 C--O 1.238 0.448 0 O-C-N 121.788 -0.831 . . . . 0.0 112.446 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.41 163.43 38.61 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 N-CA-C 107.409 -1.804 . . . . 0.0 107.409 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.29 151.39 82.7 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.72 4.95 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.593 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.5 m95 -86.06 157.99 19.93 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.956 1.878 . . . . 0.0 109.124 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -143.14 152.48 41.85 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.091 -0.38 . . . . 0.0 110.092 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -117.73 121.87 41.97 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.338 1.855 . . . . 0.0 108.939 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.34 138.78 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.65 105.08 8.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.411 1.484 . . . . 0.0 109.023 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.0 m -137.83 128.15 26.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 127.681 2.392 . . . . 0.0 108.491 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -63.79 -21.54 66.47 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.095 1.316 . . . . 0.0 112.045 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.88 -21.29 66.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.913 1.685 . . . . 0.0 112.651 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -134.24 -29.28 1.26 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.63 -108.21 2.15 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 127.351 2.405 . . . . 0.0 107.432 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -145.13 125.12 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.442 0.697 . . . . 0.0 110.274 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.32 176.92 8.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -128.39 153.4 47.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.894 1.278 . . . . 0.0 110.64 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.64 135.03 61.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.216 1.006 . . . . 0.0 108.985 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 62.1 t0 -99.8 102.71 14.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 126.578 1.951 . . . . 0.0 108.582 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -70.4 -20.36 62.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.245 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.8 m -75.81 -31.44 59.42 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 120.806 -1.184 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -117.79 -2.6 11.34 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 53.56 46.24 26.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.549 2.339 . . . . 0.0 110.252 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -119.49 167.45 11.94 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.78 51.89 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.089 1.355 . . . . 0.0 108.571 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.78 152.94 27.56 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 110.526 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.23 0.07 54.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -118.23 162.92 17.45 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.287 0.949 . . . . 0.0 112.314 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -65.11 143.94 98.96 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 124.557 1.161 . . . . 0.0 109.09 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.36 -168.3 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.021 3.147 . . . . 0.0 113.462 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -137.79 160.16 40.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.378 1.871 . . . . 0.0 107.919 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.94 170.51 22.46 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.22 -155.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.283 3.322 . . . . 0.0 109.395 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 m -137.44 159.23 42.52 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.413 -0.804 . . . . 0.0 111.249 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.93 -38.93 2.14 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.031 2.132 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.786 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -72.75 148.2 44.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.655 1.228 . . . . 0.0 111.334 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -69.72 98.43 1.19 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.425 1.09 . . . . 0.0 111.236 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.12 -88.85 1.18 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 124.55 1.071 . . . . 0.0 111.056 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.7 m -63.43 168.65 4.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.852 0.861 . . . . 0.0 111.668 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -72.79 -12.45 61.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.177 1.791 . . . . 0.0 113.626 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.42 163.01 28.33 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.947 1.261 . . . . 0.0 110.946 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.64 -58.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.169 2.579 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.79 144.96 5.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.635 1.574 . . . . 0.0 108.957 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.34 172.83 13.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -129.02 -9.47 4.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.416 1.486 . . . . 0.0 113.976 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.11 177.46 6.41 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.547 1.539 . . . . 0.0 111.244 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.29 176.71 26.51 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 123.862 0.744 . . . . 0.0 111.359 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.45 156.23 87.19 Favored Pre-proline 0 N--CA 1.468 0.45 0 O-C-N 120.933 -1.334 . . . . 0.0 111.49 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.65 165.17 33.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.86 1.707 . . . . 0.0 109.029 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.16 146.03 93.95 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.286 1.991 . . . . 0.0 110.518 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.1 -17.7 9.2 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.886 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.59 156.53 22.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 120.159 1.98 . . . . 0.0 109.414 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -140.54 153.44 46.16 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.947 -0.471 . . . . 0.0 110.651 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -121.35 121.43 37.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.8 112.42 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -110.58 130.99 55.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.673 1.189 . . . . 0.0 107.812 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -153.44 -162.61 1.49 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.175 2.59 . . . . 0.0 107.95 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -124.95 -24.09 4.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.948 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -69.83 -25.31 63.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.334 0.97 . . . . 0.0 109.895 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -127.89 -15.62 4.81 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.151 1.78 . . . . 0.0 111.873 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.95 -83.64 1.59 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.424 0.556 . . . . 0.0 113.436 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 87.6 m -156.63 129.12 7.58 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.159 -1.2 . . . . 0.0 110.665 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -142.44 171.15 14.45 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.83 149.46 48.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.378 1.471 . . . . 0.0 107.748 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.68 131.93 59.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.608 0.763 . . . . 0.0 108.956 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -94.73 107.41 19.42 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.095 1.358 . . . . 0.0 109.307 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -65.05 -19.03 65.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -76.02 -38.39 57.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.333 1.453 . . . . 0.0 113.414 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -121.0 2.07 10.43 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp 49.92 39.92 19.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.898 2.079 . . . . 0.0 112.316 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -105.86 156.98 17.81 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.23 143.07 48.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.68 1.192 . . . . 0.0 109.031 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -155.08 161.55 41.27 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.656 -0.652 . . . . 0.0 110.967 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.66 19.16 18.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.626 1.17 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.63 152.41 45.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 119.889 -1.757 . . . . 0.0 109.821 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.84 147.7 98.52 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.065 0.946 . . . . 0.0 109.612 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.78 166.63 26.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.5 2.8 . . . . 0.0 115.05 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -138.47 161.32 37.31 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.141 1.776 . . . . 0.0 108.796 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.49 -178.11 39.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.657 2.075 . . . . 0.0 108.73 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.75 161.59 36.34 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.757 2.971 . . . . 0.0 111.94 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 16.4 m -78.84 -175.33 4.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.387 1.075 . . . . 0.0 109.273 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -106.55 -49.83 3.25 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.425 1.09 . . . . 0.0 109.34 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 N-CA-C 105.139 -3.185 . . . . 0.0 105.139 -179.816 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.558 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.08 161.1 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.973 1.309 . . . . 0.0 109.368 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -142.29 153.65 44.07 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.125 1.37 . . . . 0.0 107.654 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.18 177.77 43.6 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.829 1.68 . . . . 0.0 108.976 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -148.53 91.62 1.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.615 1.208 . . . . 0.0 110.33 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -156.6 146.2 20.76 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.952 -1.093 . . . . 0.0 110.541 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.25 169.6 54.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.367 0.984 . . . . 0.0 112.862 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -58.07 -74.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 125.245 3.963 . . . . 0.0 113.592 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pp -155.46 -177.34 6.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.523 1.529 . . . . 0.0 109.1 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -133.16 -176.27 4.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.856 2.063 . . . . 0.0 107.495 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.82 19.94 2.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.468 1.107 . . . . 0.0 111.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -76.0 -177.73 4.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.595 0.758 . . . . 0.0 109.903 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.36 178.25 10.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.686 1.136 . . . . 0.0 110.934 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.7 mt -135.78 153.49 77.31 Favored Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 121.071 -1.252 . . . . 0.0 112.538 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.38 166.34 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.894 . . . . 0.0 110.214 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 140.63 82.54 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 106.966 -1.974 . . . . 0.0 106.966 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.82 -9.63 73.41 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.291 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.9 m95 -104.11 156.17 18.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 121.196 2.498 . . . . 0.0 110.161 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -145.2 157.69 44.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.033 0.933 . . . . 0.0 108.958 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -127.23 121.56 31.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.727 2.411 . . . . 0.0 106.534 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.33 149.21 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 125.789 1.636 . . . . 0.0 109.116 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.28 130.44 38.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 0.0 110.036 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -147.88 170.45 17.63 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.091 1.356 . . . . 0.0 110.56 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.1 m -91.15 -42.58 10.37 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.315 -1.49 . . . . 0.0 107.027 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -64.54 -23.84 67.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.984 1.714 . . . . 0.0 112.374 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -129.07 -12.18 4.66 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 -86.4 1.21 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.58 136.78 13.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.461 0.704 . . . . 0.0 110.678 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.81 161.59 41.51 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.604 1.093 . . . . 0.0 109.571 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -116.34 148.09 40.93 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.575 0.75 . . . . 0.0 109.109 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -107.35 102.48 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.042 1.737 . . . . 0.0 110.342 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -66.04 -18.05 65.09 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.93 -0.481 . . . . 0.0 111.658 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.3 m -73.28 -29.75 62.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.284 0.947 . . . . 0.0 111.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -127.32 -0.96 6.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.63 0.772 . . . . 0.0 112.832 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm 56.75 45.32 22.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.683 1.993 . . . . 0.0 109.899 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -121.79 153.41 38.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.846 0.858 . . . . 0.0 110.684 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.6 143.79 44.44 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.946 1.299 . . . . 0.0 108.881 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -140.01 170.85 15.1 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.909 1.684 . . . . 0.0 109.778 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.6 6.88 20.3 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 161.03 34.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.586 0.63 . . . . 0.0 109.723 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.45 138.91 89.09 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.07 167.65 26.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.372 2.715 . . . . 0.0 114.902 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m -80.05 -73.72 0.34 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.49 175.66 36.94 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.55 -174.66 2.15 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.304 3.336 . . . . 0.0 110.424 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.7 t -99.59 -96.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 m -146.19 171.85 14.32 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.567 1.076 . . . . 0.0 110.284 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.928 179.719 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.54 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.22 174.24 6.66 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.678 1.191 . . . . 0.0 109.018 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 165.01 33.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.122 0.969 . . . . 0.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.89 -170.3 26.43 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.839 2.162 . . . . 0.0 108.288 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -155.57 103.76 2.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 57.7 p -139.28 156.63 46.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.057 0.543 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.88 166.6 53.13 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -51.42 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.507 2.138 . . . . 0.0 107.82 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pp -167.96 178.86 4.93 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 130.324 3.45 . . . . 0.0 105.621 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.67 174.99 10.0 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.236 2.614 . . . . 0.0 106.068 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -136.69 7.94 3.03 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -71.63 179.66 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.2 175.86 8.21 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.205 0.907 . . . . 0.0 112.171 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -132.24 159.9 70.27 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.428 -1.042 . . . . 0.0 113.487 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.73 168.3 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.939 1.759 . . . . 0.0 109.441 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.26 151.11 86.75 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 -8.11 45.13 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.259 -1.3 . . . . 0.0 112.659 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 20.4 m95 -106.42 153.56 22.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 121.375 2.587 . . . . 0.0 110.039 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.07 157.87 45.2 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.513 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -118.32 131.83 56.31 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.976 2.11 . . . . 0.0 105.676 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.22 144.0 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.86 147.49 52.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m -158.57 158.49 34.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.898 2.079 . . . . 0.0 109.949 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -76.78 -43.41 37.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.685 1.13 . . . . 0.0 111.509 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . 0.433 ' HG3' ' CE1' ' B' ' 26' ' ' PHE . 9.8 pt-20 -67.36 -34.66 77.77 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' B' ' 25' ' ' GLU . 15.1 m-85 -98.71 -34.38 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.93 -98.32 1.98 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -147.32 132.09 17.96 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.627 -0.925 . . . . 0.0 110.892 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -140.97 158.03 44.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.546 0.689 . . . . 0.0 109.212 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.21 145.43 42.43 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.3 t -121.21 137.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 122.662 1.22 . . . . 0.0 110.342 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 26.2 t0 -103.08 102.37 12.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.088 2.955 . . . . 0.0 109.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -75.68 -22.95 56.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.62 0.768 . . . . 0.0 109.643 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 71.6 m -67.24 -18.14 65.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.871 1.269 . . . . 0.0 113.101 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.58 -12.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.537 1.135 . . . . 0.0 111.59 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm 65.07 60.42 0.8 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.826 2.05 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -128.61 164.5 22.74 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.468 1.507 . . . . 0.0 108.036 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.21 146.36 50.75 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -150.55 136.96 18.76 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.545 0.738 . . . . 0.0 109.313 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -80.08 20.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.757 1.623 . . . . 0.0 112.501 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 169.79 17.02 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.207 1.403 . . . . 0.0 110.282 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.23 149.59 97.46 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 0.0 110.461 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -68.79 157.75 60.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.073 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 7.5 t -77.59 -48.44 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.92 162.12 9.92 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.761 0.696 . . . . 0.0 112.494 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.49 -174.85 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.21 3.273 . . . . 0.0 110.363 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.3 t -110.92 -109.65 0.34 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -144.2 158.84 43.5 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.282 1.401 . . . . 0.0 109.127 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 117.644 -1.642 . . . . 0.0 109.486 179.653 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.442 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 m -60.94 161.94 7.62 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.621 1.568 . . . . 0.0 109.211 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -141.94 159.1 42.91 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.86 -4.42 9.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.541 1.543 . . . . 0.0 112.623 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -77.02 -168.99 1.19 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.112 1.765 . . . . 0.0 112.555 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -62.59 174.19 1.07 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.539 1.936 . . . . 0.0 111.857 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.33 164.32 6.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.627 1.108 . . . . 0.0 115.462 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.51 -49.67 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.338 2.025 . . . . 0.0 110.245 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -169.07 -166.97 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 C-N-CA 129.224 3.01 . . . . 0.0 106.953 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.41 177.8 2.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.881 1.672 . . . . 0.0 112.008 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 -10.97 5.13 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.758 1.623 . . . . 0.0 111.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -65.92 -1.89 3.41 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 114.336 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.78 -174.57 34.66 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 119.851 -1.781 . . . . 0.0 110.733 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.1 mt -135.42 157.19 77.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 126.105 1.762 . . . . 0.0 108.681 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 14.9 Cg_endo -71.32 155.08 60.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 N-CA-C 109.908 -0.843 . . . . 0.0 109.908 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.48 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 103.789 -3.197 . . . . 0.0 103.789 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.36 -0.41 8.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.391 1.472 . . . . 0.0 110.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.1 m95 -121.08 144.15 48.7 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 119.293 1.546 . . . . 0.0 109.69 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -116.68 150.69 37.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.153 0.981 . . . . 0.0 109.391 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -111.03 136.73 49.6 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.0 t -119.24 124.37 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -117.49 110.91 18.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.637 1.975 . . . . 0.0 108.554 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 p -125.76 171.52 10.59 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.856 1.663 . . . . 0.0 109.958 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -108.47 -23.09 12.01 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.991 -0.443 . . . . 0.0 110.948 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -83.51 -18.74 37.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.056 0.389 . . . . 0.0 111.327 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.82 -61.35 1.51 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.935 1.294 . . . . 0.0 109.078 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.05 -95.4 0.25 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -152.31 132.68 13.71 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 117.933 0.866 . . . . 0.0 111.735 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.77 169.54 19.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.11 152.37 36.63 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.95 131.76 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.082 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.503 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 27.9 t0 -98.0 103.6 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.017 1.727 . . . . 0.0 109.976 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -18.4 65.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -77.84 -35.65 50.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.194 0.906 . . . . 0.0 112.788 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -118.86 4.4 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.033 0.833 . . . . 0.0 113.177 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 53.72 47.31 24.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.642 1.177 . . . . 0.0 110.854 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -120.2 142.59 48.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.493 1.117 . . . . 0.0 111.365 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.72 138.88 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -149.33 146.49 27.55 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 120.063 1.301 . . . . 0.0 113.547 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.85 3.21 46.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.833 1.653 . . . . 0.0 112.098 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.03 143.57 48.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.327 1.451 . . . . 0.0 108.319 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -62.08 142.13 95.57 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 125.71 1.604 . . . . 0.0 110.7 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.49 178.25 6.93 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.907 2.405 . . . . 0.0 111.434 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -133.39 168.83 17.89 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.314 1.046 . . . . 0.0 109.982 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.63 154.83 19.72 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.87 -18.61 21.63 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.368 2.712 . . . . 0.0 114.945 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 t -131.13 168.85 16.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.164 1.347 . . . . 0.0 109.574 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -159.24 -17.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 106.271 -2.731 . . . . 0.0 106.271 -178.683 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.514 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.7 m -150.65 149.15 29.49 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.294 1.038 . . . . 0.0 110.126 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -128.62 -169.14 2.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.712 2.405 . . . . 0.0 108.997 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.19 24.89 74.74 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -112.9 -176.03 2.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.307 2.643 . . . . 0.0 111.972 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -178.43 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.268 2.227 . . . . 0.0 110.246 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.62 161.26 53.74 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -48.94 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.994 3.129 . . . . 0.0 112.903 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.57 168.38 3.18 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.484 2.714 . . . . 0.0 107.091 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.0 167.59 4.68 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.506 0.67 . . . . 0.0 111.178 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -123.97 -1.02 8.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.27 -14.98 30.45 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.39 -175.3 23.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.757 2.122 . . . . 0.0 109.949 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.7 mt -140.44 157.95 67.27 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 125.741 1.616 . . . . 0.0 110.948 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.29 168.15 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.944 1.763 . . . . 0.0 110.334 178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.72 133.21 35.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.899 2.399 . . . . 0.0 108.768 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.63 -18.91 56.19 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.628 1.109 . . . . 0.0 111.96 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 21.9 m95 -93.06 132.55 37.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.199 1.5 . . . . 0.0 108.39 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.8 159.77 35.51 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.54 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -121.16 120.96 36.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.04 133.68 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.62 150.08 46.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -149.29 175.52 11.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 59.2 m -108.1 -12.85 15.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -93.9 -19.65 20.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.99 -53.16 0.8 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.14 -134.81 5.38 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 105.993 -2.843 . . . . 0.0 105.993 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.7 m -130.78 138.28 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.299 1.04 . . . . 0.0 110.19 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -147.18 178.75 8.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.131 0.972 . . . . 0.0 110.022 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -118.19 155.39 30.58 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.102 0.961 . . . . 0.0 110.371 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.53 135.26 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.002 0.921 . . . . 0.0 108.566 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.422 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.2 t0 -103.98 105.52 15.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.67 -20.21 64.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.892 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 39.9 m -74.31 -34.89 63.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.629 0.772 . . . . 0.0 111.793 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.87 -9.92 11.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm 60.72 49.93 5.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.177 1.791 . . . . 0.0 109.195 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -121.65 160.7 23.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.81 1.244 . . . . 0.0 109.109 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.95 139.98 50.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -149.73 137.78 20.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -77.97 -2.83 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -108.65 156.62 19.35 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.458 1.103 . . . . 0.0 109.78 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . 0.427 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 52.2 t-80 -69.76 149.33 96.7 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.931 0.893 . . . . 0.0 108.751 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 72.4 Cg_endo -73.12 -176.95 2.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.709 3.606 . . . . 0.0 115.813 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 35.7 m -134.22 153.17 52.01 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.38 2.272 . . . . 0.0 108.455 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.91 171.9 47.28 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.444 0.545 . . . . 0.0 113.794 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.05 -34.85 3.47 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.568 2.845 . . . . 0.0 111.164 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 19.5 t -140.39 163.62 32.3 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.38 2.672 . . . . 0.0 105.344 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.5 m -143.91 12.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 110.379 -179.281 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.187 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.53 11.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.225 2.61 . . . . 0.0 117.181 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -81.45 72.05 8.48 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.749 -1.22 . . . . 0.0 108.116 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.62 174.0 46.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.4 t -72.37 158.36 35.94 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.1 t -152.48 -63.07 0.16 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.44 169.26 42.39 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.75 -44.96 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.412 2.075 . . . . 0.0 112.191 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.08 -179.75 7.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.112 2.165 . . . . 0.0 109.091 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -93.83 -174.33 3.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.116 0.966 . . . . 0.0 112.035 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -144.5 54.47 1.26 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.877 1.671 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -71.92 -175.93 1.57 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.67 0.788 . . . . 0.0 111.34 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.98 160.29 30.68 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.24 155.84 89.63 Favored Pre-proline 0 C--O 1.233 0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 111.798 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.24 157.98 59.49 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.437 1.425 . . . . 0.0 109.91 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.86 116.52 4.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.347 2.698 . . . . 0.0 107.359 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.18 -9.75 10.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.592 1.567 . . . . 0.0 111.582 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.431 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 23.1 m95 -107.36 163.8 12.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.531 1.166 . . . . 0.0 109.878 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -147.49 153.28 39.32 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.07 0.948 . . . . 0.0 109.775 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -118.43 121.01 39.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.15 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.15 92.12 3.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -127.87 151.96 48.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.788 1.235 . . . . 0.0 110.304 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 m -89.34 -29.53 19.06 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.769 0.827 . . . . 0.0 111.225 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.01 -38.45 88.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.289 0.636 . . . . 0.0 111.74 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -117.27 -40.61 3.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 -170.74 15.47 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.8 m -84.48 117.48 23.7 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.191 1.796 . . . . 0.0 107.892 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.439 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 50.6 p90 -136.36 -179.91 5.97 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 109.976 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -131.51 156.15 46.19 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.181 -0.95 . . . . 0.0 111.322 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.96 143.5 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.622 1.169 . . . . 0.0 109.106 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 23.8 t0 -106.17 118.78 37.51 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 127.39 2.276 . . . . 0.0 110.064 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -74.68 -21.73 59.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.915 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -65.24 -41.56 94.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 112.579 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.97 -1.87 8.78 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.278 1.431 . . . . 0.0 113.971 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 57.78 46.78 16.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 110.453 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -116.2 139.7 50.07 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.92 152.17 23.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.74 163.38 39.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.018 -1.051 . . . . 0.0 110.981 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -105.39 18.95 21.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.458 1.903 . . . . 0.0 111.846 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 154.12 51.84 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.246 -1.533 . . . . 0.0 110.948 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.65 136.67 96.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.01 67.54 4.05 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.918 3.079 . . . . 0.0 114.289 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.37 176.86 10.7 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.292 0.637 . . . . 0.0 111.067 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.19 168.44 44.67 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.076 0.845 . . . . 0.0 111.298 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -82.23 -12.34 10.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.201 3.267 . . . . 0.0 111.856 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.2 p -158.94 -177.18 6.33 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 129.428 3.091 . . . . 0.0 106.392 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 t 60.69 19.41 9.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.629 0.772 . . . . 0.0 111.832 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.28 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.94 0.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.864 2.466 . . . . 0.0 116.919 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -76.66 80.65 3.3 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.9 -175.31 36.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.8 t -67.22 122.53 18.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.7 t -142.44 164.75 29.29 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.506 1.523 . . . . 0.0 107.242 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.46 169.11 53.39 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.98 -33.26 32.97 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.035 2.49 . . . . 0.0 112.131 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.39 162.27 39.33 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 128.553 2.741 . . . . 0.0 107.708 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.63 169.04 18.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.18 0.592 . . . . 0.0 109.971 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -110.9 37.55 2.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.674 1.19 . . . . 0.0 111.899 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.91 171.37 0.95 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.129 1.371 . . . . 0.0 112.157 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 173.17 34.6 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 121.509 -0.744 . . . . 0.0 112.479 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.61 160.74 80.64 Favored Pre-proline 0 C--O 1.235 0.301 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.54 155.76 58.95 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.627 2.218 . . . . 0.0 109.084 177.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.13 94.53 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.379 3.386 . . . . 0.0 109.356 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.57 -7.56 1.53 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.334 1.445 . . . . 0.0 111.509 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -108.56 156.46 19.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.895 0.878 . . . . 0.0 109.293 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.439 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 5.5 tp10 -129.91 155.74 45.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.595 0.758 . . . . 0.0 109.641 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -129.39 121.66 27.83 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.92 142.76 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.16 111.3 10.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 57.7 m -134.01 141.82 47.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.462 1.505 . . . . 0.0 111.407 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -70.01 -25.5 63.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.536 1.062 . . . . 0.0 111.104 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.41 -26.72 63.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.199 -0.905 . . . . 0.0 113.176 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.18 -23.68 2.41 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -107.74 1.66 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.383 1.944 . . . . 0.0 111.82 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 54.5 m -141.85 132.43 25.41 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.488 1.915 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -150.83 174.82 12.64 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.95 0.795 . . . . 0.0 109.771 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -124.93 154.34 41.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.06 0.944 . . . . 0.0 110.511 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.94 143.08 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.601 1.16 . . . . 0.0 109.446 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -106.91 143.21 35.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.951 1.7 . . . . 0.0 108.256 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -105.87 2.21 27.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.136 1.374 . . . . 0.0 111.26 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -91.62 -38.5 12.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.04 1.736 . . . . 0.0 112.658 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -132.25 6.06 4.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.945 2.098 . . . . 0.0 113.145 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt 51.03 52.05 15.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.703 1.601 . . . . 0.0 111.822 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -110.57 150.51 28.85 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.46 146.85 49.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -155.49 172.42 18.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.725 1.148 . . . . 0.0 112.084 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -113.54 13.23 18.75 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 0.0 111.589 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 161.11 23.35 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -70.06 150.84 96.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.102 0.864 . . . . 0.0 110.298 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.01 51.26 3.79 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.874 2.383 . . . . 0.0 111.827 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -141.54 161.06 38.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.371 1.868 . . . . 0.0 109.674 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.71 -176.65 50.99 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.66 -26.82 22.93 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.806 2.337 . . . . 0.0 112.34 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -76.69 -170.31 1.53 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.709 1.604 . . . . 0.0 109.528 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -56.92 -9.85 0.93 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.312 0 CA-C-N 120.454 1.479 . . . . 0.0 109.416 179.345 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -117.87 166.7 12.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.979 1.712 . . . . 0.0 110.245 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -144.24 -8.65 0.68 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.493 0.717 . . . . 0.0 112.885 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.8 -163.32 52.08 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.797 1.181 . . . . 0.0 110.923 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 m -128.31 163.2 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.854 1.662 . . . . 0.0 110.043 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 p -157.17 173.98 16.16 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.485 0.584 . . . . 0.0 109.691 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.5 177.72 52.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.871 -0.518 . . . . 0.0 113.105 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.68 -47.67 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.016 2.477 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.6 pp -164.61 173.42 11.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.4 1.88 . . . . 0.0 109.627 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -158.75 152.32 23.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -81.01 -0.25 38.74 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.3 155.68 31.39 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 119.375 0.989 . . . . 0.0 110.933 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.47 173.03 33.95 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.8 mt -114.7 151.02 44.95 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 122.962 0.505 . . . . 0.0 112.116 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.94 164.11 31.06 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.696 2.264 . . . . 0.0 110.894 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.02 127.97 19.65 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.119 1.879 . . . . 0.0 108.057 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.38 -20.98 31.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.294 0.949 . . . . 0.0 111.567 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.416 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 17.9 m95 -91.98 154.97 18.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.278 1.539 . . . . 0.0 108.171 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -142.07 146.24 35.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -107.25 126.86 52.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.303 1.841 . . . . 0.0 107.293 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.71 117.19 54.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -102.3 137.45 40.54 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.457 1.503 . . . . 0.0 107.829 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -149.44 178.96 8.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.911 0.884 . . . . 0.0 111.688 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.9 m -106.0 -11.05 16.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 0.0 111.412 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -104.41 -47.45 4.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.35 0.595 . . . . 0.0 110.669 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -91.93 -8.27 46.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.078 1.351 . . . . 0.0 113.108 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.17 -88.56 1.19 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.74 134.27 10.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.33 176.48 9.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -134.56 159.79 40.08 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.85 133.41 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.331 0.652 . . . . 0.0 110.284 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 14.9 t0 -92.56 108.37 19.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.893 2.477 . . . . 0.0 107.275 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -68.98 -28.15 66.36 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 122.12 -0.362 . . . . 0.0 111.948 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.5 m -69.6 -44.76 70.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.113 0.965 . . . . 0.0 111.892 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -103.45 -8.2 20.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.389 1.076 . . . . 0.0 113.696 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 55.74 60.81 3.09 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.653 1.581 . . . . 0.0 108.901 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -136.44 154.65 50.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.842 1.257 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.46 149.51 36.2 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -153.29 160.1 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.652 0.781 . . . . 0.0 111.413 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -108.0 13.66 25.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 0.0 113.219 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 160.38 29.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.931 1.292 . . . . 0.0 108.753 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.7 139.93 91.58 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.95 -75.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.964 3.776 . . . . 0.0 114.858 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 t -63.67 -43.65 96.06 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.51 -178.03 47.27 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.968 0.794 . . . . 0.0 112.427 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.78 102.46 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.764 3.643 . . . . 0.0 112.289 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.8 t -75.41 164.8 26.02 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -136.16 50.42 2.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.378 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.553 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -134.0 161.38 34.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.754 0.777 . . . . 0.0 109.62 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -125.89 -1.91 7.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.356 1.062 . . . . 0.0 112.217 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.95 -171.34 22.94 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -121.88 134.23 54.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -139.68 166.82 23.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.872 0.76 . . . . 0.0 112.296 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.59 -168.2 43.12 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.953 1.74 . . . . 0.0 112.758 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.35 -41.99 3.12 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.109 2.539 . . . . 0.0 112.903 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 pp 167.4 -172.67 0.02 OUTLIER 'General case' 0 C--O 1.238 0.457 0 C-N-CA 131.184 3.793 . . . . 0.0 106.853 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -157.76 168.32 27.55 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.22 1.808 . . . . 0.0 107.071 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -83.47 2.29 37.5 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.462 -0.774 . . . . 0.0 112.929 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.36 149.76 19.78 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.314 1.446 . . . . 0.0 110.558 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.77 -179.46 28.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.31 160.44 50.24 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.806 0.803 . . . . 0.0 112.044 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.37 158.06 51.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.235 1.956 . . . . 0.0 109.764 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.13 103.64 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.376 3.384 . . . . 0.0 109.983 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.99 3.52 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.004 1.764 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.181 -1.188 . . . . 0.0 109.151 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.24 155.07 44.42 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.233 0.54 . . . . 0.0 110.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -116.99 136.82 52.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 128.071 2.549 . . . . 0.0 105.365 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.38 143.95 27.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -128.16 137.18 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 m -154.44 -172.64 4.28 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.111 1.764 . . . . 0.0 110.508 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -105.21 -59.22 1.78 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -60.69 -18.04 51.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 114.192 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.72 -12.77 5.98 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.584 1.154 . . . . 0.0 114.06 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.64 -92.02 0.78 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.463 1.982 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.19 127.5 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.133 -0.627 . . . . 0.0 111.61 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -141.85 174.07 10.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.616 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.82 146.87 50.8 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.383 -1.448 . . . . 0.0 110.768 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.86 136.79 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.024 1.329 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -97.44 112.82 24.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.471 1.908 . . . . 0.0 106.328 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -22.57 53.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.899 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -67.08 -53.18 33.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.01 1.277 . . . . 0.0 111.746 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.78 -4.04 31.44 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.353 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm 56.55 58.14 4.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.533 1.533 . . . . 0.0 107.072 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -119.66 169.6 9.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.175 1.39 . . . . 0.0 109.693 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.65 146.39 50.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.245 1.018 . . . . 0.0 110.43 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.45 167.67 21.64 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.937 1.295 . . . . 0.0 109.487 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.7 4.88 18.85 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.045 0.938 . . . . 0.0 113.153 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.08 176.36 8.14 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.96 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -71.54 141.54 85.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.85 -73.45 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.16 2.573 . . . . 0.0 114.733 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.8 m -66.58 -21.76 66.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.123 1.328 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 -166.52 52.72 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.85 151.32 84.57 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -134.37 170.37 15.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.451 . . . . 0.0 107.769 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -131.77 88.45 2.57 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 108.489 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.58 -179.761 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -87.02 88.73 7.77 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p -116.06 148.12 40.55 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.722 1.209 . . . . 0.0 110.408 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.99 64.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.5 m -78.18 89.83 4.27 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.23 -177.85 6.29 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.343 2.257 . . . . 0.0 107.718 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.95 176.46 25.6 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.74 -75.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.015 1.81 . . . . 0.0 111.752 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.77 111.17 16.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.992 1.717 . . . . 0.0 106.978 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -136.29 174.16 10.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.408 1.483 . . . . 0.0 107.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.4 ptp85 -123.72 20.32 9.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.625 1.57 . . . . 0.0 109.357 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -129.84 151.33 50.53 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.84 -74.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.15 160.85 27.89 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 125.306 1.442 . . . . 0.0 112.585 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.67 159.51 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.066 2.511 . . . . 0.0 110.773 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.79 117.6 5.12 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.971 2.448 . . . . 0.0 107.038 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.58 -20.76 8.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.317 1.437 . . . . 0.0 112.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.5 m95 -90.99 157.43 17.29 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 119.793 1.796 . . . . 0.0 110.005 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -135.03 145.15 47.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -118.53 130.53 55.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.57 139.4 47.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 140.29 49.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.594 1.958 . . . . 0.0 106.761 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.45 150.87 20.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.26 1.024 . . . . 0.0 108.374 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -74.27 -24.1 59.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.743 1.156 . . . . 0.0 110.35 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.43 -39.03 28.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.418 1.087 . . . . 0.0 113.732 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -109.55 -9.23 14.91 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.106 . . . . 0.0 113.528 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.32 -88.82 1.1 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 126.404 1.954 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 m -152.98 119.77 5.71 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.54 168.13 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.948 0.899 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -125.48 139.54 53.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.364 1.066 . . . . 0.0 109.695 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.5 t -122.12 131.87 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.02 0.928 . . . . 0.0 110.08 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.6 t0 -91.24 121.85 33.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 127.144 2.178 . . . . 0.0 108.836 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -85.97 -9.87 56.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.988 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -73.07 -43.56 61.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.794 1.179 . . . . 0.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -120.49 2.92 10.76 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.96 1.304 . . . . 0.0 112.871 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 56.59 45.84 21.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 110.973 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -117.21 138.6 51.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.28 20.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -151.91 164.95 36.04 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.322 1.058 . . . . 0.0 110.482 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.427 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 51.7 m-85 -107.76 26.4 10.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.8 1.64 . . . . 0.0 111.204 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -140.55 160.96 38.86 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -74.61 141.5 76.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.586 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.32 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.438 2.092 . . . . 0.0 112.444 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m -134.36 -47.45 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.358 0.663 . . . . 0.0 111.943 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.91 174.91 5.57 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.817 -0.552 . . . . 0.0 112.359 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.12 177.84 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.081 2.521 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.0 p -140.44 159.55 41.94 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.612 1.565 . . . . 0.0 106.809 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -144.47 3.21 1.14 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.081 . . . . 0.0 111.888 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.637 0 N-CA-C 105.591 -3.004 . . . . 0.0 105.591 179.739 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -78.67 143.43 36.3 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.681 1.24 . . . . 0.0 110.59 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -167.52 172.15 9.74 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.693 1.197 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.59 84.31 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 105.59 -3.004 . . . . 0.0 105.59 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.8 m -65.13 88.49 0.07 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.703 1.201 . . . . 0.0 107.873 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 14.6 p -140.44 173.95 10.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.932 2.093 . . . . 0.0 111.791 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.89 172.41 54.13 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.92 -66.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.421 2.081 . . . . 0.0 113.621 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -133.26 102.93 5.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.082 0.953 . . . . 0.0 110.441 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -134.88 177.37 7.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.173 2.589 . . . . 0.0 107.878 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -116.83 9.83 14.0 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.978 1.311 . . . . 0.0 111.902 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -120.16 141.37 49.93 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.941 0.896 . . . . 0.0 111.0 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.74 -3.8 11.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.53 1.538 . . . . 0.0 114.35 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -134.07 157.23 78.14 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 120.283 2.042 . . . . 0.0 110.044 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.04 157.53 57.6 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.234 1.29 . . . . 0.0 110.373 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.12 125.25 13.78 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.648 2.232 . . . . 0.0 106.349 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.92 -10.84 27.34 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.779 1.657 . . . . 0.0 110.75 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.434 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 27.7 m95 -113.04 148.98 34.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.897 1.349 . . . . 0.0 109.695 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -139.3 155.83 47.46 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.927 0.767 . . . . 0.0 109.779 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -116.15 138.69 51.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.731 1.612 . . . . 0.0 108.257 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.59 139.58 42.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.43 133.26 46.21 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -149.02 172.03 15.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.885 1.274 . . . . 0.0 113.685 -175.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m -84.93 -32.48 23.07 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.541 1.137 . . . . 0.0 113.921 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -100.89 -12.03 19.31 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.464 1.106 . . . . 0.0 112.667 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -116.86 -21.08 9.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.315 1.046 . . . . 0.0 111.57 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.61 -89.97 1.34 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 24.1 m -156.74 129.16 7.52 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.082 -1.246 . . . . 0.0 109.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -138.45 174.75 10.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -130.53 143.03 50.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 22.2 t -119.19 131.78 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 12.2 t0 -92.66 109.32 20.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.57 -11.83 60.3 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.662 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.7 m -66.84 -41.25 87.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.498 1.499 . . . . 0.0 110.572 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.02 1.73 8.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.427 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 46.1 mmtm 59.39 51.75 6.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.756 1.222 . . . . 0.0 109.466 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -122.68 146.05 47.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.57 131.36 54.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -134.68 157.89 45.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.492 1.117 . . . . 0.0 108.291 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -104.26 3.21 32.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -105.04 156.04 18.42 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.826 1.65 . . . . 0.0 109.107 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -69.13 149.61 97.6 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-O 117.541 -1.219 . . . . 0.0 107.966 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.49 160.43 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.352 1.519 . . . . 0.0 110.276 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.2 m -130.42 -66.32 0.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.833 0.853 . . . . 0.0 110.829 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.01 177.02 28.22 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.211 0.459 . . . . 0.0 113.749 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.17 178.93 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.202 3.268 . . . . 0.0 110.436 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 66.3 p -147.74 166.62 26.93 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.779 0.832 . . . . 0.0 109.587 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.2 14.57 2.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.945 1.698 . . . . 0.0 110.611 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.477 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.565 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.903 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.59 177.04 4.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.195 1.398 . . . . 0.0 109.746 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 t -153.7 173.35 15.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.083 0.953 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 38.98 2.95 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.492 1.52 . . . . 0.0 110.882 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.3 m -132.32 139.12 48.05 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.404 1.081 . . . . 0.0 111.58 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 p -77.82 167.14 22.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.15 179.81 31.77 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.46 -39.37 2.8 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.315 2.01 . . . . 0.0 110.991 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -142.73 152.13 42.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.685 1.594 . . . . 0.0 110.05 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.2 -169.04 1.9 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.9 mtm-85 -138.61 -32.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.804 1.242 . . . . 0.0 110.164 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.43 170.72 11.37 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.433 1.493 . . . . 0.0 110.575 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.72 170.9 54.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 122.404 1.002 . . . . 0.0 110.782 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.6 mt -82.82 162.71 54.33 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 125.835 1.654 . . . . 0.0 110.738 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.21 164.97 31.95 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.601 1.534 . . . . 0.0 109.982 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.69 149.03 78.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 N-CA-C 105.698 -2.462 . . . . 0.0 105.698 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.72 -11.43 70.32 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -111.7 136.18 51.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.431 1.615 . . . . 0.0 107.405 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.6 152.09 37.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 0.0 110.388 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -115.68 120.51 39.6 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.1 t -104.53 138.53 28.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.98 129.09 50.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.965 1.306 . . . . 0.0 107.816 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -147.76 169.22 20.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.812 2.045 . . . . 0.0 108.213 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -105.7 -23.89 12.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -78.16 -35.1 49.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -96.5 -69.65 0.75 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.978 1.311 . . . . 0.0 108.851 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.97 -132.75 6.27 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 104.316 -3.514 . . . . 0.0 104.316 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.97 132.14 54.46 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 109.421 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -141.71 166.51 24.52 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.512 0.725 . . . . 0.0 109.682 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -122.55 139.64 53.68 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 111.035 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.61 148.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -108.08 113.03 25.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.214 1.806 . . . . 0.0 111.963 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -21.08 64.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.695 0.679 . . . . 0.0 111.748 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -73.63 -30.85 63.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.17 0.988 . . . . 0.0 113.045 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -129.13 -1.09 5.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' CE ' ' CE2' ' B' ' 40' ' ' TYR . 17.6 mmtp 59.06 46.7 12.99 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.679 1.192 . . . . 0.0 110.616 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -125.35 146.41 49.59 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.635 -0.665 . . . . 0.0 110.78 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.19 142.11 36.42 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 107.858 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -148.83 161.48 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 108.833 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -106.99 14.17 26.74 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.948 0.899 . . . . 0.0 111.002 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -118.51 160.29 22.01 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 120.97 -1.081 . . . . 0.0 110.744 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.88 133.83 88.09 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.947 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.06 24.32 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.362 3.374 . . . . 0.0 115.398 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.9 p -63.67 -38.67 92.01 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.948 1.249 . . . . 0.0 109.98 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.34 -173.48 46.14 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.55 167.3 27.61 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.815 2.343 . . . . 0.0 110.221 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -120.95 161.45 21.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -147.72 105.78 3.74 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.94 -1.1 . . . . 0.0 108.605 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.657 0 N-CA-C 105.121 -3.192 . . . . 0.0 105.121 -178.884 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.495 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -71.18 -177.02 1.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.037 2.135 . . . . 0.0 110.779 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -158.45 169.91 23.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.631 1.172 . . . . 0.0 108.469 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.72 95.98 1.14 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -176.17 144.45 0.57 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.583 1.953 . . . . 0.0 108.392 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.8 p -74.94 175.52 8.02 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.094 1.357 . . . . 0.0 109.654 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.27 166.53 39.31 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.205 -0.934 . . . . 0.0 111.732 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.28 -35.25 63.81 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.399 2.733 . . . . 0.0 113.097 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 pp -142.52 -173.48 3.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.837 2.455 . . . . 0.0 108.403 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -134.02 143.98 48.42 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -95.69 27.16 3.6 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.39 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.02 177.38 8.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.033 0.921 . . . . 0.0 113.016 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.48 171.81 51.16 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 125.167 1.365 . . . . 0.0 112.207 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 74.8 mt -90.54 160.13 39.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.594 1.158 . . . . 0.0 111.842 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -67.2 157.19 62.94 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.042 1.828 . . . . 0.0 109.407 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.18 93.34 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.573 3.515 . . . . 0.0 111.64 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.36 -19.65 2.26 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.279 1.419 . . . . 0.0 111.153 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.414 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 18.6 m95 -94.43 149.89 20.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -131.74 141.09 49.43 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.07 0.548 . . . . 0.0 109.788 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -107.48 121.83 45.41 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.0 t -110.91 141.53 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -130.18 150.23 51.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 m -154.87 -165.63 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.115 1.366 . . . . 0.0 109.435 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.0 m -115.43 -45.16 2.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.07 0.948 . . . . 0.0 108.957 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.79 -14.73 62.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.989 0.516 . . . . 0.0 110.559 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.61 -25.63 4.32 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.69 1.596 . . . . 0.0 113.192 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.79 -86.61 1.55 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.9 m -159.61 140.06 12.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.121 1.46 . . . . 0.0 110.577 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.64 176.34 9.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.414 -0.804 . . . . 0.0 109.689 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.34 151.9 50.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 108.931 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.5 t -128.32 136.6 59.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.217 1.007 . . . . 0.0 109.136 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.414 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.3 t0 -101.53 104.08 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.978 1.311 . . . . 0.0 108.879 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.24 -19.89 66.18 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.795 -0.565 . . . . 0.0 111.26 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.45 -33.16 69.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.682 1.593 . . . . 0.0 112.661 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -126.78 0.75 6.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 54.57 36.99 27.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -111.75 161.16 16.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.37 148.44 48.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.986 0.914 . . . . 0.0 108.587 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.42 168.51 26.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.82 1.248 . . . . 0.0 110.118 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.502 ' CE2' ' CE ' ' A' ' 36' ' ' LYS . 69.2 m-85 -105.36 -1.02 25.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.8 167.88 9.5 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.064 -1.023 . . . . 0.0 111.233 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.29 149.89 89.35 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.44 45.49 1.43 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.447 2.765 . . . . 0.0 115.436 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 45.5 p -69.22 -58.41 4.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.196 0.907 . . . . 0.0 111.756 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.28 43.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.64 170.87 19.34 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.82 2.347 . . . . 0.0 110.311 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.4 m -135.41 176.6 8.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.94 0.896 . . . . 0.0 110.675 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -149.36 163.12 38.62 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 128.595 2.758 . . . . 0.0 104.326 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 N-CA-C 105.262 -3.135 . . . . 0.0 105.262 -178.89 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -89.37 113.67 25.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 108.759 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -100.04 113.28 25.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.45 -171.42 26.35 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m -164.94 175.49 9.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.903 1.681 . . . . 0.0 109.399 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.9 m -128.49 24.42 5.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.805 2.042 . . . . 0.0 111.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.9 -178.82 16.4 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.014 0.816 . . . . 0.0 112.453 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.31 -36.79 3.77 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.357 2.704 . . . . 0.0 112.331 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.42 163.13 33.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.573 2.349 . . . . 0.0 107.77 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -130.49 173.55 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.936 1.295 . . . . 0.0 110.673 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -132.39 69.36 1.48 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.61 1.564 . . . . 0.0 107.02 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -142.7 174.67 10.44 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.021 0.929 . . . . 0.0 109.961 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.58 -163.69 38.8 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.6 mt -125.4 155.05 72.28 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.65 1.225 . . . . 0.0 111.917 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.56 162.39 42.36 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.119 1.879 . . . . 0.0 110.705 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 121.22 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.12 2.546 . . . . 0.0 110.41 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.42 47.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.315 1.435 . . . . 0.0 112.904 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.2 m95 -92.2 151.09 20.54 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.454 1.627 . . . . 0.0 108.151 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.02 154.74 47.87 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.557 1.143 . . . . 0.0 109.919 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -125.87 124.86 41.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t -108.33 115.03 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 108.426 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.67 128.27 44.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.5 m -139.94 -173.72 3.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.575 1.15 . . . . 0.0 109.885 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -116.45 -43.96 2.9 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.853 1.261 . . . . 0.0 108.801 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.55 -18.81 62.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.928 0.891 . . . . 0.0 112.695 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -128.17 -19.28 3.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.3 -100.24 1.79 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -157.95 139.58 13.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.493 0.717 . . . . 0.0 109.641 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -146.31 170.57 16.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -119.33 152.79 36.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.576 1.55 . . . . 0.0 107.59 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.44 135.33 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.204 0.601 . . . . 0.0 110.321 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 20.4 t0 -101.53 106.19 17.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.248 1.419 . . . . 0.0 108.176 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.94 -13.87 61.76 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.561 -0.712 . . . . 0.0 111.233 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.5 m -75.11 -39.12 60.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.88 1.218 . . . . 0.0 112.528 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -124.25 8.12 8.5 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm 54.18 53.72 10.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.421 1.488 . . . . 0.0 109.414 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -121.97 134.93 54.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.792 1.637 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 135.35 39.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.318 1.447 . . . . 0.0 107.621 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -139.07 153.63 48.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.848 1.204 . . . . 0.0 113.227 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -96.96 15.81 21.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.891 1.276 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 158.44 43.99 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 119.955 -1.716 . . . . 0.0 109.742 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -58.37 141.71 82.71 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 124.391 1.057 . . . . 0.0 110.726 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.97 94.47 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.743 2.295 . . . . 0.0 109.306 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.2 m -47.08 -33.64 5.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 0.0 113.128 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.05 158.16 28.6 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.3 0.955 . . . . 0.0 112.142 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.87 -13.45 21.72 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.671 2.914 . . . . 0.0 111.478 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 m -166.87 177.86 6.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.477 3.511 . . . . 0.0 105.754 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -25.63 8.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.923 0.889 . . . . 0.0 112.386 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 -179.687 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -150.53 171.0 17.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.728 1.611 . . . . 0.0 108.39 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.1 p -162.41 121.63 2.29 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.68 170.47 41.43 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 123.857 0.741 . . . . 0.0 111.306 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -148.12 -179.36 6.87 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.322 1.849 . . . . 0.0 108.423 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 19.3 t -128.02 -33.96 2.17 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.519 1.128 . . . . 0.0 110.86 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.31 169.39 35.45 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 119.216 0.917 . . . . 0.0 111.882 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.32 -37.75 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.781 2.321 . . . . 0.0 111.576 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -142.61 106.35 4.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.58 1.952 . . . . 0.0 108.644 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.39 172.25 13.9 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -133.14 -19.98 2.18 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.62 169.97 17.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.54 175.35 21.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.272 0.939 . . . . 0.0 112.122 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.02 160.73 25.31 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.643 1.577 . . . . 0.0 111.887 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -69.06 163.35 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.914 1.742 . . . . 0.0 109.336 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.0 137.79 49.99 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.31 74.24 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.635 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -114.3 142.03 46.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 121.171 2.486 . . . . 0.0 109.094 177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -125.32 157.68 36.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.647 0.779 . . . . 0.0 110.553 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -128.05 125.04 38.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.469 2.308 . . . . 0.0 106.906 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.51 133.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.96 119.06 35.94 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 65.1 m -138.51 158.46 44.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.462 1.105 . . . . 0.0 109.738 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -84.81 -39.55 18.22 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.695 -1.253 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.26 -16.24 59.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -124.83 -13.04 7.01 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.91 -94.66 1.99 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.998 1.761 . . . . 0.0 110.543 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -151.91 135.83 16.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.037 -0.684 . . . . 0.0 110.47 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -148.54 167.79 24.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.22 155.05 37.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 108.337 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.9 139.31 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.889 0.852 . . . . 0.0 109.236 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -100.61 102.47 13.62 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 128.533 2.733 . . . . 0.0 106.938 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -20.19 64.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.535 0.607 . . . . 0.0 112.413 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -71.86 -36.88 70.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.375 0.989 . . . . 0.0 110.7 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -116.82 -1.47 12.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 58.02 53.52 6.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.027 1.331 . . . . 0.0 108.285 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -123.41 147.38 47.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.702 0.401 . . . . 0.0 110.016 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.85 136.23 48.76 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 150.41 40.74 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.856 0.753 . . . . 0.0 110.376 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -88.73 1.32 55.35 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 156.5 33.61 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.583 1.153 . . . . 0.0 110.169 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -64.48 146.42 98.09 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.21 144.51 90.45 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m -87.06 -13.65 43.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.781 1.232 . . . . 0.0 113.151 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.83 162.91 10.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.773 1.178 . . . . 0.0 111.878 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.55 -57.33 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.865 3.043 . . . . 0.0 112.625 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 3.6 m -133.22 149.48 52.0 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.249 0.931 . . . . 0.0 111.471 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -17.95 58.78 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.773 0.829 . . . . 0.0 111.329 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.633 2.54 . . . . 0.0 106.777 -179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 m -141.48 88.93 2.18 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -167.27 162.69 15.1 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.265 1.426 . . . . 0.0 108.334 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.69 58.6 0.5 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p -138.7 162.24 35.17 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.646 1.579 . . . . 0.0 108.516 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 p -85.19 -169.28 2.57 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.726 0.811 . . . . 0.0 110.054 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.09 -179.98 21.79 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.6 -32.39 79.39 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.069 2.513 . . . . 0.0 112.15 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 11' ' ' ARG . 0.3 OUTLIER -157.48 167.18 30.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.729 2.011 . . . . 0.0 108.727 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -73.79 31.95 0.08 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.366 2.266 . . . . 0.0 110.465 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 9' ' ' LEU . 64.4 mtm180 56.22 36.75 27.99 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.318 1.847 . . . . 0.0 111.286 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.98 84.9 2.88 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 129.495 3.118 . . . . 0.0 104.744 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.67 74.14 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 O-C-N 121.078 -1.014 . . . . 0.0 111.579 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.35 157.59 63.03 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.41 0.684 . . . . 0.0 112.542 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.62 168.66 23.27 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.575 2.184 . . . . 0.0 109.105 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.9 149.88 72.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 -11.44 44.51 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.554 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -99.68 151.8 20.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.475 1.638 . . . . 0.0 106.619 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -135.63 151.98 50.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.922 0.489 . . . . 0.0 110.004 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -111.14 129.72 55.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.31 143.97 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.33 149.88 51.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -155.31 148.96 25.28 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.401 1.08 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -76.23 -19.48 58.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -85.37 -20.09 30.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.337 1.055 . . . . 0.0 113.209 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.53 -46.0 1.77 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.67 -109.39 1.1 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -138.56 129.23 26.37 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -144.69 163.21 34.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.75 149.03 39.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 111.444 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.14 142.49 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.492 0.717 . . . . 0.0 109.744 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 119.44 39.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 127.907 2.483 . . . . 0.0 108.844 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -84.61 -20.97 30.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -76.84 -31.98 57.25 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.284 1.034 . . . . 0.0 110.085 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -117.38 -9.42 10.9 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp 56.86 50.46 12.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.07 1.348 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -126.05 160.19 30.74 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.661 0.785 . . . . 0.0 110.287 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.77 139.5 53.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.376 1.471 . . . . 0.0 109.37 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -153.9 144.68 22.57 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.631 1.173 . . . . 0.0 108.688 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -91.25 24.41 2.92 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.46 0.704 . . . . 0.0 109.845 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 154.28 47.99 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.573 -1.329 . . . . 0.0 111.036 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.95 143.99 98.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.92 -23.78 13.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.845 2.364 . . . . 0.0 116.658 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t 61.72 18.75 9.92 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.935 1.698 . . . . 0.0 112.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.08 168.46 41.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.459 1.028 . . . . 0.0 112.0 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.33 -34.45 15.99 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.563 2.175 . . . . 0.0 112.524 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -157.75 179.04 9.59 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.371 2.269 . . . . 0.0 106.384 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 t -143.9 152.69 41.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.935 0.874 . . . . 0.0 109.286 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.819 0 C-N-CA 126.805 2.145 . . . . 0.0 107.865 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -71.77 80.4 0.86 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.301 1.041 . . . . 0.0 109.143 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -153.4 157.51 40.08 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.901 1.28 . . . . 0.0 107.905 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.54 82.43 0.18 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -147.0 163.42 36.27 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.405 1.482 . . . . 0.0 108.263 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 30.7 p -78.02 -174.5 3.62 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.467 0.707 . . . . 0.0 111.061 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.67 175.28 23.71 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.299 1.428 . . . . 0.0 110.703 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.34 -32.54 20.08 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.917 3.078 . . . . 0.0 113.373 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.06 163.06 18.22 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.013 2.925 . . . . 0.0 105.271 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.64 154.02 40.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.785 0.802 . . . . 0.0 111.832 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -74.72 56.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.823 2.449 . . . . 0.0 109.137 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.91 -28.75 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -15.44 90.68 0.01 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 129.38 3.372 . . . . 0.0 114.185 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.63 154.37 85.47 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.48 166.91 27.89 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.923 2.415 . . . . 0.0 110.291 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.67 118.63 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.703 2.268 . . . . 0.0 109.975 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.5 -11.96 33.12 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.181 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 32.2 m95 -100.54 150.43 22.68 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 119.303 1.551 . . . . 0.0 108.373 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.02 168.03 19.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 108.669 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -133.06 121.34 22.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.116 1.366 . . . . 0.0 108.585 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.76 107.98 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 124.168 0.917 . . . . 0.0 109.221 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -95.48 133.36 39.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.3 m -155.78 -177.64 6.71 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.006 -1.684 . . . . 0.0 110.833 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -102.68 -44.75 5.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.806 0.843 . . . . 0.0 111.896 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.74 -11.85 59.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.69 -19.86 3.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.17 -105.33 3.26 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -144.96 124.19 12.95 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.909 0.484 . . . . 0.0 110.905 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.45 178.51 7.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.373 1.069 . . . . 0.0 108.838 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.35 155.57 47.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.557 1.143 . . . . 0.0 109.767 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.4 131.58 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.473 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 51.7 t0 -98.82 104.66 16.72 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -70.06 -21.95 63.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.843 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 90.3 m -67.7 -45.19 75.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.837 1.653 . . . . 0.0 110.823 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -106.63 1.11 24.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.81 0.844 . . . . 0.0 112.424 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp 49.85 54.73 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.756 2.022 . . . . 0.0 110.611 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -119.62 167.39 12.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.089 0.956 . . . . 0.0 109.168 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 143.32 50.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -155.05 149.43 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.896 0.878 . . . . 0.0 108.968 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -90.98 -8.76 48.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.226 1.01 . . . . 0.0 110.14 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -93.56 152.4 19.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 124.539 1.136 . . . . 0.0 108.584 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . 0.405 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 42.5 t-80 -67.26 151.33 97.26 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.61 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 92.0 Cg_endo -84.21 -31.86 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 N-CA-C 117.357 2.022 . . . . 0.0 117.357 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t 63.67 3.27 1.48 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.135 0.88 . . . . 0.0 113.239 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.23 166.77 42.68 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.807 1.64 . . . . 0.0 114.059 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.4 -35.39 23.72 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.797 2.998 . . . . 0.0 113.753 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.0 m -146.21 -173.9 4.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 112.473 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.1 t -132.99 121.08 22.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -179.626 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.97 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 m -163.15 169.99 18.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.358 1.863 . . . . 0.0 107.68 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -61.89 147.08 47.85 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.04 85.89 0.14 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -60.56 110.29 1.24 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -157.91 155.36 29.43 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.75 170.35 14.86 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.583 1.087 . . . . 0.0 110.573 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.44 -42.82 44.96 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.032 2.488 . . . . 0.0 113.611 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.95 131.79 13.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.202 1.801 . . . . 0.0 106.212 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -144.94 157.86 44.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.49 1.916 . . . . 0.0 106.55 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -103.23 13.62 33.51 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.19 -179.84 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.518 1.127 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.57 -165.7 31.15 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.563 1.554 . . . . 0.0 110.442 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.84 162.88 38.47 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 124.934 1.294 . . . . 0.0 111.695 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 40.5 Cg_endo -72.09 164.55 35.31 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.405 1.403 . . . . 0.0 109.304 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.18 134.65 40.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.57 1.513 . . . . 0.0 108.919 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.68 -10.8 72.19 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 117.615 -1.659 . . . . 0.0 114.216 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.42 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.2 m95 -93.91 168.18 11.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.147 1.973 . . . . 0.0 109.181 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -140.95 156.27 46.1 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.608 0.763 . . . . 0.0 109.986 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -125.04 129.99 51.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.68 132.74 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.32 139.61 41.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -142.84 -172.41 3.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.8 2.44 . . . . 0.0 109.819 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -126.28 -38.86 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.535 1.934 . . . . 0.0 107.594 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -34.8 71.24 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -113.33 -17.11 12.37 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.76 -85.7 1.51 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -157.63 146.03 19.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.343 1.072 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -154.63 166.99 31.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.296 0.638 . . . . 0.0 109.606 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.0 144.98 45.09 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.78 142.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.823 0.849 . . . . 0.0 110.261 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -107.43 112.55 25.4 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 127.255 2.222 . . . . 0.0 109.498 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -74.22 -22.37 59.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.767 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.4 m -69.53 -34.1 73.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.59 1.086 . . . . 0.0 112.148 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -121.92 1.84 9.9 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.341 0.656 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HE3' ' CE1' ' B' ' 40' ' ' TYR . 34.9 mmtm 51.15 52.5 14.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.983 1.713 . . . . 0.0 108.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -121.75 154.84 36.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.664 0.786 . . . . 0.0 108.984 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.83 140.95 51.03 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.67 1.188 . . . . 0.0 108.371 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -150.22 147.28 27.51 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.522 -0.736 . . . . 0.0 110.527 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.31 -13.28 52.87 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.365 1.466 . . . . 0.0 112.965 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.69 144.01 27.1 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.481 1.912 . . . . 0.0 107.158 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -68.05 142.14 94.91 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.2 -169.09 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.822 3.015 . . . . 0.0 112.591 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.1 t -129.05 -31.88 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.222 1.009 . . . . 0.0 110.512 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.58 -170.59 2.66 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 119.336 0.971 . . . . 0.0 113.807 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.15 -69.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.44 2.76 . . . . 0.0 110.621 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.8 m -155.91 -174.46 4.97 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.831 2.853 . . . . 0.0 107.773 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -63.32 168.03 4.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.129 0.971 . . . . 0.0 109.426 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 N-CA-C 105.644 -2.982 . . . . 0.0 105.644 179.372 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -134.97 167.84 20.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.183 0.992 . . . . 0.0 110.5 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m 54.2 80.98 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 126.672 1.989 . . . . 0.0 108.483 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.83 80.86 0.22 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -61.87 106.67 0.72 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.517 1.527 . . . . 0.0 109.25 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.9 t -142.61 154.64 44.58 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.07 172.41 14.32 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.843 1.201 . . . . 0.0 113.382 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.7 -37.18 81.03 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.609 2.206 . . . . 0.0 109.465 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 pp -176.85 134.32 0.21 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.81 3.644 . . . . 0.0 105.516 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 -167.06 2.05 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 131.457 3.903 . . . . 0.0 106.325 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -140.44 15.56 2.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.947 1.249 . . . . 0.0 113.935 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.31 -178.29 2.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.821 1.248 . . . . 0.0 112.007 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.35 -165.63 24.73 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.092 1.329 . . . . 0.0 111.611 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt -129.61 157.69 75.76 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.034 0.933 . . . . 0.0 111.007 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -74.25 164.0 35.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.59 2.194 . . . . 0.0 112.773 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.74 130.69 26.95 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 105.282 -2.622 . . . . 0.0 105.282 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.2 -1.83 56.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.532 -1.705 . . . . 0.0 113.283 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.431 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 16.0 m95 -117.18 165.98 12.79 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.226 2.013 . . . . 0.0 111.467 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -152.1 150.89 30.41 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.116 0.966 . . . . 0.0 109.153 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -104.59 149.46 25.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.04 114.43 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -105.9 145.94 30.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -156.22 -168.14 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.639 1.175 . . . . 0.0 109.364 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -120.6 -44.07 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.478 1.911 . . . . 0.0 107.954 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -63.88 -25.12 68.01 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.325 1.05 . . . . 0.0 113.263 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.01 -33.15 3.38 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.2 -104.51 1.35 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -150.24 136.47 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -151.09 -175.3 5.1 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -132.35 155.77 47.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.093 1.357 . . . . 0.0 109.43 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.61 133.63 61.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.431 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 57.2 t0 -97.06 111.51 23.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.166 1.787 . . . . 0.0 110.587 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -70.75 -18.75 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.436 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -67.52 -37.03 82.16 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.947 1.699 . . . . 0.0 112.377 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -127.13 3.96 6.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.585 0.754 . . . . 0.0 112.724 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 53.4 42.85 31.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.216 1.806 . . . . 0.0 110.878 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -113.97 161.37 17.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.03 146.92 46.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -158.06 155.6 29.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.321 1.048 . . . . 0.0 109.126 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . 0.41 ' CE1' ' HE3' ' A' ' 36' ' ' LYS . 75.5 m-85 -95.04 -4.2 46.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.568 1.147 . . . . 0.0 112.574 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.85 140.5 37.05 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . 0.469 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 61.1 t-80 -59.24 151.89 55.77 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 124.411 1.085 . . . . 0.0 109.672 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 87.0 Cg_endo -70.43 -158.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.121 1.88 . . . . 0.0 110.283 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.18 -58.12 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.595 1.558 . . . . 0.0 107.523 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 159.43 23.67 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.14 -35.59 6.72 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.398 2.066 . . . . 0.0 110.099 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 36.9 m -168.12 172.02 9.05 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 131.546 3.938 . . . . 0.0 107.128 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -69.75 161.63 29.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.396 179.753 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.449 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -78.95 170.64 16.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.511 0.655 . . . . 0.0 111.928 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 128.77 56.56 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 127.818 2.447 . . . . 0.0 105.913 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.11 -8.02 0.56 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.411 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -130.94 153.31 49.32 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.524 1.662 . . . . 0.0 110.75 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.7 t -107.36 152.29 24.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.33 1.852 . . . . 0.0 107.52 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.04 168.97 41.95 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 -42.36 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.373 2.049 . . . . 0.0 113.628 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -161.22 179.27 8.49 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.903 1.281 . . . . 0.0 108.687 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.13 162.11 35.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.674 0.79 . . . . 0.0 111.341 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.14 -9.47 4.78 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.83 1.252 . . . . 0.0 111.478 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.25 -178.15 1.96 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.164 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.82 158.67 49.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.5 mt -80.8 160.94 65.38 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 121.107 -1.231 . . . . 0.0 110.755 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.65 163.54 36.59 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 107.965 -1.59 . . . . 0.0 107.965 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.1 149.99 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.23 -21.47 10.18 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.83 1.205 . . . . 0.0 112.64 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -88.12 143.54 27.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.759 1.78 . . . . 0.0 107.74 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HG2' ' HH ' ' B' ' 29' ' ' TYR . 8.4 tp10 -117.33 151.6 36.66 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.609 0.764 . . . . 0.0 111.011 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -117.71 119.42 34.89 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.32 145.12 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.15 139.79 52.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -157.48 132.27 8.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.216 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -59.64 -33.74 71.91 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.166 1.348 . . . . 0.0 112.512 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -16.5 61.64 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.96 -30.72 1.35 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.05 -94.15 0.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 126.647 2.07 . . . . 0.0 108.575 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.64 133.78 16.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -143.5 143.65 31.65 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.659 1.118 . . . . 0.0 109.739 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -96.87 156.48 16.33 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.261 -0.899 . . . . 0.0 109.806 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.16 142.17 44.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -105.2 108.69 20.34 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 127.344 2.258 . . . . 0.0 107.426 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -25.54 62.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.7 m -70.8 -41.43 71.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.235 1.014 . . . . 0.0 110.815 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -105.97 -10.01 16.8 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.935 0.894 . . . . 0.0 113.003 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 56.24 59.4 3.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.26 1.824 . . . . 0.0 107.198 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -126.4 166.69 16.72 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.895 1.678 . . . . 0.0 109.238 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.13 145.66 50.89 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.1 1.36 . . . . 0.0 107.414 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.14 163.79 36.57 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.268 -0.895 . . . . 0.0 112.448 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.6 19.07 20.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.915 1.686 . . . . 0.0 112.878 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 152.28 43.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.737 -1.227 . . . . 0.0 109.911 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.37 140.63 91.7 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.843 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.21 99.45 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.629 2.886 . . . . 0.0 111.852 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -79.11 1.43 24.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.657 1.183 . . . . 0.0 112.686 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.3 48.38 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.94 39.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 125.071 3.848 . . . . 0.0 110.897 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 p -138.8 169.34 17.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.757 1.623 . . . . 0.0 110.102 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 p -59.73 -45.31 92.59 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.387 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.14 124.0 2.77 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -64.02 159.92 19.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.143 0.977 . . . . 0.0 110.542 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.36 -5.86 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.693 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -117.2 -173.54 2.43 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.457 1.629 . . . . 0.0 110.054 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 33.8 t -144.65 124.74 13.62 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.57 163.35 31.16 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.49 -38.36 19.75 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 112.455 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -165.42 173.6 10.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.144 2.578 . . . . 0.0 107.596 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -143.24 -176.83 5.08 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.141 1.376 . . . . 0.0 109.538 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -139.17 -7.44 1.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.58 176.81 2.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 111.593 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.95 175.0 3.01 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.71 1.624 . . . . 0.0 114.631 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.95 155.44 36.45 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 124.557 1.143 . . . . 0.0 112.893 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.89 162.32 42.59 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.204 1.936 . . . . 0.0 109.131 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.53 139.77 72.06 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.574 -1.741 . . . . 0.0 107.574 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.14 73.05 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.413 -1.77 . . . . 0.0 112.588 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.434 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 11.4 m95 -101.62 157.49 16.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 120.434 2.117 . . . . 0.0 108.396 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -146.01 147.39 31.6 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.83 -0.544 . . . . 0.0 110.296 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.67 135.95 44.28 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.5 120.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.302 1.041 . . . . 0.0 109.1 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -111.76 136.93 50.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -143.44 135.65 26.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.606 1.562 . . . . 0.0 108.901 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.9 m -66.8 -28.52 68.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 120.61 1.55 . . . . 0.0 111.422 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.69 -21.5 57.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.76 -22.6 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.13 -98.37 1.22 Allowed Glycine 0 CA--C 1.519 0.339 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.2 m -158.17 145.55 18.11 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.232 1.013 . . . . 0.0 108.501 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.472 ' HH ' ' HG2' ' A' ' 19' ' ' GLU . 54.7 p90 -152.51 178.28 9.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.16 1.784 . . . . 0.0 106.623 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -128.26 158.08 39.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 66.1 t -132.08 131.43 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.434 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 59.7 t0 -91.61 103.86 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 127.435 2.294 . . . . 0.0 107.669 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -27.14 67.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.87 0.759 . . . . 0.0 111.877 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 63.1 m -69.13 -24.48 64.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.113 0.965 . . . . 0.0 112.535 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -126.72 -2.47 6.65 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.53 0.732 . . . . 0.0 112.752 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm 51.06 52.22 15.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.946 2.098 . . . . 0.0 110.301 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -127.5 160.72 30.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.66 -0.65 . . . . 0.0 109.724 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.36 139.93 50.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.352 1.061 . . . . 0.0 110.179 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.15 159.78 42.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.459 1.104 . . . . 0.0 109.977 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -100.25 15.15 28.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.085 1.354 . . . . 0.0 114.071 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.07 151.7 51.52 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.21 -1.556 . . . . 0.0 110.829 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -60.41 143.73 89.2 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.883 0.873 . . . . 0.0 109.891 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.68 119.01 5.97 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.809 2.339 . . . . 0.0 112.55 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.8 p -111.41 5.35 19.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.227 2.211 . . . . 0.0 111.55 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.4 -171.75 13.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.177 0.894 . . . . 0.0 112.551 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -74.06 78.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.027 3.151 . . . . 0.0 109.443 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -158.19 175.14 14.15 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.655 1.982 . . . . 0.0 107.691 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -104.61 8.13 35.22 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.983 1.713 . . . . 0.0 112.09 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 -179.487 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.633 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.9 t -83.94 -8.14 59.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.454 1.101 . . . . 0.0 112.255 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.9 m -125.43 165.24 18.78 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.59 1.156 . . . . 0.0 108.739 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.86 -5.91 7.35 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.678 -1.068 . . . . 0.0 114.018 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.9 m -70.55 170.08 12.88 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 1.158 . . . . 0.0 111.424 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.8 m -59.73 128.06 35.08 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.72 1.208 . . . . 0.0 107.878 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.26 175.56 48.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.83 -67.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.562 2.175 . . . . 0.0 112.429 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.8 179.91 4.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.07 1.748 . . . . 0.0 111.339 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.94 -174.56 3.61 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 110.868 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -128.67 22.92 5.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.472 1.509 . . . . 0.0 109.684 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.64 138.22 36.14 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.159 0.984 . . . . 0.0 108.567 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.72 91.05 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.72 158.61 85.21 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 117.622 0.711 . . . . 0.0 109.622 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.2 164.42 35.69 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.794 1.663 . . . . 0.0 109.727 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.02 117.26 4.93 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.175 2.583 . . . . 0.0 109.906 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.81 7.92 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.158 1.837 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -88.95 136.66 32.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.397 -1.06 . . . . 0.0 109.705 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -119.68 139.95 51.42 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.284 1.033 . . . . 0.0 110.19 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -108.75 120.75 43.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.9 140.12 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -125.97 118.17 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.114 -2.551 . . . . 0.0 104.114 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m -140.86 170.62 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.526 1.131 . . . . 0.0 111.176 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -85.03 -65.14 1.04 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -60.43 -16.51 36.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.508 1.923 . . . . 0.0 114.911 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.15 -14.59 7.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.509 1.124 . . . . 0.0 112.45 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.38 -85.66 0.93 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 125.242 1.401 . . . . 0.0 111.759 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.83 136.43 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.249 -1.148 . . . . 0.0 109.497 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -149.03 175.21 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.565 1.075 . . . . 0.0 110.057 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -123.99 149.21 46.27 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.878 0.871 . . . . 0.0 109.82 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.79 143.06 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.683 1.193 . . . . 0.0 109.073 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.71 112.95 26.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.862 2.065 . . . . 0.0 105.599 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' ND1' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -74.17 -23.67 59.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -68.66 -36.83 79.06 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.854 0.862 . . . . 0.0 112.307 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.73 -3.57 11.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.121 . . . . 0.0 112.317 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HE3' ' ND1' ' A' ' 33' ' ' HIS . 6.9 mmtp 58.17 51.99 8.0 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.943 1.697 . . . . 0.0 109.78 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -118.23 161.86 19.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.463 0.705 . . . . 0.0 110.497 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.62 148.72 46.17 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.45 155.86 37.09 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.216 0.607 . . . . 0.0 111.223 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -95.58 27.28 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.594 1.558 . . . . 0.0 111.538 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -142.78 146.69 34.49 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 119.799 -1.813 . . . . 0.0 109.682 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.72 141.75 94.92 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -55.54 -56.78 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.956 2.437 . . . . 0.0 116.476 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -69.7 0.12 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.609 0.763 . . . . 0.0 112.557 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.2 -170.69 51.93 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.97 125.91 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.359 2.039 . . . . 0.0 107.511 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.35 -176.31 5.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.3 t -150.32 -82.68 0.1 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 C-N-CA 124.662 1.125 . . . . 0.0 110.644 179.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 CA-C-O 121.233 0.352 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t -128.9 -147.14 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 109.603 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -4.96 101.08 0.01 OUTLIER 'General case' 0 C--O 1.237 0.427 1 C-N-CA 131.862 4.065 . . . . 0.0 113.686 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.9 9.13 5.37 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.308 1.432 . . . . 0.0 115.18 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.6 m -71.49 175.27 5.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.835 1.254 . . . . 0.0 111.607 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.9 m -58.81 133.3 55.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.753 1.221 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.05 174.62 54.88 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.14 -46.86 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.404 2.069 . . . . 0.0 112.829 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.49 -159.46 0.98 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.099 1.36 . . . . 0.0 110.844 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.35 165.0 4.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.428 1.109 . . . . 0.0 110.816 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -124.79 46.98 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.231 1.413 . . . . 0.0 108.409 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -140.04 -178.57 5.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.018 1.727 . . . . 0.0 111.074 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.65 88.04 0.1 OUTLIER Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.853 1.692 . . . . 0.0 110.617 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.57 147.19 96.6 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 118.374 1.087 . . . . 0.0 110.311 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.68 160.09 50.96 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.304 2.003 . . . . 0.0 112.553 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 84.95 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.784 3.656 . . . . 0.0 110.07 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.7 4.73 0.28 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.837 2.16 . . . . 0.0 112.162 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -124.71 157.78 34.84 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.27 155.9 44.05 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 122.047 -0.408 . . . . 0.0 109.933 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.17 121.84 46.01 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.538 1.535 . . . . 0.0 107.547 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.83 131.71 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.84 126.5 47.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.1 m -147.88 -176.0 5.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 110.767 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m -112.55 -29.88 7.32 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 110.004 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -79.07 -14.57 59.07 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.793 -0.567 . . . . 0.0 109.669 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -130.71 -19.5 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.97 -92.74 1.71 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.613 1.101 . . . . 0.0 111.093 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -151.41 131.2 13.22 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.811 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -148.75 172.57 14.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -120.73 156.6 31.46 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.919 -0.488 . . . . 0.0 110.606 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.51 140.04 49.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -101.37 112.75 25.37 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.572 2.349 . . . . 0.0 108.733 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -76.54 -13.09 60.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -88.96 -22.88 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 111.66 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -123.79 -5.62 8.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.505 0.722 . . . . 0.0 111.461 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp 51.76 52.73 13.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.23 1.812 . . . . 0.0 111.724 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -132.75 153.55 51.09 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.504 0.722 . . . . 0.0 109.459 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.91 153.97 21.22 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 108.584 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -158.96 151.91 22.16 Favored 'General case' 0 C--N 1.334 -0.071 0 O-C-N 121.608 -0.682 . . . . 0.0 111.107 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -95.45 27.63 3.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.002 1.321 . . . . 0.0 112.082 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 147.05 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 119.891 -1.755 . . . . 0.0 108.432 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -64.95 142.19 98.58 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 119.036 -0.507 . . . . 0.0 109.765 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.76 -37.78 34.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.256 2.638 . . . . 0.0 114.056 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.0 t -63.69 -77.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.09 0.956 . . . . 0.0 108.777 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.66 -175.68 43.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.06 138.75 63.71 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.312 2.008 . . . . 0.0 109.454 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 58.1 m -165.98 175.68 8.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.139 2.576 . . . . 0.0 107.492 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -148.78 -36.36 0.18 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.109 0.964 . . . . 0.0 110.196 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.135 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.438 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.8 p -150.37 170.54 18.78 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 110.459 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.45 172.26 13.06 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.453 2.301 . . . . 0.0 107.971 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.98 167.27 36.85 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 120.781 -1.2 . . . . 0.0 111.217 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t 55.6 21.62 4.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 112.721 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.49 151.11 20.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.398 1.079 . . . . 0.0 111.145 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.76 -173.51 45.79 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.87 -63.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.065 1.843 . . . . 0.0 108.509 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.3 153.7 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 129.115 2.966 . . . . 0.0 107.748 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -166.64 56.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.401 1.88 . . . . 0.0 106.801 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 51.85 7.13 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.169 2.588 . . . . 0.0 115.373 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -66.76 5.56 0.61 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.047 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -25.72 103.53 0.01 OUTLIER Glycine 0 N--CA 1.471 0.969 0 C-N-CA 128.287 2.851 . . . . 0.0 112.193 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.1 mt -48.81 154.62 1.19 Allowed Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 128.254 2.622 . . . . 0.0 115.177 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.83 164.86 34.34 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.282 1.988 . . . . 0.0 110.205 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.98 124.04 11.36 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.543 2.162 . . . . 0.0 108.457 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.17 -12.08 33.96 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.723 1.154 . . . . 0.0 111.736 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -104.13 150.93 23.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.646 1.223 . . . . 0.0 108.608 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -144.09 156.8 44.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.105 0.962 . . . . 0.0 108.613 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -116.04 122.0 43.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.561 1.545 . . . . 0.0 107.055 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.78 127.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.03 116.03 22.16 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.9 m -140.46 155.23 46.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 111.709 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.5 m -76.71 -20.25 56.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.85 -1.157 . . . . 0.0 112.937 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -83.09 -53.63 5.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.8 0.727 . . . . 0.0 111.405 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.74 -11.85 30.5 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.74 -91.34 1.62 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -155.68 147.99 23.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.213 0.506 . . . . 0.0 111.851 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.506 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 38.1 p90 -161.16 179.64 8.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.74 1.616 . . . . 0.0 108.099 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.67 158.91 33.57 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.085 -1.009 . . . . 0.0 110.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.25 140.86 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 108.027 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -109.7 117.59 34.29 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.239 2.216 . . . . 0.0 109.512 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -82.35 -14.13 55.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.584 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.7 m -70.82 -47.83 57.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 120.217 1.371 . . . . 0.0 110.277 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -108.08 -3.41 18.69 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.25 1.42 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp 56.89 53.15 8.45 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.525 1.53 . . . . 0.0 110.073 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -120.86 165.64 14.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.41 138.34 53.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.99 151.64 32.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.19 0.905 . . . . 0.0 110.6 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.422 ' CZ ' ' HE2' ' B' ' 36' ' ' LYS . 54.6 m-85 -83.06 8.2 13.6 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.25 153.26 44.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.295 1.407 . . . . 0.0 113.221 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -62.31 139.93 96.37 Favored Pre-proline 0 C--O 1.24 0.57 0 O-C-N 124.99 1.431 . . . . 0.0 109.345 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.13 178.99 3.12 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.308 2.672 . . . . 0.0 114.572 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -126.92 -79.1 0.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.22 1.408 . . . . 0.0 110.532 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.46 174.58 37.98 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 119.521 1.055 . . . . 0.0 112.441 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.37 -25.08 3.38 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.245 3.296 . . . . 0.0 113.657 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.8 p 178.82 166.61 0.9 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 128.865 2.866 . . . . 0.0 106.737 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 p -129.66 -53.66 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.771 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -154.51 167.75 29.0 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.523 1.529 . . . . 0.0 107.223 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.5 p -158.94 -179.04 7.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.15 -173.36 41.74 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.673 1.606 . . . . 0.0 109.263 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.8 t -48.54 123.89 7.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.185 1.394 . . . . 0.0 109.388 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 25.9 m -100.26 177.81 4.95 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.163 1.785 . . . . 0.0 110.722 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.85 164.79 10.19 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 123.799 0.714 . . . . 0.0 112.481 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.06 -39.06 52.43 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.83 2.353 . . . . 0.0 112.225 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.03 148.18 33.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.723 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -160.45 35.11 0.16 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.894 0.878 . . . . 0.0 111.052 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.37 24.59 6.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.509 1.924 . . . . 0.0 112.882 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.38 37.29 1.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.628 2.771 . . . . 0.0 112.581 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -44.63 113.9 0.96 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.561 1.553 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -58.75 154.94 33.54 Favored Pre-proline 0 C--O 1.233 0.222 0 C-N-CA 123.87 0.868 . . . . 0.0 112.662 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.24 155.96 63.2 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.38 140.07 62.2 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 105.385 -2.583 . . . . 0.0 105.385 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.81 70.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.639 -1.089 . . . . 0.0 112.071 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -107.01 167.62 9.76 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.954 1.877 . . . . 0.0 106.58 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.506 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 7.5 tp10 -144.43 154.45 42.97 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -119.06 133.34 55.87 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -124.87 136.96 59.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -127.17 134.94 50.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -150.94 179.1 8.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.522 2.329 . . . . 0.0 110.281 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 69.4 m -110.77 -25.05 10.11 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.099 -1.001 . . . . 0.0 111.7 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.08 -23.13 57.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 110.527 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.46 -53.65 1.9 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.243 1.417 . . . . 0.0 112.036 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.21 -104.36 0.64 Allowed Glycine 0 N--CA 1.469 0.84 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.7 m -144.13 131.01 20.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.506 1.653 . . . . 0.0 108.536 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.54 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.211 1.004 . . . . 0.0 109.829 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -127.18 142.94 51.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.035 1.334 . . . . 0.0 108.086 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.53 135.22 59.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.81 0.814 . . . . 0.0 110.11 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -100.63 104.26 15.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -72.94 -24.94 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 119.158 -0.448 . . . . 0.0 111.826 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -71.0 -37.21 72.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.363 1.465 . . . . 0.0 111.615 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -115.25 1.89 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.575 1.15 . . . . 0.0 112.574 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.422 ' HE2' ' CZ ' ' A' ' 40' ' ' TYR . 4.9 mmtp 48.19 62.17 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.554 1.942 . . . . 0.0 109.901 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -128.62 160.17 33.27 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.821 0.848 . . . . 0.0 110.018 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.8 131.41 47.76 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.356 1.462 . . . . 0.0 108.447 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -146.34 148.93 32.89 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.227 0.467 . . . . 0.0 110.538 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -91.44 25.7 2.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.04 1.736 . . . . 0.0 111.055 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -137.77 153.5 49.69 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . 0.424 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 4.7 t-80 -68.71 147.0 97.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 111.799 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 73.2 Cg_endo -71.44 -174.01 1.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.122 3.215 . . . . 0.0 113.449 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t -125.66 -38.72 2.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.131 0.972 . . . . 0.0 111.444 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.3 178.8 15.53 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.314 1.435 . . . . 0.0 111.43 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.01 -42.15 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.736 2.958 . . . . 0.0 110.534 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.1 p -158.79 -162.43 1.09 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.832 2.453 . . . . 0.0 105.927 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.3 p -141.22 -78.04 0.28 Allowed 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.581 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -164.45 125.02 2.08 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.435 1.117 . . . . 0.0 110.403 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.8 t -136.59 128.19 28.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.1 169.88 42.43 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 m -77.41 167.34 21.84 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.168 -1.195 . . . . 0.0 111.348 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 t -151.69 162.63 40.69 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.422 1.489 . . . . 0.0 108.05 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.08 169.63 45.72 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.1 -59.8 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.251 2.634 . . . . 0.0 110.036 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.71 142.94 5.57 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 128.526 2.73 . . . . 0.0 104.627 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -121.13 177.43 5.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.37 1.468 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -124.34 6.63 8.39 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -58.34 165.82 1.91 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.57 121.41 20.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.157 1.36 . . . . 0.0 110.402 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.0 mt -82.85 157.61 66.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 125.209 1.403 . . . . 0.0 113.986 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.81 161.73 40.96 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.536 2.157 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.36 123.71 11.18 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.851 2.368 . . . . 0.0 108.545 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.45 5.58 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.673 1.13 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.426 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 24.2 m95 -81.33 151.82 27.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.397 1.098 . . . . 0.0 108.993 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -135.43 140.87 45.24 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.468 0.707 . . . . 0.0 109.534 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -103.11 132.24 49.52 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.6 136.02 55.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.23 142.55 49.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -154.24 146.36 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.4 m -74.82 -12.82 60.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.559 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.27 -45.71 5.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 110.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -93.85 -18.1 22.36 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.11 -92.54 1.79 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.704 1.621 . . . . 0.0 111.544 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -153.75 124.44 7.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.41 ' HH ' ' HG2' ' B' ' 19' ' ' GLU . 53.5 p90 -139.43 177.15 8.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.806 0.442 . . . . 0.0 109.995 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.14 148.04 51.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 108.923 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.46 137.12 57.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.226 0.61 . . . . 0.0 110.271 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 9.2 t0 -99.14 115.74 29.74 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.597 2.759 . . . . 0.0 108.941 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -82.94 -10.04 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.598 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -75.45 -43.43 49.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 120.747 1.612 . . . . 0.0 110.164 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -117.74 0.41 11.99 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.157 0.983 . . . . 0.0 112.176 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 57.17 60.71 2.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.595 1.558 . . . . 0.0 108.509 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -129.47 143.63 50.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.789 0.835 . . . . 0.0 109.441 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.79 145.84 33.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 109.288 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.86 162.86 38.99 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.461 1.104 . . . . 0.0 110.276 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.78 8.91 41.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 160.56 32.15 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.819 1.19 . . . . 0.0 111.007 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -61.88 134.83 94.29 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.08 -6.66 18.82 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.29 3.327 . . . . 0.0 116.028 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.73 -74.76 0.47 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.88 -178.11 18.38 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.73 -14.65 44.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.431 2.754 . . . . 0.0 113.378 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 p -148.92 151.99 35.61 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.964 1.706 . . . . 0.0 108.007 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -109.21 -5.0 16.09 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 106.009 -2.836 . . . . 0.0 106.009 -179.155 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -127.54 153.11 46.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.841 0.856 . . . . 0.0 109.384 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -158.8 159.74 35.46 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 105.585 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.53 -135.77 32.74 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.743 0.687 . . . . 0.0 112.064 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -134.81 170.98 15.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.667 1.587 . . . . 0.0 108.38 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 t -145.6 170.44 16.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 126.157 1.783 . . . . 0.0 106.555 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.8 -167.3 39.08 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.374 1.464 . . . . 0.0 111.062 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.88 -72.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.681 2.92 . . . . 0.0 104.998 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 pp -159.69 158.33 31.2 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.608 1.563 . . . . 0.0 109.324 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -137.57 171.34 14.59 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.704 2.002 . . . . 0.0 106.356 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -133.55 9.86 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.7 172.77 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.745 1.157 . . . . 0.0 112.036 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.36 159.0 1.63 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.746 2.117 . . . . 0.0 113.348 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -128.44 155.9 77.89 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.437 1.095 . . . . 0.0 112.865 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.9 158.53 52.61 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.283 1.989 . . . . 0.0 110.567 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.8 123.61 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.558 2.172 . . . . 0.0 106.87 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.96 -26.41 6.8 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.643 1.592 . . . . 0.0 110.789 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 25.6 m95 -90.0 157.01 18.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.381 1.091 . . . . 0.0 110.172 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.41 ' HG2' ' HH ' ' A' ' 29' ' ' TYR . 8.5 tp10 -141.19 150.5 42.8 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.802 0.841 . . . . 0.0 108.761 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -115.48 128.55 56.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -117.77 120.3 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.879 0.872 . . . . 0.0 109.509 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -107.31 146.28 31.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -150.11 170.77 18.14 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.754 1.622 . . . . 0.0 110.914 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -96.24 -34.23 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -74.87 -27.01 60.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.133 0.973 . . . . 0.0 110.756 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.93 -19.42 5.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.65 -86.5 1.28 Allowed Glycine 0 N--CA 1.461 0.331 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -159.67 134.23 7.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.902 1.351 . . . . 0.0 111.307 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -143.76 158.11 43.91 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 107.417 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -110.87 159.58 17.55 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.821 -1.174 . . . . 0.0 108.587 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.11 135.23 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 122.817 0.447 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 42.9 t0 -99.06 113.18 25.25 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.912 1.285 . . . . 0.0 108.689 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -72.92 -16.89 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.687 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 79.4 m -79.78 -28.91 40.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.996 0.919 . . . . 0.0 112.857 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -121.76 -4.79 9.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.893 0.769 . . . . 0.0 111.537 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp 56.21 47.66 18.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.829 1.652 . . . . 0.0 109.7 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.81 160.85 21.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.153 0.981 . . . . 0.0 111.175 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.61 140.59 51.32 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.972 1.309 . . . . 0.0 109.111 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -150.9 156.05 40.4 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.438 1.095 . . . . 0.0 110.169 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -97.47 -7.63 31.11 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.917 0.887 . . . . 0.0 111.67 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -100.1 142.43 31.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.06 1.344 . . . . 0.0 108.825 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -58.66 143.57 81.7 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.37 -29.78 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.575 2.183 . . . . 0.0 116.734 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -78.75 -84.92 0.08 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.697 1.135 . . . . 0.0 108.578 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.0 -174.07 23.82 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 119.384 0.993 . . . . 0.0 112.512 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.53 -5.42 16.63 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.483 2.788 . . . . 0.0 112.613 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 18.3 p -160.23 167.26 27.98 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.813 1.245 . . . . 0.0 109.342 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.4 m -135.04 29.89 3.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.878 1.271 . . . . 0.0 109.645 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -178.789 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -78.52 171.46 15.07 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.01 -167.5 2.75 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 109.617 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.86 82.1 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-O 119.293 -0.726 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.9 m -94.94 89.26 5.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 p -70.03 171.18 9.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.554 1.142 . . . . 0.0 110.533 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.22 164.92 16.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.543 1.068 . . . . 0.0 111.675 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.45 -62.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.187 2.592 . . . . 0.0 108.728 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.4 mt -140.56 163.69 32.17 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.738 1.615 . . . . 0.0 108.396 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -126.6 172.67 10.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.729 1.612 . . . . 0.0 108.723 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -133.16 40.11 3.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 0.0 109.81 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -125.22 -176.79 3.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.221 1.409 . . . . 0.0 107.296 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 -78.15 0.34 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 119.217 0.917 . . . . 0.0 112.22 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.0 mt -144.74 159.77 49.58 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 109.475 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.9 158.87 54.43 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.43 1.42 . . . . 0.0 110.454 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 95.55 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.528 2.819 . . . . 0.0 107.589 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 139.98 -2.04 2.33 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.347 0.975 . . . . 0.0 112.982 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -118.24 151.47 37.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -137.18 153.53 50.42 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.265 0.626 . . . . 0.0 109.964 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -114.49 127.62 55.91 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.23 1.812 . . . . 0.0 107.789 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.25 117.76 56.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.83 152.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -151.2 177.39 10.27 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 120.647 -1.283 . . . . 0.0 111.622 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -114.07 -18.08 11.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.81 -10.97 12.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.701 0.801 . . . . 0.0 110.087 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -123.69 -12.36 7.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.466 1.906 . . . . 0.0 112.563 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.87 -77.04 1.15 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 126.11 1.814 . . . . 0.0 110.329 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -161.24 138.43 8.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.628 1.714 . . . . 0.0 110.357 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -143.17 171.74 13.67 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.93 153.1 43.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.911 0.885 . . . . 0.0 109.686 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.92 141.5 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.885 0.874 . . . . 0.0 110.846 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.55 111.07 23.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 129.729 3.212 . . . . 0.0 108.477 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -76.56 -18.53 58.63 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -78.26 -32.45 49.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.98 0.809 . . . . 0.0 110.313 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -116.44 -4.97 11.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm 55.29 52.52 11.33 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.989 2.116 . . . . 0.0 109.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -124.52 165.69 17.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.454 1.102 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.68 151.52 47.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.158 1.383 . . . . 0.0 108.57 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.43 159.98 43.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.828 0.823 . . . . 0.0 111.643 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.572 ' CE1' ' HE2' ' B' ' 36' ' ' LYS . 14.2 m-30 -93.8 17.28 12.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.411 1.484 . . . . 0.0 113.837 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.36 150.84 38.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.464 -1.398 . . . . 0.0 110.072 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -59.92 142.33 88.87 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.96 44.84 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.747 4.298 . . . . 0.0 116.083 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.64 131.09 34.64 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.69 164.41 19.38 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.287 1.899 . . . . 0.0 113.628 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.72 151.06 45.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.481 . . . . 0.0 109.024 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 p -75.22 135.56 41.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.059 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.43 -55.7 2.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 178.501 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.865 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -61.44 160.63 10.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.912 1.685 . . . . 0.0 114.154 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -141.24 162.16 36.16 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 107.951 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.14 109.34 0.39 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.0 m -123.87 66.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.05 1.34 . . . . 0.0 108.595 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.7 133.66 47.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.67 175.62 54.83 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.74 -71.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.069 3.179 . . . . 0.0 110.912 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.3 mt -146.4 123.83 11.68 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.884 2.074 . . . . 0.0 107.118 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -85.27 162.42 19.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -98.54 -18.83 17.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.041 -0.412 . . . . 0.0 109.96 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -70.0 176.48 3.73 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.952 0.901 . . . . 0.0 112.32 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -68.72 1.55 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.657 1.122 . . . . 0.0 112.804 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -150.85 160.58 32.06 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 125.179 1.392 . . . . 0.0 109.585 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.28 162.57 35.55 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.12 1.88 . . . . 0.0 110.336 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.95 108.62 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.423 2.749 . . . . 0.0 110.17 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.41 -26.19 6.73 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.674 1.131 . . . . 0.0 112.706 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 9.6 m95 -80.85 148.99 29.7 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 119.428 1.614 . . . . 0.0 108.867 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -131.24 152.19 50.76 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -111.65 138.84 47.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.6 136.15 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -124.58 141.19 52.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.0 p -154.25 -166.57 2.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.657 2.383 . . . . 0.0 109.209 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -121.15 -47.69 2.26 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.71 -50.99 70.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -80.61 -59.02 2.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.83 -98.49 0.53 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -150.96 136.34 17.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.446 1.623 . . . . 0.0 107.673 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -150.52 178.08 9.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.07 152.75 43.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.397 0.679 . . . . 0.0 109.409 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.66 139.0 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.455 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 55.0 t0 -100.01 104.91 16.54 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.051 1.74 . . . . 0.0 107.753 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -27.77 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.89 0.768 . . . . 0.0 112.386 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -64.2 -39.37 93.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 111.573 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -118.57 -1.33 11.19 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 40' ' ' TYR . 34.5 mmtm 52.63 50.71 17.57 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 125.019 1.328 . . . . 0.0 111.069 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -125.41 164.77 19.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.2 151.52 40.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.717 0.807 . . . . 0.0 109.104 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -146.14 152.25 38.97 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.271 0.941 . . . . 0.0 111.419 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.2 26.21 3.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.61 1.564 . . . . 0.0 112.622 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.86 167.52 28.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.15 -1.594 . . . . 0.0 109.011 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.11 154.84 91.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.159 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.82 42.19 1.09 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.651 2.901 . . . . 0.0 110.605 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 6.9 t -73.3 122.41 21.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.59 169.53 5.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.322 1.439 . . . . 0.0 112.216 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.16 142.15 72.57 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.57 103.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.092 1.357 . . . . 0.0 110.766 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -58.62 -16.52 16.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 112.893 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.321 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 179.369 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 54.6 Cg_endo -69.36 161.55 45.43 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 121.914 1.743 . . . . 0.0 109.566 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.44 108.7 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.316 2.678 . . . . 0.0 108.653 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.28 -16.42 6.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.684 1.611 . . . . 0.0 111.704 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.0 m95 -95.38 142.68 27.48 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.261 -1.141 . . . . 0.0 109.429 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -125.32 140.73 52.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.273 0.629 . . . . 0.0 110.818 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -104.13 134.8 46.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 t -115.0 138.65 44.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.78 131.01 40.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.262 1.025 . . . . 0.0 110.729 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.82 170.9 18.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.01 1.724 . . . . 0.0 111.283 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -86.76 -29.36 22.41 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.446 1.098 . . . . 0.0 112.534 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.82 -44.38 27.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.97 1.259 . . . . 0.0 110.952 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.84 -24.73 14.58 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -94.75 1.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.55 130.35 10.07 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.216 -0.579 . . . . 0.0 110.752 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.29 173.48 11.67 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -125.76 146.07 49.93 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.22 -0.925 . . . . 0.0 108.559 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 143.44 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.614 0.721 . . . . 0.0 109.546 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 64.6 t0 -108.2 109.75 21.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.709 2.003 . . . . 0.0 109.829 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.086 0.857 . . . . 0.0 111.092 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 m -68.12 -33.43 74.49 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.615 1.166 . . . . 0.0 111.603 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -122.38 1.05 9.57 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' B' ' 38' ' ' ALA . 22.2 mmmt 50.31 51.48 16.69 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.584 1.953 . . . . 0.0 110.023 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.34 166.91 16.94 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 123.809 0.844 . . . . 0.0 110.227 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' O ' ' HE3' ' B' ' 36' ' ' LYS . . . -122.78 149.91 43.5 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -150.55 171.39 17.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.406 1.482 . . . . 0.0 107.988 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -112.89 -8.15 13.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -100.74 167.49 10.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.972 1.309 . . . . 0.0 110.865 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 149.48 82.82 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 110.059 178.011 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 119.727 -0.178 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 72.7 Cg_endo -71.56 160.97 46.84 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.338 2.025 . . . . 0.0 111.009 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.73 115.43 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.249 2.632 . . . . 0.0 108.696 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.23 -21.31 13.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.661 1.124 . . . . 0.0 112.514 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 8.5 m95 -87.56 164.06 16.3 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 119.229 1.514 . . . . 0.0 108.144 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.82 152.65 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.943 -0.473 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -112.75 133.88 54.55 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.341 1.857 . . . . 0.0 107.005 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.32 128.51 75.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -109.93 141.56 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 10.1 t -153.07 -169.81 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.9 m -130.32 -38.29 1.38 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.564 1.946 . . . . 0.0 107.093 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.41 -27.22 66.9 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -121.36 -26.21 5.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.67 -91.48 1.04 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.06 1.315 . . . . 0.0 110.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.4 m -154.93 137.07 14.75 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.491 -1.594 . . . . 0.0 109.3 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.14 179.21 7.65 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -131.65 154.44 48.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.46 0.704 . . . . 0.0 109.424 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.96 142.01 41.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.38 0.672 . . . . 0.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -102.9 125.69 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.478 2.711 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -85.17 -19.81 31.19 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.924 -0.485 . . . . 0.0 110.657 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 46.7 m -73.06 -32.69 65.21 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.82 1.248 . . . . 0.0 110.247 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -123.54 -2.94 8.37 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 38' ' ' ALA . 25.8 mmmt 54.88 40.38 31.95 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.802 1.241 . . . . 0.0 110.71 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -115.27 158.6 22.11 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HE3' ' A' ' 36' ' ' LYS . . . -116.89 147.48 42.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.51 1.124 . . . . 0.0 108.482 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -152.51 162.54 41.06 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.393 1.477 . . . . 0.0 108.745 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -103.33 -4.68 23.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.116 0.966 . . . . 0.0 113.023 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 163.28 13.46 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.18 0.992 . . . . 0.0 110.615 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -79.58 143.43 59.09 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.535 0.545 0 C-N-CA 121.627 1.551 . . . . 0.0 113.278 -178.651 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.236 0.393 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 37.6 Cg_endo -66.92 159.66 50.7 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.533 0.822 . . . . 0.0 110.314 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.1 110.68 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.493 2.795 . . . . 0.0 108.872 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.17 -14.48 16.1 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-O 117.942 -1.477 . . . . 0.0 114.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 43' ' ' PRO . 11.5 m95 -96.22 150.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.447 1.623 . . . . 0.0 107.036 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -135.08 148.31 49.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.488 0.185 . . . . 0.0 110.917 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -103.83 130.06 51.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.57 144.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.3 147.01 50.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 p -158.08 164.34 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.288 1.435 . . . . 0.0 110.701 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -92.06 -29.16 16.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.926 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -17.99 35.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.46 -46.87 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.83 -104.35 0.87 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -138.34 124.01 19.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -135.93 176.61 8.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.826 0.45 . . . . 0.0 111.043 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.39 151.88 51.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.541 0.737 . . . . 0.0 110.767 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.61 137.79 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.061 0.544 . . . . 0.0 111.146 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 34.3 t0 -101.26 107.97 19.49 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 127.946 2.498 . . . . 0.0 105.447 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -74.77 -19.71 60.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.0 m -80.75 -47.42 13.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.303 0.956 . . . . 0.0 110.276 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.91 -10.14 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.937 1.295 . . . . 0.0 112.213 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm 55.58 45.06 25.63 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.73 2.012 . . . . 0.0 110.868 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -114.46 164.29 14.17 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.096 0.959 . . . . 0.0 109.411 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.42 150.37 48.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.365 1.466 . . . . 0.0 109.102 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -160.23 151.97 19.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.015 1.326 . . . . 0.0 109.968 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -93.14 11.12 28.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.028 0.931 . . . . 0.0 111.388 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 160.24 34.64 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.522 -1.361 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -63.22 138.66 97.4 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.449 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 46.4 Cg_endo . . . . . 0 CA--C 1.532 0.421 1 C-N-CA 125.928 4.418 . . . . 0.0 115.305 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 39.8 Cg_endo -72.09 164.72 34.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.365 2.044 . . . . 0.0 111.686 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.09 121.36 9.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.7 58.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.288 -1.285 . . . . 0.0 115.063 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 24.3 m95 -94.04 161.29 14.34 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 119.521 1.66 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.84 169.15 20.43 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -128.5 121.94 30.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 109.355 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.58 123.74 49.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.96 137.92 50.62 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -150.93 -154.51 0.55 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.71 1.604 . . . . 0.0 108.96 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.1 m -127.31 -55.58 1.34 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.604 1.962 . . . . 0.0 107.101 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -60.83 -26.29 67.23 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.752 1.221 . . . . 0.0 113.312 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -113.93 -41.98 3.47 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.75 -96.72 1.02 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.068 0.842 . . . . 0.0 112.339 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -149.28 108.35 3.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.609 0.705 . . . . 0.0 109.567 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -125.22 176.77 6.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 109.726 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.25 156.9 44.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 110.239 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.34 142.59 32.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.506 1.122 . . . . 0.0 108.783 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -106.19 115.04 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.548 2.339 . . . . 0.0 105.096 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -79.55 -17.1 54.74 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 112.773 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -79.98 -45.11 19.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.214 1.405 . . . . 0.0 109.33 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -95.32 -15.12 23.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.188 0.995 . . . . 0.0 111.54 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 58.48 53.41 6.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.454 2.302 . . . . 0.0 109.312 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -134.66 153.61 51.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.967 0.507 . . . . 0.0 111.291 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.08 145.78 36.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.831 1.253 . . . . 0.0 110.524 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -147.23 150.87 35.7 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.682 0.793 . . . . 0.0 109.277 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.54 19.2 11.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.815 1.646 . . . . 0.0 112.613 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 159.69 41.67 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.41 -1.431 . . . . 0.0 109.037 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.63 152.09 76.06 Favored Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 123.956 0.902 . . . . 0.0 112.588 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 CA--C 1.535 0.556 0 C-N-CA 123.32 2.68 . . . . 0.0 116.047 -178.428 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 mt . . . . . 0 C--O 1.235 0.301 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.05 163.7 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.458 2.105 . . . . 0.0 110.614 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 140.49 64.31 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.954 1.77 . . . . 0.0 108.747 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.12 -12.6 63.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.057 -1.413 . . . . 0.0 113.23 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 5.9 m95 -90.59 164.14 14.31 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 120.657 2.229 . . . . 0.0 109.112 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -147.43 155.27 41.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.804 0.812 . . . . 0.0 109.847 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -124.87 140.81 52.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.99 139.19 50.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.8 121.53 37.43 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.212 1.805 . . . . 0.0 106.474 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 p -131.53 172.25 12.44 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.012 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -95.64 -28.21 14.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.791 1.236 . . . . 0.0 110.674 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -95.93 -28.14 14.82 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -107.97 -34.79 6.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 -98.23 0.98 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.33 0.968 . . . . 0.0 112.762 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 m -148.16 121.83 9.23 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.521 0.728 . . . . 0.0 109.202 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -140.14 176.44 8.75 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.206 -0.934 . . . . 0.0 109.67 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -129.42 150.09 50.92 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.814 0.734 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.5 131.85 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.747 0.819 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.3 t0 -98.78 116.98 32.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -86.84 -20.46 27.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.115 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m -76.97 -31.71 56.75 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.591 1.087 . . . . 0.0 110.118 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -109.96 -12.01 14.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.893 1.677 . . . . 0.0 111.959 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HE2' ' CE2' ' B' ' 40' ' ' TYR . 42.5 mmtm 54.11 56.91 6.44 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.476 1.51 . . . . 0.0 110.782 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -130.58 169.6 15.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.24 1.016 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.37 142.74 51.42 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.896 1.679 . . . . 0.0 108.923 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.77 161.01 43.37 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.432 1.493 . . . . 0.0 110.522 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.57 25.78 11.06 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.906 1.282 . . . . 0.0 112.142 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 160.03 40.81 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.704 -1.248 . . . . 0.0 110.059 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 153.41 55.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.913 . . . . 0.0 110.481 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 C-N-CA 123.636 2.891 . . . . 0.0 114.509 -178.552 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.78 160.51 49.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.108 1.872 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.62 99.21 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.797 2.998 . . . . 0.0 109.769 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.59 -1.62 5.22 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.645 1.593 . . . . 0.0 112.235 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -117.37 153.75 32.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.651 1.225 . . . . 0.0 109.479 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.01 168.47 19.64 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -130.8 125.54 33.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.643 2.377 . . . . 0.0 105.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.54 145.73 15.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -124.5 138.9 54.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.477 1.111 . . . . 0.0 108.276 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.7 p -154.66 177.66 10.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.363 1.865 . . . . 0.0 111.479 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -105.52 -33.47 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.62 -35.57 81.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.908 1.683 . . . . 0.0 110.865 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.05 -35.96 3.22 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.811 0.844 . . . . 0.0 113.006 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.05 -100.37 1.3 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 22.9 m -147.36 127.56 13.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 120.225 -1.75 . . . . 0.0 108.818 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -142.37 173.99 11.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.641 0.776 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -122.62 148.04 45.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.168 0.987 . . . . 0.0 112.944 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.49 140.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 108.66 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -107.94 115.61 30.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 127.862 2.465 . . . . 0.0 108.418 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -77.27 -30.31 54.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 87.3 m -67.61 -39.07 84.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.55 1.14 . . . . 0.0 110.783 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -106.9 -6.77 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.094 0.558 . . . . 0.0 112.441 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp 51.74 52.94 13.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.854 1.662 . . . . 0.0 110.633 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -126.48 166.46 17.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.846 1.258 . . . . 0.0 109.954 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.47 140.63 52.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.351 1.461 . . . . 0.0 107.727 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -147.06 171.67 14.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.607 1.163 . . . . 0.0 108.743 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.472 ' CE2' ' HE2' ' A' ' 36' ' ' LYS . 84.3 m-85 -112.79 -2.08 14.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.66 0.664 . . . . 0.0 112.429 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 160.89 14.84 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.964 0.906 . . . . 0.0 109.37 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -71.72 143.72 87.49 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.51 2.14 . . . . 0.0 114.155 -179.143 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.595 -0.24 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.91 163.56 35.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.058 1.172 . . . . 0.0 110.949 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.27 133.11 36.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.042 1.828 . . . . 0.0 109.006 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.1 -14.96 61.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.72 1.629 . . . . 0.0 111.644 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -105.9 142.54 35.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.394 1.097 . . . . 0.0 108.884 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.94 160.19 39.36 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.475 1.51 . . . . 0.0 107.705 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -120.26 120.7 36.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.16 149.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.43 148.38 52.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.72 1.208 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 t -160.82 153.88 21.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.784 1.634 . . . . 0.0 112.819 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -80.44 -29.75 37.57 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -80.58 -27.1 37.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.918 1.687 . . . . 0.0 112.41 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -117.26 -38.13 3.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.95 -109.83 2.3 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.25 126.98 20.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -138.48 170.04 16.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.508 0.67 . . . . 0.0 109.665 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.27 148.45 52.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.225 1.01 . . . . 0.0 109.0 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' B' ' 31' ' ' VAL . 58.6 t -134.42 139.68 47.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 109.355 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -103.34 116.1 31.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.734 2.014 . . . . 0.0 108.319 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -72.23 -17.55 61.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.581 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -71.21 -51.22 25.92 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.877 0.871 . . . . 0.0 111.665 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -110.4 4.75 20.92 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.516 0.727 . . . . 0.0 112.776 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 51.87 41.69 29.59 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.97 1.308 . . . . 0.0 111.387 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -105.74 156.34 18.39 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.21 49.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.942 1.297 . . . . 0.0 107.952 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.44 168.31 25.43 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.865 -1.147 . . . . 0.0 110.647 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.85 15.73 27.28 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 112.302 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.22 153.95 31.99 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.047 -1.033 . . . . 0.0 109.977 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -71.18 136.63 84.42 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 121.781 1.654 . . . . 0.0 108.197 -179.845 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--O 1.236 0.378 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 18.8 Cg_endo -63.78 160.21 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.786 1.657 . . . . 0.0 111.368 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.86 91.05 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.534 3.489 . . . . 0.0 110.149 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.49 -3.28 2.93 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.477 1.513 . . . . 0.0 111.734 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.5 m95 -110.36 156.73 20.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.487 1.144 . . . . 0.0 108.195 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -148.95 158.56 44.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.21 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -112.04 144.95 40.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.787 1.635 . . . . 0.0 106.949 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.44 118.82 54.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -110.28 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 t -154.77 148.72 25.7 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.745 1.218 . . . . 0.0 110.804 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -76.16 -23.34 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.494 1.043 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -81.22 -22.67 38.63 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -120.69 -43.97 2.46 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.52 -113.29 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -141.05 111.99 7.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -131.71 -179.96 5.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -131.35 155.9 46.43 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.89 0.876 . . . . 0.0 111.345 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 31' ' ' VAL . 44.9 t -131.66 138.7 52.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.795 1.238 . . . . 0.0 109.301 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 22.1 t0 -106.68 118.96 38.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.474 1.91 . . . . 0.0 109.258 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -77.88 -20.9 52.15 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -69.28 -49.98 51.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.5 1.046 . . . . 0.0 110.49 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -105.85 -0.06 25.55 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt 53.87 53.49 11.21 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.008 1.323 . . . . 0.0 109.919 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -119.27 162.48 18.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.466 0.706 . . . . 0.0 109.578 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.93 142.68 50.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.861 1.264 . . . . 0.0 108.856 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -154.9 164.81 38.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.349 1.059 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -103.71 -6.56 21.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 142.5 34.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.0 t-80 -56.12 146.69 49.42 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.807 1.243 . . . . 0.0 110.572 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 56.4 Cg_endo . . . . . 0 C--N 1.348 0.515 0 C-N-CA 122.469 2.113 . . . . 0.0 112.492 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 163.27 39.2 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.863 2.375 . . . . 0.0 110.921 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.52 123.92 11.02 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.391 2.061 . . . . 0.0 107.991 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.71 -17.75 22.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.176 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 24.5 m95 -100.77 164.07 12.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -143.52 151.33 40.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.883 0.373 . . . . 0.0 111.851 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -112.82 121.16 43.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.79 146.28 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.8 111.83 11.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.98 1.712 . . . . 0.0 106.902 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.11 174.68 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.43 1.492 . . . . 0.0 111.427 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -106.85 -22.13 12.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 112.205 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.39 -12.96 47.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.724 0.693 . . . . 0.0 111.314 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.59 -63.41 0.71 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.192 0.997 . . . . 0.0 109.673 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.36 -109.47 0.71 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.627 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.1 m -131.37 112.05 12.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.757 1.279 . . . . 0.0 109.257 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -134.07 146.1 50.01 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.496 1.518 . . . . 0.0 108.255 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.11 146.87 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.859 1.264 . . . . 0.0 111.204 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.08 138.34 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.303 1.041 . . . . 0.0 110.15 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 36.3 t70 -105.92 110.48 22.77 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 127.044 2.137 . . . . 0.0 108.032 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -75.81 -18.08 59.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.2 m -71.72 -28.98 64.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.751 1.614 . . . . 0.0 111.807 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -126.18 -7.75 6.5 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 124.555 1.142 . . . . 0.0 112.536 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 mtmm 58.66 60.03 2.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.472 1.909 . . . . 0.0 109.047 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -124.33 168.79 12.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.54 1.136 . . . . 0.0 108.974 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.92 52.08 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -155.1 167.82 29.07 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.09 -1.006 . . . . 0.0 110.978 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.15 10.9 27.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.041 0.937 . . . . 0.0 112.927 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 153.27 46.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.327 1.051 . . . . 0.0 110.39 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.58 136.74 89.49 Favored Pre-proline 0 N--CA 1.451 -0.415 0 O-C-N 124.398 1.061 . . . . 0.0 109.946 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 88.4 Cg_endo . . . . . 0 N--CA 1.451 -0.992 0 C-N-CA 123.312 2.675 . . . . 0.0 110.564 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--O 1.233 0.2 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 42.6 Cg_endo -67.44 165.49 26.91 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.51 2.14 . . . . 0.0 109.841 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.81 128.05 22.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.273 1.982 . . . . 0.0 108.367 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.41 58.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.15 1.357 . . . . 0.0 114.28 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 6.8 m95 -83.96 153.79 23.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.955 1.877 . . . . 0.0 109.498 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.25 151.54 47.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.51 134.54 54.62 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.94 134.24 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.802 0.841 . . . . 0.0 109.055 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.18 140.71 52.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -159.9 133.52 7.11 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.222 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -60.06 -14.95 19.14 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -89.3 -20.73 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.011 0.823 . . . . 0.0 112.128 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.33 -16.4 3.95 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.03 -99.1 2.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 25.4 m -152.03 142.49 22.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.466 0.706 . . . . 0.0 109.497 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.09 -179.42 7.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 109.017 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -131.66 151.9 51.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.623 1.569 . . . . 0.0 106.898 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.93 145.97 34.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 123.556 0.743 . . . . 0.0 109.108 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -107.34 102.54 11.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 128.975 2.91 . . . . 0.0 105.918 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -23.84 61.65 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -74.95 -16.89 60.63 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.762 2.025 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.84 -12.45 2.94 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.253 1.421 . . . . 0.0 112.35 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 57.61 56.78 4.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.346 2.258 . . . . 0.0 109.095 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -133.22 155.7 48.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.525 1.13 . . . . 0.0 109.589 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.49 153.7 29.51 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.497 1.119 . . . . 0.0 110.865 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -153.78 147.82 25.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.34 10.62 12.13 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.78 23.83 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.207 1.367 . . . . 0.0 112.983 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -55.81 144.7 55.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.406 1.882 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 C-N-CA 124.791 3.66 . . . . 0.0 113.866 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.238 0.448 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.41 163.43 38.61 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 N-CA-C 107.409 -1.804 . . . . 0.0 107.409 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.29 151.39 82.7 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.72 4.95 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.593 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.477 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 19.5 m95 -86.06 157.99 19.93 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.956 1.878 . . . . 0.0 109.124 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -143.14 152.48 41.85 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.091 -0.38 . . . . 0.0 110.092 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -117.73 121.87 41.97 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.338 1.855 . . . . 0.0 108.939 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.34 138.78 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.65 105.08 8.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.411 1.484 . . . . 0.0 109.023 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.0 m -137.83 128.15 26.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 127.681 2.392 . . . . 0.0 108.491 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -63.79 -21.54 66.47 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.095 1.316 . . . . 0.0 112.045 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.88 -21.29 66.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.913 1.685 . . . . 0.0 112.651 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -134.24 -29.28 1.26 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.63 -108.21 2.15 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 127.351 2.405 . . . . 0.0 107.432 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -145.13 125.12 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.442 0.697 . . . . 0.0 110.274 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.32 176.92 8.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -128.39 153.4 47.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.894 1.278 . . . . 0.0 110.64 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.64 135.03 61.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.216 1.006 . . . . 0.0 108.985 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 62.1 t0 -99.8 102.71 14.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 126.578 1.951 . . . . 0.0 108.582 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -70.4 -20.36 62.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.245 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.8 m -75.81 -31.44 59.42 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 120.806 -1.184 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -117.79 -2.6 11.34 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 53.56 46.24 26.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.549 2.339 . . . . 0.0 110.252 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -119.49 167.45 11.94 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.78 51.89 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.089 1.355 . . . . 0.0 108.571 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.78 152.94 27.56 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 110.526 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.23 0.07 54.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -118.23 162.92 17.45 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.287 0.949 . . . . 0.0 112.314 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -65.11 143.94 98.96 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 124.557 1.161 . . . . 0.0 109.09 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 89.9 Cg_endo . . . . . 0 CA--C 1.535 0.565 0 C-N-CA 124.021 3.147 . . . . 0.0 113.462 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.65 165.17 33.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.86 1.707 . . . . 0.0 109.029 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.16 146.03 93.95 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.286 1.991 . . . . 0.0 110.518 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.1 -17.7 9.2 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.886 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' B' ' 43' ' ' PRO . 11.3 m95 -83.59 156.53 22.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 120.159 1.98 . . . . 0.0 109.414 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -140.54 153.44 46.16 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.947 -0.471 . . . . 0.0 110.651 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -121.35 121.43 37.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.8 112.42 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -110.58 130.99 55.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.673 1.189 . . . . 0.0 107.812 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -153.44 -162.61 1.49 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.175 2.59 . . . . 0.0 107.95 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -124.95 -24.09 4.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.948 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -69.83 -25.31 63.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.334 0.97 . . . . 0.0 109.895 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -127.89 -15.62 4.81 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.151 1.78 . . . . 0.0 111.873 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.95 -83.64 1.59 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.424 0.556 . . . . 0.0 113.436 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 87.6 m -156.63 129.12 7.58 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.159 -1.2 . . . . 0.0 110.665 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -142.44 171.15 14.45 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.83 149.46 48.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.378 1.471 . . . . 0.0 107.748 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.68 131.93 59.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.608 0.763 . . . . 0.0 108.956 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -94.73 107.41 19.42 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.095 1.358 . . . . 0.0 109.307 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -65.05 -19.03 65.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -76.02 -38.39 57.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.333 1.453 . . . . 0.0 113.414 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -121.0 2.07 10.43 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp 49.92 39.92 19.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.898 2.079 . . . . 0.0 112.316 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -105.86 156.98 17.81 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.23 143.07 48.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.68 1.192 . . . . 0.0 109.031 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -155.08 161.55 41.27 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.656 -0.652 . . . . 0.0 110.967 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.66 19.16 18.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.626 1.17 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.63 152.41 45.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 119.889 -1.757 . . . . 0.0 109.821 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.84 147.7 98.52 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.065 0.946 . . . . 0.0 109.612 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' B' ' 18' ' ' TRP . 59.8 Cg_endo . . . . . 0 N--CA 1.461 -0.437 0 C-N-CA 123.5 2.8 . . . . 0.0 115.05 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.7 mt . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 36.6 Cg_endo -70.38 166.34 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.894 . . . . 0.0 110.214 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 140.63 82.54 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 106.966 -1.974 . . . . 0.0 106.966 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.82 -9.63 73.41 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.291 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.9 m95 -104.11 156.17 18.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 121.196 2.498 . . . . 0.0 110.161 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -145.2 157.69 44.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.033 0.933 . . . . 0.0 108.958 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -127.23 121.56 31.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.727 2.411 . . . . 0.0 106.534 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.33 149.21 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 125.789 1.636 . . . . 0.0 109.116 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.28 130.44 38.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 0.0 110.036 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -147.88 170.45 17.63 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.091 1.356 . . . . 0.0 110.56 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.1 m -91.15 -42.58 10.37 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.315 -1.49 . . . . 0.0 107.027 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -64.54 -23.84 67.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.984 1.714 . . . . 0.0 112.374 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -129.07 -12.18 4.66 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 -86.4 1.21 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.58 136.78 13.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.461 0.704 . . . . 0.0 110.678 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.81 161.59 41.51 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.604 1.093 . . . . 0.0 109.571 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -116.34 148.09 40.93 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.575 0.75 . . . . 0.0 109.109 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 31' ' ' VAL . 57.4 t -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 50.3 t0 -107.35 102.48 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.042 1.737 . . . . 0.0 110.342 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -66.04 -18.05 65.09 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.93 -0.481 . . . . 0.0 111.658 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.3 m -73.28 -29.75 62.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.284 0.947 . . . . 0.0 111.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -127.32 -0.96 6.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.63 0.772 . . . . 0.0 112.832 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm 56.75 45.32 22.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.683 1.993 . . . . 0.0 109.899 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -121.79 153.41 38.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.846 0.858 . . . . 0.0 110.684 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.6 143.79 44.44 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.946 1.299 . . . . 0.0 108.881 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -140.01 170.85 15.1 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.909 1.684 . . . . 0.0 109.778 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.6 6.88 20.3 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 161.03 34.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.586 0.63 . . . . 0.0 109.723 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.45 138.91 89.09 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.372 2.715 . . . . 0.0 114.902 -178.413 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.73 168.3 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.939 1.759 . . . . 0.0 109.441 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.26 151.11 86.75 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 -8.11 45.13 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.259 -1.3 . . . . 0.0 112.659 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 20.4 m95 -106.42 153.56 22.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 121.375 2.587 . . . . 0.0 110.039 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.07 157.87 45.2 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.513 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -118.32 131.83 56.31 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.976 2.11 . . . . 0.0 105.676 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.22 144.0 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.86 147.49 52.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m -158.57 158.49 34.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.898 2.079 . . . . 0.0 109.949 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -76.78 -43.41 37.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.685 1.13 . . . . 0.0 111.509 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' B' ' 26' ' ' PHE . 9.8 pt-20 -67.36 -34.66 77.77 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.47 ' CE1' ' HG3' ' B' ' 25' ' ' GLU . 15.1 m-85 -98.71 -34.38 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.93 -98.32 1.98 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -147.32 132.09 17.96 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.627 -0.925 . . . . 0.0 110.892 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -140.97 158.03 44.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.546 0.689 . . . . 0.0 109.212 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.21 145.43 42.43 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 31' ' ' VAL . 46.3 t -121.21 137.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 122.662 1.22 . . . . 0.0 110.342 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 26.2 t0 -103.08 102.37 12.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.088 2.955 . . . . 0.0 109.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -75.68 -22.95 56.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.62 0.768 . . . . 0.0 109.643 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 71.6 m -67.24 -18.14 65.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.871 1.269 . . . . 0.0 113.101 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.58 -12.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.537 1.135 . . . . 0.0 111.59 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm 65.07 60.42 0.8 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.826 2.05 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -128.61 164.5 22.74 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.468 1.507 . . . . 0.0 108.036 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.21 146.36 50.75 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -150.55 136.96 18.76 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.545 0.738 . . . . 0.0 109.313 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -80.08 20.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.757 1.623 . . . . 0.0 112.501 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 169.79 17.02 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.207 1.403 . . . . 0.0 110.282 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.23 149.59 97.46 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 0.0 110.461 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.073 179.237 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--O 1.234 0.279 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 14.9 Cg_endo -71.32 155.08 60.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 N-CA-C 109.908 -0.843 . . . . 0.0 109.908 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.48 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 103.789 -3.197 . . . . 0.0 103.789 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.36 -0.41 8.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.391 1.472 . . . . 0.0 110.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.1 m95 -121.08 144.15 48.7 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 119.293 1.546 . . . . 0.0 109.69 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -116.68 150.69 37.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.153 0.981 . . . . 0.0 109.391 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -111.03 136.73 49.6 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.0 t -119.24 124.37 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -117.49 110.91 18.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.637 1.975 . . . . 0.0 108.554 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 p -125.76 171.52 10.59 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.856 1.663 . . . . 0.0 109.958 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -108.47 -23.09 12.01 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.991 -0.443 . . . . 0.0 110.948 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -83.51 -18.74 37.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.056 0.389 . . . . 0.0 111.327 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.82 -61.35 1.51 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.935 1.294 . . . . 0.0 109.078 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.05 -95.4 0.25 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -152.31 132.68 13.71 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 117.933 0.866 . . . . 0.0 111.735 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.77 169.54 19.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.11 152.37 36.63 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.95 131.76 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.082 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 27.9 t0 -98.0 103.6 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.017 1.727 . . . . 0.0 109.976 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -18.4 65.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -77.84 -35.65 50.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.194 0.906 . . . . 0.0 112.788 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -118.86 4.4 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.033 0.833 . . . . 0.0 113.177 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 53.72 47.31 24.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.642 1.177 . . . . 0.0 110.854 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -120.2 142.59 48.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.493 1.117 . . . . 0.0 111.365 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.72 138.88 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -149.33 146.49 27.55 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 120.063 1.301 . . . . 0.0 113.547 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.85 3.21 46.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.833 1.653 . . . . 0.0 112.098 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.03 143.57 48.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.327 1.451 . . . . 0.0 108.319 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -62.08 142.13 95.57 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 125.71 1.604 . . . . 0.0 110.7 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.907 2.405 . . . . 0.0 111.434 179.016 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.7 mt . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 119.747 -0.168 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 67.5 Cg_endo -73.29 168.15 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.944 1.763 . . . . 0.0 110.334 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.72 133.21 35.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.899 2.399 . . . . 0.0 108.768 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.63 -18.91 56.19 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.628 1.109 . . . . 0.0 111.96 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 21.9 m95 -93.06 132.55 37.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.199 1.5 . . . . 0.0 108.39 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.8 159.77 35.51 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.54 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -121.16 120.96 36.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.04 133.68 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.62 150.08 46.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -149.29 175.52 11.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 59.2 m -108.1 -12.85 15.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -93.9 -19.65 20.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.99 -53.16 0.8 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.14 -134.81 5.38 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 105.993 -2.843 . . . . 0.0 105.993 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.7 m -130.78 138.28 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.299 1.04 . . . . 0.0 110.19 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -147.18 178.75 8.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.131 0.972 . . . . 0.0 110.022 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -118.19 155.39 30.58 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.102 0.961 . . . . 0.0 110.371 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.53 135.26 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.002 0.921 . . . . 0.0 108.566 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.443 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.2 t0 -103.98 105.52 15.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.67 -20.21 64.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.892 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 39.9 m -74.31 -34.89 63.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.629 0.772 . . . . 0.0 111.793 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.87 -9.92 11.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm 60.72 49.93 5.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.177 1.791 . . . . 0.0 109.195 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -121.65 160.7 23.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.81 1.244 . . . . 0.0 109.109 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.95 139.98 50.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -149.73 137.78 20.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -77.97 -2.83 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -108.65 156.62 19.35 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.458 1.103 . . . . 0.0 109.78 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' HIS . . . . . 0.455 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 52.2 t-80 -69.76 149.33 96.7 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.931 0.893 . . . . 0.0 108.751 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 72.4 Cg_endo . . . . . 0 CA--C 1.54 0.822 0 C-N-CA 124.709 3.606 . . . . 0.0 115.813 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 C--O 1.233 0.235 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.24 157.98 59.49 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.437 1.425 . . . . 0.0 109.91 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.86 116.52 4.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.347 2.698 . . . . 0.0 107.359 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.18 -9.75 10.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.592 1.567 . . . . 0.0 111.582 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.466 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 23.1 m95 -107.36 163.8 12.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.531 1.166 . . . . 0.0 109.878 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -147.49 153.28 39.32 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.07 0.948 . . . . 0.0 109.775 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -118.43 121.01 39.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.15 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.15 92.12 3.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -127.87 151.96 48.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.788 1.235 . . . . 0.0 110.304 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 m -89.34 -29.53 19.06 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.769 0.827 . . . . 0.0 111.225 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.01 -38.45 88.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.289 0.636 . . . . 0.0 111.74 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -117.27 -40.61 3.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 -170.74 15.47 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.8 m -84.48 117.48 23.7 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.191 1.796 . . . . 0.0 107.892 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -136.36 -179.91 5.97 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 109.976 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -131.51 156.15 46.19 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.181 -0.95 . . . . 0.0 111.322 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.96 143.5 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.622 1.169 . . . . 0.0 109.106 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 23.8 t0 -106.17 118.78 37.51 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 127.39 2.276 . . . . 0.0 110.064 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -74.68 -21.73 59.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.915 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -65.24 -41.56 94.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 112.579 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.97 -1.87 8.78 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.278 1.431 . . . . 0.0 113.971 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 57.78 46.78 16.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 110.453 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -116.2 139.7 50.07 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.92 152.17 23.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.74 163.38 39.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.018 -1.051 . . . . 0.0 110.981 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -105.39 18.95 21.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.458 1.903 . . . . 0.0 111.846 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 154.12 51.84 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.246 -1.533 . . . . 0.0 110.948 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.65 136.67 96.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 68.2 Cg_endo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 123.918 3.079 . . . . 0.0 114.289 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 C--O 1.235 0.301 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 60.1 Cg_endo -71.54 155.76 58.95 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.627 2.218 . . . . 0.0 109.084 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.13 94.53 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.379 3.386 . . . . 0.0 109.356 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.57 -7.56 1.53 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.334 1.445 . . . . 0.0 111.509 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.456 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.1 m95 -108.56 156.46 19.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.895 0.878 . . . . 0.0 109.293 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.91 155.74 45.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.595 0.758 . . . . 0.0 109.641 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -129.39 121.66 27.83 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.92 142.76 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.16 111.3 10.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 57.7 m -134.01 141.82 47.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.462 1.505 . . . . 0.0 111.407 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -70.01 -25.5 63.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.536 1.062 . . . . 0.0 111.104 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.41 -26.72 63.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.199 -0.905 . . . . 0.0 113.176 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.18 -23.68 2.41 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -107.74 1.66 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.383 1.944 . . . . 0.0 111.82 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 54.5 m -141.85 132.43 25.41 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.488 1.915 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -150.83 174.82 12.64 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.95 0.795 . . . . 0.0 109.771 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -124.93 154.34 41.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.06 0.944 . . . . 0.0 110.511 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.94 143.08 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.601 1.16 . . . . 0.0 109.446 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.403 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 12.0 t0 -106.91 143.21 35.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.951 1.7 . . . . 0.0 108.256 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -105.87 2.21 27.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.136 1.374 . . . . 0.0 111.26 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -91.62 -38.5 12.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.04 1.736 . . . . 0.0 112.658 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -132.25 6.06 4.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.945 2.098 . . . . 0.0 113.145 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt 51.03 52.05 15.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.703 1.601 . . . . 0.0 111.822 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -110.57 150.51 28.85 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.46 146.85 49.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -155.49 172.42 18.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.725 1.148 . . . . 0.0 112.084 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -113.54 13.23 18.75 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 0.0 111.589 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 161.11 23.35 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' HIS . . . . . 0.426 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 1.8 t-80 -70.06 150.84 96.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.102 0.864 . . . . 0.0 110.298 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 73.3 Cg_endo . . . . . 0 CA--C 1.541 0.844 0 C-N-CA 122.874 2.383 . . . . 0.0 111.827 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--O 1.234 0.25 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.94 164.11 31.06 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.696 2.264 . . . . 0.0 110.894 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.02 127.97 19.65 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.119 1.879 . . . . 0.0 108.057 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.38 -20.98 31.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.294 0.949 . . . . 0.0 111.567 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 17.9 m95 -91.98 154.97 18.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.278 1.539 . . . . 0.0 108.171 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -142.07 146.24 35.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -107.25 126.86 52.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.303 1.841 . . . . 0.0 107.293 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.71 117.19 54.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -102.3 137.45 40.54 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.457 1.503 . . . . 0.0 107.829 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -149.44 178.96 8.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.911 0.884 . . . . 0.0 111.688 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.9 m -106.0 -11.05 16.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 0.0 111.412 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -104.41 -47.45 4.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.35 0.595 . . . . 0.0 110.669 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -91.93 -8.27 46.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.078 1.351 . . . . 0.0 113.108 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.17 -88.56 1.19 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.74 134.27 10.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.33 176.48 9.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -134.56 159.79 40.08 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.85 133.41 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.331 0.652 . . . . 0.0 110.284 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 14.9 t0 -92.56 108.37 19.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.893 2.477 . . . . 0.0 107.275 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -68.98 -28.15 66.36 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 122.12 -0.362 . . . . 0.0 111.948 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.5 m -69.6 -44.76 70.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.113 0.965 . . . . 0.0 111.892 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -103.45 -8.2 20.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.389 1.076 . . . . 0.0 113.696 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 55.74 60.81 3.09 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.653 1.581 . . . . 0.0 108.901 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -136.44 154.65 50.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.842 1.257 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.46 149.51 36.2 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -153.29 160.1 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.652 0.781 . . . . 0.0 111.413 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -108.0 13.66 25.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 0.0 113.219 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 160.38 29.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.931 1.292 . . . . 0.0 108.753 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.7 139.93 91.58 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.349 0.591 0 C-N-CA 124.964 3.776 . . . . 0.0 114.858 -178.535 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--O 1.234 0.247 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.4 Cg_endo -64.37 158.06 51.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.235 1.956 . . . . 0.0 109.764 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.13 103.64 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.376 3.384 . . . . 0.0 109.983 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.99 3.52 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.004 1.764 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.476 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 7.4 m95 -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.181 -1.188 . . . . 0.0 109.151 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.24 155.07 44.42 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.233 0.54 . . . . 0.0 110.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -116.99 136.82 52.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 128.071 2.549 . . . . 0.0 105.365 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.38 143.95 27.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -128.16 137.18 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 m -154.44 -172.64 4.28 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.111 1.764 . . . . 0.0 110.508 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -105.21 -59.22 1.78 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -60.69 -18.04 51.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 114.192 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.72 -12.77 5.98 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.584 1.154 . . . . 0.0 114.06 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.64 -92.02 0.78 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.463 1.982 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.19 127.5 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.133 -0.627 . . . . 0.0 111.61 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -141.85 174.07 10.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.616 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.82 146.87 50.8 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.383 -1.448 . . . . 0.0 110.768 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.86 136.79 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.024 1.329 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -97.44 112.82 24.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.471 1.908 . . . . 0.0 106.328 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -22.57 53.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.899 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -67.08 -53.18 33.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.01 1.277 . . . . 0.0 111.746 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.78 -4.04 31.44 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.353 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm 56.55 58.14 4.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.533 1.533 . . . . 0.0 107.072 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -119.66 169.6 9.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.175 1.39 . . . . 0.0 109.693 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.65 146.39 50.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.245 1.018 . . . . 0.0 110.43 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.45 167.67 21.64 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.937 1.295 . . . . 0.0 109.487 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.7 4.88 18.85 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.045 0.938 . . . . 0.0 113.153 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.08 176.36 8.14 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.96 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -71.54 141.54 85.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 CA--C 1.538 0.682 0 C-N-CA 123.16 2.573 . . . . 0.0 114.733 -178.706 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.67 159.51 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.066 2.511 . . . . 0.0 110.773 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.79 117.6 5.12 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.971 2.448 . . . . 0.0 107.038 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.58 -20.76 8.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.317 1.437 . . . . 0.0 112.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 13.5 m95 -90.99 157.43 17.29 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 119.793 1.796 . . . . 0.0 110.005 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -135.03 145.15 47.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -118.53 130.53 55.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.57 139.4 47.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 140.29 49.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.594 1.958 . . . . 0.0 106.761 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.45 150.87 20.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.26 1.024 . . . . 0.0 108.374 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -74.27 -24.1 59.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.743 1.156 . . . . 0.0 110.35 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.43 -39.03 28.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.418 1.087 . . . . 0.0 113.732 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -109.55 -9.23 14.91 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.106 . . . . 0.0 113.528 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.32 -88.82 1.1 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 126.404 1.954 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 m -152.98 119.77 5.71 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.54 168.13 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.948 0.899 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -125.48 139.54 53.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.364 1.066 . . . . 0.0 109.695 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' B' ' 31' ' ' VAL . 93.5 t -122.12 131.87 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.02 0.928 . . . . 0.0 110.08 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.6 t0 -91.24 121.85 33.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 127.144 2.178 . . . . 0.0 108.836 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -85.97 -9.87 56.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.988 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -73.07 -43.56 61.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.794 1.179 . . . . 0.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -120.49 2.92 10.76 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.96 1.304 . . . . 0.0 112.871 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 56.59 45.84 21.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 110.973 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -117.21 138.6 51.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.28 20.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -151.91 164.95 36.04 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.322 1.058 . . . . 0.0 110.482 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 51.7 m-85 -107.76 26.4 10.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.8 1.64 . . . . 0.0 111.204 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -140.55 160.96 38.86 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -74.61 141.5 76.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.586 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 72.6 Cg_endo . . . . . 0 N--CA 1.458 -0.593 0 C-N-CA 122.438 2.092 . . . . 0.0 112.444 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 61.2 Cg_endo -71.04 157.53 57.6 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.234 1.29 . . . . 0.0 110.373 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.12 125.25 13.78 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.648 2.232 . . . . 0.0 106.349 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.92 -10.84 27.34 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.779 1.657 . . . . 0.0 110.75 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 27.7 m95 -113.04 148.98 34.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.897 1.349 . . . . 0.0 109.695 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -139.3 155.83 47.46 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.927 0.767 . . . . 0.0 109.779 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -116.15 138.69 51.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.731 1.612 . . . . 0.0 108.257 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.59 139.58 42.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.43 133.26 46.21 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -149.02 172.03 15.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.885 1.274 . . . . 0.0 113.685 -175.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m -84.93 -32.48 23.07 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.541 1.137 . . . . 0.0 113.921 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -100.89 -12.03 19.31 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.464 1.106 . . . . 0.0 112.667 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -116.86 -21.08 9.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.315 1.046 . . . . 0.0 111.57 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.61 -89.97 1.34 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 24.1 m -156.74 129.16 7.52 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.082 -1.246 . . . . 0.0 109.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -138.45 174.75 10.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -130.53 143.03 50.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' A' ' 31' ' ' VAL . 22.2 t -119.19 131.78 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 12.2 t0 -92.66 109.32 20.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.57 -11.83 60.3 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.662 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.7 m -66.84 -41.25 87.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.498 1.499 . . . . 0.0 110.572 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.02 1.73 8.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 46.1 mmtm 59.39 51.75 6.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.756 1.222 . . . . 0.0 109.466 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -122.68 146.05 47.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.57 131.36 54.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -134.68 157.89 45.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.492 1.117 . . . . 0.0 108.291 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -104.26 3.21 32.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -105.04 156.04 18.42 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.826 1.65 . . . . 0.0 109.107 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -69.13 149.61 97.6 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-O 117.541 -1.219 . . . . 0.0 107.966 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.456 -0.695 0 CA-C-N 121.352 1.519 . . . . 0.0 110.276 -179.765 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 C--O 1.236 0.344 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.21 164.97 31.95 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.601 1.534 . . . . 0.0 109.982 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.69 149.03 78.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 N-CA-C 105.698 -2.462 . . . . 0.0 105.698 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.72 -11.43 70.32 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -111.7 136.18 51.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.431 1.615 . . . . 0.0 107.405 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.6 152.09 37.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 0.0 110.388 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -115.68 120.51 39.6 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.1 t -104.53 138.53 28.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.98 129.09 50.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.965 1.306 . . . . 0.0 107.816 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -147.76 169.22 20.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.812 2.045 . . . . 0.0 108.213 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -105.7 -23.89 12.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -78.16 -35.1 49.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -96.5 -69.65 0.75 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.978 1.311 . . . . 0.0 108.851 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.97 -132.75 6.27 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 104.316 -3.514 . . . . 0.0 104.316 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.97 132.14 54.46 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 109.421 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -141.71 166.51 24.52 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.512 0.725 . . . . 0.0 109.682 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -122.55 139.64 53.68 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 111.035 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' B' ' 31' ' ' VAL . 55.4 t -121.61 148.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -108.08 113.03 25.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.214 1.806 . . . . 0.0 111.963 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -21.08 64.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.695 0.679 . . . . 0.0 111.748 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -73.63 -30.85 63.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.17 0.988 . . . . 0.0 113.045 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -129.13 -1.09 5.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' CE ' ' CE2' ' B' ' 40' ' ' TYR . 17.6 mmtp 59.06 46.7 12.99 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.679 1.192 . . . . 0.0 110.616 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -125.35 146.41 49.59 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.635 -0.665 . . . . 0.0 110.78 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.19 142.11 36.42 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 107.858 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -148.83 161.48 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 108.833 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -106.99 14.17 26.74 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.948 0.899 . . . . 0.0 111.002 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -118.51 160.29 22.01 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 120.97 -1.081 . . . . 0.0 110.744 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.88 133.83 88.09 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.947 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.54 0.799 0 C-N-CA 124.362 3.374 . . . . 0.0 115.398 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 20' ' ' ARG . 74.8 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.409 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 48.2 Cg_endo -67.2 157.19 62.94 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.042 1.828 . . . . 0.0 109.407 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.18 93.34 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.573 3.515 . . . . 0.0 111.64 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.36 -19.65 2.26 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.279 1.419 . . . . 0.0 111.153 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 18.6 m95 -94.43 149.89 20.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -131.74 141.09 49.43 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.07 0.548 . . . . 0.0 109.788 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.411 ' HB2' HD11 ' B' ' 14' ' ' LEU . 42.0 ttp180 -107.48 121.83 45.41 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.0 t -110.91 141.53 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -130.18 150.23 51.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 m -154.87 -165.63 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.115 1.366 . . . . 0.0 109.435 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.0 m -115.43 -45.16 2.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.07 0.948 . . . . 0.0 108.957 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.79 -14.73 62.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.989 0.516 . . . . 0.0 110.559 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.61 -25.63 4.32 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.69 1.596 . . . . 0.0 113.192 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.79 -86.61 1.55 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.9 m -159.61 140.06 12.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.121 1.46 . . . . 0.0 110.577 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.64 176.34 9.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.414 -0.804 . . . . 0.0 109.689 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.34 151.9 50.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 108.931 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 31' ' ' VAL . 42.5 t -128.32 136.6 59.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.217 1.007 . . . . 0.0 109.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.3 t0 -101.53 104.08 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.978 1.311 . . . . 0.0 108.879 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.24 -19.89 66.18 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.795 -0.565 . . . . 0.0 111.26 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.45 -33.16 69.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.682 1.593 . . . . 0.0 112.661 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -126.78 0.75 6.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 54.57 36.99 27.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -111.75 161.16 16.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.37 148.44 48.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.986 0.914 . . . . 0.0 108.587 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.42 168.51 26.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.82 1.248 . . . . 0.0 110.118 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.502 ' CE2' ' CE ' ' A' ' 36' ' ' LYS . 69.2 m-85 -105.36 -1.02 25.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.8 167.88 9.5 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.064 -1.023 . . . . 0.0 111.233 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.29 149.89 89.35 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 C-N-CA 123.447 2.765 . . . . 0.0 115.436 -178.216 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ARG . 36.6 mt . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.917 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 57.8 Cg_endo -71.56 162.39 42.36 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.119 1.879 . . . . 0.0 110.705 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 121.22 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.12 2.546 . . . . 0.0 110.41 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.42 47.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.315 1.435 . . . . 0.0 112.904 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.2 m95 -92.2 151.09 20.54 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.454 1.627 . . . . 0.0 108.151 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.02 154.74 47.87 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.557 1.143 . . . . 0.0 109.919 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.8 ttp180 -125.87 124.86 41.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t -108.33 115.03 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 108.426 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.67 128.27 44.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.5 m -139.94 -173.72 3.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.575 1.15 . . . . 0.0 109.885 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -116.45 -43.96 2.9 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.853 1.261 . . . . 0.0 108.801 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.55 -18.81 62.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.928 0.891 . . . . 0.0 112.695 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -128.17 -19.28 3.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.3 -100.24 1.79 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -157.95 139.58 13.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.493 0.717 . . . . 0.0 109.641 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -146.31 170.57 16.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -119.33 152.79 36.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.576 1.55 . . . . 0.0 107.59 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.44 135.33 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.204 0.601 . . . . 0.0 110.321 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 20.4 t0 -101.53 106.19 17.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.248 1.419 . . . . 0.0 108.176 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.94 -13.87 61.76 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.561 -0.712 . . . . 0.0 111.233 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.5 m -75.11 -39.12 60.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.88 1.218 . . . . 0.0 112.528 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -124.25 8.12 8.5 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm 54.18 53.72 10.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.421 1.488 . . . . 0.0 109.414 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -121.97 134.93 54.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.792 1.637 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 135.35 39.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.318 1.447 . . . . 0.0 107.621 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -139.07 153.63 48.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.848 1.204 . . . . 0.0 113.227 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -96.96 15.81 21.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.891 1.276 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 158.44 43.99 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 119.955 -1.716 . . . . 0.0 109.742 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -58.37 141.71 82.71 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 124.391 1.057 . . . . 0.0 110.726 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.451 -0.999 0 C-N-CA 122.743 2.295 . . . . 0.0 109.306 178.624 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' B' ' 20' ' ' ARG . 86.4 mt . . . . . 0 C--O 1.238 0.475 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 28.4 Cg_endo -69.06 163.35 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.914 1.742 . . . . 0.0 109.336 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.0 137.79 49.99 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.31 74.24 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.635 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 9.8 m95 -114.3 142.03 46.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 121.171 2.486 . . . . 0.0 109.094 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -125.32 157.68 36.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.647 0.779 . . . . 0.0 110.553 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.421 ' HB2' HD11 ' B' ' 14' ' ' LEU . 38.0 ttp180 -128.05 125.04 38.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.469 2.308 . . . . 0.0 106.906 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.51 133.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.96 119.06 35.94 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 65.1 m -138.51 158.46 44.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.462 1.105 . . . . 0.0 109.738 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -84.81 -39.55 18.22 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.695 -1.253 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.26 -16.24 59.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -124.83 -13.04 7.01 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.91 -94.66 1.99 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.998 1.761 . . . . 0.0 110.543 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -151.91 135.83 16.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.037 -0.684 . . . . 0.0 110.47 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -148.54 167.79 24.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.22 155.05 37.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 108.337 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.9 139.31 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.889 0.852 . . . . 0.0 109.236 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -100.61 102.47 13.62 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 128.533 2.733 . . . . 0.0 106.938 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -20.19 64.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.535 0.607 . . . . 0.0 112.413 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -71.86 -36.88 70.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.375 0.989 . . . . 0.0 110.7 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -116.82 -1.47 12.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 58.02 53.52 6.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.027 1.331 . . . . 0.0 108.285 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -123.41 147.38 47.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.702 0.401 . . . . 0.0 110.016 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.85 136.23 48.76 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 150.41 40.74 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.856 0.753 . . . . 0.0 110.376 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -88.73 1.32 55.35 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 156.5 33.61 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.583 1.153 . . . . 0.0 110.169 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -64.48 146.42 98.09 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 -179.074 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 74.2 Cg_endo -76.62 168.66 23.27 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.575 2.184 . . . . 0.0 109.105 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.9 149.88 72.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 -11.44 44.51 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.554 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 16.2 m95 -99.68 151.8 20.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.475 1.638 . . . . 0.0 106.619 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -135.63 151.98 50.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.922 0.489 . . . . 0.0 110.004 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -111.14 129.72 55.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.31 143.97 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.33 149.88 51.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -155.31 148.96 25.28 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.401 1.08 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -76.23 -19.48 58.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -85.37 -20.09 30.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.337 1.055 . . . . 0.0 113.209 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.53 -46.0 1.77 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.67 -109.39 1.1 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -138.56 129.23 26.37 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -144.69 163.21 34.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.75 149.03 39.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 111.444 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.14 142.49 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.492 0.717 . . . . 0.0 109.744 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 119.44 39.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 127.907 2.483 . . . . 0.0 108.844 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -84.61 -20.97 30.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -76.84 -31.98 57.25 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.284 1.034 . . . . 0.0 110.085 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -117.38 -9.42 10.9 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp 56.86 50.46 12.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.07 1.348 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -126.05 160.19 30.74 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.661 0.785 . . . . 0.0 110.287 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.77 139.5 53.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.376 1.471 . . . . 0.0 109.37 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -153.9 144.68 22.57 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.631 1.173 . . . . 0.0 108.688 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 62.8 m-85 -91.25 24.41 2.92 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.46 0.704 . . . . 0.0 109.845 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 154.28 47.99 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.573 -1.329 . . . . 0.0 111.036 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.95 143.99 98.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 59.6 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 C-N-CA 122.845 2.364 . . . . 0.0 116.658 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--O 1.233 0.186 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.48 166.91 27.89 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.923 2.415 . . . . 0.0 110.291 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.67 118.63 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.703 2.268 . . . . 0.0 109.975 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.5 -11.96 33.12 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.181 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 32.2 m95 -100.54 150.43 22.68 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 119.303 1.551 . . . . 0.0 108.373 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.02 168.03 19.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 108.669 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -133.06 121.34 22.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.116 1.366 . . . . 0.0 108.585 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.76 107.98 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 124.168 0.917 . . . . 0.0 109.221 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -95.48 133.36 39.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.3 m -155.78 -177.64 6.71 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.006 -1.684 . . . . 0.0 110.833 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -102.68 -44.75 5.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.806 0.843 . . . . 0.0 111.896 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.74 -11.85 59.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.69 -19.86 3.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.17 -105.33 3.26 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -144.96 124.19 12.95 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.909 0.484 . . . . 0.0 110.905 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.45 178.51 7.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.373 1.069 . . . . 0.0 108.838 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.35 155.57 47.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.557 1.143 . . . . 0.0 109.767 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.4 131.58 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 51.7 t0 -98.82 104.66 16.72 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -70.06 -21.95 63.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.843 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 90.3 m -67.7 -45.19 75.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.837 1.653 . . . . 0.0 110.823 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -106.63 1.11 24.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.81 0.844 . . . . 0.0 112.424 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 2.4 mmtp 49.85 54.73 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.756 2.022 . . . . 0.0 110.611 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -119.62 167.39 12.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.089 0.956 . . . . 0.0 109.168 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 143.32 50.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -155.05 149.43 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.896 0.878 . . . . 0.0 108.968 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -90.98 -8.76 48.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.226 1.01 . . . . 0.0 110.14 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -93.56 152.4 19.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 124.539 1.136 . . . . 0.0 108.584 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 42.5 t-80 -67.26 151.33 97.26 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.61 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 92.0 Cg_endo . . . . . 0 C--N 1.348 0.542 0 N-CA-C 117.357 2.022 . . . . 0.0 117.357 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 40.5 Cg_endo -72.09 164.55 35.31 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.405 1.403 . . . . 0.0 109.304 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.18 134.65 40.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.57 1.513 . . . . 0.0 108.919 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.68 -10.8 72.19 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 117.615 -1.659 . . . . 0.0 114.216 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.459 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.2 m95 -93.91 168.18 11.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.147 1.973 . . . . 0.0 109.181 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -140.95 156.27 46.1 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.608 0.763 . . . . 0.0 109.986 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -125.04 129.99 51.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.68 132.74 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.32 139.61 41.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -142.84 -172.41 3.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.8 2.44 . . . . 0.0 109.819 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -126.28 -38.86 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.535 1.934 . . . . 0.0 107.594 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -34.8 71.24 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -113.33 -17.11 12.37 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.76 -85.7 1.51 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -157.63 146.03 19.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.343 1.072 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -154.63 166.99 31.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.296 0.638 . . . . 0.0 109.606 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.0 144.98 45.09 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' B' ' 31' ' ' VAL . 85.3 t -123.78 142.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.823 0.849 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -107.43 112.55 25.4 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 127.255 2.222 . . . . 0.0 109.498 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -74.22 -22.37 59.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.767 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.4 m -69.53 -34.1 73.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.59 1.086 . . . . 0.0 112.148 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -121.92 1.84 9.9 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.341 0.656 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' B' ' 40' ' ' TYR . 34.9 mmtm 51.15 52.5 14.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.983 1.713 . . . . 0.0 108.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -121.75 154.84 36.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.664 0.786 . . . . 0.0 108.984 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.83 140.95 51.03 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.67 1.188 . . . . 0.0 108.371 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -150.22 147.28 27.51 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.522 -0.736 . . . . 0.0 110.527 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.31 -13.28 52.87 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.365 1.466 . . . . 0.0 112.965 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.69 144.01 27.1 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.481 1.912 . . . . 0.0 107.158 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -68.05 142.14 94.91 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 CA--C 1.536 0.612 0 C-N-CA 123.822 3.015 . . . . 0.0 112.591 179.543 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt . . . . . 0 C--O 1.237 0.41 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 43.6 Cg_endo -74.25 164.0 35.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.59 2.194 . . . . 0.0 112.773 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.74 130.69 26.95 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 105.282 -2.622 . . . . 0.0 105.282 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.2 -1.83 56.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.532 -1.705 . . . . 0.0 113.283 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 16.0 m95 -117.18 165.98 12.79 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.226 2.013 . . . . 0.0 111.467 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -152.1 150.89 30.41 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.116 0.966 . . . . 0.0 109.153 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -104.59 149.46 25.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.04 114.43 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -105.9 145.94 30.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -156.22 -168.14 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.639 1.175 . . . . 0.0 109.364 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -120.6 -44.07 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.478 1.911 . . . . 0.0 107.954 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -63.88 -25.12 68.01 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.325 1.05 . . . . 0.0 113.263 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.01 -33.15 3.38 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.2 -104.51 1.35 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -150.24 136.47 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -151.09 -175.3 5.1 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -132.35 155.77 47.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.093 1.357 . . . . 0.0 109.43 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 31' ' ' VAL . 57.7 t -131.61 133.63 61.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.462 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 57.2 t0 -97.06 111.51 23.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.166 1.787 . . . . 0.0 110.587 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -70.75 -18.75 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.436 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -67.52 -37.03 82.16 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.947 1.699 . . . . 0.0 112.377 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -127.13 3.96 6.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.585 0.754 . . . . 0.0 112.724 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 53.4 42.85 31.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.216 1.806 . . . . 0.0 110.878 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -113.97 161.37 17.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.03 146.92 46.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -158.06 155.6 29.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.321 1.048 . . . . 0.0 109.126 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' TYR . . . . . 0.447 ' CE1' ' HE3' ' A' ' 36' ' ' LYS . 75.5 m-85 -95.04 -4.2 46.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.568 1.147 . . . . 0.0 112.574 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.85 140.5 37.05 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' HIS . . . . . 0.507 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 61.1 t-80 -59.24 151.89 55.77 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 124.411 1.085 . . . . 0.0 109.672 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 87.0 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 C-N-CA 122.121 1.88 . . . . 0.0 110.283 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.65 163.54 36.59 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 107.965 -1.59 . . . . 0.0 107.965 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.1 149.99 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.23 -21.47 10.18 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.83 1.205 . . . . 0.0 112.64 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -88.12 143.54 27.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.759 1.78 . . . . 0.0 107.74 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -117.33 151.6 36.66 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.609 0.764 . . . . 0.0 111.011 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -117.71 119.42 34.89 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.32 145.12 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.15 139.79 52.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -157.48 132.27 8.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.216 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -59.64 -33.74 71.91 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.166 1.348 . . . . 0.0 112.512 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -16.5 61.64 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.96 -30.72 1.35 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.05 -94.15 0.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 126.647 2.07 . . . . 0.0 108.575 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.64 133.78 16.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -143.5 143.65 31.65 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.659 1.118 . . . . 0.0 109.739 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -96.87 156.48 16.33 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.261 -0.899 . . . . 0.0 109.806 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.16 142.17 44.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -105.2 108.69 20.34 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 127.344 2.258 . . . . 0.0 107.426 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -25.54 62.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.7 m -70.8 -41.43 71.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.235 1.014 . . . . 0.0 110.815 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -105.97 -10.01 16.8 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.935 0.894 . . . . 0.0 113.003 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 56.24 59.4 3.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.26 1.824 . . . . 0.0 107.198 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -126.4 166.69 16.72 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.895 1.678 . . . . 0.0 109.238 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.13 145.66 50.89 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.1 1.36 . . . . 0.0 107.414 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.14 163.79 36.57 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.268 -0.895 . . . . 0.0 112.448 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CZ ' ' HE3' ' B' ' 36' ' ' LYS . 78.6 m-85 -103.6 19.07 20.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.915 1.686 . . . . 0.0 112.878 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 152.28 43.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.737 -1.227 . . . . 0.0 109.911 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.37 140.63 91.7 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.843 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 N--CA 1.453 -0.862 0 C-N-CA 123.629 2.886 . . . . 0.0 111.852 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.238 0.473 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 40.1 Cg_endo -69.89 162.32 42.59 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.204 1.936 . . . . 0.0 109.131 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.53 139.77 72.06 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.574 -1.741 . . . . 0.0 107.574 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.14 73.05 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.413 -1.77 . . . . 0.0 112.588 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.444 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 11.4 m95 -101.62 157.49 16.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 120.434 2.117 . . . . 0.0 108.396 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -146.01 147.39 31.6 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.83 -0.544 . . . . 0.0 110.296 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.67 135.95 44.28 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.5 120.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.302 1.041 . . . . 0.0 109.1 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -111.76 136.93 50.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -143.44 135.65 26.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.606 1.562 . . . . 0.0 108.901 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.9 m -66.8 -28.52 68.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 120.61 1.55 . . . . 0.0 111.422 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.69 -21.5 57.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.76 -22.6 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.13 -98.37 1.22 Allowed Glycine 0 CA--C 1.519 0.339 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.2 m -158.17 145.55 18.11 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.232 1.013 . . . . 0.0 108.501 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.51 178.28 9.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.16 1.784 . . . . 0.0 106.623 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -128.26 158.08 39.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 66.1 t -132.08 131.43 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 59.7 t0 -91.61 103.86 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 127.435 2.294 . . . . 0.0 107.669 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -27.14 67.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.87 0.759 . . . . 0.0 111.877 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 63.1 m -69.13 -24.48 64.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.113 0.965 . . . . 0.0 112.535 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -126.72 -2.47 6.65 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.53 0.732 . . . . 0.0 112.752 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HE3' ' CZ ' ' A' ' 40' ' ' TYR . 40.1 mmtm 51.06 52.22 15.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.946 2.098 . . . . 0.0 110.301 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -127.5 160.72 30.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.66 -0.65 . . . . 0.0 109.724 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.36 139.93 50.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.352 1.061 . . . . 0.0 110.179 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.15 159.78 42.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.459 1.104 . . . . 0.0 109.977 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -100.25 15.15 28.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.085 1.354 . . . . 0.0 114.071 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.07 151.7 51.52 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.21 -1.556 . . . . 0.0 110.829 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.4 t-80 -60.41 143.73 89.2 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.883 0.873 . . . . 0.0 109.891 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 42.4 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 122.809 2.339 . . . . 0.0 112.55 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 C--O 1.235 0.311 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.2 164.42 35.69 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.794 1.663 . . . . 0.0 109.727 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.02 117.26 4.93 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.175 2.583 . . . . 0.0 109.906 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.81 7.92 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.158 1.837 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 31.6 m95 -88.95 136.66 32.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.397 -1.06 . . . . 0.0 109.705 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -119.68 139.95 51.42 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.284 1.033 . . . . 0.0 110.19 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -108.75 120.75 43.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.9 140.12 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -125.97 118.17 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.114 -2.551 . . . . 0.0 104.114 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m -140.86 170.62 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.526 1.131 . . . . 0.0 111.176 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -85.03 -65.14 1.04 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -60.43 -16.51 36.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.508 1.923 . . . . 0.0 114.911 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.15 -14.59 7.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.509 1.124 . . . . 0.0 112.45 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.38 -85.66 0.93 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 125.242 1.401 . . . . 0.0 111.759 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.83 136.43 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.249 -1.148 . . . . 0.0 109.497 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -149.03 175.21 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.565 1.075 . . . . 0.0 110.057 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -123.99 149.21 46.27 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.878 0.871 . . . . 0.0 109.82 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.79 143.06 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.683 1.193 . . . . 0.0 109.073 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.71 112.95 26.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.862 2.065 . . . . 0.0 105.599 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.454 ' ND1' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -74.17 -23.67 59.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -68.66 -36.83 79.06 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.854 0.862 . . . . 0.0 112.307 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.73 -3.57 11.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.121 . . . . 0.0 112.317 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HE3' ' ND1' ' A' ' 33' ' ' HIS . 6.9 mmtp 58.17 51.99 8.0 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.943 1.697 . . . . 0.0 109.78 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -118.23 161.86 19.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.463 0.705 . . . . 0.0 110.497 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.62 148.72 46.17 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.45 155.86 37.09 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.216 0.607 . . . . 0.0 111.223 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -95.58 27.28 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.594 1.558 . . . . 0.0 111.538 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -142.78 146.69 34.49 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 119.799 -1.813 . . . . 0.0 109.682 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.72 141.75 94.92 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 18' ' ' TRP . 19.6 Cg_endo . . . . . 0 N--CA 1.453 -0.903 0 C-N-CA 122.956 2.437 . . . . 0.0 116.476 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 57.0 mt . . . . . 0 C--O 1.232 0.159 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.68 160.09 50.96 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.304 2.003 . . . . 0.0 112.553 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 84.95 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.784 3.656 . . . . 0.0 110.07 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.7 4.73 0.28 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.837 2.16 . . . . 0.0 112.162 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -124.71 157.78 34.84 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.27 155.9 44.05 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 122.047 -0.408 . . . . 0.0 109.933 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.17 121.84 46.01 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.538 1.535 . . . . 0.0 107.547 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.83 131.71 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.84 126.5 47.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.1 m -147.88 -176.0 5.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 110.767 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m -112.55 -29.88 7.32 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 110.004 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -79.07 -14.57 59.07 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.793 -0.567 . . . . 0.0 109.669 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -130.71 -19.5 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.97 -92.74 1.71 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.613 1.101 . . . . 0.0 111.093 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -151.41 131.2 13.22 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.811 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -148.75 172.57 14.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -120.73 156.6 31.46 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.919 -0.488 . . . . 0.0 110.606 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.51 140.04 49.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -101.37 112.75 25.37 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.572 2.349 . . . . 0.0 108.733 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' HIS . . . . . 0.409 ' ND1' ' HE2' ' B' ' 36' ' ' LYS . 1.8 m-70 -76.54 -13.09 60.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -88.96 -22.88 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 111.66 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -123.79 -5.62 8.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.505 0.722 . . . . 0.0 111.461 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.409 ' HE2' ' ND1' ' B' ' 33' ' ' HIS . 21.6 mmtp 51.76 52.73 13.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.23 1.812 . . . . 0.0 111.724 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -132.75 153.55 51.09 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.504 0.722 . . . . 0.0 109.459 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.91 153.97 21.22 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 108.584 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -158.96 151.91 22.16 Favored 'General case' 0 C--N 1.334 -0.071 0 O-C-N 121.608 -0.682 . . . . 0.0 111.107 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -95.45 27.63 3.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.002 1.321 . . . . 0.0 112.082 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 147.05 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 119.891 -1.755 . . . . 0.0 108.432 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -64.95 142.19 98.58 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 119.036 -0.507 . . . . 0.0 109.765 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 123.256 2.638 . . . . 0.0 114.056 -179.671 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 51.7 Cg_endo -71.83 164.86 34.34 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.282 1.988 . . . . 0.0 110.205 178.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.98 124.04 11.36 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.543 2.162 . . . . 0.0 108.457 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.17 -12.08 33.96 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.723 1.154 . . . . 0.0 111.736 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.411 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 37.3 m95 -104.13 150.93 23.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.646 1.223 . . . . 0.0 108.608 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -144.09 156.8 44.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.105 0.962 . . . . 0.0 108.613 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -116.04 122.0 43.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.561 1.545 . . . . 0.0 107.055 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.78 127.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.03 116.03 22.16 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.9 m -140.46 155.23 46.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 111.709 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.5 m -76.71 -20.25 56.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.85 -1.157 . . . . 0.0 112.937 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -83.09 -53.63 5.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.8 0.727 . . . . 0.0 111.405 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.74 -11.85 30.5 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.74 -91.34 1.62 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -155.68 147.99 23.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.213 0.506 . . . . 0.0 111.851 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -161.16 179.64 8.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.74 1.616 . . . . 0.0 108.099 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.67 158.91 33.57 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.085 -1.009 . . . . 0.0 110.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.25 140.86 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 108.027 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -109.7 117.59 34.29 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.239 2.216 . . . . 0.0 109.512 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -82.35 -14.13 55.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.584 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.7 m -70.82 -47.83 57.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 120.217 1.371 . . . . 0.0 110.277 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -108.08 -3.41 18.69 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.25 1.42 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp 56.89 53.15 8.45 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.525 1.53 . . . . 0.0 110.073 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -120.86 165.64 14.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.41 138.34 53.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.99 151.64 32.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.19 0.905 . . . . 0.0 110.6 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' B' ' 36' ' ' LYS . 54.6 m-85 -83.06 8.2 13.6 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.25 153.26 44.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.295 1.407 . . . . 0.0 113.221 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -62.31 139.93 96.37 Favored Pre-proline 0 C--O 1.24 0.57 0 O-C-N 124.99 1.431 . . . . 0.0 109.345 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.456 -0.68 0 C-N-CA 123.308 2.672 . . . . 0.0 114.572 -179.616 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt . . . . . 0 C--O 1.233 0.222 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 20.0 Cg_endo -70.24 155.96 63.2 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.38 140.07 62.2 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 105.385 -2.583 . . . . 0.0 105.385 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.81 70.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.639 -1.089 . . . . 0.0 112.071 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CZ2' ' HB3' ' B' ' 43' ' ' PRO . 6.7 m95 -107.01 167.62 9.76 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.954 1.877 . . . . 0.0 106.58 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -144.43 154.45 42.97 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -119.06 133.34 55.87 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -124.87 136.96 59.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -127.17 134.94 50.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -150.94 179.1 8.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.522 2.329 . . . . 0.0 110.281 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 69.4 m -110.77 -25.05 10.11 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.099 -1.001 . . . . 0.0 111.7 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.08 -23.13 57.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 110.527 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.46 -53.65 1.9 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.243 1.417 . . . . 0.0 112.036 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.21 -104.36 0.64 Allowed Glycine 0 N--CA 1.469 0.84 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.7 m -144.13 131.01 20.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.506 1.653 . . . . 0.0 108.536 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.54 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.211 1.004 . . . . 0.0 109.829 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -127.18 142.94 51.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.035 1.334 . . . . 0.0 108.086 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.53 135.22 59.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.81 0.814 . . . . 0.0 110.11 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -100.63 104.26 15.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -72.94 -24.94 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 119.158 -0.448 . . . . 0.0 111.826 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -71.0 -37.21 72.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.363 1.465 . . . . 0.0 111.615 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -115.25 1.89 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.575 1.15 . . . . 0.0 112.574 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 40' ' ' TYR . 4.9 mmtp 48.19 62.17 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.554 1.942 . . . . 0.0 109.901 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -128.62 160.17 33.27 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.821 0.848 . . . . 0.0 110.018 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.8 131.41 47.76 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.356 1.462 . . . . 0.0 108.447 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -146.34 148.93 32.89 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.227 0.467 . . . . 0.0 110.538 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -91.44 25.7 2.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.04 1.736 . . . . 0.0 111.055 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -137.77 153.5 49.69 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' HIS . . . . . 0.454 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 4.7 t-80 -68.71 147.0 97.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 111.799 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' PRO . . . . . 0.462 ' HB3' ' CZ2' ' B' ' 18' ' ' TRP . 73.2 Cg_endo . . . . . 0 CA--C 1.539 0.742 0 C-N-CA 124.122 3.215 . . . . 0.0 113.449 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.81 161.73 40.96 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.536 2.157 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.36 123.71 11.18 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.851 2.368 . . . . 0.0 108.545 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.45 5.58 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.673 1.13 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 24.2 m95 -81.33 151.82 27.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.397 1.098 . . . . 0.0 108.993 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -135.43 140.87 45.24 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.468 0.707 . . . . 0.0 109.534 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -103.11 132.24 49.52 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.6 136.02 55.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.23 142.55 49.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -154.24 146.36 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.4 m -74.82 -12.82 60.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.559 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.27 -45.71 5.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 110.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -93.85 -18.1 22.36 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.11 -92.54 1.79 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.704 1.621 . . . . 0.0 111.544 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -153.75 124.44 7.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -139.43 177.15 8.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.806 0.442 . . . . 0.0 109.995 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.14 148.04 51.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 108.923 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.46 137.12 57.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.226 0.61 . . . . 0.0 110.271 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 9.2 t0 -99.14 115.74 29.74 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.597 2.759 . . . . 0.0 108.941 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -82.94 -10.04 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.598 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -75.45 -43.43 49.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 120.747 1.612 . . . . 0.0 110.164 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -117.74 0.41 11.99 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.157 0.983 . . . . 0.0 112.176 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 57.17 60.71 2.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.595 1.558 . . . . 0.0 108.509 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -129.47 143.63 50.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.789 0.835 . . . . 0.0 109.441 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.79 145.84 33.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 109.288 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.86 162.86 38.99 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.461 1.104 . . . . 0.0 110.276 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.78 8.91 41.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 160.56 32.15 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.819 1.19 . . . . 0.0 111.007 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -61.88 134.83 94.29 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 89.8 Cg_endo . . . . . 0 C--O 1.236 0.396 0 C-N-CA 124.29 3.327 . . . . 0.0 116.028 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.9 158.53 52.61 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.283 1.989 . . . . 0.0 110.567 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.8 123.61 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.558 2.172 . . . . 0.0 106.87 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.96 -26.41 6.8 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.643 1.592 . . . . 0.0 110.789 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 25.6 m95 -90.0 157.01 18.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.381 1.091 . . . . 0.0 110.172 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.19 150.5 42.8 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.802 0.841 . . . . 0.0 108.761 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -115.48 128.55 56.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -117.77 120.3 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.879 0.872 . . . . 0.0 109.509 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -107.31 146.28 31.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -150.11 170.77 18.14 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.754 1.622 . . . . 0.0 110.914 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -96.24 -34.23 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -74.87 -27.01 60.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.133 0.973 . . . . 0.0 110.756 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.93 -19.42 5.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.65 -86.5 1.28 Allowed Glycine 0 N--CA 1.461 0.331 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -159.67 134.23 7.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.902 1.351 . . . . 0.0 111.307 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -143.76 158.11 43.91 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 107.417 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -110.87 159.58 17.55 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.821 -1.174 . . . . 0.0 108.587 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.11 135.23 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 122.817 0.447 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.447 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 42.9 t0 -99.06 113.18 25.25 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.912 1.285 . . . . 0.0 108.689 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -72.92 -16.89 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.687 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 79.4 m -79.78 -28.91 40.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.996 0.919 . . . . 0.0 112.857 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -121.76 -4.79 9.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.893 0.769 . . . . 0.0 111.537 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp 56.21 47.66 18.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.829 1.652 . . . . 0.0 109.7 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.81 160.85 21.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.153 0.981 . . . . 0.0 111.175 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.61 140.59 51.32 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.972 1.309 . . . . 0.0 109.111 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -150.9 156.05 40.4 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.438 1.095 . . . . 0.0 110.169 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -97.47 -7.63 31.11 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.917 0.887 . . . . 0.0 111.67 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -100.1 142.43 31.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.06 1.344 . . . . 0.0 108.825 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -58.66 143.57 81.7 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.458 -0.563 0 C-N-CA 122.575 2.183 . . . . 0.0 116.734 -179.123 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 33.1 Cg_endo -66.9 158.87 54.43 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.43 1.42 . . . . 0.0 110.454 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 95.55 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.528 2.819 . . . . 0.0 107.589 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 139.98 -2.04 2.33 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.347 0.975 . . . . 0.0 112.982 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 19.8 m95 -118.24 151.47 37.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -137.18 153.53 50.42 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.265 0.626 . . . . 0.0 109.964 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -114.49 127.62 55.91 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.23 1.812 . . . . 0.0 107.789 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.25 117.76 56.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.83 152.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -151.2 177.39 10.27 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 120.647 -1.283 . . . . 0.0 111.622 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -114.07 -18.08 11.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.81 -10.97 12.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.701 0.801 . . . . 0.0 110.087 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -123.69 -12.36 7.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.466 1.906 . . . . 0.0 112.563 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.87 -77.04 1.15 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 126.11 1.814 . . . . 0.0 110.329 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -161.24 138.43 8.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.628 1.714 . . . . 0.0 110.357 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -143.17 171.74 13.67 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.93 153.1 43.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.911 0.885 . . . . 0.0 109.686 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.92 141.5 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.885 0.874 . . . . 0.0 110.846 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.55 111.07 23.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 129.729 3.212 . . . . 0.0 108.477 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -76.56 -18.53 58.63 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -78.26 -32.45 49.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.98 0.809 . . . . 0.0 110.313 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -116.44 -4.97 11.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 38' ' ' ALA . 6.4 mmmm 55.29 52.52 11.33 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.989 2.116 . . . . 0.0 109.886 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -124.52 165.69 17.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.454 1.102 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.68 151.52 47.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.158 1.383 . . . . 0.0 108.57 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.43 159.98 43.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.828 0.823 . . . . 0.0 111.643 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' B' ' 36' ' ' LYS . 14.2 m-30 -93.8 17.28 12.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.411 1.484 . . . . 0.0 113.837 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.36 150.84 38.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.464 -1.398 . . . . 0.0 110.072 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -59.92 142.33 88.87 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo . . . . . 0 CA--C 1.542 0.899 1 C-N-CA 125.747 4.298 . . . . 0.0 116.083 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.234 0.255 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 15' ' ' PRO . . . . . 0.412 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.8 Cg_endo -66.28 162.57 35.55 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.12 1.88 . . . . 0.0 110.336 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.95 108.62 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.423 2.749 . . . . 0.0 110.17 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.41 -26.19 6.73 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.674 1.131 . . . . 0.0 112.706 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 9.6 m95 -80.85 148.99 29.7 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 119.428 1.614 . . . . 0.0 108.867 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -131.24 152.19 50.76 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -111.65 138.84 47.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.6 136.15 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -124.58 141.19 52.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.0 p -154.25 -166.57 2.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.657 2.383 . . . . 0.0 109.209 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -121.15 -47.69 2.26 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.71 -50.99 70.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -80.61 -59.02 2.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.83 -98.49 0.53 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -150.96 136.34 17.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.446 1.623 . . . . 0.0 107.673 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -150.52 178.08 9.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.07 152.75 43.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.397 0.679 . . . . 0.0 109.409 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.66 139.0 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.464 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 55.0 t0 -100.01 104.91 16.54 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.051 1.74 . . . . 0.0 107.753 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -27.77 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.89 0.768 . . . . 0.0 112.386 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -64.2 -39.37 93.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 111.573 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -118.57 -1.33 11.19 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 40' ' ' TYR . 34.5 mmtm 52.63 50.71 17.57 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 125.019 1.328 . . . . 0.0 111.069 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -125.41 164.77 19.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ALA . . . . . 0.4 ' O ' ' HE2' ' A' ' 36' ' ' LYS . . . -122.2 151.52 40.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.717 0.807 . . . . 0.0 109.104 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -146.14 152.25 38.97 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.271 0.941 . . . . 0.0 111.419 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.2 26.21 3.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.61 1.564 . . . . 0.0 112.622 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.86 167.52 28.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.15 -1.594 . . . . 0.0 109.011 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.11 154.84 91.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.159 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 0 CA--C 1.533 0.456 0 C-N-CA 123.651 2.901 . . . . 0.0 110.605 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.2 t -58.64 150.07 24.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.61 1.164 . . . . 0.0 111.803 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 p -112.16 12.91 20.51 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.829 2.452 . . . . 0.0 108.912 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.81 -11.75 5.66 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 126.181 1.848 . . . . 0.0 113.143 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 m -149.4 89.79 1.67 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.829 1.815 . . . . 0.0 109.674 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -61.59 153.28 28.19 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 160.68 47.42 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.38 0.434 . . . . 0.0 112.976 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.1 -16.81 6.0 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.368 2.712 . . . . 0.0 111.861 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.0 159.57 44.09 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.45 3.9 . . . . 0.0 106.293 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.3 0.76 5.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.018 1.327 . . . . 0.0 112.864 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 80.64 -21.15 0.34 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.388 3.475 . . . . 0.0 111.869 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.52 171.81 7.01 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.898 2.479 . . . . 0.0 112.258 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.91 166.22 53.92 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.31 162.14 62.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.642 1.177 . . . . 0.0 110.705 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 54.6 Cg_endo -69.36 161.55 45.43 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 121.914 1.743 . . . . 0.0 109.566 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.44 108.7 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.316 2.678 . . . . 0.0 108.653 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.28 -16.42 6.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.684 1.611 . . . . 0.0 111.704 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.0 m95 -95.38 142.68 27.48 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.261 -1.141 . . . . 0.0 109.429 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -125.32 140.73 52.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.273 0.629 . . . . 0.0 110.818 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -104.13 134.8 46.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 t -115.0 138.65 44.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.78 131.01 40.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.262 1.025 . . . . 0.0 110.729 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.82 170.9 18.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.01 1.724 . . . . 0.0 111.283 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -86.76 -29.36 22.41 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.446 1.098 . . . . 0.0 112.534 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.82 -44.38 27.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.97 1.259 . . . . 0.0 110.952 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.84 -24.73 14.58 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -94.75 1.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.55 130.35 10.07 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.216 -0.579 . . . . 0.0 110.752 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.29 173.48 11.67 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -125.76 146.07 49.93 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.22 -0.925 . . . . 0.0 108.559 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 143.44 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.614 0.721 . . . . 0.0 109.546 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 64.6 t0 -108.2 109.75 21.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.709 2.003 . . . . 0.0 109.829 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.086 0.857 . . . . 0.0 111.092 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 m -68.12 -33.43 74.49 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.615 1.166 . . . . 0.0 111.603 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -122.38 1.05 9.57 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' B' ' 38' ' ' ALA . 22.2 mmmt 50.31 51.48 16.69 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.584 1.953 . . . . 0.0 110.023 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.34 166.91 16.94 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 123.809 0.844 . . . . 0.0 110.227 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' O ' ' HE3' ' B' ' 36' ' ' LYS . . . -122.78 149.91 43.5 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -150.55 171.39 17.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.406 1.482 . . . . 0.0 107.988 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -112.89 -8.15 13.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -100.74 167.49 10.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.972 1.309 . . . . 0.0 110.865 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 149.48 82.82 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.05 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 110.059 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -152.27 118.6 5.59 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.465 -0.772 . . . . 0.0 111.238 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.94 167.98 25.2 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -84.45 79.25 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.062 3.842 . . . . 0.0 109.759 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 m -53.6 -29.43 37.64 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.8 m -128.2 137.02 51.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.6 t -62.6 148.03 47.39 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.365 1.082 . . . . 0.0 108.946 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 18.2 p -138.79 28.19 2.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.317 1.847 . . . . 0.0 109.195 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.7 -81.99 0.07 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.4 m -131.6 145.05 51.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.237 1.015 . . . . 0.0 109.642 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 135.83 53.07 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.92 168.73 9.61 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 123.665 0.65 . . . . 0.0 112.114 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.88 -35.32 9.52 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.034 1.822 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.99 157.19 25.9 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.854 1.262 . . . . 0.0 108.579 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.31 4.64 20.98 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.799 1.64 . . . . 0.0 110.058 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 71.48 -2.5 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.087 2.555 . . . . 0.0 113.107 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -69.07 173.76 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.488 1.915 . . . . 0.0 110.492 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.99 -175.69 47.15 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.26 158.07 32.9 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 121.514 -0.992 . . . . 0.0 110.951 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 72.7 Cg_endo -71.56 160.97 46.84 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.338 2.025 . . . . 0.0 111.009 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.73 115.43 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.249 2.632 . . . . 0.0 108.696 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.23 -21.31 13.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.661 1.124 . . . . 0.0 112.514 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 8.5 m95 -87.56 164.06 16.3 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 119.229 1.514 . . . . 0.0 108.144 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.82 152.65 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.943 -0.473 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -112.75 133.88 54.55 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.341 1.857 . . . . 0.0 107.005 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.32 128.51 75.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -109.93 141.56 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 10.1 t -153.07 -169.81 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.9 m -130.32 -38.29 1.38 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.564 1.946 . . . . 0.0 107.093 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.41 -27.22 66.9 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -121.36 -26.21 5.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.67 -91.48 1.04 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.06 1.315 . . . . 0.0 110.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.4 m -154.93 137.07 14.75 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.491 -1.594 . . . . 0.0 109.3 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.14 179.21 7.65 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -131.65 154.44 48.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.46 0.704 . . . . 0.0 109.424 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.96 142.01 41.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.38 0.672 . . . . 0.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -102.9 125.69 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.478 2.711 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -85.17 -19.81 31.19 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.924 -0.485 . . . . 0.0 110.657 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 46.7 m -73.06 -32.69 65.21 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.82 1.248 . . . . 0.0 110.247 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -123.54 -2.94 8.37 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 38' ' ' ALA . 25.8 mmmt 54.88 40.38 31.95 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.802 1.241 . . . . 0.0 110.71 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -115.27 158.6 22.11 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HE3' ' A' ' 36' ' ' LYS . . . -116.89 147.48 42.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.51 1.124 . . . . 0.0 108.482 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -152.51 162.54 41.06 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.393 1.477 . . . . 0.0 108.745 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -103.33 -4.68 23.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.116 0.966 . . . . 0.0 113.023 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 163.28 13.46 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.18 0.992 . . . . 0.0 110.615 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -79.58 143.43 59.09 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.45 168.6 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.627 1.551 . . . . 0.0 113.278 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.0 p -148.96 178.23 8.87 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.92 1.288 . . . . 0.0 111.397 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.87 -173.47 18.83 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.708 2.099 . . . . 0.0 111.105 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.79 165.8 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.072 3.182 . . . . 0.0 110.124 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -136.3 -8.98 1.98 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.299 1.039 . . . . 0.0 113.256 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.2 m -142.14 -176.22 4.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.035 1.334 . . . . 0.0 109.662 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.814 0 N-CA-C 106.564 -2.615 . . . . 0.0 106.564 -179.741 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -119.55 -28.54 5.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.54 1.936 . . . . 0.0 109.118 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p -65.01 142.43 58.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.81 1.244 . . . . 0.0 108.528 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.39 -90.99 0.13 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.5 p -137.4 167.89 20.72 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.494 1.118 . . . . 0.0 109.321 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t 155.54 -168.63 0.0 OUTLIER 'General case' 0 C--O 1.241 0.644 1 C-N-CA 132.126 4.17 . . . . 0.0 104.809 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.9 169.68 54.69 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.6 -51.54 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.576 2.184 . . . . 0.0 109.091 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.21 179.12 9.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 130.508 3.523 . . . . 0.0 106.665 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.25 -161.56 0.52 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.288 1.435 . . . . 0.0 112.956 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.44 ' HB2' HH11 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -135.29 11.55 3.53 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.936 1.694 . . . . 0.0 112.249 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -129.85 62.09 1.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.058 1.343 . . . . 0.0 107.997 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.79 5.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.805 -0.997 . . . . 0.0 114.818 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.77 161.89 51.85 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 119.104 1.452 . . . . 0.0 107.353 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 37.6 Cg_endo -66.92 159.66 50.7 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.533 0.822 . . . . 0.0 110.314 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.1 110.68 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.493 2.795 . . . . 0.0 108.872 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.17 -14.48 16.1 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-O 117.942 -1.477 . . . . 0.0 114.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 43' ' ' PRO . 11.5 m95 -96.22 150.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.447 1.623 . . . . 0.0 107.036 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -135.08 148.31 49.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.488 0.185 . . . . 0.0 110.917 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -103.83 130.06 51.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.57 144.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.3 147.01 50.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 p -158.08 164.34 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.288 1.435 . . . . 0.0 110.701 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -92.06 -29.16 16.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.926 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -17.99 35.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.46 -46.87 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.83 -104.35 0.87 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -138.34 124.01 19.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -135.93 176.61 8.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.826 0.45 . . . . 0.0 111.043 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.39 151.88 51.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.541 0.737 . . . . 0.0 110.767 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.61 137.79 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.061 0.544 . . . . 0.0 111.146 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 34.3 t0 -101.26 107.97 19.49 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 127.946 2.498 . . . . 0.0 105.447 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -74.77 -19.71 60.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.0 m -80.75 -47.42 13.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.303 0.956 . . . . 0.0 110.276 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.91 -10.14 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.937 1.295 . . . . 0.0 112.213 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm 55.58 45.06 25.63 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.73 2.012 . . . . 0.0 110.868 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -114.46 164.29 14.17 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.096 0.959 . . . . 0.0 109.411 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.42 150.37 48.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.365 1.466 . . . . 0.0 109.102 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -160.23 151.97 19.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.015 1.326 . . . . 0.0 109.968 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -93.14 11.12 28.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.028 0.931 . . . . 0.0 111.388 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 160.24 34.64 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.522 -1.361 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -63.22 138.66 97.4 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.449 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 46.4 Cg_endo -74.5 53.1 3.01 Favored 'Trans proline' 0 CA--C 1.532 0.421 1 C-N-CA 125.928 4.418 . . . . 0.0 115.305 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -60.49 138.04 58.07 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.757 -0.589 . . . . 0.0 109.874 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.1 178.67 48.85 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.42 160.85 25.66 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.396 2.064 . . . . 0.0 109.61 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -143.26 77.46 1.56 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -82.73 -56.4 3.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.173 -0.441 . . . . 0.0 109.89 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 119.005 -0.886 . . . . 0.0 110.89 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 118.609 -1.106 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -128.31 -7.31 5.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.139 0.97 . . . . 0.0 112.84 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -76.29 160.72 29.37 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.668 1.122 . . . . 0.0 108.242 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.68 -83.58 0.86 Allowed Glycine 0 C--N 1.332 0.325 0 N-CA-C 103.614 -3.794 . . . . 0.0 103.614 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -156.16 125.24 6.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -166.07 179.0 6.02 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.466 1.106 . . . . 0.0 109.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.53 171.57 49.7 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 -51.94 0.75 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.929 2.419 . . . . 0.0 114.89 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.27 179.26 9.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.163 1.785 . . . . 0.0 109.868 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -85.94 -177.81 6.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.98 2.112 . . . . 0.0 110.771 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -107.0 -54.62 2.44 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.012 0.925 . . . . 0.0 111.318 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 -3.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.085 2.954 . . . . 0.0 116.876 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.43 -2.57 61.76 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 119.782 1.174 . . . . 0.0 114.67 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -78.31 157.86 77.44 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.085 1.442 . . . . 0.0 112.444 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 39.8 Cg_endo -72.09 164.72 34.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.365 2.044 . . . . 0.0 111.686 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.09 121.36 9.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.7 58.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.288 -1.285 . . . . 0.0 115.063 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 24.3 m95 -94.04 161.29 14.34 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 119.521 1.66 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.84 169.15 20.43 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -128.5 121.94 30.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 109.355 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.58 123.74 49.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.96 137.92 50.62 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -150.93 -154.51 0.55 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.71 1.604 . . . . 0.0 108.96 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.1 m -127.31 -55.58 1.34 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.604 1.962 . . . . 0.0 107.101 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -60.83 -26.29 67.23 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.752 1.221 . . . . 0.0 113.312 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -113.93 -41.98 3.47 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.75 -96.72 1.02 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.068 0.842 . . . . 0.0 112.339 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -149.28 108.35 3.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.609 0.705 . . . . 0.0 109.567 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -125.22 176.77 6.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 109.726 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.25 156.9 44.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 110.239 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.34 142.59 32.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.506 1.122 . . . . 0.0 108.783 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -106.19 115.04 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.548 2.339 . . . . 0.0 105.096 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -79.55 -17.1 54.74 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 112.773 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -79.98 -45.11 19.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.214 1.405 . . . . 0.0 109.33 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -95.32 -15.12 23.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.188 0.995 . . . . 0.0 111.54 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 58.48 53.41 6.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.454 2.302 . . . . 0.0 109.312 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -134.66 153.61 51.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.967 0.507 . . . . 0.0 111.291 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.08 145.78 36.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.831 1.253 . . . . 0.0 110.524 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -147.23 150.87 35.7 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.682 0.793 . . . . 0.0 109.277 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.54 19.2 11.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.815 1.646 . . . . 0.0 112.613 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 159.69 41.67 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.41 -1.431 . . . . 0.0 109.037 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.63 152.09 76.06 Favored Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 123.956 0.902 . . . . 0.0 112.588 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.11 77.31 3.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.32 2.68 . . . . 0.0 116.047 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.9 162.03 26.31 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.579 -0.701 . . . . 0.0 109.227 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.91 164.52 10.9 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.91 0.767 . . . . 0.0 113.739 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 150.75 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 106.451 -2.173 . . . . 0.0 106.451 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -141.53 63.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.764 0.792 . . . . 0.0 109.177 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -73.42 -13.01 61.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.642 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 p -132.65 155.55 48.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.502 1.151 . . . . 0.0 109.967 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -133.3 149.01 51.94 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.991 2.117 . . . . 0.0 108.313 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.64 -19.92 2.99 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.073 0.844 . . . . 0.0 112.5 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m -79.09 175.31 10.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.546 1.173 . . . . 0.0 110.985 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -37.96 109.15 0.09 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 126.419 1.888 . . . . 0.0 110.865 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.63 30.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -61.4 -38.88 60.76 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.918 2.412 . . . . 0.0 113.534 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.84 -171.0 2.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.268 1.827 . . . . 0.0 109.639 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.0 158.23 2.2 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.84 1.656 . . . . 0.0 112.628 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -130.43 68.12 1.47 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.371 1.468 . . . . 0.0 107.075 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -139.02 165.95 25.77 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.248 1.019 . . . . 0.0 108.963 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.77 -10.39 0.11 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.25 -1.305 . . . . 0.0 114.203 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 mt -123.38 160.17 51.64 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.747 1.619 . . . . 0.0 110.568 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.05 163.7 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.458 2.105 . . . . 0.0 110.614 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 140.49 64.31 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.954 1.77 . . . . 0.0 108.747 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.12 -12.6 63.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.057 -1.413 . . . . 0.0 113.23 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 5.9 m95 -90.59 164.14 14.31 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 120.657 2.229 . . . . 0.0 109.112 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -147.43 155.27 41.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.804 0.812 . . . . 0.0 109.847 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -124.87 140.81 52.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.99 139.19 50.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.8 121.53 37.43 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.212 1.805 . . . . 0.0 106.474 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 p -131.53 172.25 12.44 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.012 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -95.64 -28.21 14.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.791 1.236 . . . . 0.0 110.674 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -95.93 -28.14 14.82 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -107.97 -34.79 6.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 -98.23 0.98 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.33 0.968 . . . . 0.0 112.762 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 m -148.16 121.83 9.23 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.521 0.728 . . . . 0.0 109.202 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -140.14 176.44 8.75 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.206 -0.934 . . . . 0.0 109.67 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -129.42 150.09 50.92 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.814 0.734 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.5 131.85 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.747 0.819 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.3 t0 -98.78 116.98 32.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -86.84 -20.46 27.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.115 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m -76.97 -31.71 56.75 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.591 1.087 . . . . 0.0 110.118 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -109.96 -12.01 14.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.893 1.677 . . . . 0.0 111.959 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HE2' ' CE2' ' B' ' 40' ' ' TYR . 42.5 mmtm 54.11 56.91 6.44 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.476 1.51 . . . . 0.0 110.782 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -130.58 169.6 15.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.24 1.016 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.37 142.74 51.42 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.896 1.679 . . . . 0.0 108.923 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.77 161.01 43.37 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.432 1.493 . . . . 0.0 110.522 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.57 25.78 11.06 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.906 1.282 . . . . 0.0 112.142 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 160.03 40.81 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.704 -1.248 . . . . 0.0 110.059 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 153.41 55.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.913 . . . . 0.0 110.481 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.49 83.8 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.636 2.891 . . . . 0.0 114.509 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 p -50.95 -55.41 17.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.332 1.453 . . . . 0.0 112.786 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -175.44 32.98 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.96 -16.28 16.1 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.512 2.808 . . . . 0.0 113.949 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 p -139.34 175.87 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.518 1.127 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 p -147.87 -176.44 5.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.415 2.286 . . . . 0.0 106.385 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.699 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.603 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -145.43 179.14 7.6 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.773 1.229 . . . . 0.0 109.102 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -157.74 179.37 9.28 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.639 1.576 . . . . 0.0 108.343 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.2 -13.27 0.59 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.529 1.061 . . . . 0.0 113.274 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.7 m -82.79 166.58 18.9 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 119.007 1.403 . . . . 0.0 110.257 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -47.98 137.7 9.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.146 1.378 . . . . 0.0 111.922 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.22 166.51 35.11 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.776 0.703 . . . . 0.0 112.568 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.41 -39.14 10.19 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.814 2.343 . . . . 0.0 110.102 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.67 178.97 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.263 2.625 . . . . 0.0 107.069 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.17 168.92 2.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.985 0.898 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -130.16 12.88 5.64 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.086 1.354 . . . . 0.0 112.479 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -83.5 141.9 31.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.99 0.916 . . . . 0.0 109.66 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.83 -86.97 1.34 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 123.036 0.351 . . . . 0.0 113.294 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -50.5 153.26 2.77 Favored Pre-proline 0 N--CA 1.465 0.294 0 C-N-CA 126.15 1.78 . . . . 0.0 114.302 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.78 160.51 49.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.108 1.872 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.62 99.21 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.797 2.998 . . . . 0.0 109.769 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.59 -1.62 5.22 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.645 1.593 . . . . 0.0 112.235 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -117.37 153.75 32.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.651 1.225 . . . . 0.0 109.479 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.01 168.47 19.64 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -130.8 125.54 33.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.643 2.377 . . . . 0.0 105.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.54 145.73 15.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -124.5 138.9 54.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.477 1.111 . . . . 0.0 108.276 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.7 p -154.66 177.66 10.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.363 1.865 . . . . 0.0 111.479 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -105.52 -33.47 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.62 -35.57 81.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.908 1.683 . . . . 0.0 110.865 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.05 -35.96 3.22 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.811 0.844 . . . . 0.0 113.006 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.05 -100.37 1.3 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 22.9 m -147.36 127.56 13.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 120.225 -1.75 . . . . 0.0 108.818 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -142.37 173.99 11.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.641 0.776 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -122.62 148.04 45.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.168 0.987 . . . . 0.0 112.944 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.49 140.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 108.66 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -107.94 115.61 30.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 127.862 2.465 . . . . 0.0 108.418 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -77.27 -30.31 54.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 87.3 m -67.61 -39.07 84.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.55 1.14 . . . . 0.0 110.783 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -106.9 -6.77 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.094 0.558 . . . . 0.0 112.441 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp 51.74 52.94 13.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.854 1.662 . . . . 0.0 110.633 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -126.48 166.46 17.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.846 1.258 . . . . 0.0 109.954 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.47 140.63 52.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.351 1.461 . . . . 0.0 107.727 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -147.06 171.67 14.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.607 1.163 . . . . 0.0 108.743 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.472 ' CE2' ' HE2' ' A' ' 36' ' ' LYS . 84.3 m-85 -112.79 -2.08 14.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.66 0.664 . . . . 0.0 112.429 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 160.89 14.84 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.964 0.906 . . . . 0.0 109.37 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -71.72 143.72 87.49 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.81 147.68 50.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.51 2.14 . . . . 0.0 114.155 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -114.12 -89.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.117 1.767 . . . . 0.0 107.534 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.94 -177.37 20.03 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.457 1.98 . . . . 0.0 109.519 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.6 -8.43 19.36 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.778 2.986 . . . . 0.0 112.836 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.8 p -151.73 168.48 24.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.104 1.362 . . . . 0.0 109.226 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 p -172.75 160.52 4.51 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.897 1.679 . . . . 0.0 108.127 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.756 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -68.02 168.8 11.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.043 0.921 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.59 143.24 32.35 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.6 135.25 8.78 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 p -165.91 170.43 13.76 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.7 t -153.72 172.39 17.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.857 1.663 . . . . 0.0 107.01 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.7 -176.54 14.46 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.839 2.161 . . . . 0.0 109.142 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.2 -47.02 6.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.79 1.66 . . . . 0.0 109.626 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.17 177.84 11.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.953 2.501 . . . . 0.0 107.482 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -125.97 169.56 12.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.699 1.2 . . . . 0.0 108.545 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -130.17 44.42 2.97 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.557 1.543 . . . . 0.0 110.522 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -105.92 171.83 7.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.797 0.839 . . . . 0.0 110.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.47 -164.58 10.82 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.196 2.808 . . . . 0.0 108.834 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt -138.56 157.89 71.34 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 118.977 1.389 . . . . 0.0 111.438 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.91 163.56 35.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.058 1.172 . . . . 0.0 110.949 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.27 133.11 36.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.042 1.828 . . . . 0.0 109.006 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.1 -14.96 61.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.72 1.629 . . . . 0.0 111.644 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -105.9 142.54 35.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.394 1.097 . . . . 0.0 108.884 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.94 160.19 39.36 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.475 1.51 . . . . 0.0 107.705 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -120.26 120.7 36.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.16 149.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.43 148.38 52.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.72 1.208 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 t -160.82 153.88 21.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.784 1.634 . . . . 0.0 112.819 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -80.44 -29.75 37.57 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -80.58 -27.1 37.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.918 1.687 . . . . 0.0 112.41 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -117.26 -38.13 3.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.95 -109.83 2.3 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.25 126.98 20.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -138.48 170.04 16.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.508 0.67 . . . . 0.0 109.665 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.27 148.45 52.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.225 1.01 . . . . 0.0 109.0 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' B' ' 31' ' ' VAL . 58.6 t -134.42 139.68 47.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 109.355 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -103.34 116.1 31.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.734 2.014 . . . . 0.0 108.319 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -72.23 -17.55 61.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.581 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -71.21 -51.22 25.92 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.877 0.871 . . . . 0.0 111.665 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -110.4 4.75 20.92 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.516 0.727 . . . . 0.0 112.776 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 51.87 41.69 29.59 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.97 1.308 . . . . 0.0 111.387 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -105.74 156.34 18.39 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.21 49.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.942 1.297 . . . . 0.0 107.952 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.44 168.31 25.43 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.865 -1.147 . . . . 0.0 110.647 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.85 15.73 27.28 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 112.302 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.22 153.95 31.99 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.047 -1.033 . . . . 0.0 109.977 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -71.18 136.63 84.42 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.88 118.0 5.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.781 1.654 . . . . 0.0 108.197 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -116.58 54.15 0.86 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.559 1.544 . . . . 0.0 111.511 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.85 26.1 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.822 -1.174 . . . . 0.0 114.396 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 160.75 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.099 3.2 . . . . 0.0 111.473 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 m -86.09 114.51 23.01 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.806 0.843 . . . . 0.0 108.822 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.73 -45.83 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.865 0.866 . . . . 0.0 109.352 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.641 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -71.09 168.58 16.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -128.83 173.61 10.21 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 128.069 2.548 . . . . 0.0 107.048 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.26 165.28 12.16 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p -173.9 169.52 4.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.14 1.776 . . . . 0.0 108.51 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.7 t -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.17 169.62 40.17 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.97 -31.32 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.557 2.171 . . . . 0.0 111.423 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 pp -170.76 173.82 5.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.523 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -147.9 178.99 8.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.31 1.044 . . . . 0.0 110.989 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -126.37 17.09 7.68 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.933 2.493 . . . . 0.0 110.681 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.55 173.83 11.07 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.475 -0.765 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.9 -163.92 13.31 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 49.1 mt -130.32 156.12 79.93 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.627 1.571 . . . . 0.0 109.766 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 18.8 Cg_endo -63.78 160.21 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.786 1.657 . . . . 0.0 111.368 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.86 91.05 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.534 3.489 . . . . 0.0 110.149 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.49 -3.28 2.93 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.477 1.513 . . . . 0.0 111.734 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.5 m95 -110.36 156.73 20.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.487 1.144 . . . . 0.0 108.195 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -148.95 158.56 44.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.21 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -112.04 144.95 40.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.787 1.635 . . . . 0.0 106.949 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.44 118.82 54.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -110.28 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 t -154.77 148.72 25.7 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.745 1.218 . . . . 0.0 110.804 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -76.16 -23.34 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.494 1.043 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -81.22 -22.67 38.63 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -120.69 -43.97 2.46 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.52 -113.29 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -141.05 111.99 7.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -131.71 -179.96 5.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -131.35 155.9 46.43 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.89 0.876 . . . . 0.0 111.345 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 31' ' ' VAL . 44.9 t -131.66 138.7 52.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.795 1.238 . . . . 0.0 109.301 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 22.1 t0 -106.68 118.96 38.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.474 1.91 . . . . 0.0 109.258 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -77.88 -20.9 52.15 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -69.28 -49.98 51.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.5 1.046 . . . . 0.0 110.49 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -105.85 -0.06 25.55 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt 53.87 53.49 11.21 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.008 1.323 . . . . 0.0 109.919 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -119.27 162.48 18.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.466 0.706 . . . . 0.0 109.578 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.93 142.68 50.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.861 1.264 . . . . 0.0 108.856 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -154.9 164.81 38.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.349 1.059 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -103.71 -6.56 21.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 142.5 34.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.0 t-80 -56.12 146.69 49.42 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.807 1.243 . . . . 0.0 110.572 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 56.4 Cg_endo -67.73 158.53 56.8 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.469 2.113 . . . . 0.0 112.492 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.37 125.21 3.81 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.785 1.234 . . . . 0.0 108.531 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -177.64 21.98 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.918 1.247 . . . . 0.0 111.688 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -83.03 -169.88 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 124.996 3.797 . . . . 0.0 109.858 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -109.65 112.44 24.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.607 1.163 . . . . 0.0 109.357 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -145.73 -81.53 0.15 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.145 1.378 . . . . 0.0 107.514 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.505 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -70.86 146.47 49.61 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.849 1.325 . . . . 0.0 108.932 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.9 m -149.22 170.74 17.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.688 1.995 . . . . 0.0 109.152 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.39 167.5 20.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p -161.45 178.34 9.23 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.08 0.552 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -164.31 -163.82 0.79 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.303 1.841 . . . . 0.0 106.787 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.66 176.34 44.48 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.16 -39.18 2.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.291 1.994 . . . . 0.0 112.057 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.6 mt -148.47 145.04 27.78 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 128.014 2.526 . . . . 0.0 107.994 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -121.74 168.64 11.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.187 1.395 . . . . 0.0 108.497 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.33 21.32 1.71 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.933 1.293 . . . . 0.0 113.038 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -82.21 -177.18 6.54 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.567 1.147 . . . . 0.0 112.752 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.65 122.66 27.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.41 157.64 63.13 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 163.27 39.2 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.863 2.375 . . . . 0.0 110.921 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.52 123.92 11.02 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.391 2.061 . . . . 0.0 107.991 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.71 -17.75 22.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.176 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 24.5 m95 -100.77 164.07 12.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -143.52 151.33 40.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.883 0.373 . . . . 0.0 111.851 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -112.82 121.16 43.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.79 146.28 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.8 111.83 11.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.98 1.712 . . . . 0.0 106.902 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.11 174.68 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.43 1.492 . . . . 0.0 111.427 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -106.85 -22.13 12.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 112.205 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.39 -12.96 47.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.724 0.693 . . . . 0.0 111.314 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.59 -63.41 0.71 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.192 0.997 . . . . 0.0 109.673 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.36 -109.47 0.71 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.627 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.1 m -131.37 112.05 12.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.757 1.279 . . . . 0.0 109.257 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -134.07 146.1 50.01 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.496 1.518 . . . . 0.0 108.255 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.11 146.87 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.859 1.264 . . . . 0.0 111.204 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.08 138.34 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.303 1.041 . . . . 0.0 110.15 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 36.3 t70 -105.92 110.48 22.77 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 127.044 2.137 . . . . 0.0 108.032 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -75.81 -18.08 59.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.2 m -71.72 -28.98 64.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.751 1.614 . . . . 0.0 111.807 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -126.18 -7.75 6.5 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 124.555 1.142 . . . . 0.0 112.536 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 mtmm 58.66 60.03 2.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.472 1.909 . . . . 0.0 109.047 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -124.33 168.79 12.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.54 1.136 . . . . 0.0 108.974 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.92 52.08 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -155.1 167.82 29.07 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.09 -1.006 . . . . 0.0 110.978 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.15 10.9 27.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.041 0.937 . . . . 0.0 112.927 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 153.27 46.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.327 1.051 . . . . 0.0 110.39 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.58 136.74 89.49 Favored Pre-proline 0 N--CA 1.451 -0.415 0 O-C-N 124.398 1.061 . . . . 0.0 109.946 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 88.4 Cg_endo -75.5 92.12 1.03 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.312 2.675 . . . . 0.0 110.564 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.0 m -143.02 140.22 30.91 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 109.149 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.28 173.13 22.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.264 0.935 . . . . 0.0 111.351 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.36 125.21 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.286 2.657 . . . . 0.0 108.701 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.4 m -125.67 98.06 5.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.127 1.371 . . . . 0.0 108.641 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 t -70.7 -62.1 1.52 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.803 0.841 . . . . 0.0 109.124 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.205 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -65.35 157.51 28.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.545 1.172 . . . . 0.0 108.898 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.1 m -147.68 161.37 41.31 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.859 1.264 . . . . 0.0 109.118 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.5 -175.85 31.26 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.421 1.486 . . . . 0.0 110.571 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -162.77 133.49 4.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.09 0.445 . . . . 0.0 111.037 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m -155.95 139.03 15.48 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 129.201 3.0 . . . . 0.0 107.198 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 174.62 40.91 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.3 -49.2 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.148 2.565 . . . . 0.0 116.941 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -147.67 79.89 1.49 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.403 1.881 . . . . 0.0 110.922 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.05 165.59 15.46 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -142.3 67.44 1.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 125.299 1.44 . . . . 0.0 107.554 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -128.0 -170.03 2.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.99 167.67 10.98 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -115.27 157.23 44.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 121.341 -1.093 . . . . 0.0 112.038 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 42.6 Cg_endo -67.44 165.49 26.91 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.51 2.14 . . . . 0.0 109.841 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.81 128.05 22.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.273 1.982 . . . . 0.0 108.367 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.41 58.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.15 1.357 . . . . 0.0 114.28 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 6.8 m95 -83.96 153.79 23.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.955 1.877 . . . . 0.0 109.498 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.25 151.54 47.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.51 134.54 54.62 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.94 134.24 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.802 0.841 . . . . 0.0 109.055 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.18 140.71 52.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -159.9 133.52 7.11 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.222 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -60.06 -14.95 19.14 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -89.3 -20.73 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.011 0.823 . . . . 0.0 112.128 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.33 -16.4 3.95 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.03 -99.1 2.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 25.4 m -152.03 142.49 22.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.466 0.706 . . . . 0.0 109.497 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.09 -179.42 7.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 109.017 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -131.66 151.9 51.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.623 1.569 . . . . 0.0 106.898 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.93 145.97 34.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 123.556 0.743 . . . . 0.0 109.108 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -107.34 102.54 11.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 128.975 2.91 . . . . 0.0 105.918 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -23.84 61.65 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -74.95 -16.89 60.63 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.762 2.025 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -132.84 -12.45 2.94 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.253 1.421 . . . . 0.0 112.35 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 57.61 56.78 4.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.346 2.258 . . . . 0.0 109.095 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -133.22 155.7 48.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.525 1.13 . . . . 0.0 109.589 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.49 153.7 29.51 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.497 1.119 . . . . 0.0 110.865 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -153.78 147.82 25.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.34 10.62 12.13 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.78 23.83 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.207 1.367 . . . . 0.0 112.983 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -55.81 144.7 55.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.406 1.882 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.91 68.89 3.83 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.791 3.66 . . . . 0.0 113.866 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -81.91 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.835 1.254 . . . . 0.0 110.847 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.19 158.71 17.64 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.129 1.347 . . . . 0.0 113.093 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.99 167.35 22.11 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.335 3.357 . . . . 0.0 112.287 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -138.35 167.02 22.76 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.591 1.956 . . . . 0.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.2 t -134.31 -63.56 0.72 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.567 1.947 . . . . 0.0 108.232 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.666 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p -86.39 169.36 12.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.273 1.037 . . . . 0.0 110.589 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -77.51 31.45 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.482 1.913 . . . . 0.0 112.734 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.45 -87.78 0.18 Allowed Glycine 0 C--N 1.338 0.677 0 O-C-N 120.837 -1.164 . . . . 0.0 112.616 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m -103.22 -172.25 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.561 1.145 . . . . 0.0 110.379 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m -59.06 131.56 51.4 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.234 0.614 . . . . 0.0 109.384 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.91 -174.95 40.98 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.13 -54.33 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.302 2.668 . . . . 0.0 112.677 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -176.33 165.01 2.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.578 2.351 . . . . 0.0 109.024 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.53 175.81 9.04 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.057 1.343 . . . . 0.0 111.81 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -121.63 -8.1 9.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.796 1.238 . . . . 0.0 114.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.97 180.0 4.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.235 1.014 . . . . 0.0 112.605 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 174.8 51.0 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.522 1.058 . . . . 0.0 110.834 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.42 154.55 63.27 Favored Pre-proline 0 C--O 1.238 0.448 0 O-C-N 121.788 -0.831 . . . . 0.0 112.446 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.41 163.43 38.61 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 N-CA-C 107.409 -1.804 . . . . 0.0 107.409 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.29 151.39 82.7 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.72 4.95 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.593 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.477 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 19.5 m95 -86.06 157.99 19.93 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.956 1.878 . . . . 0.0 109.124 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -143.14 152.48 41.85 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.091 -0.38 . . . . 0.0 110.092 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -117.73 121.87 41.97 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.338 1.855 . . . . 0.0 108.939 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.34 138.78 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.65 105.08 8.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.411 1.484 . . . . 0.0 109.023 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.0 m -137.83 128.15 26.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 127.681 2.392 . . . . 0.0 108.491 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -63.79 -21.54 66.47 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.095 1.316 . . . . 0.0 112.045 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.88 -21.29 66.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.913 1.685 . . . . 0.0 112.651 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -134.24 -29.28 1.26 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.63 -108.21 2.15 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 127.351 2.405 . . . . 0.0 107.432 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -145.13 125.12 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.442 0.697 . . . . 0.0 110.274 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.32 176.92 8.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -128.39 153.4 47.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.894 1.278 . . . . 0.0 110.64 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.64 135.03 61.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.216 1.006 . . . . 0.0 108.985 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 62.1 t0 -99.8 102.71 14.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 126.578 1.951 . . . . 0.0 108.582 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -70.4 -20.36 62.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.245 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.8 m -75.81 -31.44 59.42 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 120.806 -1.184 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -117.79 -2.6 11.34 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 53.56 46.24 26.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.549 2.339 . . . . 0.0 110.252 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -119.49 167.45 11.94 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.78 51.89 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.089 1.355 . . . . 0.0 108.571 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.78 152.94 27.56 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 110.526 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.23 0.07 54.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -118.23 162.92 17.45 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.287 0.949 . . . . 0.0 112.314 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -65.11 143.94 98.96 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 124.557 1.161 . . . . 0.0 109.09 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 89.9 Cg_endo -73.36 -168.3 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.021 3.147 . . . . 0.0 113.462 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -137.79 160.16 40.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.378 1.871 . . . . 0.0 107.919 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.94 170.51 22.46 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.22 -155.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.283 3.322 . . . . 0.0 109.395 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 m -137.44 159.23 42.52 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.413 -0.804 . . . . 0.0 111.249 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.93 -38.93 2.14 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.031 2.132 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.813 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.786 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -72.75 148.2 44.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.655 1.228 . . . . 0.0 111.334 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -69.72 98.43 1.19 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.425 1.09 . . . . 0.0 111.236 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.12 -88.85 1.18 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 124.55 1.071 . . . . 0.0 111.056 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.7 m -63.43 168.65 4.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.852 0.861 . . . . 0.0 111.668 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -72.79 -12.45 61.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.177 1.791 . . . . 0.0 113.626 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.42 163.01 28.33 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.947 1.261 . . . . 0.0 110.946 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.64 -58.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.169 2.579 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.79 144.96 5.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.635 1.574 . . . . 0.0 108.957 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.34 172.83 13.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -129.02 -9.47 4.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.416 1.486 . . . . 0.0 113.976 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.11 177.46 6.41 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.547 1.539 . . . . 0.0 111.244 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.29 176.71 26.51 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 123.862 0.744 . . . . 0.0 111.359 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.45 156.23 87.19 Favored Pre-proline 0 N--CA 1.468 0.45 0 O-C-N 120.933 -1.334 . . . . 0.0 111.49 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.65 165.17 33.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.86 1.707 . . . . 0.0 109.029 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.16 146.03 93.95 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.286 1.991 . . . . 0.0 110.518 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.1 -17.7 9.2 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.886 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' B' ' 43' ' ' PRO . 11.3 m95 -83.59 156.53 22.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 120.159 1.98 . . . . 0.0 109.414 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -140.54 153.44 46.16 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.947 -0.471 . . . . 0.0 110.651 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -121.35 121.43 37.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.8 112.42 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -110.58 130.99 55.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.673 1.189 . . . . 0.0 107.812 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -153.44 -162.61 1.49 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.175 2.59 . . . . 0.0 107.95 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -124.95 -24.09 4.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.948 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -69.83 -25.31 63.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.334 0.97 . . . . 0.0 109.895 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -127.89 -15.62 4.81 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.151 1.78 . . . . 0.0 111.873 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.95 -83.64 1.59 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.424 0.556 . . . . 0.0 113.436 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 87.6 m -156.63 129.12 7.58 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.159 -1.2 . . . . 0.0 110.665 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -142.44 171.15 14.45 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.83 149.46 48.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.378 1.471 . . . . 0.0 107.748 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.68 131.93 59.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.608 0.763 . . . . 0.0 108.956 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -94.73 107.41 19.42 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.095 1.358 . . . . 0.0 109.307 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -65.05 -19.03 65.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -76.02 -38.39 57.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.333 1.453 . . . . 0.0 113.414 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -121.0 2.07 10.43 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp 49.92 39.92 19.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.898 2.079 . . . . 0.0 112.316 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -105.86 156.98 17.81 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.23 143.07 48.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.68 1.192 . . . . 0.0 109.031 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -155.08 161.55 41.27 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.656 -0.652 . . . . 0.0 110.967 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.66 19.16 18.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.626 1.17 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.63 152.41 45.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 119.889 -1.757 . . . . 0.0 109.821 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.84 147.7 98.52 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.065 0.946 . . . . 0.0 109.612 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' B' ' 18' ' ' TRP . 59.8 Cg_endo -69.78 166.63 26.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.5 2.8 . . . . 0.0 115.05 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -138.47 161.32 37.31 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.141 1.776 . . . . 0.0 108.796 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.49 -178.11 39.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.657 2.075 . . . . 0.0 108.73 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.75 161.59 36.34 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.757 2.971 . . . . 0.0 111.94 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 16.4 m -78.84 -175.33 4.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.387 1.075 . . . . 0.0 109.273 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -106.55 -49.83 3.25 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.425 1.09 . . . . 0.0 109.34 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 N-CA-C 105.139 -3.185 . . . . 0.0 105.139 -179.816 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.558 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.08 161.1 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.973 1.309 . . . . 0.0 109.368 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -142.29 153.65 44.07 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.125 1.37 . . . . 0.0 107.654 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.18 177.77 43.6 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.829 1.68 . . . . 0.0 108.976 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -148.53 91.62 1.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.615 1.208 . . . . 0.0 110.33 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -156.6 146.2 20.76 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.952 -1.093 . . . . 0.0 110.541 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.25 169.6 54.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.367 0.984 . . . . 0.0 112.862 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -58.07 -74.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 125.245 3.963 . . . . 0.0 113.592 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pp -155.46 -177.34 6.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.523 1.529 . . . . 0.0 109.1 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -133.16 -176.27 4.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.856 2.063 . . . . 0.0 107.495 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.82 19.94 2.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.468 1.107 . . . . 0.0 111.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -76.0 -177.73 4.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.595 0.758 . . . . 0.0 109.903 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.36 178.25 10.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.686 1.136 . . . . 0.0 110.934 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.7 mt -135.78 153.49 77.31 Favored Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 121.071 -1.252 . . . . 0.0 112.538 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 36.6 Cg_endo -70.38 166.34 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.894 . . . . 0.0 110.214 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 140.63 82.54 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 106.966 -1.974 . . . . 0.0 106.966 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.82 -9.63 73.41 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.291 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.9 m95 -104.11 156.17 18.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 121.196 2.498 . . . . 0.0 110.161 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -145.2 157.69 44.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.033 0.933 . . . . 0.0 108.958 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -127.23 121.56 31.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.727 2.411 . . . . 0.0 106.534 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.33 149.21 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 125.789 1.636 . . . . 0.0 109.116 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.28 130.44 38.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 0.0 110.036 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -147.88 170.45 17.63 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.091 1.356 . . . . 0.0 110.56 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.1 m -91.15 -42.58 10.37 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.315 -1.49 . . . . 0.0 107.027 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -64.54 -23.84 67.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.984 1.714 . . . . 0.0 112.374 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -129.07 -12.18 4.66 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 -86.4 1.21 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.58 136.78 13.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.461 0.704 . . . . 0.0 110.678 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.81 161.59 41.51 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.604 1.093 . . . . 0.0 109.571 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -116.34 148.09 40.93 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.575 0.75 . . . . 0.0 109.109 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 31' ' ' VAL . 57.4 t -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 50.3 t0 -107.35 102.48 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.042 1.737 . . . . 0.0 110.342 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -66.04 -18.05 65.09 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.93 -0.481 . . . . 0.0 111.658 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.3 m -73.28 -29.75 62.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.284 0.947 . . . . 0.0 111.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -127.32 -0.96 6.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.63 0.772 . . . . 0.0 112.832 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm 56.75 45.32 22.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.683 1.993 . . . . 0.0 109.899 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -121.79 153.41 38.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.846 0.858 . . . . 0.0 110.684 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.6 143.79 44.44 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.946 1.299 . . . . 0.0 108.881 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -140.01 170.85 15.1 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.909 1.684 . . . . 0.0 109.778 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.6 6.88 20.3 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 161.03 34.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.586 0.63 . . . . 0.0 109.723 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.45 138.91 89.09 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.07 167.65 26.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.372 2.715 . . . . 0.0 114.902 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m -80.05 -73.72 0.34 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.49 175.66 36.94 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.55 -174.66 2.15 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.304 3.336 . . . . 0.0 110.424 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.7 t -99.59 -96.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 m -146.19 171.85 14.32 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.567 1.076 . . . . 0.0 110.284 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.928 179.719 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.54 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.22 174.24 6.66 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.678 1.191 . . . . 0.0 109.018 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 165.01 33.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.122 0.969 . . . . 0.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.89 -170.3 26.43 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.839 2.162 . . . . 0.0 108.288 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -155.57 103.76 2.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 57.7 p -139.28 156.63 46.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.057 0.543 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.88 166.6 53.13 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -51.42 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.507 2.138 . . . . 0.0 107.82 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pp -167.96 178.86 4.93 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 130.324 3.45 . . . . 0.0 105.621 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.67 174.99 10.0 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.236 2.614 . . . . 0.0 106.068 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -136.69 7.94 3.03 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -71.63 179.66 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.2 175.86 8.21 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.205 0.907 . . . . 0.0 112.171 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -132.24 159.9 70.27 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.428 -1.042 . . . . 0.0 113.487 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.73 168.3 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.939 1.759 . . . . 0.0 109.441 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.26 151.11 86.75 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 -8.11 45.13 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.259 -1.3 . . . . 0.0 112.659 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 20.4 m95 -106.42 153.56 22.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 121.375 2.587 . . . . 0.0 110.039 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.07 157.87 45.2 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.513 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -118.32 131.83 56.31 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.976 2.11 . . . . 0.0 105.676 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.22 144.0 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.86 147.49 52.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m -158.57 158.49 34.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.898 2.079 . . . . 0.0 109.949 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -76.78 -43.41 37.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.685 1.13 . . . . 0.0 111.509 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' B' ' 26' ' ' PHE . 9.8 pt-20 -67.36 -34.66 77.77 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.47 ' CE1' ' HG3' ' B' ' 25' ' ' GLU . 15.1 m-85 -98.71 -34.38 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.93 -98.32 1.98 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -147.32 132.09 17.96 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.627 -0.925 . . . . 0.0 110.892 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -140.97 158.03 44.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.546 0.689 . . . . 0.0 109.212 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.21 145.43 42.43 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 31' ' ' VAL . 46.3 t -121.21 137.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 122.662 1.22 . . . . 0.0 110.342 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 26.2 t0 -103.08 102.37 12.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.088 2.955 . . . . 0.0 109.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -75.68 -22.95 56.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.62 0.768 . . . . 0.0 109.643 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 71.6 m -67.24 -18.14 65.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.871 1.269 . . . . 0.0 113.101 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.58 -12.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.537 1.135 . . . . 0.0 111.59 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm 65.07 60.42 0.8 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.826 2.05 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -128.61 164.5 22.74 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.468 1.507 . . . . 0.0 108.036 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.21 146.36 50.75 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -150.55 136.96 18.76 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.545 0.738 . . . . 0.0 109.313 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -80.08 20.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.757 1.623 . . . . 0.0 112.501 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 169.79 17.02 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.207 1.403 . . . . 0.0 110.282 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.23 149.59 97.46 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 0.0 110.461 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -68.79 157.75 60.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.073 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 7.5 t -77.59 -48.44 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.92 162.12 9.92 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.761 0.696 . . . . 0.0 112.494 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.49 -174.85 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.21 3.273 . . . . 0.0 110.363 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.3 t -110.92 -109.65 0.34 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -144.2 158.84 43.5 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.282 1.401 . . . . 0.0 109.127 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 117.644 -1.642 . . . . 0.0 109.486 179.653 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.442 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 m -60.94 161.94 7.62 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.621 1.568 . . . . 0.0 109.211 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -141.94 159.1 42.91 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.86 -4.42 9.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.541 1.543 . . . . 0.0 112.623 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -77.02 -168.99 1.19 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.112 1.765 . . . . 0.0 112.555 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -62.59 174.19 1.07 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.539 1.936 . . . . 0.0 111.857 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.33 164.32 6.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.627 1.108 . . . . 0.0 115.462 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.51 -49.67 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.338 2.025 . . . . 0.0 110.245 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -169.07 -166.97 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 C-N-CA 129.224 3.01 . . . . 0.0 106.953 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.41 177.8 2.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.881 1.672 . . . . 0.0 112.008 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 -10.97 5.13 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.758 1.623 . . . . 0.0 111.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -65.92 -1.89 3.41 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 114.336 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.78 -174.57 34.66 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 119.851 -1.781 . . . . 0.0 110.733 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.1 mt -135.42 157.19 77.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 126.105 1.762 . . . . 0.0 108.681 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 14.9 Cg_endo -71.32 155.08 60.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 N-CA-C 109.908 -0.843 . . . . 0.0 109.908 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.48 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 103.789 -3.197 . . . . 0.0 103.789 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.36 -0.41 8.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.391 1.472 . . . . 0.0 110.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.1 m95 -121.08 144.15 48.7 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 119.293 1.546 . . . . 0.0 109.69 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -116.68 150.69 37.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.153 0.981 . . . . 0.0 109.391 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -111.03 136.73 49.6 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.0 t -119.24 124.37 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -117.49 110.91 18.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.637 1.975 . . . . 0.0 108.554 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 p -125.76 171.52 10.59 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.856 1.663 . . . . 0.0 109.958 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -108.47 -23.09 12.01 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.991 -0.443 . . . . 0.0 110.948 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -83.51 -18.74 37.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.056 0.389 . . . . 0.0 111.327 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.82 -61.35 1.51 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.935 1.294 . . . . 0.0 109.078 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.05 -95.4 0.25 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -152.31 132.68 13.71 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 117.933 0.866 . . . . 0.0 111.735 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.77 169.54 19.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.11 152.37 36.63 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.95 131.76 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.082 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 27.9 t0 -98.0 103.6 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.017 1.727 . . . . 0.0 109.976 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -18.4 65.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -77.84 -35.65 50.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.194 0.906 . . . . 0.0 112.788 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -118.86 4.4 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.033 0.833 . . . . 0.0 113.177 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 53.72 47.31 24.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.642 1.177 . . . . 0.0 110.854 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -120.2 142.59 48.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.493 1.117 . . . . 0.0 111.365 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.72 138.88 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -149.33 146.49 27.55 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 120.063 1.301 . . . . 0.0 113.547 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.85 3.21 46.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.833 1.653 . . . . 0.0 112.098 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.03 143.57 48.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.327 1.451 . . . . 0.0 108.319 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -62.08 142.13 95.57 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 125.71 1.604 . . . . 0.0 110.7 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.49 178.25 6.93 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.907 2.405 . . . . 0.0 111.434 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -133.39 168.83 17.89 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.314 1.046 . . . . 0.0 109.982 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.63 154.83 19.72 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.87 -18.61 21.63 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.368 2.712 . . . . 0.0 114.945 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 t -131.13 168.85 16.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.164 1.347 . . . . 0.0 109.574 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -159.24 -17.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 106.271 -2.731 . . . . 0.0 106.271 -178.683 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.514 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.7 m -150.65 149.15 29.49 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.294 1.038 . . . . 0.0 110.126 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -128.62 -169.14 2.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.712 2.405 . . . . 0.0 108.997 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.19 24.89 74.74 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -112.9 -176.03 2.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.307 2.643 . . . . 0.0 111.972 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -178.43 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.268 2.227 . . . . 0.0 110.246 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.62 161.26 53.74 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -48.94 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.994 3.129 . . . . 0.0 112.903 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.57 168.38 3.18 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.484 2.714 . . . . 0.0 107.091 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.0 167.59 4.68 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.506 0.67 . . . . 0.0 111.178 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -123.97 -1.02 8.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.27 -14.98 30.45 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.39 -175.3 23.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.757 2.122 . . . . 0.0 109.949 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.7 mt -140.44 157.95 67.27 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 125.741 1.616 . . . . 0.0 110.948 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 67.5 Cg_endo -73.29 168.15 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.944 1.763 . . . . 0.0 110.334 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.72 133.21 35.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.899 2.399 . . . . 0.0 108.768 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.63 -18.91 56.19 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.628 1.109 . . . . 0.0 111.96 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 21.9 m95 -93.06 132.55 37.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.199 1.5 . . . . 0.0 108.39 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.8 159.77 35.51 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.54 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -121.16 120.96 36.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.04 133.68 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.62 150.08 46.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -149.29 175.52 11.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 59.2 m -108.1 -12.85 15.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -93.9 -19.65 20.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.99 -53.16 0.8 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.14 -134.81 5.38 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 105.993 -2.843 . . . . 0.0 105.993 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.7 m -130.78 138.28 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.299 1.04 . . . . 0.0 110.19 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -147.18 178.75 8.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.131 0.972 . . . . 0.0 110.022 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -118.19 155.39 30.58 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.102 0.961 . . . . 0.0 110.371 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.53 135.26 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.002 0.921 . . . . 0.0 108.566 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.443 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.2 t0 -103.98 105.52 15.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.67 -20.21 64.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.892 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 39.9 m -74.31 -34.89 63.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.629 0.772 . . . . 0.0 111.793 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.87 -9.92 11.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm 60.72 49.93 5.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.177 1.791 . . . . 0.0 109.195 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -121.65 160.7 23.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.81 1.244 . . . . 0.0 109.109 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.95 139.98 50.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -149.73 137.78 20.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -77.97 -2.83 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -108.65 156.62 19.35 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.458 1.103 . . . . 0.0 109.78 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' HIS . . . . . 0.455 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 52.2 t-80 -69.76 149.33 96.7 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.931 0.893 . . . . 0.0 108.751 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 72.4 Cg_endo -73.12 -176.95 2.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.709 3.606 . . . . 0.0 115.813 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 35.7 m -134.22 153.17 52.01 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.38 2.272 . . . . 0.0 108.455 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.91 171.9 47.28 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.444 0.545 . . . . 0.0 113.794 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.05 -34.85 3.47 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.568 2.845 . . . . 0.0 111.164 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 19.5 t -140.39 163.62 32.3 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.38 2.672 . . . . 0.0 105.344 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.5 m -143.91 12.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 110.379 -179.281 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.187 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.53 11.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.225 2.61 . . . . 0.0 117.181 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -81.45 72.05 8.48 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.749 -1.22 . . . . 0.0 108.116 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.62 174.0 46.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.4 t -72.37 158.36 35.94 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.1 t -152.48 -63.07 0.16 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.44 169.26 42.39 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.75 -44.96 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.412 2.075 . . . . 0.0 112.191 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.08 -179.75 7.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.112 2.165 . . . . 0.0 109.091 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -93.83 -174.33 3.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.116 0.966 . . . . 0.0 112.035 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -144.5 54.47 1.26 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.877 1.671 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -71.92 -175.93 1.57 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.67 0.788 . . . . 0.0 111.34 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.98 160.29 30.68 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.24 155.84 89.63 Favored Pre-proline 0 C--O 1.233 0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 111.798 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.24 157.98 59.49 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.437 1.425 . . . . 0.0 109.91 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.86 116.52 4.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.347 2.698 . . . . 0.0 107.359 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.18 -9.75 10.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.592 1.567 . . . . 0.0 111.582 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.466 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 23.1 m95 -107.36 163.8 12.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.531 1.166 . . . . 0.0 109.878 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -147.49 153.28 39.32 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.07 0.948 . . . . 0.0 109.775 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -118.43 121.01 39.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.15 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.15 92.12 3.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -127.87 151.96 48.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.788 1.235 . . . . 0.0 110.304 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 m -89.34 -29.53 19.06 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.769 0.827 . . . . 0.0 111.225 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.01 -38.45 88.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.289 0.636 . . . . 0.0 111.74 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -117.27 -40.61 3.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 -170.74 15.47 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.8 m -84.48 117.48 23.7 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.191 1.796 . . . . 0.0 107.892 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -136.36 -179.91 5.97 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 109.976 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -131.51 156.15 46.19 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.181 -0.95 . . . . 0.0 111.322 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.96 143.5 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.622 1.169 . . . . 0.0 109.106 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 23.8 t0 -106.17 118.78 37.51 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 127.39 2.276 . . . . 0.0 110.064 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -74.68 -21.73 59.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.915 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -65.24 -41.56 94.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 112.579 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.97 -1.87 8.78 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.278 1.431 . . . . 0.0 113.971 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 57.78 46.78 16.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 110.453 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -116.2 139.7 50.07 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.92 152.17 23.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.74 163.38 39.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.018 -1.051 . . . . 0.0 110.981 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -105.39 18.95 21.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.458 1.903 . . . . 0.0 111.846 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 154.12 51.84 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.246 -1.533 . . . . 0.0 110.948 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.65 136.67 96.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 68.2 Cg_endo -73.01 67.54 4.05 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.918 3.079 . . . . 0.0 114.289 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.37 176.86 10.7 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.292 0.637 . . . . 0.0 111.067 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.19 168.44 44.67 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.076 0.845 . . . . 0.0 111.298 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -82.23 -12.34 10.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.201 3.267 . . . . 0.0 111.856 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.2 p -158.94 -177.18 6.33 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 129.428 3.091 . . . . 0.0 106.392 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 t 60.69 19.41 9.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.629 0.772 . . . . 0.0 111.832 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.28 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.94 0.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.864 2.466 . . . . 0.0 116.919 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -76.66 80.65 3.3 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.9 -175.31 36.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.8 t -67.22 122.53 18.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.7 t -142.44 164.75 29.29 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.506 1.523 . . . . 0.0 107.242 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.46 169.11 53.39 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.98 -33.26 32.97 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.035 2.49 . . . . 0.0 112.131 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.39 162.27 39.33 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 128.553 2.741 . . . . 0.0 107.708 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.63 169.04 18.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.18 0.592 . . . . 0.0 109.971 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -110.9 37.55 2.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.674 1.19 . . . . 0.0 111.899 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.91 171.37 0.95 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.129 1.371 . . . . 0.0 112.157 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 173.17 34.6 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 121.509 -0.744 . . . . 0.0 112.479 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.61 160.74 80.64 Favored Pre-proline 0 C--O 1.235 0.301 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 60.1 Cg_endo -71.54 155.76 58.95 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.627 2.218 . . . . 0.0 109.084 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.13 94.53 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.379 3.386 . . . . 0.0 109.356 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.57 -7.56 1.53 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.334 1.445 . . . . 0.0 111.509 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.456 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.1 m95 -108.56 156.46 19.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.895 0.878 . . . . 0.0 109.293 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.91 155.74 45.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.595 0.758 . . . . 0.0 109.641 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -129.39 121.66 27.83 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.92 142.76 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.16 111.3 10.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 57.7 m -134.01 141.82 47.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.462 1.505 . . . . 0.0 111.407 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -70.01 -25.5 63.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.536 1.062 . . . . 0.0 111.104 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.41 -26.72 63.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.199 -0.905 . . . . 0.0 113.176 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.18 -23.68 2.41 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -107.74 1.66 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.383 1.944 . . . . 0.0 111.82 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 54.5 m -141.85 132.43 25.41 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.488 1.915 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -150.83 174.82 12.64 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.95 0.795 . . . . 0.0 109.771 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -124.93 154.34 41.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.06 0.944 . . . . 0.0 110.511 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.94 143.08 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.601 1.16 . . . . 0.0 109.446 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.403 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 12.0 t0 -106.91 143.21 35.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.951 1.7 . . . . 0.0 108.256 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -105.87 2.21 27.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.136 1.374 . . . . 0.0 111.26 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -91.62 -38.5 12.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.04 1.736 . . . . 0.0 112.658 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -132.25 6.06 4.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.945 2.098 . . . . 0.0 113.145 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt 51.03 52.05 15.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.703 1.601 . . . . 0.0 111.822 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -110.57 150.51 28.85 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.46 146.85 49.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -155.49 172.42 18.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.725 1.148 . . . . 0.0 112.084 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -113.54 13.23 18.75 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 0.0 111.589 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 161.11 23.35 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' HIS . . . . . 0.426 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 1.8 t-80 -70.06 150.84 96.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.102 0.864 . . . . 0.0 110.298 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 73.3 Cg_endo -79.01 51.26 3.79 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.874 2.383 . . . . 0.0 111.827 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -141.54 161.06 38.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.371 1.868 . . . . 0.0 109.674 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.71 -176.65 50.99 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.66 -26.82 22.93 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.806 2.337 . . . . 0.0 112.34 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -76.69 -170.31 1.53 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.709 1.604 . . . . 0.0 109.528 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -56.92 -9.85 0.93 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.312 0 CA-C-N 120.454 1.479 . . . . 0.0 109.416 179.345 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -117.87 166.7 12.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.979 1.712 . . . . 0.0 110.245 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -144.24 -8.65 0.68 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.493 0.717 . . . . 0.0 112.885 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.8 -163.32 52.08 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.797 1.181 . . . . 0.0 110.923 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 m -128.31 163.2 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.854 1.662 . . . . 0.0 110.043 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 p -157.17 173.98 16.16 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.485 0.584 . . . . 0.0 109.691 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.5 177.72 52.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.871 -0.518 . . . . 0.0 113.105 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.68 -47.67 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.016 2.477 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 9' ' ' LEU . 3.6 pp -164.61 173.42 11.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.4 1.88 . . . . 0.0 109.627 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -158.75 152.32 23.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -81.01 -0.25 38.74 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.3 155.68 31.39 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 119.375 0.989 . . . . 0.0 110.933 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.47 173.03 33.95 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.8 mt -114.7 151.02 44.95 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 122.962 0.505 . . . . 0.0 112.116 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.94 164.11 31.06 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.696 2.264 . . . . 0.0 110.894 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.02 127.97 19.65 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.119 1.879 . . . . 0.0 108.057 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.38 -20.98 31.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.294 0.949 . . . . 0.0 111.567 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 17.9 m95 -91.98 154.97 18.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.278 1.539 . . . . 0.0 108.171 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -142.07 146.24 35.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -107.25 126.86 52.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.303 1.841 . . . . 0.0 107.293 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.71 117.19 54.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -102.3 137.45 40.54 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.457 1.503 . . . . 0.0 107.829 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -149.44 178.96 8.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.911 0.884 . . . . 0.0 111.688 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.9 m -106.0 -11.05 16.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 0.0 111.412 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -104.41 -47.45 4.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.35 0.595 . . . . 0.0 110.669 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -91.93 -8.27 46.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.078 1.351 . . . . 0.0 113.108 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.17 -88.56 1.19 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.74 134.27 10.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.33 176.48 9.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -134.56 159.79 40.08 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.85 133.41 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.331 0.652 . . . . 0.0 110.284 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 14.9 t0 -92.56 108.37 19.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.893 2.477 . . . . 0.0 107.275 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -68.98 -28.15 66.36 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 122.12 -0.362 . . . . 0.0 111.948 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.5 m -69.6 -44.76 70.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.113 0.965 . . . . 0.0 111.892 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -103.45 -8.2 20.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.389 1.076 . . . . 0.0 113.696 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 55.74 60.81 3.09 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.653 1.581 . . . . 0.0 108.901 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -136.44 154.65 50.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.842 1.257 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.46 149.51 36.2 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -153.29 160.1 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.652 0.781 . . . . 0.0 111.413 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -108.0 13.66 25.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 0.0 113.219 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 160.38 29.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.931 1.292 . . . . 0.0 108.753 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.7 139.93 91.58 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.95 -75.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.964 3.776 . . . . 0.0 114.858 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 t -63.67 -43.65 96.06 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.51 -178.03 47.27 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.968 0.794 . . . . 0.0 112.427 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.78 102.46 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.764 3.643 . . . . 0.0 112.289 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.8 t -75.41 164.8 26.02 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -136.16 50.42 2.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.378 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.553 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -134.0 161.38 34.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.754 0.777 . . . . 0.0 109.62 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -125.89 -1.91 7.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.356 1.062 . . . . 0.0 112.217 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.95 -171.34 22.94 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -121.88 134.23 54.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -139.68 166.82 23.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.872 0.76 . . . . 0.0 112.296 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.59 -168.2 43.12 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.953 1.74 . . . . 0.0 112.758 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.35 -41.99 3.12 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.109 2.539 . . . . 0.0 112.903 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 pp 167.4 -172.67 0.02 OUTLIER 'General case' 0 C--O 1.238 0.457 0 C-N-CA 131.184 3.793 . . . . 0.0 106.853 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -157.76 168.32 27.55 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.22 1.808 . . . . 0.0 107.071 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -83.47 2.29 37.5 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.462 -0.774 . . . . 0.0 112.929 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.36 149.76 19.78 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.314 1.446 . . . . 0.0 110.558 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.77 -179.46 28.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.31 160.44 50.24 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.806 0.803 . . . . 0.0 112.044 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.4 Cg_endo -64.37 158.06 51.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.235 1.956 . . . . 0.0 109.764 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.13 103.64 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.376 3.384 . . . . 0.0 109.983 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.99 3.52 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.004 1.764 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.476 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 7.4 m95 -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.181 -1.188 . . . . 0.0 109.151 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.24 155.07 44.42 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.233 0.54 . . . . 0.0 110.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -116.99 136.82 52.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 128.071 2.549 . . . . 0.0 105.365 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.38 143.95 27.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -128.16 137.18 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 m -154.44 -172.64 4.28 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.111 1.764 . . . . 0.0 110.508 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -105.21 -59.22 1.78 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -60.69 -18.04 51.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 114.192 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.72 -12.77 5.98 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.584 1.154 . . . . 0.0 114.06 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.64 -92.02 0.78 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.463 1.982 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.19 127.5 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.133 -0.627 . . . . 0.0 111.61 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -141.85 174.07 10.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.616 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.82 146.87 50.8 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.383 -1.448 . . . . 0.0 110.768 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.86 136.79 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.024 1.329 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -97.44 112.82 24.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.471 1.908 . . . . 0.0 106.328 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -22.57 53.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.899 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -67.08 -53.18 33.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.01 1.277 . . . . 0.0 111.746 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.78 -4.04 31.44 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.353 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm 56.55 58.14 4.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.533 1.533 . . . . 0.0 107.072 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -119.66 169.6 9.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.175 1.39 . . . . 0.0 109.693 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.65 146.39 50.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.245 1.018 . . . . 0.0 110.43 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.45 167.67 21.64 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.937 1.295 . . . . 0.0 109.487 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.7 4.88 18.85 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.045 0.938 . . . . 0.0 113.153 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.08 176.36 8.14 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.96 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -71.54 141.54 85.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.85 -73.45 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.16 2.573 . . . . 0.0 114.733 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.8 m -66.58 -21.76 66.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.123 1.328 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 -166.52 52.72 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.85 151.32 84.57 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -134.37 170.37 15.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.451 . . . . 0.0 107.769 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -131.77 88.45 2.57 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 108.489 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.58 -179.761 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -87.02 88.73 7.77 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p -116.06 148.12 40.55 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.722 1.209 . . . . 0.0 110.408 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.99 64.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.5 m -78.18 89.83 4.27 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.23 -177.85 6.29 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.343 2.257 . . . . 0.0 107.718 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.95 176.46 25.6 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.74 -75.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.015 1.81 . . . . 0.0 111.752 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.77 111.17 16.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.992 1.717 . . . . 0.0 106.978 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -136.29 174.16 10.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.408 1.483 . . . . 0.0 107.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.4 ptp85 -123.72 20.32 9.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.625 1.57 . . . . 0.0 109.357 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -129.84 151.33 50.53 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.84 -74.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.15 160.85 27.89 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 125.306 1.442 . . . . 0.0 112.585 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.67 159.51 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.066 2.511 . . . . 0.0 110.773 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.79 117.6 5.12 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.971 2.448 . . . . 0.0 107.038 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.58 -20.76 8.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.317 1.437 . . . . 0.0 112.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 13.5 m95 -90.99 157.43 17.29 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 119.793 1.796 . . . . 0.0 110.005 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -135.03 145.15 47.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -118.53 130.53 55.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.57 139.4 47.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 140.29 49.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.594 1.958 . . . . 0.0 106.761 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.45 150.87 20.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.26 1.024 . . . . 0.0 108.374 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -74.27 -24.1 59.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.743 1.156 . . . . 0.0 110.35 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.43 -39.03 28.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.418 1.087 . . . . 0.0 113.732 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -109.55 -9.23 14.91 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.106 . . . . 0.0 113.528 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.32 -88.82 1.1 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 126.404 1.954 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 m -152.98 119.77 5.71 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.54 168.13 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.948 0.899 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -125.48 139.54 53.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.364 1.066 . . . . 0.0 109.695 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' B' ' 31' ' ' VAL . 93.5 t -122.12 131.87 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.02 0.928 . . . . 0.0 110.08 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.6 t0 -91.24 121.85 33.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 127.144 2.178 . . . . 0.0 108.836 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -85.97 -9.87 56.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.988 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -73.07 -43.56 61.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.794 1.179 . . . . 0.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -120.49 2.92 10.76 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.96 1.304 . . . . 0.0 112.871 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 56.59 45.84 21.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 110.973 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -117.21 138.6 51.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.28 20.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -151.91 164.95 36.04 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.322 1.058 . . . . 0.0 110.482 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 51.7 m-85 -107.76 26.4 10.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.8 1.64 . . . . 0.0 111.204 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -140.55 160.96 38.86 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -74.61 141.5 76.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.586 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 72.6 Cg_endo -71.32 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.438 2.092 . . . . 0.0 112.444 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m -134.36 -47.45 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.358 0.663 . . . . 0.0 111.943 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.91 174.91 5.57 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.817 -0.552 . . . . 0.0 112.359 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.12 177.84 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.081 2.521 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.0 p -140.44 159.55 41.94 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.612 1.565 . . . . 0.0 106.809 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -144.47 3.21 1.14 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.081 . . . . 0.0 111.888 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.637 0 N-CA-C 105.591 -3.004 . . . . 0.0 105.591 179.739 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -78.67 143.43 36.3 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.681 1.24 . . . . 0.0 110.59 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -167.52 172.15 9.74 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.693 1.197 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.59 84.31 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 105.59 -3.004 . . . . 0.0 105.59 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.8 m -65.13 88.49 0.07 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.703 1.201 . . . . 0.0 107.873 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 14.6 p -140.44 173.95 10.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.932 2.093 . . . . 0.0 111.791 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.89 172.41 54.13 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.92 -66.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.421 2.081 . . . . 0.0 113.621 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -133.26 102.93 5.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.082 0.953 . . . . 0.0 110.441 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -134.88 177.37 7.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.173 2.589 . . . . 0.0 107.878 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -116.83 9.83 14.0 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.978 1.311 . . . . 0.0 111.902 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -120.16 141.37 49.93 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.941 0.896 . . . . 0.0 111.0 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.74 -3.8 11.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.53 1.538 . . . . 0.0 114.35 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -134.07 157.23 78.14 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 120.283 2.042 . . . . 0.0 110.044 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 61.2 Cg_endo -71.04 157.53 57.6 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.234 1.29 . . . . 0.0 110.373 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.12 125.25 13.78 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.648 2.232 . . . . 0.0 106.349 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.92 -10.84 27.34 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.779 1.657 . . . . 0.0 110.75 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 27.7 m95 -113.04 148.98 34.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.897 1.349 . . . . 0.0 109.695 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -139.3 155.83 47.46 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.927 0.767 . . . . 0.0 109.779 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -116.15 138.69 51.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.731 1.612 . . . . 0.0 108.257 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.59 139.58 42.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.43 133.26 46.21 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -149.02 172.03 15.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.885 1.274 . . . . 0.0 113.685 -175.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m -84.93 -32.48 23.07 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.541 1.137 . . . . 0.0 113.921 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -100.89 -12.03 19.31 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.464 1.106 . . . . 0.0 112.667 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -116.86 -21.08 9.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.315 1.046 . . . . 0.0 111.57 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.61 -89.97 1.34 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 24.1 m -156.74 129.16 7.52 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.082 -1.246 . . . . 0.0 109.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -138.45 174.75 10.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -130.53 143.03 50.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' A' ' 31' ' ' VAL . 22.2 t -119.19 131.78 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 12.2 t0 -92.66 109.32 20.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.57 -11.83 60.3 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.662 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.7 m -66.84 -41.25 87.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.498 1.499 . . . . 0.0 110.572 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.02 1.73 8.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 46.1 mmtm 59.39 51.75 6.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.756 1.222 . . . . 0.0 109.466 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -122.68 146.05 47.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.57 131.36 54.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -134.68 157.89 45.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.492 1.117 . . . . 0.0 108.291 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -104.26 3.21 32.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -105.04 156.04 18.42 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.826 1.65 . . . . 0.0 109.107 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -69.13 149.61 97.6 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-O 117.541 -1.219 . . . . 0.0 107.966 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.49 160.43 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.352 1.519 . . . . 0.0 110.276 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.2 m -130.42 -66.32 0.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.833 0.853 . . . . 0.0 110.829 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.01 177.02 28.22 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.211 0.459 . . . . 0.0 113.749 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.17 178.93 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.202 3.268 . . . . 0.0 110.436 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 66.3 p -147.74 166.62 26.93 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.779 0.832 . . . . 0.0 109.587 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.2 14.57 2.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.945 1.698 . . . . 0.0 110.611 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.477 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.565 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.903 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.59 177.04 4.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.195 1.398 . . . . 0.0 109.746 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 t -153.7 173.35 15.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.083 0.953 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 38.98 2.95 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.492 1.52 . . . . 0.0 110.882 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.3 m -132.32 139.12 48.05 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.404 1.081 . . . . 0.0 111.58 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 p -77.82 167.14 22.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.15 179.81 31.77 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.46 -39.37 2.8 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.315 2.01 . . . . 0.0 110.991 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -142.73 152.13 42.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.685 1.594 . . . . 0.0 110.05 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.2 -169.04 1.9 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.9 mtm-85 -138.61 -32.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.804 1.242 . . . . 0.0 110.164 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.43 170.72 11.37 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.433 1.493 . . . . 0.0 110.575 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.72 170.9 54.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 122.404 1.002 . . . . 0.0 110.782 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.6 mt -82.82 162.71 54.33 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 125.835 1.654 . . . . 0.0 110.738 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.21 164.97 31.95 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.601 1.534 . . . . 0.0 109.982 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.69 149.03 78.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 N-CA-C 105.698 -2.462 . . . . 0.0 105.698 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.72 -11.43 70.32 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -111.7 136.18 51.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.431 1.615 . . . . 0.0 107.405 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.6 152.09 37.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 0.0 110.388 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -115.68 120.51 39.6 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.1 t -104.53 138.53 28.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.98 129.09 50.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.965 1.306 . . . . 0.0 107.816 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -147.76 169.22 20.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.812 2.045 . . . . 0.0 108.213 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -105.7 -23.89 12.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -78.16 -35.1 49.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -96.5 -69.65 0.75 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.978 1.311 . . . . 0.0 108.851 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.97 -132.75 6.27 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 104.316 -3.514 . . . . 0.0 104.316 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.97 132.14 54.46 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 109.421 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -141.71 166.51 24.52 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.512 0.725 . . . . 0.0 109.682 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -122.55 139.64 53.68 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 111.035 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' B' ' 31' ' ' VAL . 55.4 t -121.61 148.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -108.08 113.03 25.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.214 1.806 . . . . 0.0 111.963 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -21.08 64.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.695 0.679 . . . . 0.0 111.748 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -73.63 -30.85 63.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.17 0.988 . . . . 0.0 113.045 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -129.13 -1.09 5.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' CE ' ' CE2' ' B' ' 40' ' ' TYR . 17.6 mmtp 59.06 46.7 12.99 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.679 1.192 . . . . 0.0 110.616 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -125.35 146.41 49.59 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.635 -0.665 . . . . 0.0 110.78 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.19 142.11 36.42 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 107.858 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -148.83 161.48 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 108.833 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -106.99 14.17 26.74 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.948 0.899 . . . . 0.0 111.002 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -118.51 160.29 22.01 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 120.97 -1.081 . . . . 0.0 110.744 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.88 133.83 88.09 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.947 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.06 24.32 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.362 3.374 . . . . 0.0 115.398 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.9 p -63.67 -38.67 92.01 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.948 1.249 . . . . 0.0 109.98 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.34 -173.48 46.14 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.55 167.3 27.61 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.815 2.343 . . . . 0.0 110.221 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -120.95 161.45 21.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -147.72 105.78 3.74 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.94 -1.1 . . . . 0.0 108.605 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.657 0 N-CA-C 105.121 -3.192 . . . . 0.0 105.121 -178.884 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.495 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -71.18 -177.02 1.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.037 2.135 . . . . 0.0 110.779 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -158.45 169.91 23.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.631 1.172 . . . . 0.0 108.469 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.72 95.98 1.14 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -176.17 144.45 0.57 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.583 1.953 . . . . 0.0 108.392 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.8 p -74.94 175.52 8.02 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.094 1.357 . . . . 0.0 109.654 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.27 166.53 39.31 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.205 -0.934 . . . . 0.0 111.732 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.28 -35.25 63.81 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.399 2.733 . . . . 0.0 113.097 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 pp -142.52 -173.48 3.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.837 2.455 . . . . 0.0 108.403 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -134.02 143.98 48.42 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -95.69 27.16 3.6 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.39 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.02 177.38 8.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.033 0.921 . . . . 0.0 113.016 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.48 171.81 51.16 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 125.167 1.365 . . . . 0.0 112.207 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 20' ' ' ARG . 74.8 mt -90.54 160.13 39.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.594 1.158 . . . . 0.0 111.842 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.409 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 48.2 Cg_endo -67.2 157.19 62.94 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.042 1.828 . . . . 0.0 109.407 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.18 93.34 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.573 3.515 . . . . 0.0 111.64 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.36 -19.65 2.26 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.279 1.419 . . . . 0.0 111.153 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 18.6 m95 -94.43 149.89 20.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -131.74 141.09 49.43 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.07 0.548 . . . . 0.0 109.788 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.411 ' HB2' HD11 ' B' ' 14' ' ' LEU . 42.0 ttp180 -107.48 121.83 45.41 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.0 t -110.91 141.53 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -130.18 150.23 51.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 m -154.87 -165.63 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.115 1.366 . . . . 0.0 109.435 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.0 m -115.43 -45.16 2.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.07 0.948 . . . . 0.0 108.957 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.79 -14.73 62.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.989 0.516 . . . . 0.0 110.559 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.61 -25.63 4.32 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.69 1.596 . . . . 0.0 113.192 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.79 -86.61 1.55 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.9 m -159.61 140.06 12.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.121 1.46 . . . . 0.0 110.577 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.64 176.34 9.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.414 -0.804 . . . . 0.0 109.689 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.34 151.9 50.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 108.931 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 31' ' ' VAL . 42.5 t -128.32 136.6 59.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.217 1.007 . . . . 0.0 109.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.3 t0 -101.53 104.08 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.978 1.311 . . . . 0.0 108.879 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.24 -19.89 66.18 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.795 -0.565 . . . . 0.0 111.26 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.45 -33.16 69.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.682 1.593 . . . . 0.0 112.661 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -126.78 0.75 6.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 54.57 36.99 27.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -111.75 161.16 16.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.37 148.44 48.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.986 0.914 . . . . 0.0 108.587 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.42 168.51 26.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.82 1.248 . . . . 0.0 110.118 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.502 ' CE2' ' CE ' ' A' ' 36' ' ' LYS . 69.2 m-85 -105.36 -1.02 25.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.8 167.88 9.5 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.064 -1.023 . . . . 0.0 111.233 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.29 149.89 89.35 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.44 45.49 1.43 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.447 2.765 . . . . 0.0 115.436 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 45.5 p -69.22 -58.41 4.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.196 0.907 . . . . 0.0 111.756 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.28 43.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.64 170.87 19.34 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.82 2.347 . . . . 0.0 110.311 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.4 m -135.41 176.6 8.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.94 0.896 . . . . 0.0 110.675 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -149.36 163.12 38.62 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 128.595 2.758 . . . . 0.0 104.326 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 N-CA-C 105.262 -3.135 . . . . 0.0 105.262 -178.89 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -89.37 113.67 25.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 108.759 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -100.04 113.28 25.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.45 -171.42 26.35 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m -164.94 175.49 9.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.903 1.681 . . . . 0.0 109.399 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.9 m -128.49 24.42 5.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.805 2.042 . . . . 0.0 111.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.9 -178.82 16.4 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.014 0.816 . . . . 0.0 112.453 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.31 -36.79 3.77 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.357 2.704 . . . . 0.0 112.331 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.42 163.13 33.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.573 2.349 . . . . 0.0 107.77 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -130.49 173.55 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.936 1.295 . . . . 0.0 110.673 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -132.39 69.36 1.48 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.61 1.564 . . . . 0.0 107.02 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -142.7 174.67 10.44 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.021 0.929 . . . . 0.0 109.961 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.58 -163.69 38.8 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ARG . 36.6 mt -125.4 155.05 72.28 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.65 1.225 . . . . 0.0 111.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 57.8 Cg_endo -71.56 162.39 42.36 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.119 1.879 . . . . 0.0 110.705 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 121.22 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.12 2.546 . . . . 0.0 110.41 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.42 47.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.315 1.435 . . . . 0.0 112.904 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.2 m95 -92.2 151.09 20.54 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.454 1.627 . . . . 0.0 108.151 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.02 154.74 47.87 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.557 1.143 . . . . 0.0 109.919 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.8 ttp180 -125.87 124.86 41.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t -108.33 115.03 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 108.426 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.67 128.27 44.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.5 m -139.94 -173.72 3.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.575 1.15 . . . . 0.0 109.885 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -116.45 -43.96 2.9 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.853 1.261 . . . . 0.0 108.801 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.55 -18.81 62.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.928 0.891 . . . . 0.0 112.695 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -128.17 -19.28 3.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.3 -100.24 1.79 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -157.95 139.58 13.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.493 0.717 . . . . 0.0 109.641 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -146.31 170.57 16.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -119.33 152.79 36.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.576 1.55 . . . . 0.0 107.59 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.44 135.33 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.204 0.601 . . . . 0.0 110.321 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 20.4 t0 -101.53 106.19 17.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.248 1.419 . . . . 0.0 108.176 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.94 -13.87 61.76 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.561 -0.712 . . . . 0.0 111.233 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.5 m -75.11 -39.12 60.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.88 1.218 . . . . 0.0 112.528 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -124.25 8.12 8.5 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm 54.18 53.72 10.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.421 1.488 . . . . 0.0 109.414 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -121.97 134.93 54.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.792 1.637 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 135.35 39.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.318 1.447 . . . . 0.0 107.621 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -139.07 153.63 48.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.848 1.204 . . . . 0.0 113.227 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -96.96 15.81 21.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.891 1.276 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 158.44 43.99 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 119.955 -1.716 . . . . 0.0 109.742 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -58.37 141.71 82.71 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 124.391 1.057 . . . . 0.0 110.726 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.97 94.47 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.743 2.295 . . . . 0.0 109.306 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.2 m -47.08 -33.64 5.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 0.0 113.128 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.05 158.16 28.6 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.3 0.955 . . . . 0.0 112.142 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.87 -13.45 21.72 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.671 2.914 . . . . 0.0 111.478 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 m -166.87 177.86 6.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.477 3.511 . . . . 0.0 105.754 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -25.63 8.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.923 0.889 . . . . 0.0 112.386 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 -179.687 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -150.53 171.0 17.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.728 1.611 . . . . 0.0 108.39 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.1 p -162.41 121.63 2.29 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.68 170.47 41.43 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 123.857 0.741 . . . . 0.0 111.306 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -148.12 -179.36 6.87 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.322 1.849 . . . . 0.0 108.423 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 19.3 t -128.02 -33.96 2.17 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.519 1.128 . . . . 0.0 110.86 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.31 169.39 35.45 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 119.216 0.917 . . . . 0.0 111.882 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.32 -37.75 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.781 2.321 . . . . 0.0 111.576 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -142.61 106.35 4.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.58 1.952 . . . . 0.0 108.644 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.39 172.25 13.9 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -133.14 -19.98 2.18 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.62 169.97 17.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.54 175.35 21.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.272 0.939 . . . . 0.0 112.122 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' B' ' 20' ' ' ARG . 86.4 mt -107.02 160.73 25.31 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.643 1.577 . . . . 0.0 111.887 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 28.4 Cg_endo -69.06 163.35 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.914 1.742 . . . . 0.0 109.336 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.0 137.79 49.99 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.31 74.24 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.635 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 9.8 m95 -114.3 142.03 46.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 121.171 2.486 . . . . 0.0 109.094 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -125.32 157.68 36.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.647 0.779 . . . . 0.0 110.553 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.421 ' HB2' HD11 ' B' ' 14' ' ' LEU . 38.0 ttp180 -128.05 125.04 38.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.469 2.308 . . . . 0.0 106.906 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.51 133.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.96 119.06 35.94 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 65.1 m -138.51 158.46 44.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.462 1.105 . . . . 0.0 109.738 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -84.81 -39.55 18.22 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.695 -1.253 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.26 -16.24 59.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -124.83 -13.04 7.01 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.91 -94.66 1.99 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.998 1.761 . . . . 0.0 110.543 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -151.91 135.83 16.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.037 -0.684 . . . . 0.0 110.47 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -148.54 167.79 24.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.22 155.05 37.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 108.337 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.9 139.31 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.889 0.852 . . . . 0.0 109.236 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -100.61 102.47 13.62 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 128.533 2.733 . . . . 0.0 106.938 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -20.19 64.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.535 0.607 . . . . 0.0 112.413 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -71.86 -36.88 70.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.375 0.989 . . . . 0.0 110.7 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -116.82 -1.47 12.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 58.02 53.52 6.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.027 1.331 . . . . 0.0 108.285 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -123.41 147.38 47.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.702 0.401 . . . . 0.0 110.016 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.85 136.23 48.76 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 150.41 40.74 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.856 0.753 . . . . 0.0 110.376 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -88.73 1.32 55.35 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 156.5 33.61 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.583 1.153 . . . . 0.0 110.169 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -64.48 146.42 98.09 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.21 144.51 90.45 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m -87.06 -13.65 43.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.781 1.232 . . . . 0.0 113.151 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.83 162.91 10.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.773 1.178 . . . . 0.0 111.878 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.55 -57.33 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.865 3.043 . . . . 0.0 112.625 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 3.6 m -133.22 149.48 52.0 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.249 0.931 . . . . 0.0 111.471 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -17.95 58.78 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.773 0.829 . . . . 0.0 111.329 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.633 2.54 . . . . 0.0 106.777 -179.989 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 m -141.48 88.93 2.18 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -167.27 162.69 15.1 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.265 1.426 . . . . 0.0 108.334 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.69 58.6 0.5 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p -138.7 162.24 35.17 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.646 1.579 . . . . 0.0 108.516 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 p -85.19 -169.28 2.57 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.726 0.811 . . . . 0.0 110.054 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.09 -179.98 21.79 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.6 -32.39 79.39 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.069 2.513 . . . . 0.0 112.15 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.48 167.18 30.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.729 2.011 . . . . 0.0 108.727 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -73.79 31.95 0.08 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.366 2.266 . . . . 0.0 110.465 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 56.22 36.75 27.99 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.318 1.847 . . . . 0.0 111.286 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.98 84.9 2.88 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 129.495 3.118 . . . . 0.0 104.744 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.67 74.14 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 O-C-N 121.078 -1.014 . . . . 0.0 111.579 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.35 157.59 63.03 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.41 0.684 . . . . 0.0 112.542 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 74.2 Cg_endo -76.62 168.66 23.27 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.575 2.184 . . . . 0.0 109.105 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.9 149.88 72.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 -11.44 44.51 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.554 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 16.2 m95 -99.68 151.8 20.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.475 1.638 . . . . 0.0 106.619 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -135.63 151.98 50.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.922 0.489 . . . . 0.0 110.004 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -111.14 129.72 55.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.31 143.97 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.33 149.88 51.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -155.31 148.96 25.28 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.401 1.08 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -76.23 -19.48 58.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -85.37 -20.09 30.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.337 1.055 . . . . 0.0 113.209 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.53 -46.0 1.77 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.67 -109.39 1.1 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -138.56 129.23 26.37 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -144.69 163.21 34.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.75 149.03 39.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 111.444 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.14 142.49 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.492 0.717 . . . . 0.0 109.744 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 119.44 39.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 127.907 2.483 . . . . 0.0 108.844 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -84.61 -20.97 30.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -76.84 -31.98 57.25 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.284 1.034 . . . . 0.0 110.085 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -117.38 -9.42 10.9 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp 56.86 50.46 12.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.07 1.348 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -126.05 160.19 30.74 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.661 0.785 . . . . 0.0 110.287 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.77 139.5 53.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.376 1.471 . . . . 0.0 109.37 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -153.9 144.68 22.57 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.631 1.173 . . . . 0.0 108.688 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 62.8 m-85 -91.25 24.41 2.92 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.46 0.704 . . . . 0.0 109.845 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 154.28 47.99 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.573 -1.329 . . . . 0.0 111.036 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.95 143.99 98.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 59.6 Cg_endo -74.92 -23.78 13.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.845 2.364 . . . . 0.0 116.658 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t 61.72 18.75 9.92 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.935 1.698 . . . . 0.0 112.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.08 168.46 41.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.459 1.028 . . . . 0.0 112.0 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.33 -34.45 15.99 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.563 2.175 . . . . 0.0 112.524 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -157.75 179.04 9.59 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.371 2.269 . . . . 0.0 106.384 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 t -143.9 152.69 41.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.935 0.874 . . . . 0.0 109.286 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.819 0 C-N-CA 126.805 2.145 . . . . 0.0 107.865 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -71.77 80.4 0.86 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.301 1.041 . . . . 0.0 109.143 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -153.4 157.51 40.08 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.901 1.28 . . . . 0.0 107.905 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.54 82.43 0.18 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -147.0 163.42 36.27 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.405 1.482 . . . . 0.0 108.263 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 30.7 p -78.02 -174.5 3.62 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.467 0.707 . . . . 0.0 111.061 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.67 175.28 23.71 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.299 1.428 . . . . 0.0 110.703 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.34 -32.54 20.08 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.917 3.078 . . . . 0.0 113.373 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.06 163.06 18.22 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.013 2.925 . . . . 0.0 105.271 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.64 154.02 40.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.785 0.802 . . . . 0.0 111.832 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -74.72 56.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.823 2.449 . . . . 0.0 109.137 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.91 -28.75 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -15.44 90.68 0.01 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 129.38 3.372 . . . . 0.0 114.185 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.63 154.37 85.47 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.48 166.91 27.89 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.923 2.415 . . . . 0.0 110.291 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.67 118.63 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.703 2.268 . . . . 0.0 109.975 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.5 -11.96 33.12 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.181 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 32.2 m95 -100.54 150.43 22.68 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 119.303 1.551 . . . . 0.0 108.373 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.02 168.03 19.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 108.669 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -133.06 121.34 22.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.116 1.366 . . . . 0.0 108.585 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.76 107.98 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 124.168 0.917 . . . . 0.0 109.221 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -95.48 133.36 39.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.3 m -155.78 -177.64 6.71 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.006 -1.684 . . . . 0.0 110.833 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -102.68 -44.75 5.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.806 0.843 . . . . 0.0 111.896 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.74 -11.85 59.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.69 -19.86 3.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.17 -105.33 3.26 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -144.96 124.19 12.95 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.909 0.484 . . . . 0.0 110.905 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.45 178.51 7.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.373 1.069 . . . . 0.0 108.838 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.35 155.57 47.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.557 1.143 . . . . 0.0 109.767 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.4 131.58 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 51.7 t0 -98.82 104.66 16.72 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -70.06 -21.95 63.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.843 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 90.3 m -67.7 -45.19 75.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.837 1.653 . . . . 0.0 110.823 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -106.63 1.11 24.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.81 0.844 . . . . 0.0 112.424 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 2.4 mmtp 49.85 54.73 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.756 2.022 . . . . 0.0 110.611 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -119.62 167.39 12.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.089 0.956 . . . . 0.0 109.168 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 143.32 50.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -155.05 149.43 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.896 0.878 . . . . 0.0 108.968 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -90.98 -8.76 48.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.226 1.01 . . . . 0.0 110.14 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -93.56 152.4 19.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 124.539 1.136 . . . . 0.0 108.584 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 42.5 t-80 -67.26 151.33 97.26 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.61 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 92.0 Cg_endo -84.21 -31.86 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 N-CA-C 117.357 2.022 . . . . 0.0 117.357 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t 63.67 3.27 1.48 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.135 0.88 . . . . 0.0 113.239 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.23 166.77 42.68 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.807 1.64 . . . . 0.0 114.059 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.4 -35.39 23.72 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.797 2.998 . . . . 0.0 113.753 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.0 m -146.21 -173.9 4.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 112.473 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.1 t -132.99 121.08 22.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -179.626 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.97 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 m -163.15 169.99 18.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.358 1.863 . . . . 0.0 107.68 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -61.89 147.08 47.85 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.04 85.89 0.14 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -60.56 110.29 1.24 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -157.91 155.36 29.43 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.75 170.35 14.86 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.583 1.087 . . . . 0.0 110.573 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.44 -42.82 44.96 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.032 2.488 . . . . 0.0 113.611 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.95 131.79 13.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.202 1.801 . . . . 0.0 106.212 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -144.94 157.86 44.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.49 1.916 . . . . 0.0 106.55 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -103.23 13.62 33.51 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.19 -179.84 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.518 1.127 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.57 -165.7 31.15 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.563 1.554 . . . . 0.0 110.442 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.84 162.88 38.47 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 124.934 1.294 . . . . 0.0 111.695 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 40.5 Cg_endo -72.09 164.55 35.31 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.405 1.403 . . . . 0.0 109.304 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.18 134.65 40.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.57 1.513 . . . . 0.0 108.919 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.68 -10.8 72.19 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 117.615 -1.659 . . . . 0.0 114.216 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.459 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.2 m95 -93.91 168.18 11.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.147 1.973 . . . . 0.0 109.181 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -140.95 156.27 46.1 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.608 0.763 . . . . 0.0 109.986 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -125.04 129.99 51.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.68 132.74 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.32 139.61 41.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -142.84 -172.41 3.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.8 2.44 . . . . 0.0 109.819 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -126.28 -38.86 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.535 1.934 . . . . 0.0 107.594 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -34.8 71.24 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -113.33 -17.11 12.37 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.76 -85.7 1.51 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -157.63 146.03 19.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.343 1.072 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -154.63 166.99 31.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.296 0.638 . . . . 0.0 109.606 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.0 144.98 45.09 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' B' ' 31' ' ' VAL . 85.3 t -123.78 142.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.823 0.849 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -107.43 112.55 25.4 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 127.255 2.222 . . . . 0.0 109.498 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -74.22 -22.37 59.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.767 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.4 m -69.53 -34.1 73.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.59 1.086 . . . . 0.0 112.148 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -121.92 1.84 9.9 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.341 0.656 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' B' ' 40' ' ' TYR . 34.9 mmtm 51.15 52.5 14.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.983 1.713 . . . . 0.0 108.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -121.75 154.84 36.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.664 0.786 . . . . 0.0 108.984 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.83 140.95 51.03 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.67 1.188 . . . . 0.0 108.371 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -150.22 147.28 27.51 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.522 -0.736 . . . . 0.0 110.527 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.31 -13.28 52.87 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.365 1.466 . . . . 0.0 112.965 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.69 144.01 27.1 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.481 1.912 . . . . 0.0 107.158 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -68.05 142.14 94.91 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.2 -169.09 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.822 3.015 . . . . 0.0 112.591 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.1 t -129.05 -31.88 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.222 1.009 . . . . 0.0 110.512 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.58 -170.59 2.66 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 119.336 0.971 . . . . 0.0 113.807 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.15 -69.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.44 2.76 . . . . 0.0 110.621 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.8 m -155.91 -174.46 4.97 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.831 2.853 . . . . 0.0 107.773 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -63.32 168.03 4.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.129 0.971 . . . . 0.0 109.426 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 N-CA-C 105.644 -2.982 . . . . 0.0 105.644 179.372 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -134.97 167.84 20.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.183 0.992 . . . . 0.0 110.5 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m 54.2 80.98 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 126.672 1.989 . . . . 0.0 108.483 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.83 80.86 0.22 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -61.87 106.67 0.72 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.517 1.527 . . . . 0.0 109.25 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.9 t -142.61 154.64 44.58 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.07 172.41 14.32 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.843 1.201 . . . . 0.0 113.382 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.7 -37.18 81.03 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.609 2.206 . . . . 0.0 109.465 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 pp -176.85 134.32 0.21 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.81 3.644 . . . . 0.0 105.516 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 -167.06 2.05 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 131.457 3.903 . . . . 0.0 106.325 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -140.44 15.56 2.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.947 1.249 . . . . 0.0 113.935 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.31 -178.29 2.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.821 1.248 . . . . 0.0 112.007 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.35 -165.63 24.73 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.092 1.329 . . . . 0.0 111.611 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt -129.61 157.69 75.76 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.034 0.933 . . . . 0.0 111.007 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 43.6 Cg_endo -74.25 164.0 35.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.59 2.194 . . . . 0.0 112.773 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.74 130.69 26.95 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 105.282 -2.622 . . . . 0.0 105.282 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.2 -1.83 56.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.532 -1.705 . . . . 0.0 113.283 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 16.0 m95 -117.18 165.98 12.79 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.226 2.013 . . . . 0.0 111.467 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -152.1 150.89 30.41 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.116 0.966 . . . . 0.0 109.153 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -104.59 149.46 25.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.04 114.43 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -105.9 145.94 30.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -156.22 -168.14 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.639 1.175 . . . . 0.0 109.364 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -120.6 -44.07 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.478 1.911 . . . . 0.0 107.954 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -63.88 -25.12 68.01 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.325 1.05 . . . . 0.0 113.263 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.01 -33.15 3.38 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.2 -104.51 1.35 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -150.24 136.47 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -151.09 -175.3 5.1 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -132.35 155.77 47.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.093 1.357 . . . . 0.0 109.43 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 31' ' ' VAL . 57.7 t -131.61 133.63 61.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.462 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 57.2 t0 -97.06 111.51 23.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.166 1.787 . . . . 0.0 110.587 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -70.75 -18.75 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.436 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -67.52 -37.03 82.16 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.947 1.699 . . . . 0.0 112.377 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -127.13 3.96 6.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.585 0.754 . . . . 0.0 112.724 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 53.4 42.85 31.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.216 1.806 . . . . 0.0 110.878 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -113.97 161.37 17.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.03 146.92 46.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -158.06 155.6 29.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.321 1.048 . . . . 0.0 109.126 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' TYR . . . . . 0.447 ' CE1' ' HE3' ' A' ' 36' ' ' LYS . 75.5 m-85 -95.04 -4.2 46.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.568 1.147 . . . . 0.0 112.574 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.85 140.5 37.05 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' HIS . . . . . 0.507 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 61.1 t-80 -59.24 151.89 55.77 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 124.411 1.085 . . . . 0.0 109.672 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 87.0 Cg_endo -70.43 -158.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.121 1.88 . . . . 0.0 110.283 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.18 -58.12 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.595 1.558 . . . . 0.0 107.523 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 159.43 23.67 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.14 -35.59 6.72 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.398 2.066 . . . . 0.0 110.099 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 36.9 m -168.12 172.02 9.05 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 131.546 3.938 . . . . 0.0 107.128 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -69.75 161.63 29.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.396 179.753 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.449 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -78.95 170.64 16.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.511 0.655 . . . . 0.0 111.928 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 128.77 56.56 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 127.818 2.447 . . . . 0.0 105.913 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.11 -8.02 0.56 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.411 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -130.94 153.31 49.32 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.524 1.662 . . . . 0.0 110.75 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.7 t -107.36 152.29 24.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.33 1.852 . . . . 0.0 107.52 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.04 168.97 41.95 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 -42.36 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.373 2.049 . . . . 0.0 113.628 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -161.22 179.27 8.49 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.903 1.281 . . . . 0.0 108.687 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.13 162.11 35.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.674 0.79 . . . . 0.0 111.341 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.14 -9.47 4.78 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.83 1.252 . . . . 0.0 111.478 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.25 -178.15 1.96 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.164 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.82 158.67 49.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.5 mt -80.8 160.94 65.38 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 121.107 -1.231 . . . . 0.0 110.755 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.65 163.54 36.59 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 107.965 -1.59 . . . . 0.0 107.965 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.1 149.99 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.23 -21.47 10.18 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.83 1.205 . . . . 0.0 112.64 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -88.12 143.54 27.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.759 1.78 . . . . 0.0 107.74 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -117.33 151.6 36.66 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.609 0.764 . . . . 0.0 111.011 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -117.71 119.42 34.89 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.32 145.12 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.15 139.79 52.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -157.48 132.27 8.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.216 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -59.64 -33.74 71.91 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.166 1.348 . . . . 0.0 112.512 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -16.5 61.64 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.96 -30.72 1.35 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.05 -94.15 0.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 126.647 2.07 . . . . 0.0 108.575 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.64 133.78 16.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -143.5 143.65 31.65 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.659 1.118 . . . . 0.0 109.739 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -96.87 156.48 16.33 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.261 -0.899 . . . . 0.0 109.806 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.16 142.17 44.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -105.2 108.69 20.34 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 127.344 2.258 . . . . 0.0 107.426 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -25.54 62.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.7 m -70.8 -41.43 71.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.235 1.014 . . . . 0.0 110.815 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -105.97 -10.01 16.8 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.935 0.894 . . . . 0.0 113.003 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 56.24 59.4 3.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.26 1.824 . . . . 0.0 107.198 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -126.4 166.69 16.72 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.895 1.678 . . . . 0.0 109.238 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.13 145.66 50.89 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.1 1.36 . . . . 0.0 107.414 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.14 163.79 36.57 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.268 -0.895 . . . . 0.0 112.448 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CZ ' ' HE3' ' B' ' 36' ' ' LYS . 78.6 m-85 -103.6 19.07 20.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.915 1.686 . . . . 0.0 112.878 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 152.28 43.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.737 -1.227 . . . . 0.0 109.911 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.37 140.63 91.7 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.843 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.21 99.45 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.629 2.886 . . . . 0.0 111.852 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -79.11 1.43 24.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.657 1.183 . . . . 0.0 112.686 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.3 48.38 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.94 39.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 125.071 3.848 . . . . 0.0 110.897 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 p -138.8 169.34 17.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.757 1.623 . . . . 0.0 110.102 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 p -59.73 -45.31 92.59 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.387 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.14 124.0 2.77 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -64.02 159.92 19.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.143 0.977 . . . . 0.0 110.542 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.36 -5.86 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.693 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -117.2 -173.54 2.43 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.457 1.629 . . . . 0.0 110.054 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 33.8 t -144.65 124.74 13.62 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.57 163.35 31.16 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.49 -38.36 19.75 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 112.455 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -165.42 173.6 10.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.144 2.578 . . . . 0.0 107.596 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -143.24 -176.83 5.08 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.141 1.376 . . . . 0.0 109.538 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -139.17 -7.44 1.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.58 176.81 2.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 111.593 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.95 175.0 3.01 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.71 1.624 . . . . 0.0 114.631 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.95 155.44 36.45 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 124.557 1.143 . . . . 0.0 112.893 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 40.1 Cg_endo -69.89 162.32 42.59 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.204 1.936 . . . . 0.0 109.131 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.53 139.77 72.06 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.574 -1.741 . . . . 0.0 107.574 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.14 73.05 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.413 -1.77 . . . . 0.0 112.588 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.444 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 11.4 m95 -101.62 157.49 16.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 120.434 2.117 . . . . 0.0 108.396 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -146.01 147.39 31.6 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.83 -0.544 . . . . 0.0 110.296 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.67 135.95 44.28 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.5 120.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.302 1.041 . . . . 0.0 109.1 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -111.76 136.93 50.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -143.44 135.65 26.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.606 1.562 . . . . 0.0 108.901 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.9 m -66.8 -28.52 68.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 120.61 1.55 . . . . 0.0 111.422 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.69 -21.5 57.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.76 -22.6 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.13 -98.37 1.22 Allowed Glycine 0 CA--C 1.519 0.339 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.2 m -158.17 145.55 18.11 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.232 1.013 . . . . 0.0 108.501 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.51 178.28 9.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.16 1.784 . . . . 0.0 106.623 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -128.26 158.08 39.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 66.1 t -132.08 131.43 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 59.7 t0 -91.61 103.86 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 127.435 2.294 . . . . 0.0 107.669 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -27.14 67.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.87 0.759 . . . . 0.0 111.877 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 63.1 m -69.13 -24.48 64.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.113 0.965 . . . . 0.0 112.535 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -126.72 -2.47 6.65 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.53 0.732 . . . . 0.0 112.752 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HE3' ' CZ ' ' A' ' 40' ' ' TYR . 40.1 mmtm 51.06 52.22 15.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.946 2.098 . . . . 0.0 110.301 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -127.5 160.72 30.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.66 -0.65 . . . . 0.0 109.724 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.36 139.93 50.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.352 1.061 . . . . 0.0 110.179 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.15 159.78 42.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.459 1.104 . . . . 0.0 109.977 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -100.25 15.15 28.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.085 1.354 . . . . 0.0 114.071 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.07 151.7 51.52 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.21 -1.556 . . . . 0.0 110.829 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.4 t-80 -60.41 143.73 89.2 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.883 0.873 . . . . 0.0 109.891 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 42.4 Cg_endo -65.68 119.01 5.97 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.809 2.339 . . . . 0.0 112.55 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.8 p -111.41 5.35 19.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.227 2.211 . . . . 0.0 111.55 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.4 -171.75 13.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.177 0.894 . . . . 0.0 112.551 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -74.06 78.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.027 3.151 . . . . 0.0 109.443 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -158.19 175.14 14.15 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.655 1.982 . . . . 0.0 107.691 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -104.61 8.13 35.22 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.983 1.713 . . . . 0.0 112.09 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 -179.487 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.633 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.9 t -83.94 -8.14 59.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.454 1.101 . . . . 0.0 112.255 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.9 m -125.43 165.24 18.78 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.59 1.156 . . . . 0.0 108.739 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.86 -5.91 7.35 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.678 -1.068 . . . . 0.0 114.018 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.9 m -70.55 170.08 12.88 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 1.158 . . . . 0.0 111.424 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.8 m -59.73 128.06 35.08 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.72 1.208 . . . . 0.0 107.878 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.26 175.56 48.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.83 -67.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.562 2.175 . . . . 0.0 112.429 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.8 179.91 4.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.07 1.748 . . . . 0.0 111.339 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.94 -174.56 3.61 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 110.868 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -128.67 22.92 5.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.472 1.509 . . . . 0.0 109.684 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.64 138.22 36.14 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.159 0.984 . . . . 0.0 108.567 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.72 91.05 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.72 158.61 85.21 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 117.622 0.711 . . . . 0.0 109.622 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.2 164.42 35.69 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.794 1.663 . . . . 0.0 109.727 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.02 117.26 4.93 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.175 2.583 . . . . 0.0 109.906 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.81 7.92 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.158 1.837 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 31.6 m95 -88.95 136.66 32.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.397 -1.06 . . . . 0.0 109.705 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -119.68 139.95 51.42 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.284 1.033 . . . . 0.0 110.19 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -108.75 120.75 43.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.9 140.12 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -125.97 118.17 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.114 -2.551 . . . . 0.0 104.114 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m -140.86 170.62 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.526 1.131 . . . . 0.0 111.176 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -85.03 -65.14 1.04 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -60.43 -16.51 36.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.508 1.923 . . . . 0.0 114.911 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.15 -14.59 7.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.509 1.124 . . . . 0.0 112.45 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.38 -85.66 0.93 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 125.242 1.401 . . . . 0.0 111.759 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.83 136.43 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.249 -1.148 . . . . 0.0 109.497 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -149.03 175.21 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.565 1.075 . . . . 0.0 110.057 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -123.99 149.21 46.27 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.878 0.871 . . . . 0.0 109.82 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.79 143.06 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.683 1.193 . . . . 0.0 109.073 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.71 112.95 26.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.862 2.065 . . . . 0.0 105.599 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' ND1' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -74.17 -23.67 59.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -68.66 -36.83 79.06 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.854 0.862 . . . . 0.0 112.307 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.73 -3.57 11.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.121 . . . . 0.0 112.317 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HE3' ' ND1' ' A' ' 33' ' ' HIS . 6.9 mmtp 58.17 51.99 8.0 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.943 1.697 . . . . 0.0 109.78 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -118.23 161.86 19.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.463 0.705 . . . . 0.0 110.497 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.62 148.72 46.17 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.45 155.86 37.09 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.216 0.607 . . . . 0.0 111.223 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -95.58 27.28 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.594 1.558 . . . . 0.0 111.538 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -142.78 146.69 34.49 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 119.799 -1.813 . . . . 0.0 109.682 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.72 141.75 94.92 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 18' ' ' TRP . 19.6 Cg_endo -55.54 -56.78 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.956 2.437 . . . . 0.0 116.476 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -69.7 0.12 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.609 0.763 . . . . 0.0 112.557 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.2 -170.69 51.93 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.97 125.91 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.359 2.039 . . . . 0.0 107.511 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.35 -176.31 5.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.3 t -150.32 -82.68 0.1 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 C-N-CA 124.662 1.125 . . . . 0.0 110.644 179.653 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 CA-C-O 121.233 0.352 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t -128.9 -147.14 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 109.603 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -4.96 101.08 0.01 OUTLIER 'General case' 0 C--O 1.237 0.427 1 C-N-CA 131.862 4.065 . . . . 0.0 113.686 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.9 9.13 5.37 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.308 1.432 . . . . 0.0 115.18 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.6 m -71.49 175.27 5.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.835 1.254 . . . . 0.0 111.607 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.9 m -58.81 133.3 55.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.753 1.221 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.05 174.62 54.88 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.14 -46.86 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.404 2.069 . . . . 0.0 112.829 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.49 -159.46 0.98 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.099 1.36 . . . . 0.0 110.844 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.35 165.0 4.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.428 1.109 . . . . 0.0 110.816 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -124.79 46.98 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.231 1.413 . . . . 0.0 108.409 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -140.04 -178.57 5.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.018 1.727 . . . . 0.0 111.074 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.65 88.04 0.1 OUTLIER Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.853 1.692 . . . . 0.0 110.617 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.57 147.19 96.6 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 118.374 1.087 . . . . 0.0 110.311 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.68 160.09 50.96 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.304 2.003 . . . . 0.0 112.553 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 84.95 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.784 3.656 . . . . 0.0 110.07 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.7 4.73 0.28 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.837 2.16 . . . . 0.0 112.162 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -124.71 157.78 34.84 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.27 155.9 44.05 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 122.047 -0.408 . . . . 0.0 109.933 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.17 121.84 46.01 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.538 1.535 . . . . 0.0 107.547 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.83 131.71 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.84 126.5 47.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.1 m -147.88 -176.0 5.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 110.767 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m -112.55 -29.88 7.32 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 110.004 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -79.07 -14.57 59.07 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.793 -0.567 . . . . 0.0 109.669 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -130.71 -19.5 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.97 -92.74 1.71 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.613 1.101 . . . . 0.0 111.093 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -151.41 131.2 13.22 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.811 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -148.75 172.57 14.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -120.73 156.6 31.46 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.919 -0.488 . . . . 0.0 110.606 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.51 140.04 49.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -101.37 112.75 25.37 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.572 2.349 . . . . 0.0 108.733 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' HIS . . . . . 0.409 ' ND1' ' HE2' ' B' ' 36' ' ' LYS . 1.8 m-70 -76.54 -13.09 60.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -88.96 -22.88 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 111.66 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -123.79 -5.62 8.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.505 0.722 . . . . 0.0 111.461 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.409 ' HE2' ' ND1' ' B' ' 33' ' ' HIS . 21.6 mmtp 51.76 52.73 13.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.23 1.812 . . . . 0.0 111.724 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -132.75 153.55 51.09 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.504 0.722 . . . . 0.0 109.459 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.91 153.97 21.22 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 108.584 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -158.96 151.91 22.16 Favored 'General case' 0 C--N 1.334 -0.071 0 O-C-N 121.608 -0.682 . . . . 0.0 111.107 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -95.45 27.63 3.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.002 1.321 . . . . 0.0 112.082 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 147.05 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 119.891 -1.755 . . . . 0.0 108.432 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -64.95 142.19 98.58 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 119.036 -0.507 . . . . 0.0 109.765 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.76 -37.78 34.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.256 2.638 . . . . 0.0 114.056 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.0 t -63.69 -77.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.09 0.956 . . . . 0.0 108.777 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.66 -175.68 43.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.06 138.75 63.71 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.312 2.008 . . . . 0.0 109.454 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 58.1 m -165.98 175.68 8.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.139 2.576 . . . . 0.0 107.492 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -148.78 -36.36 0.18 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.109 0.964 . . . . 0.0 110.196 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.135 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.438 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.8 p -150.37 170.54 18.78 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 110.459 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.45 172.26 13.06 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.453 2.301 . . . . 0.0 107.971 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.98 167.27 36.85 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 120.781 -1.2 . . . . 0.0 111.217 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t 55.6 21.62 4.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 112.721 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.49 151.11 20.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.398 1.079 . . . . 0.0 111.145 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.76 -173.51 45.79 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.87 -63.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.065 1.843 . . . . 0.0 108.509 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.3 153.7 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 129.115 2.966 . . . . 0.0 107.748 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -166.64 56.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.401 1.88 . . . . 0.0 106.801 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 51.85 7.13 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.169 2.588 . . . . 0.0 115.373 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -66.76 5.56 0.61 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.047 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -25.72 103.53 0.01 OUTLIER Glycine 0 N--CA 1.471 0.969 0 C-N-CA 128.287 2.851 . . . . 0.0 112.193 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.1 mt -48.81 154.62 1.19 Allowed Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 128.254 2.622 . . . . 0.0 115.177 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 51.7 Cg_endo -71.83 164.86 34.34 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.282 1.988 . . . . 0.0 110.205 178.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.98 124.04 11.36 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.543 2.162 . . . . 0.0 108.457 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.17 -12.08 33.96 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.723 1.154 . . . . 0.0 111.736 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.411 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 37.3 m95 -104.13 150.93 23.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.646 1.223 . . . . 0.0 108.608 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -144.09 156.8 44.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.105 0.962 . . . . 0.0 108.613 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -116.04 122.0 43.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.561 1.545 . . . . 0.0 107.055 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.78 127.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.03 116.03 22.16 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.9 m -140.46 155.23 46.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 111.709 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.5 m -76.71 -20.25 56.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.85 -1.157 . . . . 0.0 112.937 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -83.09 -53.63 5.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.8 0.727 . . . . 0.0 111.405 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.74 -11.85 30.5 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.74 -91.34 1.62 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -155.68 147.99 23.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.213 0.506 . . . . 0.0 111.851 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -161.16 179.64 8.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.74 1.616 . . . . 0.0 108.099 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.67 158.91 33.57 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.085 -1.009 . . . . 0.0 110.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.25 140.86 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 108.027 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -109.7 117.59 34.29 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.239 2.216 . . . . 0.0 109.512 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -82.35 -14.13 55.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.584 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.7 m -70.82 -47.83 57.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 120.217 1.371 . . . . 0.0 110.277 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -108.08 -3.41 18.69 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.25 1.42 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp 56.89 53.15 8.45 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.525 1.53 . . . . 0.0 110.073 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -120.86 165.64 14.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.41 138.34 53.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.99 151.64 32.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.19 0.905 . . . . 0.0 110.6 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' B' ' 36' ' ' LYS . 54.6 m-85 -83.06 8.2 13.6 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.25 153.26 44.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.295 1.407 . . . . 0.0 113.221 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -62.31 139.93 96.37 Favored Pre-proline 0 C--O 1.24 0.57 0 O-C-N 124.99 1.431 . . . . 0.0 109.345 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.13 178.99 3.12 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.308 2.672 . . . . 0.0 114.572 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -126.92 -79.1 0.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.22 1.408 . . . . 0.0 110.532 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.46 174.58 37.98 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 119.521 1.055 . . . . 0.0 112.441 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.37 -25.08 3.38 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.245 3.296 . . . . 0.0 113.657 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.8 p 178.82 166.61 0.9 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 128.865 2.866 . . . . 0.0 106.737 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 p -129.66 -53.66 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.771 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -154.51 167.75 29.0 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.523 1.529 . . . . 0.0 107.223 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.5 p -158.94 -179.04 7.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.15 -173.36 41.74 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.673 1.606 . . . . 0.0 109.263 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.8 t -48.54 123.89 7.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.185 1.394 . . . . 0.0 109.388 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 25.9 m -100.26 177.81 4.95 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.163 1.785 . . . . 0.0 110.722 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.85 164.79 10.19 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 123.799 0.714 . . . . 0.0 112.481 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.06 -39.06 52.43 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.83 2.353 . . . . 0.0 112.225 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.03 148.18 33.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.723 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -160.45 35.11 0.16 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.894 0.878 . . . . 0.0 111.052 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.37 24.59 6.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.509 1.924 . . . . 0.0 112.882 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.38 37.29 1.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.628 2.771 . . . . 0.0 112.581 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -44.63 113.9 0.96 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.561 1.553 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -58.75 154.94 33.54 Favored Pre-proline 0 C--O 1.233 0.222 0 C-N-CA 123.87 0.868 . . . . 0.0 112.662 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 20.0 Cg_endo -70.24 155.96 63.2 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.38 140.07 62.2 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 105.385 -2.583 . . . . 0.0 105.385 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.81 70.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.639 -1.089 . . . . 0.0 112.071 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CZ2' ' HB3' ' B' ' 43' ' ' PRO . 6.7 m95 -107.01 167.62 9.76 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.954 1.877 . . . . 0.0 106.58 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -144.43 154.45 42.97 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -119.06 133.34 55.87 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -124.87 136.96 59.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -127.17 134.94 50.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -150.94 179.1 8.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.522 2.329 . . . . 0.0 110.281 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 69.4 m -110.77 -25.05 10.11 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.099 -1.001 . . . . 0.0 111.7 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.08 -23.13 57.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 110.527 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.46 -53.65 1.9 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.243 1.417 . . . . 0.0 112.036 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.21 -104.36 0.64 Allowed Glycine 0 N--CA 1.469 0.84 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.7 m -144.13 131.01 20.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.506 1.653 . . . . 0.0 108.536 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.54 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.211 1.004 . . . . 0.0 109.829 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -127.18 142.94 51.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.035 1.334 . . . . 0.0 108.086 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.53 135.22 59.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.81 0.814 . . . . 0.0 110.11 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -100.63 104.26 15.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -72.94 -24.94 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 119.158 -0.448 . . . . 0.0 111.826 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -71.0 -37.21 72.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.363 1.465 . . . . 0.0 111.615 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -115.25 1.89 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.575 1.15 . . . . 0.0 112.574 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 40' ' ' TYR . 4.9 mmtp 48.19 62.17 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.554 1.942 . . . . 0.0 109.901 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -128.62 160.17 33.27 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.821 0.848 . . . . 0.0 110.018 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.8 131.41 47.76 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.356 1.462 . . . . 0.0 108.447 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -146.34 148.93 32.89 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.227 0.467 . . . . 0.0 110.538 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -91.44 25.7 2.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.04 1.736 . . . . 0.0 111.055 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -137.77 153.5 49.69 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' HIS . . . . . 0.454 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 4.7 t-80 -68.71 147.0 97.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 111.799 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' PRO . . . . . 0.462 ' HB3' ' CZ2' ' B' ' 18' ' ' TRP . 73.2 Cg_endo -71.44 -174.01 1.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.122 3.215 . . . . 0.0 113.449 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t -125.66 -38.72 2.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.131 0.972 . . . . 0.0 111.444 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.3 178.8 15.53 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.314 1.435 . . . . 0.0 111.43 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.01 -42.15 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.736 2.958 . . . . 0.0 110.534 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.1 p -158.79 -162.43 1.09 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.832 2.453 . . . . 0.0 105.927 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.3 p -141.22 -78.04 0.28 Allowed 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.581 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -164.45 125.02 2.08 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.435 1.117 . . . . 0.0 110.403 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.8 t -136.59 128.19 28.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.1 169.88 42.43 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 m -77.41 167.34 21.84 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.168 -1.195 . . . . 0.0 111.348 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 t -151.69 162.63 40.69 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.422 1.489 . . . . 0.0 108.05 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.08 169.63 45.72 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.1 -59.8 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.251 2.634 . . . . 0.0 110.036 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.71 142.94 5.57 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 128.526 2.73 . . . . 0.0 104.627 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -121.13 177.43 5.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.37 1.468 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -124.34 6.63 8.39 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -58.34 165.82 1.91 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.57 121.41 20.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.157 1.36 . . . . 0.0 110.402 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.0 mt -82.85 157.61 66.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 125.209 1.403 . . . . 0.0 113.986 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.81 161.73 40.96 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.536 2.157 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.36 123.71 11.18 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.851 2.368 . . . . 0.0 108.545 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.45 5.58 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.673 1.13 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 24.2 m95 -81.33 151.82 27.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.397 1.098 . . . . 0.0 108.993 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -135.43 140.87 45.24 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.468 0.707 . . . . 0.0 109.534 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -103.11 132.24 49.52 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.6 136.02 55.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.23 142.55 49.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -154.24 146.36 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.4 m -74.82 -12.82 60.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.559 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.27 -45.71 5.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 110.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -93.85 -18.1 22.36 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.11 -92.54 1.79 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.704 1.621 . . . . 0.0 111.544 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -153.75 124.44 7.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -139.43 177.15 8.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.806 0.442 . . . . 0.0 109.995 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.14 148.04 51.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 108.923 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.46 137.12 57.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.226 0.61 . . . . 0.0 110.271 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 9.2 t0 -99.14 115.74 29.74 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.597 2.759 . . . . 0.0 108.941 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -82.94 -10.04 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.598 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -75.45 -43.43 49.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 120.747 1.612 . . . . 0.0 110.164 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -117.74 0.41 11.99 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.157 0.983 . . . . 0.0 112.176 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 57.17 60.71 2.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.595 1.558 . . . . 0.0 108.509 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -129.47 143.63 50.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.789 0.835 . . . . 0.0 109.441 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.79 145.84 33.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 109.288 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.86 162.86 38.99 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.461 1.104 . . . . 0.0 110.276 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.78 8.91 41.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 160.56 32.15 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.819 1.19 . . . . 0.0 111.007 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -61.88 134.83 94.29 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 89.8 Cg_endo -74.08 -6.66 18.82 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.29 3.327 . . . . 0.0 116.028 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.73 -74.76 0.47 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.88 -178.11 18.38 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.73 -14.65 44.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.431 2.754 . . . . 0.0 113.378 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 p -148.92 151.99 35.61 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.964 1.706 . . . . 0.0 108.007 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -109.21 -5.0 16.09 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 106.009 -2.836 . . . . 0.0 106.009 -179.155 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -127.54 153.11 46.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.841 0.856 . . . . 0.0 109.384 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -158.8 159.74 35.46 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 105.585 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.53 -135.77 32.74 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.743 0.687 . . . . 0.0 112.064 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -134.81 170.98 15.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.667 1.587 . . . . 0.0 108.38 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 t -145.6 170.44 16.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 126.157 1.783 . . . . 0.0 106.555 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.8 -167.3 39.08 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.374 1.464 . . . . 0.0 111.062 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.88 -72.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.681 2.92 . . . . 0.0 104.998 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 pp -159.69 158.33 31.2 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.608 1.563 . . . . 0.0 109.324 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -137.57 171.34 14.59 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.704 2.002 . . . . 0.0 106.356 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -133.55 9.86 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.7 172.77 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.745 1.157 . . . . 0.0 112.036 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.36 159.0 1.63 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.746 2.117 . . . . 0.0 113.348 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -128.44 155.9 77.89 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.437 1.095 . . . . 0.0 112.865 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.9 158.53 52.61 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.283 1.989 . . . . 0.0 110.567 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.8 123.61 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.558 2.172 . . . . 0.0 106.87 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.96 -26.41 6.8 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.643 1.592 . . . . 0.0 110.789 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 25.6 m95 -90.0 157.01 18.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.381 1.091 . . . . 0.0 110.172 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.19 150.5 42.8 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.802 0.841 . . . . 0.0 108.761 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -115.48 128.55 56.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -117.77 120.3 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.879 0.872 . . . . 0.0 109.509 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -107.31 146.28 31.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -150.11 170.77 18.14 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.754 1.622 . . . . 0.0 110.914 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -96.24 -34.23 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -74.87 -27.01 60.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.133 0.973 . . . . 0.0 110.756 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.93 -19.42 5.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.65 -86.5 1.28 Allowed Glycine 0 N--CA 1.461 0.331 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -159.67 134.23 7.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.902 1.351 . . . . 0.0 111.307 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -143.76 158.11 43.91 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 107.417 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -110.87 159.58 17.55 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.821 -1.174 . . . . 0.0 108.587 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.11 135.23 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 122.817 0.447 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.447 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 42.9 t0 -99.06 113.18 25.25 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.912 1.285 . . . . 0.0 108.689 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -72.92 -16.89 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.687 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 79.4 m -79.78 -28.91 40.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.996 0.919 . . . . 0.0 112.857 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -121.76 -4.79 9.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.893 0.769 . . . . 0.0 111.537 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp 56.21 47.66 18.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.829 1.652 . . . . 0.0 109.7 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.81 160.85 21.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.153 0.981 . . . . 0.0 111.175 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.61 140.59 51.32 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.972 1.309 . . . . 0.0 109.111 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -150.9 156.05 40.4 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.438 1.095 . . . . 0.0 110.169 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -97.47 -7.63 31.11 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.917 0.887 . . . . 0.0 111.67 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -100.1 142.43 31.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.06 1.344 . . . . 0.0 108.825 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -58.66 143.57 81.7 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.37 -29.78 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.575 2.183 . . . . 0.0 116.734 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -78.75 -84.92 0.08 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.697 1.135 . . . . 0.0 108.578 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.0 -174.07 23.82 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 119.384 0.993 . . . . 0.0 112.512 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.53 -5.42 16.63 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.483 2.788 . . . . 0.0 112.613 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 18.3 p -160.23 167.26 27.98 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.813 1.245 . . . . 0.0 109.342 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.4 m -135.04 29.89 3.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.878 1.271 . . . . 0.0 109.645 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -178.789 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -78.52 171.46 15.07 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.01 -167.5 2.75 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 109.617 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.86 82.1 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-O 119.293 -0.726 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.9 m -94.94 89.26 5.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 p -70.03 171.18 9.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.554 1.142 . . . . 0.0 110.533 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.22 164.92 16.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.543 1.068 . . . . 0.0 111.675 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.45 -62.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.187 2.592 . . . . 0.0 108.728 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.4 mt -140.56 163.69 32.17 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.738 1.615 . . . . 0.0 108.396 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -126.6 172.67 10.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.729 1.612 . . . . 0.0 108.723 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -133.16 40.11 3.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 0.0 109.81 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -125.22 -176.79 3.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.221 1.409 . . . . 0.0 107.296 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 -78.15 0.34 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 119.217 0.917 . . . . 0.0 112.22 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.0 mt -144.74 159.77 49.58 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 109.475 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 33.1 Cg_endo -66.9 158.87 54.43 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.43 1.42 . . . . 0.0 110.454 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 95.55 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.528 2.819 . . . . 0.0 107.589 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 139.98 -2.04 2.33 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.347 0.975 . . . . 0.0 112.982 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 19.8 m95 -118.24 151.47 37.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -137.18 153.53 50.42 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.265 0.626 . . . . 0.0 109.964 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -114.49 127.62 55.91 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.23 1.812 . . . . 0.0 107.789 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.25 117.76 56.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.83 152.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -151.2 177.39 10.27 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 120.647 -1.283 . . . . 0.0 111.622 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -114.07 -18.08 11.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.81 -10.97 12.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.701 0.801 . . . . 0.0 110.087 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -123.69 -12.36 7.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.466 1.906 . . . . 0.0 112.563 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.87 -77.04 1.15 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 126.11 1.814 . . . . 0.0 110.329 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -161.24 138.43 8.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.628 1.714 . . . . 0.0 110.357 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -143.17 171.74 13.67 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.93 153.1 43.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.911 0.885 . . . . 0.0 109.686 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.92 141.5 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.885 0.874 . . . . 0.0 110.846 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.55 111.07 23.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 129.729 3.212 . . . . 0.0 108.477 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -76.56 -18.53 58.63 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -78.26 -32.45 49.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.98 0.809 . . . . 0.0 110.313 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -116.44 -4.97 11.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 38' ' ' ALA . 6.4 mmmm 55.29 52.52 11.33 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.989 2.116 . . . . 0.0 109.886 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -124.52 165.69 17.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.454 1.102 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.68 151.52 47.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.158 1.383 . . . . 0.0 108.57 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.43 159.98 43.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.828 0.823 . . . . 0.0 111.643 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' B' ' 36' ' ' LYS . 14.2 m-30 -93.8 17.28 12.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.411 1.484 . . . . 0.0 113.837 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.36 150.84 38.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.464 -1.398 . . . . 0.0 110.072 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -59.92 142.33 88.87 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.96 44.84 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.747 4.298 . . . . 0.0 116.083 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.64 131.09 34.64 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.69 164.41 19.38 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.287 1.899 . . . . 0.0 113.628 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.72 151.06 45.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.481 . . . . 0.0 109.024 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 p -75.22 135.56 41.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.059 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.43 -55.7 2.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 178.501 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.865 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -61.44 160.63 10.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.912 1.685 . . . . 0.0 114.154 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -141.24 162.16 36.16 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 107.951 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.14 109.34 0.39 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.0 m -123.87 66.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.05 1.34 . . . . 0.0 108.595 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.7 133.66 47.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.67 175.62 54.83 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.74 -71.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.069 3.179 . . . . 0.0 110.912 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.3 mt -146.4 123.83 11.68 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.884 2.074 . . . . 0.0 107.118 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -85.27 162.42 19.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -98.54 -18.83 17.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.041 -0.412 . . . . 0.0 109.96 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -70.0 176.48 3.73 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.952 0.901 . . . . 0.0 112.32 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -68.72 1.55 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.657 1.122 . . . . 0.0 112.804 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -150.85 160.58 32.06 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 125.179 1.392 . . . . 0.0 109.585 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PRO . . . . . 0.412 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.8 Cg_endo -66.28 162.57 35.55 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.12 1.88 . . . . 0.0 110.336 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.95 108.62 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.423 2.749 . . . . 0.0 110.17 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.41 -26.19 6.73 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.674 1.131 . . . . 0.0 112.706 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 9.6 m95 -80.85 148.99 29.7 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 119.428 1.614 . . . . 0.0 108.867 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -131.24 152.19 50.76 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -111.65 138.84 47.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.6 136.15 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -124.58 141.19 52.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.0 p -154.25 -166.57 2.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.657 2.383 . . . . 0.0 109.209 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -121.15 -47.69 2.26 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.71 -50.99 70.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -80.61 -59.02 2.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.83 -98.49 0.53 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -150.96 136.34 17.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.446 1.623 . . . . 0.0 107.673 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -150.52 178.08 9.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.07 152.75 43.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.397 0.679 . . . . 0.0 109.409 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.66 139.0 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.464 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 55.0 t0 -100.01 104.91 16.54 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.051 1.74 . . . . 0.0 107.753 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -27.77 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.89 0.768 . . . . 0.0 112.386 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -64.2 -39.37 93.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 111.573 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -118.57 -1.33 11.19 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 40' ' ' TYR . 34.5 mmtm 52.63 50.71 17.57 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 125.019 1.328 . . . . 0.0 111.069 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -125.41 164.77 19.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ALA . . . . . 0.4 ' O ' ' HE2' ' A' ' 36' ' ' LYS . . . -122.2 151.52 40.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.717 0.807 . . . . 0.0 109.104 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -146.14 152.25 38.97 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.271 0.941 . . . . 0.0 111.419 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.2 26.21 3.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.61 1.564 . . . . 0.0 112.622 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.86 167.52 28.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.15 -1.594 . . . . 0.0 109.011 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.11 154.84 91.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.159 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.82 42.19 1.09 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.651 2.901 . . . . 0.0 110.605 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 6.9 t -73.3 122.41 21.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.59 169.53 5.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.322 1.439 . . . . 0.0 112.216 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.16 142.15 72.57 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.57 103.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.092 1.357 . . . . 0.0 110.766 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -58.62 -16.52 16.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 112.893 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.321 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 179.369 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 54.6 Cg_endo -69.36 161.55 45.43 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 121.914 1.743 . . . . 0.0 109.566 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.44 108.7 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.316 2.678 . . . . 0.0 108.653 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.28 -16.42 6.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.684 1.611 . . . . 0.0 111.704 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.0 m95 -95.38 142.68 27.48 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.261 -1.141 . . . . 0.0 109.429 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -125.32 140.73 52.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.273 0.629 . . . . 0.0 110.818 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -104.13 134.8 46.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 t -115.0 138.65 44.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.78 131.01 40.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.262 1.025 . . . . 0.0 110.729 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.82 170.9 18.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.01 1.724 . . . . 0.0 111.283 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -86.76 -29.36 22.41 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.446 1.098 . . . . 0.0 112.534 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.82 -44.38 27.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.97 1.259 . . . . 0.0 110.952 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.84 -24.73 14.58 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -94.75 1.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.55 130.35 10.07 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.216 -0.579 . . . . 0.0 110.752 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.29 173.48 11.67 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -125.76 146.07 49.93 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.22 -0.925 . . . . 0.0 108.559 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 143.44 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.614 0.721 . . . . 0.0 109.546 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 64.6 t0 -108.2 109.75 21.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.709 2.003 . . . . 0.0 109.829 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.086 0.857 . . . . 0.0 111.092 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 m -68.12 -33.43 74.49 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.615 1.166 . . . . 0.0 111.603 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -122.38 1.05 9.57 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' B' ' 38' ' ' ALA . 22.2 mmmt 50.31 51.48 16.69 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.584 1.953 . . . . 0.0 110.023 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.34 166.91 16.94 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 123.809 0.844 . . . . 0.0 110.227 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' O ' ' HE3' ' B' ' 36' ' ' LYS . . . -122.78 149.91 43.5 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -150.55 171.39 17.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.406 1.482 . . . . 0.0 107.988 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -112.89 -8.15 13.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -100.74 167.49 10.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.972 1.309 . . . . 0.0 110.865 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 149.48 82.82 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 110.059 178.011 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 119.727 -0.178 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 72.7 Cg_endo -71.56 160.97 46.84 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.338 2.025 . . . . 0.0 111.009 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.73 115.43 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.249 2.632 . . . . 0.0 108.696 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.23 -21.31 13.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.661 1.124 . . . . 0.0 112.514 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 8.5 m95 -87.56 164.06 16.3 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 119.229 1.514 . . . . 0.0 108.144 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.82 152.65 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.943 -0.473 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -112.75 133.88 54.55 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.341 1.857 . . . . 0.0 107.005 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.32 128.51 75.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -109.93 141.56 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 10.1 t -153.07 -169.81 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.9 m -130.32 -38.29 1.38 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.564 1.946 . . . . 0.0 107.093 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.41 -27.22 66.9 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -121.36 -26.21 5.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.67 -91.48 1.04 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.06 1.315 . . . . 0.0 110.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.4 m -154.93 137.07 14.75 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.491 -1.594 . . . . 0.0 109.3 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.14 179.21 7.65 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -131.65 154.44 48.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.46 0.704 . . . . 0.0 109.424 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.96 142.01 41.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.38 0.672 . . . . 0.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -102.9 125.69 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.478 2.711 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -85.17 -19.81 31.19 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.924 -0.485 . . . . 0.0 110.657 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 46.7 m -73.06 -32.69 65.21 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.82 1.248 . . . . 0.0 110.247 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -123.54 -2.94 8.37 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 38' ' ' ALA . 25.8 mmmt 54.88 40.38 31.95 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.802 1.241 . . . . 0.0 110.71 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -115.27 158.6 22.11 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HE3' ' A' ' 36' ' ' LYS . . . -116.89 147.48 42.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.51 1.124 . . . . 0.0 108.482 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -152.51 162.54 41.06 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.393 1.477 . . . . 0.0 108.745 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -103.33 -4.68 23.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.116 0.966 . . . . 0.0 113.023 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 163.28 13.46 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.18 0.992 . . . . 0.0 110.615 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -79.58 143.43 59.09 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.535 0.545 0 C-N-CA 121.627 1.551 . . . . 0.0 113.278 -178.651 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.236 0.393 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 37.6 Cg_endo -66.92 159.66 50.7 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.533 0.822 . . . . 0.0 110.314 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.1 110.68 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.493 2.795 . . . . 0.0 108.872 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.17 -14.48 16.1 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-O 117.942 -1.477 . . . . 0.0 114.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 43' ' ' PRO . 11.5 m95 -96.22 150.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.447 1.623 . . . . 0.0 107.036 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -135.08 148.31 49.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.488 0.185 . . . . 0.0 110.917 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -103.83 130.06 51.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.57 144.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.3 147.01 50.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 p -158.08 164.34 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.288 1.435 . . . . 0.0 110.701 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -92.06 -29.16 16.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.926 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -17.99 35.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.46 -46.87 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.83 -104.35 0.87 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -138.34 124.01 19.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -135.93 176.61 8.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.826 0.45 . . . . 0.0 111.043 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.39 151.88 51.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.541 0.737 . . . . 0.0 110.767 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.61 137.79 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.061 0.544 . . . . 0.0 111.146 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 34.3 t0 -101.26 107.97 19.49 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 127.946 2.498 . . . . 0.0 105.447 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -74.77 -19.71 60.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.0 m -80.75 -47.42 13.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.303 0.956 . . . . 0.0 110.276 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.91 -10.14 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.937 1.295 . . . . 0.0 112.213 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm 55.58 45.06 25.63 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.73 2.012 . . . . 0.0 110.868 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -114.46 164.29 14.17 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.096 0.959 . . . . 0.0 109.411 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.42 150.37 48.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.365 1.466 . . . . 0.0 109.102 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -160.23 151.97 19.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.015 1.326 . . . . 0.0 109.968 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -93.14 11.12 28.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.028 0.931 . . . . 0.0 111.388 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 160.24 34.64 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.522 -1.361 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -63.22 138.66 97.4 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.449 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 46.4 Cg_endo . . . . . 0 CA--C 1.532 0.421 1 C-N-CA 125.928 4.418 . . . . 0.0 115.305 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 39.8 Cg_endo -72.09 164.72 34.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.365 2.044 . . . . 0.0 111.686 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.09 121.36 9.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.7 58.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.288 -1.285 . . . . 0.0 115.063 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 24.3 m95 -94.04 161.29 14.34 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 119.521 1.66 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.84 169.15 20.43 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -128.5 121.94 30.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 109.355 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.58 123.74 49.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.96 137.92 50.62 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -150.93 -154.51 0.55 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.71 1.604 . . . . 0.0 108.96 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.1 m -127.31 -55.58 1.34 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.604 1.962 . . . . 0.0 107.101 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -60.83 -26.29 67.23 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.752 1.221 . . . . 0.0 113.312 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -113.93 -41.98 3.47 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.75 -96.72 1.02 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.068 0.842 . . . . 0.0 112.339 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -149.28 108.35 3.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.609 0.705 . . . . 0.0 109.567 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -125.22 176.77 6.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 109.726 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.25 156.9 44.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 110.239 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.34 142.59 32.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.506 1.122 . . . . 0.0 108.783 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -106.19 115.04 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.548 2.339 . . . . 0.0 105.096 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -79.55 -17.1 54.74 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 112.773 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -79.98 -45.11 19.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.214 1.405 . . . . 0.0 109.33 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -95.32 -15.12 23.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.188 0.995 . . . . 0.0 111.54 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 58.48 53.41 6.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.454 2.302 . . . . 0.0 109.312 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -134.66 153.61 51.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.967 0.507 . . . . 0.0 111.291 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.08 145.78 36.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.831 1.253 . . . . 0.0 110.524 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -147.23 150.87 35.7 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.682 0.793 . . . . 0.0 109.277 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.54 19.2 11.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.815 1.646 . . . . 0.0 112.613 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 159.69 41.67 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.41 -1.431 . . . . 0.0 109.037 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.63 152.09 76.06 Favored Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 123.956 0.902 . . . . 0.0 112.588 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 CA--C 1.535 0.556 0 C-N-CA 123.32 2.68 . . . . 0.0 116.047 -178.428 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 mt . . . . . 0 C--O 1.235 0.301 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.05 163.7 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.458 2.105 . . . . 0.0 110.614 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 140.49 64.31 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.954 1.77 . . . . 0.0 108.747 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.12 -12.6 63.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.057 -1.413 . . . . 0.0 113.23 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 5.9 m95 -90.59 164.14 14.31 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 120.657 2.229 . . . . 0.0 109.112 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -147.43 155.27 41.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.804 0.812 . . . . 0.0 109.847 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -124.87 140.81 52.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.99 139.19 50.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.8 121.53 37.43 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.212 1.805 . . . . 0.0 106.474 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 p -131.53 172.25 12.44 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.012 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -95.64 -28.21 14.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.791 1.236 . . . . 0.0 110.674 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -95.93 -28.14 14.82 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -107.97 -34.79 6.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 -98.23 0.98 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.33 0.968 . . . . 0.0 112.762 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 m -148.16 121.83 9.23 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.521 0.728 . . . . 0.0 109.202 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -140.14 176.44 8.75 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.206 -0.934 . . . . 0.0 109.67 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -129.42 150.09 50.92 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.814 0.734 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.5 131.85 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.747 0.819 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.3 t0 -98.78 116.98 32.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -86.84 -20.46 27.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.115 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m -76.97 -31.71 56.75 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.591 1.087 . . . . 0.0 110.118 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -109.96 -12.01 14.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.893 1.677 . . . . 0.0 111.959 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HE2' ' CE2' ' B' ' 40' ' ' TYR . 42.5 mmtm 54.11 56.91 6.44 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.476 1.51 . . . . 0.0 110.782 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -130.58 169.6 15.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.24 1.016 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.37 142.74 51.42 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.896 1.679 . . . . 0.0 108.923 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.77 161.01 43.37 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.432 1.493 . . . . 0.0 110.522 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.57 25.78 11.06 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.906 1.282 . . . . 0.0 112.142 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 160.03 40.81 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.704 -1.248 . . . . 0.0 110.059 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 153.41 55.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.913 . . . . 0.0 110.481 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 C-N-CA 123.636 2.891 . . . . 0.0 114.509 -178.552 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.78 160.51 49.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.108 1.872 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.62 99.21 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.797 2.998 . . . . 0.0 109.769 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.59 -1.62 5.22 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.645 1.593 . . . . 0.0 112.235 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -117.37 153.75 32.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.651 1.225 . . . . 0.0 109.479 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.01 168.47 19.64 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -130.8 125.54 33.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.643 2.377 . . . . 0.0 105.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.54 145.73 15.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -124.5 138.9 54.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.477 1.111 . . . . 0.0 108.276 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.7 p -154.66 177.66 10.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.363 1.865 . . . . 0.0 111.479 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -105.52 -33.47 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.62 -35.57 81.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.908 1.683 . . . . 0.0 110.865 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.05 -35.96 3.22 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.811 0.844 . . . . 0.0 113.006 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.05 -100.37 1.3 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 22.9 m -147.36 127.56 13.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 120.225 -1.75 . . . . 0.0 108.818 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -142.37 173.99 11.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.641 0.776 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -122.62 148.04 45.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.168 0.987 . . . . 0.0 112.944 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.49 140.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 108.66 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -107.94 115.61 30.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 127.862 2.465 . . . . 0.0 108.418 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -77.27 -30.31 54.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 87.3 m -67.61 -39.07 84.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.55 1.14 . . . . 0.0 110.783 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -106.9 -6.77 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.094 0.558 . . . . 0.0 112.441 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp 51.74 52.94 13.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.854 1.662 . . . . 0.0 110.633 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -126.48 166.46 17.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.846 1.258 . . . . 0.0 109.954 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.47 140.63 52.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.351 1.461 . . . . 0.0 107.727 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -147.06 171.67 14.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.607 1.163 . . . . 0.0 108.743 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.472 ' CE2' ' HE2' ' A' ' 36' ' ' LYS . 84.3 m-85 -112.79 -2.08 14.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.66 0.664 . . . . 0.0 112.429 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 160.89 14.84 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.964 0.906 . . . . 0.0 109.37 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -71.72 143.72 87.49 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.51 2.14 . . . . 0.0 114.155 -179.143 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.595 -0.24 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.91 163.56 35.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.058 1.172 . . . . 0.0 110.949 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.27 133.11 36.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.042 1.828 . . . . 0.0 109.006 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.1 -14.96 61.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.72 1.629 . . . . 0.0 111.644 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -105.9 142.54 35.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.394 1.097 . . . . 0.0 108.884 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.94 160.19 39.36 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.475 1.51 . . . . 0.0 107.705 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -120.26 120.7 36.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.16 149.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.43 148.38 52.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.72 1.208 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 t -160.82 153.88 21.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.784 1.634 . . . . 0.0 112.819 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -80.44 -29.75 37.57 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -80.58 -27.1 37.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.918 1.687 . . . . 0.0 112.41 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -117.26 -38.13 3.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.95 -109.83 2.3 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.25 126.98 20.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -138.48 170.04 16.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.508 0.67 . . . . 0.0 109.665 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.27 148.45 52.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.225 1.01 . . . . 0.0 109.0 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' B' ' 31' ' ' VAL . 58.6 t -134.42 139.68 47.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 109.355 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -103.34 116.1 31.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.734 2.014 . . . . 0.0 108.319 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -72.23 -17.55 61.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.581 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -71.21 -51.22 25.92 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.877 0.871 . . . . 0.0 111.665 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -110.4 4.75 20.92 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.516 0.727 . . . . 0.0 112.776 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 51.87 41.69 29.59 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.97 1.308 . . . . 0.0 111.387 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -105.74 156.34 18.39 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.21 49.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.942 1.297 . . . . 0.0 107.952 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.44 168.31 25.43 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.865 -1.147 . . . . 0.0 110.647 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.85 15.73 27.28 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 112.302 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.22 153.95 31.99 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.047 -1.033 . . . . 0.0 109.977 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -71.18 136.63 84.42 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 121.781 1.654 . . . . 0.0 108.197 -179.845 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--O 1.236 0.378 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 18.8 Cg_endo -63.78 160.21 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.786 1.657 . . . . 0.0 111.368 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.86 91.05 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.534 3.489 . . . . 0.0 110.149 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.49 -3.28 2.93 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.477 1.513 . . . . 0.0 111.734 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.5 m95 -110.36 156.73 20.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.487 1.144 . . . . 0.0 108.195 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -148.95 158.56 44.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.21 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -112.04 144.95 40.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.787 1.635 . . . . 0.0 106.949 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.44 118.82 54.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -110.28 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 t -154.77 148.72 25.7 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.745 1.218 . . . . 0.0 110.804 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -76.16 -23.34 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.494 1.043 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -81.22 -22.67 38.63 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -120.69 -43.97 2.46 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.52 -113.29 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -141.05 111.99 7.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -131.71 -179.96 5.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -131.35 155.9 46.43 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.89 0.876 . . . . 0.0 111.345 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 31' ' ' VAL . 44.9 t -131.66 138.7 52.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.795 1.238 . . . . 0.0 109.301 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 22.1 t0 -106.68 118.96 38.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.474 1.91 . . . . 0.0 109.258 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -77.88 -20.9 52.15 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -69.28 -49.98 51.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.5 1.046 . . . . 0.0 110.49 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -105.85 -0.06 25.55 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt 53.87 53.49 11.21 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.008 1.323 . . . . 0.0 109.919 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -119.27 162.48 18.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.466 0.706 . . . . 0.0 109.578 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.93 142.68 50.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.861 1.264 . . . . 0.0 108.856 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -154.9 164.81 38.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.349 1.059 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -103.71 -6.56 21.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 142.5 34.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.0 t-80 -56.12 146.69 49.42 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.807 1.243 . . . . 0.0 110.572 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 56.4 Cg_endo . . . . . 0 C--N 1.348 0.515 0 C-N-CA 122.469 2.113 . . . . 0.0 112.492 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--O 1.232 0.161 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 163.27 39.2 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.863 2.375 . . . . 0.0 110.921 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.52 123.92 11.02 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.391 2.061 . . . . 0.0 107.991 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.71 -17.75 22.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.176 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 24.5 m95 -100.77 164.07 12.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -143.52 151.33 40.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.883 0.373 . . . . 0.0 111.851 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -112.82 121.16 43.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.79 146.28 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.8 111.83 11.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.98 1.712 . . . . 0.0 106.902 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.11 174.68 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.43 1.492 . . . . 0.0 111.427 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -106.85 -22.13 12.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 112.205 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.39 -12.96 47.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.724 0.693 . . . . 0.0 111.314 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.59 -63.41 0.71 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.192 0.997 . . . . 0.0 109.673 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.36 -109.47 0.71 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.627 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.1 m -131.37 112.05 12.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.757 1.279 . . . . 0.0 109.257 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -134.07 146.1 50.01 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.496 1.518 . . . . 0.0 108.255 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.11 146.87 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.859 1.264 . . . . 0.0 111.204 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.08 138.34 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.303 1.041 . . . . 0.0 110.15 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 36.3 t70 -105.92 110.48 22.77 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 127.044 2.137 . . . . 0.0 108.032 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -75.81 -18.08 59.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.2 m -71.72 -28.98 64.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.751 1.614 . . . . 0.0 111.807 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -126.18 -7.75 6.5 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 124.555 1.142 . . . . 0.0 112.536 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 mtmm 58.66 60.03 2.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.472 1.909 . . . . 0.0 109.047 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -124.33 168.79 12.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.54 1.136 . . . . 0.0 108.974 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.92 52.08 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -155.1 167.82 29.07 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.09 -1.006 . . . . 0.0 110.978 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.15 10.9 27.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.041 0.937 . . . . 0.0 112.927 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 153.27 46.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.327 1.051 . . . . 0.0 110.39 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.58 136.74 89.49 Favored Pre-proline 0 N--CA 1.451 -0.415 0 O-C-N 124.398 1.061 . . . . 0.0 109.946 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 88.4 Cg_endo . . . . . 0 N--CA 1.451 -0.992 0 C-N-CA 123.312 2.675 . . . . 0.0 110.564 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--O 1.233 0.2 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 42.6 Cg_endo -67.44 165.49 26.91 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.51 2.14 . . . . 0.0 109.841 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.81 128.05 22.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.273 1.982 . . . . 0.0 108.367 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.41 58.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.15 1.357 . . . . 0.0 114.28 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 6.8 m95 -83.96 153.79 23.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.955 1.877 . . . . 0.0 109.498 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.25 151.54 47.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.51 134.54 54.62 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.94 134.24 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.802 0.841 . . . . 0.0 109.055 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.18 140.71 52.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -159.9 133.52 7.11 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.222 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -60.06 -14.95 19.14 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -89.3 -20.73 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.011 0.823 . . . . 0.0 112.128 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.33 -16.4 3.95 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.03 -99.1 2.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 25.4 m -152.03 142.49 22.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.466 0.706 . . . . 0.0 109.497 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.09 -179.42 7.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 109.017 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -131.66 151.9 51.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.623 1.569 . . . . 0.0 106.898 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.93 145.97 34.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 123.556 0.743 . . . . 0.0 109.108 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -107.34 102.54 11.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 128.975 2.91 . . . . 0.0 105.918 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -23.84 61.65 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -74.95 -16.89 60.63 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.762 2.025 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.84 -12.45 2.94 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.253 1.421 . . . . 0.0 112.35 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 57.61 56.78 4.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.346 2.258 . . . . 0.0 109.095 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -133.22 155.7 48.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.525 1.13 . . . . 0.0 109.589 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.49 153.7 29.51 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.497 1.119 . . . . 0.0 110.865 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -153.78 147.82 25.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.34 10.62 12.13 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.78 23.83 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.207 1.367 . . . . 0.0 112.983 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -55.81 144.7 55.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.406 1.882 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 C-N-CA 124.791 3.66 . . . . 0.0 113.866 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.238 0.448 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.41 163.43 38.61 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 N-CA-C 107.409 -1.804 . . . . 0.0 107.409 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.29 151.39 82.7 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.72 4.95 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.593 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.477 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 19.5 m95 -86.06 157.99 19.93 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.956 1.878 . . . . 0.0 109.124 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -143.14 152.48 41.85 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.091 -0.38 . . . . 0.0 110.092 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -117.73 121.87 41.97 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.338 1.855 . . . . 0.0 108.939 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.34 138.78 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.65 105.08 8.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.411 1.484 . . . . 0.0 109.023 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.0 m -137.83 128.15 26.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 127.681 2.392 . . . . 0.0 108.491 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -63.79 -21.54 66.47 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.095 1.316 . . . . 0.0 112.045 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.88 -21.29 66.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.913 1.685 . . . . 0.0 112.651 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -134.24 -29.28 1.26 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.63 -108.21 2.15 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 127.351 2.405 . . . . 0.0 107.432 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -145.13 125.12 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.442 0.697 . . . . 0.0 110.274 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.32 176.92 8.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -128.39 153.4 47.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.894 1.278 . . . . 0.0 110.64 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.64 135.03 61.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.216 1.006 . . . . 0.0 108.985 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 62.1 t0 -99.8 102.71 14.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 126.578 1.951 . . . . 0.0 108.582 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -70.4 -20.36 62.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.245 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.8 m -75.81 -31.44 59.42 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 120.806 -1.184 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -117.79 -2.6 11.34 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 53.56 46.24 26.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.549 2.339 . . . . 0.0 110.252 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -119.49 167.45 11.94 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.78 51.89 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.089 1.355 . . . . 0.0 108.571 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.78 152.94 27.56 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 110.526 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.23 0.07 54.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -118.23 162.92 17.45 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.287 0.949 . . . . 0.0 112.314 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -65.11 143.94 98.96 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 124.557 1.161 . . . . 0.0 109.09 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 89.9 Cg_endo . . . . . 0 CA--C 1.535 0.565 0 C-N-CA 124.021 3.147 . . . . 0.0 113.462 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 119.303 -0.38 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.65 165.17 33.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.86 1.707 . . . . 0.0 109.029 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.16 146.03 93.95 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.286 1.991 . . . . 0.0 110.518 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.1 -17.7 9.2 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.886 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' B' ' 43' ' ' PRO . 11.3 m95 -83.59 156.53 22.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 120.159 1.98 . . . . 0.0 109.414 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -140.54 153.44 46.16 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.947 -0.471 . . . . 0.0 110.651 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -121.35 121.43 37.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.8 112.42 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -110.58 130.99 55.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.673 1.189 . . . . 0.0 107.812 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -153.44 -162.61 1.49 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.175 2.59 . . . . 0.0 107.95 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -124.95 -24.09 4.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.948 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -69.83 -25.31 63.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.334 0.97 . . . . 0.0 109.895 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -127.89 -15.62 4.81 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.151 1.78 . . . . 0.0 111.873 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.95 -83.64 1.59 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.424 0.556 . . . . 0.0 113.436 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 87.6 m -156.63 129.12 7.58 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.159 -1.2 . . . . 0.0 110.665 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -142.44 171.15 14.45 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.83 149.46 48.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.378 1.471 . . . . 0.0 107.748 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.68 131.93 59.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.608 0.763 . . . . 0.0 108.956 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -94.73 107.41 19.42 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.095 1.358 . . . . 0.0 109.307 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -65.05 -19.03 65.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -76.02 -38.39 57.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.333 1.453 . . . . 0.0 113.414 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -121.0 2.07 10.43 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp 49.92 39.92 19.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.898 2.079 . . . . 0.0 112.316 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -105.86 156.98 17.81 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.23 143.07 48.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.68 1.192 . . . . 0.0 109.031 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -155.08 161.55 41.27 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.656 -0.652 . . . . 0.0 110.967 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.66 19.16 18.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.626 1.17 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.63 152.41 45.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 119.889 -1.757 . . . . 0.0 109.821 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.84 147.7 98.52 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.065 0.946 . . . . 0.0 109.612 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' B' ' 18' ' ' TRP . 59.8 Cg_endo . . . . . 0 N--CA 1.461 -0.437 0 C-N-CA 123.5 2.8 . . . . 0.0 115.05 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.7 mt . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 36.6 Cg_endo -70.38 166.34 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.894 . . . . 0.0 110.214 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 140.63 82.54 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 106.966 -1.974 . . . . 0.0 106.966 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.82 -9.63 73.41 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.291 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.9 m95 -104.11 156.17 18.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 121.196 2.498 . . . . 0.0 110.161 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -145.2 157.69 44.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.033 0.933 . . . . 0.0 108.958 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -127.23 121.56 31.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.727 2.411 . . . . 0.0 106.534 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.33 149.21 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 125.789 1.636 . . . . 0.0 109.116 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.28 130.44 38.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 0.0 110.036 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -147.88 170.45 17.63 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.091 1.356 . . . . 0.0 110.56 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.1 m -91.15 -42.58 10.37 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.315 -1.49 . . . . 0.0 107.027 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -64.54 -23.84 67.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.984 1.714 . . . . 0.0 112.374 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -129.07 -12.18 4.66 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 -86.4 1.21 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.58 136.78 13.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.461 0.704 . . . . 0.0 110.678 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.81 161.59 41.51 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.604 1.093 . . . . 0.0 109.571 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -116.34 148.09 40.93 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.575 0.75 . . . . 0.0 109.109 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 31' ' ' VAL . 57.4 t -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 50.3 t0 -107.35 102.48 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.042 1.737 . . . . 0.0 110.342 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -66.04 -18.05 65.09 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.93 -0.481 . . . . 0.0 111.658 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.3 m -73.28 -29.75 62.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.284 0.947 . . . . 0.0 111.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -127.32 -0.96 6.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.63 0.772 . . . . 0.0 112.832 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm 56.75 45.32 22.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.683 1.993 . . . . 0.0 109.899 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -121.79 153.41 38.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.846 0.858 . . . . 0.0 110.684 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.6 143.79 44.44 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.946 1.299 . . . . 0.0 108.881 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -140.01 170.85 15.1 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.909 1.684 . . . . 0.0 109.778 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.6 6.88 20.3 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 161.03 34.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.586 0.63 . . . . 0.0 109.723 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.45 138.91 89.09 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.372 2.715 . . . . 0.0 114.902 -178.413 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.73 168.3 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.939 1.759 . . . . 0.0 109.441 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.26 151.11 86.75 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 -8.11 45.13 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.259 -1.3 . . . . 0.0 112.659 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 20.4 m95 -106.42 153.56 22.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 121.375 2.587 . . . . 0.0 110.039 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.07 157.87 45.2 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.513 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -118.32 131.83 56.31 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.976 2.11 . . . . 0.0 105.676 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.22 144.0 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.86 147.49 52.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m -158.57 158.49 34.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.898 2.079 . . . . 0.0 109.949 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -76.78 -43.41 37.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.685 1.13 . . . . 0.0 111.509 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' B' ' 26' ' ' PHE . 9.8 pt-20 -67.36 -34.66 77.77 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.47 ' CE1' ' HG3' ' B' ' 25' ' ' GLU . 15.1 m-85 -98.71 -34.38 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.93 -98.32 1.98 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -147.32 132.09 17.96 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.627 -0.925 . . . . 0.0 110.892 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -140.97 158.03 44.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.546 0.689 . . . . 0.0 109.212 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.21 145.43 42.43 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 31' ' ' VAL . 46.3 t -121.21 137.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 122.662 1.22 . . . . 0.0 110.342 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 26.2 t0 -103.08 102.37 12.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.088 2.955 . . . . 0.0 109.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -75.68 -22.95 56.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.62 0.768 . . . . 0.0 109.643 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 71.6 m -67.24 -18.14 65.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.871 1.269 . . . . 0.0 113.101 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.58 -12.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.537 1.135 . . . . 0.0 111.59 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm 65.07 60.42 0.8 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.826 2.05 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -128.61 164.5 22.74 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.468 1.507 . . . . 0.0 108.036 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.21 146.36 50.75 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -150.55 136.96 18.76 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.545 0.738 . . . . 0.0 109.313 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -80.08 20.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.757 1.623 . . . . 0.0 112.501 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 169.79 17.02 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.207 1.403 . . . . 0.0 110.282 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.23 149.59 97.46 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 0.0 110.461 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.073 179.237 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--O 1.234 0.279 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 14.9 Cg_endo -71.32 155.08 60.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 N-CA-C 109.908 -0.843 . . . . 0.0 109.908 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.48 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 103.789 -3.197 . . . . 0.0 103.789 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.36 -0.41 8.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.391 1.472 . . . . 0.0 110.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.1 m95 -121.08 144.15 48.7 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 119.293 1.546 . . . . 0.0 109.69 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -116.68 150.69 37.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.153 0.981 . . . . 0.0 109.391 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -111.03 136.73 49.6 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.0 t -119.24 124.37 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -117.49 110.91 18.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.637 1.975 . . . . 0.0 108.554 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 p -125.76 171.52 10.59 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.856 1.663 . . . . 0.0 109.958 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -108.47 -23.09 12.01 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.991 -0.443 . . . . 0.0 110.948 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -83.51 -18.74 37.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.056 0.389 . . . . 0.0 111.327 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.82 -61.35 1.51 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.935 1.294 . . . . 0.0 109.078 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.05 -95.4 0.25 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -152.31 132.68 13.71 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 117.933 0.866 . . . . 0.0 111.735 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.77 169.54 19.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.11 152.37 36.63 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.95 131.76 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.082 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 27.9 t0 -98.0 103.6 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.017 1.727 . . . . 0.0 109.976 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -18.4 65.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -77.84 -35.65 50.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.194 0.906 . . . . 0.0 112.788 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -118.86 4.4 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.033 0.833 . . . . 0.0 113.177 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 53.72 47.31 24.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.642 1.177 . . . . 0.0 110.854 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -120.2 142.59 48.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.493 1.117 . . . . 0.0 111.365 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.72 138.88 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -149.33 146.49 27.55 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 120.063 1.301 . . . . 0.0 113.547 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.85 3.21 46.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.833 1.653 . . . . 0.0 112.098 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.03 143.57 48.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.327 1.451 . . . . 0.0 108.319 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -62.08 142.13 95.57 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 125.71 1.604 . . . . 0.0 110.7 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.907 2.405 . . . . 0.0 111.434 179.016 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.7 mt . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 119.747 -0.168 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 67.5 Cg_endo -73.29 168.15 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.944 1.763 . . . . 0.0 110.334 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.72 133.21 35.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.899 2.399 . . . . 0.0 108.768 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.63 -18.91 56.19 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.628 1.109 . . . . 0.0 111.96 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 21.9 m95 -93.06 132.55 37.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.199 1.5 . . . . 0.0 108.39 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.8 159.77 35.51 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.54 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -121.16 120.96 36.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.04 133.68 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.62 150.08 46.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -149.29 175.52 11.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 59.2 m -108.1 -12.85 15.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -93.9 -19.65 20.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.99 -53.16 0.8 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.14 -134.81 5.38 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 105.993 -2.843 . . . . 0.0 105.993 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.7 m -130.78 138.28 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.299 1.04 . . . . 0.0 110.19 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -147.18 178.75 8.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.131 0.972 . . . . 0.0 110.022 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -118.19 155.39 30.58 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.102 0.961 . . . . 0.0 110.371 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.53 135.26 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.002 0.921 . . . . 0.0 108.566 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.443 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.2 t0 -103.98 105.52 15.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.67 -20.21 64.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.892 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 39.9 m -74.31 -34.89 63.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.629 0.772 . . . . 0.0 111.793 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.87 -9.92 11.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm 60.72 49.93 5.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.177 1.791 . . . . 0.0 109.195 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -121.65 160.7 23.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.81 1.244 . . . . 0.0 109.109 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.95 139.98 50.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -149.73 137.78 20.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -77.97 -2.83 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -108.65 156.62 19.35 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.458 1.103 . . . . 0.0 109.78 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . 0.455 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 52.2 t-80 -69.76 149.33 96.7 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.931 0.893 . . . . 0.0 108.751 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 72.4 Cg_endo . . . . . 0 CA--C 1.54 0.822 0 C-N-CA 124.709 3.606 . . . . 0.0 115.813 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 C--O 1.233 0.235 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.24 157.98 59.49 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.437 1.425 . . . . 0.0 109.91 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.86 116.52 4.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.347 2.698 . . . . 0.0 107.359 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.18 -9.75 10.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.592 1.567 . . . . 0.0 111.582 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.466 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 23.1 m95 -107.36 163.8 12.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.531 1.166 . . . . 0.0 109.878 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -147.49 153.28 39.32 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.07 0.948 . . . . 0.0 109.775 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -118.43 121.01 39.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.15 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.15 92.12 3.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -127.87 151.96 48.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.788 1.235 . . . . 0.0 110.304 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 m -89.34 -29.53 19.06 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.769 0.827 . . . . 0.0 111.225 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.01 -38.45 88.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.289 0.636 . . . . 0.0 111.74 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -117.27 -40.61 3.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 -170.74 15.47 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.8 m -84.48 117.48 23.7 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.191 1.796 . . . . 0.0 107.892 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -136.36 -179.91 5.97 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 109.976 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -131.51 156.15 46.19 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.181 -0.95 . . . . 0.0 111.322 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.96 143.5 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.622 1.169 . . . . 0.0 109.106 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 23.8 t0 -106.17 118.78 37.51 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 127.39 2.276 . . . . 0.0 110.064 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -74.68 -21.73 59.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.915 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -65.24 -41.56 94.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 112.579 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.97 -1.87 8.78 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.278 1.431 . . . . 0.0 113.971 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 57.78 46.78 16.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 110.453 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -116.2 139.7 50.07 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.92 152.17 23.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.74 163.38 39.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.018 -1.051 . . . . 0.0 110.981 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -105.39 18.95 21.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.458 1.903 . . . . 0.0 111.846 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 154.12 51.84 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.246 -1.533 . . . . 0.0 110.948 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.65 136.67 96.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 68.2 Cg_endo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 123.918 3.079 . . . . 0.0 114.289 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 C--O 1.235 0.301 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 60.1 Cg_endo -71.54 155.76 58.95 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.627 2.218 . . . . 0.0 109.084 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.13 94.53 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.379 3.386 . . . . 0.0 109.356 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.57 -7.56 1.53 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.334 1.445 . . . . 0.0 111.509 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.456 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.1 m95 -108.56 156.46 19.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.895 0.878 . . . . 0.0 109.293 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.91 155.74 45.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.595 0.758 . . . . 0.0 109.641 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -129.39 121.66 27.83 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.92 142.76 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.16 111.3 10.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 57.7 m -134.01 141.82 47.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.462 1.505 . . . . 0.0 111.407 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -70.01 -25.5 63.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.536 1.062 . . . . 0.0 111.104 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.41 -26.72 63.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.199 -0.905 . . . . 0.0 113.176 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.18 -23.68 2.41 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -107.74 1.66 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.383 1.944 . . . . 0.0 111.82 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 54.5 m -141.85 132.43 25.41 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.488 1.915 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -150.83 174.82 12.64 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.95 0.795 . . . . 0.0 109.771 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -124.93 154.34 41.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.06 0.944 . . . . 0.0 110.511 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.94 143.08 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.601 1.16 . . . . 0.0 109.446 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.403 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 12.0 t0 -106.91 143.21 35.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.951 1.7 . . . . 0.0 108.256 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -105.87 2.21 27.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.136 1.374 . . . . 0.0 111.26 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -91.62 -38.5 12.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.04 1.736 . . . . 0.0 112.658 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -132.25 6.06 4.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.945 2.098 . . . . 0.0 113.145 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt 51.03 52.05 15.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.703 1.601 . . . . 0.0 111.822 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -110.57 150.51 28.85 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.46 146.85 49.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -155.49 172.42 18.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.725 1.148 . . . . 0.0 112.084 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -113.54 13.23 18.75 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 0.0 111.589 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 161.11 23.35 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . 0.426 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 1.8 t-80 -70.06 150.84 96.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.102 0.864 . . . . 0.0 110.298 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 73.3 Cg_endo . . . . . 0 CA--C 1.541 0.844 0 C-N-CA 122.874 2.383 . . . . 0.0 111.827 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--O 1.234 0.25 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.94 164.11 31.06 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.696 2.264 . . . . 0.0 110.894 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.02 127.97 19.65 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.119 1.879 . . . . 0.0 108.057 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.38 -20.98 31.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.294 0.949 . . . . 0.0 111.567 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 17.9 m95 -91.98 154.97 18.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.278 1.539 . . . . 0.0 108.171 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -142.07 146.24 35.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -107.25 126.86 52.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.303 1.841 . . . . 0.0 107.293 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.71 117.19 54.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -102.3 137.45 40.54 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.457 1.503 . . . . 0.0 107.829 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -149.44 178.96 8.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.911 0.884 . . . . 0.0 111.688 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.9 m -106.0 -11.05 16.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 0.0 111.412 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -104.41 -47.45 4.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.35 0.595 . . . . 0.0 110.669 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -91.93 -8.27 46.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.078 1.351 . . . . 0.0 113.108 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.17 -88.56 1.19 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.74 134.27 10.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.33 176.48 9.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -134.56 159.79 40.08 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.85 133.41 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.331 0.652 . . . . 0.0 110.284 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 14.9 t0 -92.56 108.37 19.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.893 2.477 . . . . 0.0 107.275 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -68.98 -28.15 66.36 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 122.12 -0.362 . . . . 0.0 111.948 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.5 m -69.6 -44.76 70.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.113 0.965 . . . . 0.0 111.892 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -103.45 -8.2 20.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.389 1.076 . . . . 0.0 113.696 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 55.74 60.81 3.09 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.653 1.581 . . . . 0.0 108.901 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -136.44 154.65 50.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.842 1.257 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.46 149.51 36.2 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -153.29 160.1 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.652 0.781 . . . . 0.0 111.413 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -108.0 13.66 25.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 0.0 113.219 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 160.38 29.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.931 1.292 . . . . 0.0 108.753 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.7 139.93 91.58 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.349 0.591 0 C-N-CA 124.964 3.776 . . . . 0.0 114.858 -178.535 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 C--O 1.234 0.247 0 CA-C-O 119.118 -0.468 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.4 Cg_endo -64.37 158.06 51.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.235 1.956 . . . . 0.0 109.764 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.13 103.64 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.376 3.384 . . . . 0.0 109.983 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.99 3.52 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.004 1.764 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.476 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 7.4 m95 -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.181 -1.188 . . . . 0.0 109.151 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.24 155.07 44.42 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.233 0.54 . . . . 0.0 110.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -116.99 136.82 52.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 128.071 2.549 . . . . 0.0 105.365 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.38 143.95 27.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -128.16 137.18 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 m -154.44 -172.64 4.28 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.111 1.764 . . . . 0.0 110.508 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -105.21 -59.22 1.78 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -60.69 -18.04 51.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 114.192 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.72 -12.77 5.98 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.584 1.154 . . . . 0.0 114.06 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.64 -92.02 0.78 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.463 1.982 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.19 127.5 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.133 -0.627 . . . . 0.0 111.61 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -141.85 174.07 10.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.616 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.82 146.87 50.8 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.383 -1.448 . . . . 0.0 110.768 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.86 136.79 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.024 1.329 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -97.44 112.82 24.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.471 1.908 . . . . 0.0 106.328 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -22.57 53.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.899 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -67.08 -53.18 33.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.01 1.277 . . . . 0.0 111.746 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.78 -4.04 31.44 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.353 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm 56.55 58.14 4.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.533 1.533 . . . . 0.0 107.072 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -119.66 169.6 9.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.175 1.39 . . . . 0.0 109.693 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.65 146.39 50.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.245 1.018 . . . . 0.0 110.43 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.45 167.67 21.64 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.937 1.295 . . . . 0.0 109.487 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.7 4.88 18.85 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.045 0.938 . . . . 0.0 113.153 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.08 176.36 8.14 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.96 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -71.54 141.54 85.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 CA--C 1.538 0.682 0 C-N-CA 123.16 2.573 . . . . 0.0 114.733 -178.706 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.67 159.51 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.066 2.511 . . . . 0.0 110.773 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.79 117.6 5.12 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.971 2.448 . . . . 0.0 107.038 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.58 -20.76 8.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.317 1.437 . . . . 0.0 112.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 13.5 m95 -90.99 157.43 17.29 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 119.793 1.796 . . . . 0.0 110.005 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -135.03 145.15 47.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -118.53 130.53 55.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.57 139.4 47.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 140.29 49.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.594 1.958 . . . . 0.0 106.761 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.45 150.87 20.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.26 1.024 . . . . 0.0 108.374 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -74.27 -24.1 59.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.743 1.156 . . . . 0.0 110.35 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.43 -39.03 28.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.418 1.087 . . . . 0.0 113.732 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -109.55 -9.23 14.91 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.106 . . . . 0.0 113.528 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.32 -88.82 1.1 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 126.404 1.954 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 m -152.98 119.77 5.71 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.54 168.13 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.948 0.899 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -125.48 139.54 53.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.364 1.066 . . . . 0.0 109.695 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' B' ' 31' ' ' VAL . 93.5 t -122.12 131.87 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.02 0.928 . . . . 0.0 110.08 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.6 t0 -91.24 121.85 33.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 127.144 2.178 . . . . 0.0 108.836 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -85.97 -9.87 56.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.988 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -73.07 -43.56 61.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.794 1.179 . . . . 0.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -120.49 2.92 10.76 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.96 1.304 . . . . 0.0 112.871 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 56.59 45.84 21.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 110.973 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -117.21 138.6 51.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.28 20.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -151.91 164.95 36.04 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.322 1.058 . . . . 0.0 110.482 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 51.7 m-85 -107.76 26.4 10.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.8 1.64 . . . . 0.0 111.204 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -140.55 160.96 38.86 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -74.61 141.5 76.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.586 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 72.6 Cg_endo . . . . . 0 N--CA 1.458 -0.593 0 C-N-CA 122.438 2.092 . . . . 0.0 112.444 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 61.2 Cg_endo -71.04 157.53 57.6 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.234 1.29 . . . . 0.0 110.373 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.12 125.25 13.78 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.648 2.232 . . . . 0.0 106.349 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.92 -10.84 27.34 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.779 1.657 . . . . 0.0 110.75 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 27.7 m95 -113.04 148.98 34.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.897 1.349 . . . . 0.0 109.695 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -139.3 155.83 47.46 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.927 0.767 . . . . 0.0 109.779 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -116.15 138.69 51.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.731 1.612 . . . . 0.0 108.257 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.59 139.58 42.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.43 133.26 46.21 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -149.02 172.03 15.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.885 1.274 . . . . 0.0 113.685 -175.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m -84.93 -32.48 23.07 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.541 1.137 . . . . 0.0 113.921 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -100.89 -12.03 19.31 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.464 1.106 . . . . 0.0 112.667 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -116.86 -21.08 9.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.315 1.046 . . . . 0.0 111.57 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.61 -89.97 1.34 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 24.1 m -156.74 129.16 7.52 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.082 -1.246 . . . . 0.0 109.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -138.45 174.75 10.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -130.53 143.03 50.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' A' ' 31' ' ' VAL . 22.2 t -119.19 131.78 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 12.2 t0 -92.66 109.32 20.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.57 -11.83 60.3 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.662 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.7 m -66.84 -41.25 87.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.498 1.499 . . . . 0.0 110.572 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.02 1.73 8.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 46.1 mmtm 59.39 51.75 6.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.756 1.222 . . . . 0.0 109.466 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -122.68 146.05 47.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.57 131.36 54.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -134.68 157.89 45.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.492 1.117 . . . . 0.0 108.291 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -104.26 3.21 32.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -105.04 156.04 18.42 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.826 1.65 . . . . 0.0 109.107 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -69.13 149.61 97.6 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-O 117.541 -1.219 . . . . 0.0 107.966 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.456 -0.695 0 CA-C-N 121.352 1.519 . . . . 0.0 110.276 -179.765 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 C--O 1.236 0.344 0 CA-C-O 119.148 -0.454 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.21 164.97 31.95 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.601 1.534 . . . . 0.0 109.982 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.69 149.03 78.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 N-CA-C 105.698 -2.462 . . . . 0.0 105.698 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.72 -11.43 70.32 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -111.7 136.18 51.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.431 1.615 . . . . 0.0 107.405 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.6 152.09 37.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 0.0 110.388 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -115.68 120.51 39.6 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.1 t -104.53 138.53 28.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.98 129.09 50.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.965 1.306 . . . . 0.0 107.816 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -147.76 169.22 20.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.812 2.045 . . . . 0.0 108.213 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -105.7 -23.89 12.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -78.16 -35.1 49.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -96.5 -69.65 0.75 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.978 1.311 . . . . 0.0 108.851 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.97 -132.75 6.27 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 104.316 -3.514 . . . . 0.0 104.316 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.97 132.14 54.46 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 109.421 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -141.71 166.51 24.52 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.512 0.725 . . . . 0.0 109.682 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -122.55 139.64 53.68 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 111.035 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' B' ' 31' ' ' VAL . 55.4 t -121.61 148.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -108.08 113.03 25.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.214 1.806 . . . . 0.0 111.963 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -21.08 64.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.695 0.679 . . . . 0.0 111.748 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -73.63 -30.85 63.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.17 0.988 . . . . 0.0 113.045 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -129.13 -1.09 5.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' CE ' ' CE2' ' B' ' 40' ' ' TYR . 17.6 mmtp 59.06 46.7 12.99 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.679 1.192 . . . . 0.0 110.616 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -125.35 146.41 49.59 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.635 -0.665 . . . . 0.0 110.78 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.19 142.11 36.42 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 107.858 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -148.83 161.48 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 108.833 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -106.99 14.17 26.74 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.948 0.899 . . . . 0.0 111.002 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -118.51 160.29 22.01 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 120.97 -1.081 . . . . 0.0 110.744 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.88 133.83 88.09 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.947 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.54 0.799 0 C-N-CA 124.362 3.374 . . . . 0.0 115.398 -179.733 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 20' ' ' ARG . 74.8 mt . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.409 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 48.2 Cg_endo -67.2 157.19 62.94 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.042 1.828 . . . . 0.0 109.407 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.18 93.34 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.573 3.515 . . . . 0.0 111.64 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.36 -19.65 2.26 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.279 1.419 . . . . 0.0 111.153 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 18.6 m95 -94.43 149.89 20.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -131.74 141.09 49.43 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.07 0.548 . . . . 0.0 109.788 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.411 ' HB2' HD11 ' B' ' 14' ' ' LEU . 42.0 ttp180 -107.48 121.83 45.41 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.0 t -110.91 141.53 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -130.18 150.23 51.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 m -154.87 -165.63 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.115 1.366 . . . . 0.0 109.435 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.0 m -115.43 -45.16 2.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.07 0.948 . . . . 0.0 108.957 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.79 -14.73 62.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.989 0.516 . . . . 0.0 110.559 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.61 -25.63 4.32 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.69 1.596 . . . . 0.0 113.192 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.79 -86.61 1.55 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.9 m -159.61 140.06 12.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.121 1.46 . . . . 0.0 110.577 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.64 176.34 9.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.414 -0.804 . . . . 0.0 109.689 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.34 151.9 50.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 108.931 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 31' ' ' VAL . 42.5 t -128.32 136.6 59.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.217 1.007 . . . . 0.0 109.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.3 t0 -101.53 104.08 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.978 1.311 . . . . 0.0 108.879 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.24 -19.89 66.18 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.795 -0.565 . . . . 0.0 111.26 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.45 -33.16 69.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.682 1.593 . . . . 0.0 112.661 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -126.78 0.75 6.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 54.57 36.99 27.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -111.75 161.16 16.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.37 148.44 48.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.986 0.914 . . . . 0.0 108.587 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.42 168.51 26.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.82 1.248 . . . . 0.0 110.118 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.502 ' CE2' ' CE ' ' A' ' 36' ' ' LYS . 69.2 m-85 -105.36 -1.02 25.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.8 167.88 9.5 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.064 -1.023 . . . . 0.0 111.233 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.29 149.89 89.35 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 C-N-CA 123.447 2.765 . . . . 0.0 115.436 -178.216 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ARG . 36.6 mt . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.917 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 57.8 Cg_endo -71.56 162.39 42.36 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.119 1.879 . . . . 0.0 110.705 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 121.22 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.12 2.546 . . . . 0.0 110.41 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.42 47.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.315 1.435 . . . . 0.0 112.904 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.2 m95 -92.2 151.09 20.54 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.454 1.627 . . . . 0.0 108.151 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.02 154.74 47.87 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.557 1.143 . . . . 0.0 109.919 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.8 ttp180 -125.87 124.86 41.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t -108.33 115.03 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 108.426 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.67 128.27 44.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.5 m -139.94 -173.72 3.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.575 1.15 . . . . 0.0 109.885 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -116.45 -43.96 2.9 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.853 1.261 . . . . 0.0 108.801 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.55 -18.81 62.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.928 0.891 . . . . 0.0 112.695 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -128.17 -19.28 3.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.3 -100.24 1.79 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -157.95 139.58 13.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.493 0.717 . . . . 0.0 109.641 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -146.31 170.57 16.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -119.33 152.79 36.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.576 1.55 . . . . 0.0 107.59 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.44 135.33 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.204 0.601 . . . . 0.0 110.321 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 20.4 t0 -101.53 106.19 17.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.248 1.419 . . . . 0.0 108.176 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.94 -13.87 61.76 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.561 -0.712 . . . . 0.0 111.233 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.5 m -75.11 -39.12 60.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.88 1.218 . . . . 0.0 112.528 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -124.25 8.12 8.5 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm 54.18 53.72 10.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.421 1.488 . . . . 0.0 109.414 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -121.97 134.93 54.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.792 1.637 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 135.35 39.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.318 1.447 . . . . 0.0 107.621 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -139.07 153.63 48.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.848 1.204 . . . . 0.0 113.227 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -96.96 15.81 21.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.891 1.276 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 158.44 43.99 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 119.955 -1.716 . . . . 0.0 109.742 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -58.37 141.71 82.71 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 124.391 1.057 . . . . 0.0 110.726 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.451 -0.999 0 C-N-CA 122.743 2.295 . . . . 0.0 109.306 178.624 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' B' ' 20' ' ' ARG . 86.4 mt . . . . . 0 C--O 1.238 0.475 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 28.4 Cg_endo -69.06 163.35 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.914 1.742 . . . . 0.0 109.336 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.0 137.79 49.99 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.31 74.24 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.635 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 9.8 m95 -114.3 142.03 46.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 121.171 2.486 . . . . 0.0 109.094 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -125.32 157.68 36.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.647 0.779 . . . . 0.0 110.553 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.421 ' HB2' HD11 ' B' ' 14' ' ' LEU . 38.0 ttp180 -128.05 125.04 38.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.469 2.308 . . . . 0.0 106.906 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.51 133.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.96 119.06 35.94 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 65.1 m -138.51 158.46 44.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.462 1.105 . . . . 0.0 109.738 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -84.81 -39.55 18.22 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.695 -1.253 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.26 -16.24 59.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -124.83 -13.04 7.01 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.91 -94.66 1.99 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.998 1.761 . . . . 0.0 110.543 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -151.91 135.83 16.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.037 -0.684 . . . . 0.0 110.47 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -148.54 167.79 24.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.22 155.05 37.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 108.337 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.9 139.31 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.889 0.852 . . . . 0.0 109.236 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -100.61 102.47 13.62 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 128.533 2.733 . . . . 0.0 106.938 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -20.19 64.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.535 0.607 . . . . 0.0 112.413 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -71.86 -36.88 70.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.375 0.989 . . . . 0.0 110.7 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -116.82 -1.47 12.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 58.02 53.52 6.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.027 1.331 . . . . 0.0 108.285 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -123.41 147.38 47.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.702 0.401 . . . . 0.0 110.016 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.85 136.23 48.76 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 150.41 40.74 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.856 0.753 . . . . 0.0 110.376 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -88.73 1.32 55.35 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 156.5 33.61 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.583 1.153 . . . . 0.0 110.169 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -64.48 146.42 98.09 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 -179.074 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 74.2 Cg_endo -76.62 168.66 23.27 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.575 2.184 . . . . 0.0 109.105 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.9 149.88 72.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 -11.44 44.51 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.554 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 16.2 m95 -99.68 151.8 20.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.475 1.638 . . . . 0.0 106.619 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -135.63 151.98 50.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.922 0.489 . . . . 0.0 110.004 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -111.14 129.72 55.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.31 143.97 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.33 149.88 51.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -155.31 148.96 25.28 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.401 1.08 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -76.23 -19.48 58.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -85.37 -20.09 30.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.337 1.055 . . . . 0.0 113.209 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.53 -46.0 1.77 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.67 -109.39 1.1 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -138.56 129.23 26.37 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -144.69 163.21 34.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.75 149.03 39.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 111.444 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.14 142.49 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.492 0.717 . . . . 0.0 109.744 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 119.44 39.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 127.907 2.483 . . . . 0.0 108.844 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -84.61 -20.97 30.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -76.84 -31.98 57.25 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.284 1.034 . . . . 0.0 110.085 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -117.38 -9.42 10.9 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp 56.86 50.46 12.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.07 1.348 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -126.05 160.19 30.74 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.661 0.785 . . . . 0.0 110.287 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.77 139.5 53.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.376 1.471 . . . . 0.0 109.37 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -153.9 144.68 22.57 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.631 1.173 . . . . 0.0 108.688 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 62.8 m-85 -91.25 24.41 2.92 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.46 0.704 . . . . 0.0 109.845 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 154.28 47.99 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.573 -1.329 . . . . 0.0 111.036 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.95 143.99 98.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 59.6 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 C-N-CA 122.845 2.364 . . . . 0.0 116.658 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 C--O 1.233 0.186 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.48 166.91 27.89 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.923 2.415 . . . . 0.0 110.291 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.67 118.63 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.703 2.268 . . . . 0.0 109.975 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.5 -11.96 33.12 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.181 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 32.2 m95 -100.54 150.43 22.68 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 119.303 1.551 . . . . 0.0 108.373 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.02 168.03 19.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 108.669 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -133.06 121.34 22.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.116 1.366 . . . . 0.0 108.585 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.76 107.98 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 124.168 0.917 . . . . 0.0 109.221 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -95.48 133.36 39.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.3 m -155.78 -177.64 6.71 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.006 -1.684 . . . . 0.0 110.833 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -102.68 -44.75 5.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.806 0.843 . . . . 0.0 111.896 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.74 -11.85 59.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.69 -19.86 3.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.17 -105.33 3.26 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -144.96 124.19 12.95 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.909 0.484 . . . . 0.0 110.905 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.45 178.51 7.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.373 1.069 . . . . 0.0 108.838 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.35 155.57 47.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.557 1.143 . . . . 0.0 109.767 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.4 131.58 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 51.7 t0 -98.82 104.66 16.72 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -70.06 -21.95 63.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.843 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 90.3 m -67.7 -45.19 75.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.837 1.653 . . . . 0.0 110.823 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -106.63 1.11 24.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.81 0.844 . . . . 0.0 112.424 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 2.4 mmtp 49.85 54.73 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.756 2.022 . . . . 0.0 110.611 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -119.62 167.39 12.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.089 0.956 . . . . 0.0 109.168 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 143.32 50.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -155.05 149.43 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.896 0.878 . . . . 0.0 108.968 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -90.98 -8.76 48.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.226 1.01 . . . . 0.0 110.14 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -93.56 152.4 19.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 124.539 1.136 . . . . 0.0 108.584 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 42.5 t-80 -67.26 151.33 97.26 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.61 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 92.0 Cg_endo . . . . . 0 C--N 1.348 0.542 0 N-CA-C 117.357 2.022 . . . . 0.0 117.357 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 40.5 Cg_endo -72.09 164.55 35.31 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.405 1.403 . . . . 0.0 109.304 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.18 134.65 40.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.57 1.513 . . . . 0.0 108.919 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.68 -10.8 72.19 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 117.615 -1.659 . . . . 0.0 114.216 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.459 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.2 m95 -93.91 168.18 11.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.147 1.973 . . . . 0.0 109.181 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -140.95 156.27 46.1 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.608 0.763 . . . . 0.0 109.986 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -125.04 129.99 51.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.68 132.74 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.32 139.61 41.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -142.84 -172.41 3.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.8 2.44 . . . . 0.0 109.819 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -126.28 -38.86 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.535 1.934 . . . . 0.0 107.594 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -34.8 71.24 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -113.33 -17.11 12.37 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.76 -85.7 1.51 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -157.63 146.03 19.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.343 1.072 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -154.63 166.99 31.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.296 0.638 . . . . 0.0 109.606 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.0 144.98 45.09 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' B' ' 31' ' ' VAL . 85.3 t -123.78 142.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.823 0.849 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -107.43 112.55 25.4 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 127.255 2.222 . . . . 0.0 109.498 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -74.22 -22.37 59.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.767 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.4 m -69.53 -34.1 73.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.59 1.086 . . . . 0.0 112.148 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -121.92 1.84 9.9 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.341 0.656 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' B' ' 40' ' ' TYR . 34.9 mmtm 51.15 52.5 14.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.983 1.713 . . . . 0.0 108.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -121.75 154.84 36.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.664 0.786 . . . . 0.0 108.984 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.83 140.95 51.03 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.67 1.188 . . . . 0.0 108.371 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -150.22 147.28 27.51 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.522 -0.736 . . . . 0.0 110.527 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.31 -13.28 52.87 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.365 1.466 . . . . 0.0 112.965 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.69 144.01 27.1 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.481 1.912 . . . . 0.0 107.158 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -68.05 142.14 94.91 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 CA--C 1.536 0.612 0 C-N-CA 123.822 3.015 . . . . 0.0 112.591 179.543 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt . . . . . 0 C--O 1.237 0.41 0 CA-C-O 119.228 -0.415 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 43.6 Cg_endo -74.25 164.0 35.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.59 2.194 . . . . 0.0 112.773 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.74 130.69 26.95 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 105.282 -2.622 . . . . 0.0 105.282 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.2 -1.83 56.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.532 -1.705 . . . . 0.0 113.283 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 16.0 m95 -117.18 165.98 12.79 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.226 2.013 . . . . 0.0 111.467 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -152.1 150.89 30.41 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.116 0.966 . . . . 0.0 109.153 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -104.59 149.46 25.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.04 114.43 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -105.9 145.94 30.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -156.22 -168.14 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.639 1.175 . . . . 0.0 109.364 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -120.6 -44.07 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.478 1.911 . . . . 0.0 107.954 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -63.88 -25.12 68.01 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.325 1.05 . . . . 0.0 113.263 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.01 -33.15 3.38 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.2 -104.51 1.35 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -150.24 136.47 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -151.09 -175.3 5.1 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -132.35 155.77 47.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.093 1.357 . . . . 0.0 109.43 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 31' ' ' VAL . 57.7 t -131.61 133.63 61.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.462 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 57.2 t0 -97.06 111.51 23.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.166 1.787 . . . . 0.0 110.587 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -70.75 -18.75 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.436 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -67.52 -37.03 82.16 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.947 1.699 . . . . 0.0 112.377 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -127.13 3.96 6.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.585 0.754 . . . . 0.0 112.724 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 53.4 42.85 31.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.216 1.806 . . . . 0.0 110.878 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -113.97 161.37 17.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.03 146.92 46.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -158.06 155.6 29.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.321 1.048 . . . . 0.0 109.126 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . 0.447 ' CE1' ' HE3' ' A' ' 36' ' ' LYS . 75.5 m-85 -95.04 -4.2 46.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.568 1.147 . . . . 0.0 112.574 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.85 140.5 37.05 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . 0.507 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 61.1 t-80 -59.24 151.89 55.77 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 124.411 1.085 . . . . 0.0 109.672 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 87.0 Cg_endo . . . . . 0 CA--C 1.547 1.169 0 C-N-CA 122.121 1.88 . . . . 0.0 110.283 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 C--O 1.233 0.2 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.65 163.54 36.59 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 107.965 -1.59 . . . . 0.0 107.965 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.1 149.99 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.23 -21.47 10.18 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.83 1.205 . . . . 0.0 112.64 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -88.12 143.54 27.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.759 1.78 . . . . 0.0 107.74 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -117.33 151.6 36.66 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.609 0.764 . . . . 0.0 111.011 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -117.71 119.42 34.89 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.32 145.12 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.15 139.79 52.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -157.48 132.27 8.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.216 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -59.64 -33.74 71.91 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.166 1.348 . . . . 0.0 112.512 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -16.5 61.64 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.96 -30.72 1.35 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.05 -94.15 0.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 126.647 2.07 . . . . 0.0 108.575 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.64 133.78 16.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -143.5 143.65 31.65 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.659 1.118 . . . . 0.0 109.739 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -96.87 156.48 16.33 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.261 -0.899 . . . . 0.0 109.806 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.16 142.17 44.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -105.2 108.69 20.34 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 127.344 2.258 . . . . 0.0 107.426 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -25.54 62.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.7 m -70.8 -41.43 71.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.235 1.014 . . . . 0.0 110.815 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -105.97 -10.01 16.8 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.935 0.894 . . . . 0.0 113.003 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 56.24 59.4 3.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.26 1.824 . . . . 0.0 107.198 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -126.4 166.69 16.72 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.895 1.678 . . . . 0.0 109.238 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.13 145.66 50.89 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.1 1.36 . . . . 0.0 107.414 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.14 163.79 36.57 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.268 -0.895 . . . . 0.0 112.448 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CZ ' ' HE3' ' B' ' 36' ' ' LYS . 78.6 m-85 -103.6 19.07 20.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.915 1.686 . . . . 0.0 112.878 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 152.28 43.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.737 -1.227 . . . . 0.0 109.911 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.37 140.63 91.7 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.843 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 N--CA 1.453 -0.862 0 C-N-CA 123.629 2.886 . . . . 0.0 111.852 -179.965 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.238 0.473 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 40.1 Cg_endo -69.89 162.32 42.59 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.204 1.936 . . . . 0.0 109.131 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.53 139.77 72.06 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.574 -1.741 . . . . 0.0 107.574 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.14 73.05 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.413 -1.77 . . . . 0.0 112.588 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.444 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 11.4 m95 -101.62 157.49 16.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 120.434 2.117 . . . . 0.0 108.396 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -146.01 147.39 31.6 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.83 -0.544 . . . . 0.0 110.296 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.67 135.95 44.28 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.5 120.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.302 1.041 . . . . 0.0 109.1 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -111.76 136.93 50.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -143.44 135.65 26.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.606 1.562 . . . . 0.0 108.901 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.9 m -66.8 -28.52 68.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 120.61 1.55 . . . . 0.0 111.422 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.69 -21.5 57.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.76 -22.6 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.13 -98.37 1.22 Allowed Glycine 0 CA--C 1.519 0.339 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.2 m -158.17 145.55 18.11 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.232 1.013 . . . . 0.0 108.501 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.51 178.28 9.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.16 1.784 . . . . 0.0 106.623 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -128.26 158.08 39.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 66.1 t -132.08 131.43 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 59.7 t0 -91.61 103.86 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 127.435 2.294 . . . . 0.0 107.669 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -27.14 67.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.87 0.759 . . . . 0.0 111.877 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 63.1 m -69.13 -24.48 64.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.113 0.965 . . . . 0.0 112.535 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -126.72 -2.47 6.65 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.53 0.732 . . . . 0.0 112.752 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HE3' ' CZ ' ' A' ' 40' ' ' TYR . 40.1 mmtm 51.06 52.22 15.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.946 2.098 . . . . 0.0 110.301 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -127.5 160.72 30.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.66 -0.65 . . . . 0.0 109.724 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.36 139.93 50.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.352 1.061 . . . . 0.0 110.179 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.15 159.78 42.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.459 1.104 . . . . 0.0 109.977 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -100.25 15.15 28.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.085 1.354 . . . . 0.0 114.071 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.07 151.7 51.52 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.21 -1.556 . . . . 0.0 110.829 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.4 t-80 -60.41 143.73 89.2 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.883 0.873 . . . . 0.0 109.891 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 42.4 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 122.809 2.339 . . . . 0.0 112.55 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 C--O 1.235 0.311 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.2 164.42 35.69 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.794 1.663 . . . . 0.0 109.727 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.02 117.26 4.93 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.175 2.583 . . . . 0.0 109.906 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.81 7.92 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.158 1.837 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 31.6 m95 -88.95 136.66 32.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.397 -1.06 . . . . 0.0 109.705 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -119.68 139.95 51.42 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.284 1.033 . . . . 0.0 110.19 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -108.75 120.75 43.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.9 140.12 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -125.97 118.17 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.114 -2.551 . . . . 0.0 104.114 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m -140.86 170.62 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.526 1.131 . . . . 0.0 111.176 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -85.03 -65.14 1.04 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -60.43 -16.51 36.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.508 1.923 . . . . 0.0 114.911 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.15 -14.59 7.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.509 1.124 . . . . 0.0 112.45 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.38 -85.66 0.93 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 125.242 1.401 . . . . 0.0 111.759 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.83 136.43 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.249 -1.148 . . . . 0.0 109.497 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -149.03 175.21 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.565 1.075 . . . . 0.0 110.057 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -123.99 149.21 46.27 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.878 0.871 . . . . 0.0 109.82 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.79 143.06 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.683 1.193 . . . . 0.0 109.073 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.71 112.95 26.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.862 2.065 . . . . 0.0 105.599 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.454 ' ND1' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -74.17 -23.67 59.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -68.66 -36.83 79.06 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.854 0.862 . . . . 0.0 112.307 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.73 -3.57 11.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.121 . . . . 0.0 112.317 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HE3' ' ND1' ' A' ' 33' ' ' HIS . 6.9 mmtp 58.17 51.99 8.0 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.943 1.697 . . . . 0.0 109.78 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -118.23 161.86 19.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.463 0.705 . . . . 0.0 110.497 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.62 148.72 46.17 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.45 155.86 37.09 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.216 0.607 . . . . 0.0 111.223 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -95.58 27.28 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.594 1.558 . . . . 0.0 111.538 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -142.78 146.69 34.49 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 119.799 -1.813 . . . . 0.0 109.682 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.72 141.75 94.92 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 18' ' ' TRP . 19.6 Cg_endo . . . . . 0 N--CA 1.453 -0.903 0 C-N-CA 122.956 2.437 . . . . 0.0 116.476 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 57.0 mt . . . . . 0 C--O 1.232 0.159 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.68 160.09 50.96 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.304 2.003 . . . . 0.0 112.553 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 84.95 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.784 3.656 . . . . 0.0 110.07 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.7 4.73 0.28 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.837 2.16 . . . . 0.0 112.162 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -124.71 157.78 34.84 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.27 155.9 44.05 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 122.047 -0.408 . . . . 0.0 109.933 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.17 121.84 46.01 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.538 1.535 . . . . 0.0 107.547 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.83 131.71 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.84 126.5 47.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.1 m -147.88 -176.0 5.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 110.767 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m -112.55 -29.88 7.32 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 110.004 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -79.07 -14.57 59.07 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.793 -0.567 . . . . 0.0 109.669 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -130.71 -19.5 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.97 -92.74 1.71 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.613 1.101 . . . . 0.0 111.093 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -151.41 131.2 13.22 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.811 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -148.75 172.57 14.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -120.73 156.6 31.46 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.919 -0.488 . . . . 0.0 110.606 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.51 140.04 49.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -101.37 112.75 25.37 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.572 2.349 . . . . 0.0 108.733 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . 0.409 ' ND1' ' HE2' ' B' ' 36' ' ' LYS . 1.8 m-70 -76.54 -13.09 60.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -88.96 -22.88 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 111.66 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -123.79 -5.62 8.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.505 0.722 . . . . 0.0 111.461 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.409 ' HE2' ' ND1' ' B' ' 33' ' ' HIS . 21.6 mmtp 51.76 52.73 13.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.23 1.812 . . . . 0.0 111.724 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -132.75 153.55 51.09 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.504 0.722 . . . . 0.0 109.459 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.91 153.97 21.22 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 108.584 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -158.96 151.91 22.16 Favored 'General case' 0 C--N 1.334 -0.071 0 O-C-N 121.608 -0.682 . . . . 0.0 111.107 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -95.45 27.63 3.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.002 1.321 . . . . 0.0 112.082 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 147.05 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 119.891 -1.755 . . . . 0.0 108.432 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -64.95 142.19 98.58 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 119.036 -0.507 . . . . 0.0 109.765 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 123.256 2.638 . . . . 0.0 114.056 -179.671 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 51.7 Cg_endo -71.83 164.86 34.34 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.282 1.988 . . . . 0.0 110.205 178.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.98 124.04 11.36 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.543 2.162 . . . . 0.0 108.457 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.17 -12.08 33.96 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.723 1.154 . . . . 0.0 111.736 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.411 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 37.3 m95 -104.13 150.93 23.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.646 1.223 . . . . 0.0 108.608 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -144.09 156.8 44.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.105 0.962 . . . . 0.0 108.613 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -116.04 122.0 43.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.561 1.545 . . . . 0.0 107.055 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.78 127.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.03 116.03 22.16 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.9 m -140.46 155.23 46.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 111.709 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.5 m -76.71 -20.25 56.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.85 -1.157 . . . . 0.0 112.937 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -83.09 -53.63 5.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.8 0.727 . . . . 0.0 111.405 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.74 -11.85 30.5 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.74 -91.34 1.62 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -155.68 147.99 23.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.213 0.506 . . . . 0.0 111.851 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -161.16 179.64 8.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.74 1.616 . . . . 0.0 108.099 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.67 158.91 33.57 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.085 -1.009 . . . . 0.0 110.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.25 140.86 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 108.027 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -109.7 117.59 34.29 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.239 2.216 . . . . 0.0 109.512 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -82.35 -14.13 55.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.584 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.7 m -70.82 -47.83 57.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 120.217 1.371 . . . . 0.0 110.277 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -108.08 -3.41 18.69 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.25 1.42 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp 56.89 53.15 8.45 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.525 1.53 . . . . 0.0 110.073 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -120.86 165.64 14.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.41 138.34 53.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.99 151.64 32.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.19 0.905 . . . . 0.0 110.6 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' B' ' 36' ' ' LYS . 54.6 m-85 -83.06 8.2 13.6 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.25 153.26 44.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.295 1.407 . . . . 0.0 113.221 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -62.31 139.93 96.37 Favored Pre-proline 0 C--O 1.24 0.57 0 O-C-N 124.99 1.431 . . . . 0.0 109.345 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.456 -0.68 0 C-N-CA 123.308 2.672 . . . . 0.0 114.572 -179.616 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt . . . . . 0 C--O 1.233 0.222 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 20.0 Cg_endo -70.24 155.96 63.2 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.38 140.07 62.2 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 105.385 -2.583 . . . . 0.0 105.385 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.81 70.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.639 -1.089 . . . . 0.0 112.071 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CZ2' ' HB3' ' B' ' 43' ' ' PRO . 6.7 m95 -107.01 167.62 9.76 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.954 1.877 . . . . 0.0 106.58 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -144.43 154.45 42.97 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -119.06 133.34 55.87 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -124.87 136.96 59.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -127.17 134.94 50.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -150.94 179.1 8.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.522 2.329 . . . . 0.0 110.281 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 69.4 m -110.77 -25.05 10.11 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.099 -1.001 . . . . 0.0 111.7 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.08 -23.13 57.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 110.527 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.46 -53.65 1.9 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.243 1.417 . . . . 0.0 112.036 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.21 -104.36 0.64 Allowed Glycine 0 N--CA 1.469 0.84 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.7 m -144.13 131.01 20.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.506 1.653 . . . . 0.0 108.536 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.54 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.211 1.004 . . . . 0.0 109.829 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -127.18 142.94 51.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.035 1.334 . . . . 0.0 108.086 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.53 135.22 59.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.81 0.814 . . . . 0.0 110.11 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -100.63 104.26 15.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -72.94 -24.94 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 119.158 -0.448 . . . . 0.0 111.826 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -71.0 -37.21 72.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.363 1.465 . . . . 0.0 111.615 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -115.25 1.89 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.575 1.15 . . . . 0.0 112.574 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 40' ' ' TYR . 4.9 mmtp 48.19 62.17 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.554 1.942 . . . . 0.0 109.901 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -128.62 160.17 33.27 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.821 0.848 . . . . 0.0 110.018 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.8 131.41 47.76 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.356 1.462 . . . . 0.0 108.447 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -146.34 148.93 32.89 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.227 0.467 . . . . 0.0 110.538 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -91.44 25.7 2.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.04 1.736 . . . . 0.0 111.055 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -137.77 153.5 49.69 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . 0.454 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 4.7 t-80 -68.71 147.0 97.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 111.799 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . 0.462 ' HB3' ' CZ2' ' B' ' 18' ' ' TRP . 73.2 Cg_endo . . . . . 0 CA--C 1.539 0.742 0 C-N-CA 124.122 3.215 . . . . 0.0 113.449 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.81 161.73 40.96 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.536 2.157 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.36 123.71 11.18 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.851 2.368 . . . . 0.0 108.545 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.45 5.58 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.673 1.13 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 24.2 m95 -81.33 151.82 27.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.397 1.098 . . . . 0.0 108.993 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -135.43 140.87 45.24 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.468 0.707 . . . . 0.0 109.534 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -103.11 132.24 49.52 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.6 136.02 55.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.23 142.55 49.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -154.24 146.36 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.4 m -74.82 -12.82 60.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.559 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.27 -45.71 5.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 110.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -93.85 -18.1 22.36 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.11 -92.54 1.79 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.704 1.621 . . . . 0.0 111.544 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -153.75 124.44 7.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -139.43 177.15 8.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.806 0.442 . . . . 0.0 109.995 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.14 148.04 51.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 108.923 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.46 137.12 57.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.226 0.61 . . . . 0.0 110.271 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 9.2 t0 -99.14 115.74 29.74 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.597 2.759 . . . . 0.0 108.941 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -82.94 -10.04 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.598 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -75.45 -43.43 49.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 120.747 1.612 . . . . 0.0 110.164 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -117.74 0.41 11.99 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.157 0.983 . . . . 0.0 112.176 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 57.17 60.71 2.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.595 1.558 . . . . 0.0 108.509 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -129.47 143.63 50.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.789 0.835 . . . . 0.0 109.441 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.79 145.84 33.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 109.288 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.86 162.86 38.99 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.461 1.104 . . . . 0.0 110.276 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.78 8.91 41.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 160.56 32.15 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.819 1.19 . . . . 0.0 111.007 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -61.88 134.83 94.29 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 89.8 Cg_endo . . . . . 0 C--O 1.236 0.396 0 C-N-CA 124.29 3.327 . . . . 0.0 116.028 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.9 158.53 52.61 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.283 1.989 . . . . 0.0 110.567 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.8 123.61 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.558 2.172 . . . . 0.0 106.87 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.96 -26.41 6.8 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.643 1.592 . . . . 0.0 110.789 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 25.6 m95 -90.0 157.01 18.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.381 1.091 . . . . 0.0 110.172 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.19 150.5 42.8 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.802 0.841 . . . . 0.0 108.761 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -115.48 128.55 56.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -117.77 120.3 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.879 0.872 . . . . 0.0 109.509 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -107.31 146.28 31.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -150.11 170.77 18.14 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.754 1.622 . . . . 0.0 110.914 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -96.24 -34.23 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -74.87 -27.01 60.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.133 0.973 . . . . 0.0 110.756 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.93 -19.42 5.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.65 -86.5 1.28 Allowed Glycine 0 N--CA 1.461 0.331 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -159.67 134.23 7.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.902 1.351 . . . . 0.0 111.307 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -143.76 158.11 43.91 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 107.417 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -110.87 159.58 17.55 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.821 -1.174 . . . . 0.0 108.587 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.11 135.23 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 122.817 0.447 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.447 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 42.9 t0 -99.06 113.18 25.25 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.912 1.285 . . . . 0.0 108.689 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -72.92 -16.89 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.687 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 79.4 m -79.78 -28.91 40.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.996 0.919 . . . . 0.0 112.857 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -121.76 -4.79 9.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.893 0.769 . . . . 0.0 111.537 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp 56.21 47.66 18.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.829 1.652 . . . . 0.0 109.7 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.81 160.85 21.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.153 0.981 . . . . 0.0 111.175 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.61 140.59 51.32 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.972 1.309 . . . . 0.0 109.111 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -150.9 156.05 40.4 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.438 1.095 . . . . 0.0 110.169 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -97.47 -7.63 31.11 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.917 0.887 . . . . 0.0 111.67 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -100.1 142.43 31.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.06 1.344 . . . . 0.0 108.825 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -58.66 143.57 81.7 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.458 -0.563 0 C-N-CA 122.575 2.183 . . . . 0.0 116.734 -179.123 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--O 1.237 0.418 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 33.1 Cg_endo -66.9 158.87 54.43 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.43 1.42 . . . . 0.0 110.454 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 95.55 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.528 2.819 . . . . 0.0 107.589 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 139.98 -2.04 2.33 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.347 0.975 . . . . 0.0 112.982 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 19.8 m95 -118.24 151.47 37.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -137.18 153.53 50.42 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.265 0.626 . . . . 0.0 109.964 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -114.49 127.62 55.91 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.23 1.812 . . . . 0.0 107.789 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.25 117.76 56.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.83 152.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -151.2 177.39 10.27 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 120.647 -1.283 . . . . 0.0 111.622 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -114.07 -18.08 11.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.81 -10.97 12.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.701 0.801 . . . . 0.0 110.087 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -123.69 -12.36 7.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.466 1.906 . . . . 0.0 112.563 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.87 -77.04 1.15 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 126.11 1.814 . . . . 0.0 110.329 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -161.24 138.43 8.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.628 1.714 . . . . 0.0 110.357 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -143.17 171.74 13.67 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.93 153.1 43.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.911 0.885 . . . . 0.0 109.686 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.92 141.5 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.885 0.874 . . . . 0.0 110.846 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.55 111.07 23.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 129.729 3.212 . . . . 0.0 108.477 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -76.56 -18.53 58.63 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -78.26 -32.45 49.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.98 0.809 . . . . 0.0 110.313 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -116.44 -4.97 11.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 38' ' ' ALA . 6.4 mmmm 55.29 52.52 11.33 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.989 2.116 . . . . 0.0 109.886 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -124.52 165.69 17.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.454 1.102 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.68 151.52 47.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.158 1.383 . . . . 0.0 108.57 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.43 159.98 43.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.828 0.823 . . . . 0.0 111.643 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' B' ' 36' ' ' LYS . 14.2 m-30 -93.8 17.28 12.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.411 1.484 . . . . 0.0 113.837 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.36 150.84 38.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.464 -1.398 . . . . 0.0 110.072 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -59.92 142.33 88.87 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo . . . . . 0 CA--C 1.542 0.899 1 C-N-CA 125.747 4.298 . . . . 0.0 116.083 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.234 0.255 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' PRO . . . . . 0.412 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.8 Cg_endo -66.28 162.57 35.55 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.12 1.88 . . . . 0.0 110.336 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.95 108.62 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.423 2.749 . . . . 0.0 110.17 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.41 -26.19 6.73 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.674 1.131 . . . . 0.0 112.706 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 9.6 m95 -80.85 148.99 29.7 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 119.428 1.614 . . . . 0.0 108.867 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -131.24 152.19 50.76 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -111.65 138.84 47.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.6 136.15 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -124.58 141.19 52.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.0 p -154.25 -166.57 2.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.657 2.383 . . . . 0.0 109.209 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -121.15 -47.69 2.26 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.71 -50.99 70.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -80.61 -59.02 2.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.83 -98.49 0.53 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -150.96 136.34 17.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.446 1.623 . . . . 0.0 107.673 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -150.52 178.08 9.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.07 152.75 43.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.397 0.679 . . . . 0.0 109.409 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.66 139.0 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.464 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 55.0 t0 -100.01 104.91 16.54 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.051 1.74 . . . . 0.0 107.753 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -27.77 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.89 0.768 . . . . 0.0 112.386 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -64.2 -39.37 93.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 111.573 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -118.57 -1.33 11.19 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 40' ' ' TYR . 34.5 mmtm 52.63 50.71 17.57 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 125.019 1.328 . . . . 0.0 111.069 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -125.41 164.77 19.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . 0.4 ' O ' ' HE2' ' A' ' 36' ' ' LYS . . . -122.2 151.52 40.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.717 0.807 . . . . 0.0 109.104 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -146.14 152.25 38.97 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.271 0.941 . . . . 0.0 111.419 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.2 26.21 3.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.61 1.564 . . . . 0.0 112.622 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.86 167.52 28.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.15 -1.594 . . . . 0.0 109.011 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.11 154.84 91.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.159 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 0 CA--C 1.533 0.456 0 C-N-CA 123.651 2.901 . . . . 0.0 110.605 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.2 t -58.64 150.07 24.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.61 1.164 . . . . 0.0 111.803 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 p -112.16 12.91 20.51 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.829 2.452 . . . . 0.0 108.912 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.81 -11.75 5.66 Favored Glycine 0 C--N 1.341 0.833 0 C-N-CA 126.181 1.848 . . . . 0.0 113.143 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.2 m -149.4 89.79 1.67 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.829 1.815 . . . . 0.0 109.674 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 m -61.59 153.28 28.19 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.75 160.68 47.42 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.38 0.434 . . . . 0.0 112.976 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.1 -16.81 6.0 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.368 2.712 . . . . 0.0 111.861 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.9 mt -149.0 159.57 44.09 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.45 3.9 . . . . 0.0 106.293 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -128.3 0.76 5.73 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.018 1.327 . . . . 0.0 112.864 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 80.64 -21.15 0.34 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 130.388 3.475 . . . . 0.0 111.869 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -68.52 171.81 7.01 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.898 2.479 . . . . 0.0 112.258 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.91 166.22 53.92 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.31 162.14 62.43 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.642 1.177 . . . . 0.0 110.705 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 54.6 Cg_endo -69.36 161.55 45.43 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 121.914 1.743 . . . . 0.0 109.566 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.44 108.7 1.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.316 2.678 . . . . 0.0 108.653 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.28 -16.42 6.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.684 1.611 . . . . 0.0 111.704 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.0 m95 -95.38 142.68 27.48 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.261 -1.141 . . . . 0.0 109.429 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -125.32 140.73 52.57 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.273 0.629 . . . . 0.0 110.818 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -104.13 134.8 46.77 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.2 t -115.0 138.65 44.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.78 131.01 40.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.262 1.025 . . . . 0.0 110.729 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.82 170.9 18.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.01 1.724 . . . . 0.0 111.283 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -86.76 -29.36 22.41 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.446 1.098 . . . . 0.0 112.534 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -77.82 -44.38 27.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.97 1.259 . . . . 0.0 110.952 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.84 -24.73 14.58 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.3 -94.75 1.61 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.55 130.35 10.07 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.216 -0.579 . . . . 0.0 110.752 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.29 173.48 11.67 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -125.76 146.07 49.93 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.22 -0.925 . . . . 0.0 108.559 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.3 t -118.19 143.44 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.614 0.721 . . . . 0.0 109.546 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 64.6 t0 -108.2 109.75 21.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.709 2.003 . . . . 0.0 109.829 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -72.1 -26.36 62.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.086 0.857 . . . . 0.0 111.092 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 m -68.12 -33.43 74.49 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.615 1.166 . . . . 0.0 111.603 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -122.38 1.05 9.57 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' B' ' 38' ' ' ALA . 22.2 mmmt 50.31 51.48 16.69 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.584 1.953 . . . . 0.0 110.023 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -127.34 166.91 16.94 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 123.809 0.844 . . . . 0.0 110.227 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' O ' ' HE3' ' B' ' 36' ' ' LYS . . . -122.78 149.91 43.5 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -150.55 171.39 17.17 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.406 1.482 . . . . 0.0 107.988 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -112.89 -8.15 13.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -100.74 167.49 10.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.972 1.309 . . . . 0.0 110.865 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.93 149.48 82.82 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.05 169.71 21.55 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.327 2.685 . . . . 0.0 110.059 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -152.27 118.6 5.59 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.465 -0.772 . . . . 0.0 111.238 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.94 167.98 25.2 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -84.45 79.25 2.58 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 125.062 3.842 . . . . 0.0 109.759 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.8 m -53.6 -29.43 37.64 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.8 m -128.2 137.02 51.86 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.6 t -62.6 148.03 47.39 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.365 1.082 . . . . 0.0 108.946 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 18.2 p -138.79 28.19 2.4 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.317 1.847 . . . . 0.0 109.195 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.7 -81.99 0.07 OUTLIER Glycine 0 C--N 1.337 0.591 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.4 m -131.6 145.05 51.5 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 124.237 1.015 . . . . 0.0 109.642 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 135.83 53.07 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.92 168.73 9.61 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 123.665 0.65 . . . . 0.0 112.114 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.88 -35.32 9.52 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.034 1.822 . . . . 0.0 110.173 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.99 157.19 25.9 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.854 1.262 . . . . 0.0 108.579 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.31 4.64 20.98 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.799 1.64 . . . . 0.0 110.058 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 71.48 -2.5 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.087 2.555 . . . . 0.0 113.107 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -69.07 173.76 5.2 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.488 1.915 . . . . 0.0 110.492 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.99 -175.69 47.15 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.5 mt -99.26 158.07 32.9 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 121.514 -0.992 . . . . 0.0 110.951 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 72.7 Cg_endo -71.56 160.97 46.84 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.338 2.025 . . . . 0.0 111.009 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.73 115.43 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.249 2.632 . . . . 0.0 108.696 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.23 -21.31 13.25 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.661 1.124 . . . . 0.0 112.514 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 8.5 m95 -87.56 164.06 16.3 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 119.229 1.514 . . . . 0.0 108.144 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -144.82 152.65 40.63 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.943 -0.473 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp-105 -112.75 133.88 54.55 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.341 1.857 . . . . 0.0 107.005 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.32 128.51 75.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -109.93 141.56 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 10.1 t -153.07 -169.81 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.196 1.398 . . . . 0.0 109.15 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.9 m -130.32 -38.29 1.38 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.564 1.946 . . . . 0.0 107.093 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -67.41 -27.22 66.9 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -121.36 -26.21 5.06 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.67 -91.48 1.04 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.06 1.315 . . . . 0.0 110.27 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 60.4 m -154.93 137.07 14.75 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.491 -1.594 . . . . 0.0 109.3 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.14 179.21 7.65 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.41 -0.806 . . . . 0.0 109.245 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -131.65 154.44 48.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.46 0.704 . . . . 0.0 109.424 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.96 142.01 41.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.38 0.672 . . . . 0.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -102.9 125.69 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.478 2.711 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -85.17 -19.81 31.19 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.924 -0.485 . . . . 0.0 110.657 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 46.7 m -73.06 -32.69 65.21 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.82 1.248 . . . . 0.0 110.247 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -123.54 -2.94 8.37 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 38' ' ' ALA . 25.8 mmmt 54.88 40.38 31.95 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.802 1.241 . . . . 0.0 110.71 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -115.27 158.6 22.11 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HE3' ' A' ' 36' ' ' LYS . . . -116.89 147.48 42.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.51 1.124 . . . . 0.0 108.482 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -152.51 162.54 41.06 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.393 1.477 . . . . 0.0 108.745 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -103.33 -4.68 23.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.116 0.966 . . . . 0.0 113.023 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.54 163.28 13.46 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.18 0.992 . . . . 0.0 110.615 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -79.58 143.43 59.09 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.45 168.6 17.59 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.627 1.551 . . . . 0.0 113.278 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.0 p -148.96 178.23 8.87 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.92 1.288 . . . . 0.0 111.397 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.87 -173.47 18.83 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.708 2.099 . . . . 0.0 111.105 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.79 165.8 26.19 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.072 3.182 . . . . 0.0 110.124 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -136.3 -8.98 1.98 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.299 1.039 . . . . 0.0 113.256 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.2 m -142.14 -176.22 4.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.035 1.334 . . . . 0.0 109.662 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.814 0 N-CA-C 106.564 -2.615 . . . . 0.0 106.564 -179.741 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 m -119.55 -28.54 5.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.54 1.936 . . . . 0.0 109.118 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p -65.01 142.43 58.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.81 1.244 . . . . 0.0 108.528 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.39 -90.99 0.13 Allowed Glycine 0 CA--C 1.522 0.518 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.5 p -137.4 167.89 20.72 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.494 1.118 . . . . 0.0 109.321 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.2 t 155.54 -168.63 0.0 OUTLIER 'General case' 0 C--O 1.241 0.644 1 C-N-CA 132.126 4.17 . . . . 0.0 104.809 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.9 169.68 54.69 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.6 -51.54 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.576 2.184 . . . . 0.0 109.091 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -153.21 179.12 9.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 130.508 3.523 . . . . 0.0 106.665 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.25 -161.56 0.52 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.288 1.435 . . . . 0.0 112.956 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.44 ' HB2' HH11 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -135.29 11.55 3.53 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.936 1.694 . . . . 0.0 112.249 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -129.85 62.09 1.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.058 1.343 . . . . 0.0 107.997 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.79 5.9 0.06 OUTLIER Glycine 0 CA--C 1.529 0.91 0 CA-C-O 118.805 -0.997 . . . . 0.0 114.818 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.77 161.89 51.85 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 119.104 1.452 . . . . 0.0 107.353 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 37.6 Cg_endo -66.92 159.66 50.7 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.533 0.822 . . . . 0.0 110.314 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.1 110.68 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.493 2.795 . . . . 0.0 108.872 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.17 -14.48 16.1 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-O 117.942 -1.477 . . . . 0.0 114.155 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 43' ' ' PRO . 11.5 m95 -96.22 150.8 20.13 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 119.447 1.623 . . . . 0.0 107.036 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -135.08 148.31 49.81 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.488 0.185 . . . . 0.0 110.917 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -103.83 130.06 51.34 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -117.57 144.64 24.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.3 147.01 50.24 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.5 p -158.08 164.34 36.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.288 1.435 . . . . 0.0 110.701 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.7 m -92.06 -29.16 16.71 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.926 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -17.99 35.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.46 -46.87 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.83 -104.35 0.87 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -138.34 124.01 19.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -135.93 176.61 8.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 122.826 0.45 . . . . 0.0 111.043 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -132.39 151.88 51.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.541 0.737 . . . . 0.0 110.767 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.61 137.79 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.061 0.544 . . . . 0.0 111.146 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 34.3 t0 -101.26 107.97 19.49 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 127.946 2.498 . . . . 0.0 105.447 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -74.77 -19.71 60.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.0 m -80.75 -47.42 13.96 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.303 0.956 . . . . 0.0 110.276 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -93.91 -10.14 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.937 1.295 . . . . 0.0 112.213 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm 55.58 45.06 25.63 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.73 2.012 . . . . 0.0 110.868 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -114.46 164.29 14.17 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.096 0.959 . . . . 0.0 109.411 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.42 150.37 48.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.365 1.466 . . . . 0.0 109.102 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -160.23 151.97 19.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.015 1.326 . . . . 0.0 109.968 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -93.14 11.12 28.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.028 0.931 . . . . 0.0 111.388 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.43 160.24 34.64 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.522 -1.361 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -63.22 138.66 97.4 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.449 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 46.4 Cg_endo -74.5 53.1 3.01 Favored 'Trans proline' 0 CA--C 1.532 0.421 1 C-N-CA 125.928 4.418 . . . . 0.0 115.305 -178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -60.49 138.04 58.07 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.757 -0.589 . . . . 0.0 109.874 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.1 178.67 48.85 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.42 160.85 25.66 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.396 2.064 . . . . 0.0 109.61 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -143.26 77.46 1.56 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 m -82.73 -56.4 3.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 119.173 -0.441 . . . . 0.0 109.89 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 119.005 -0.886 . . . . 0.0 110.89 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 CA-C-O 118.609 -1.106 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -128.31 -7.31 5.31 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.139 0.97 . . . . 0.0 112.84 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -76.29 160.72 29.37 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.668 1.122 . . . . 0.0 108.242 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.68 -83.58 0.86 Allowed Glycine 0 C--N 1.332 0.325 0 N-CA-C 103.614 -3.794 . . . . 0.0 103.614 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -156.16 125.24 6.09 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.6 t -166.07 179.0 6.02 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.466 1.106 . . . . 0.0 109.499 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.53 171.57 49.7 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 -51.94 0.75 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.929 2.419 . . . . 0.0 114.89 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -157.27 179.26 9.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.163 1.785 . . . . 0.0 109.868 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -85.94 -177.81 6.41 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.98 2.112 . . . . 0.0 110.771 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 61.6 mtt85 -107.0 -54.62 2.44 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.012 0.925 . . . . 0.0 111.318 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 -3.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.085 2.954 . . . . 0.0 116.876 -178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.43 -2.57 61.76 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 119.782 1.174 . . . . 0.0 114.67 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -78.31 157.86 77.44 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.085 1.442 . . . . 0.0 112.444 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 39.8 Cg_endo -72.09 164.72 34.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.365 2.044 . . . . 0.0 111.686 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.09 121.36 9.54 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -10.7 58.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.288 -1.285 . . . . 0.0 115.063 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 24.3 m95 -94.04 161.29 14.34 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 119.521 1.66 . . . . 0.0 108.525 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -147.84 169.15 20.43 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -128.5 121.94 30.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.361 1.464 . . . . 0.0 109.355 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -96.58 123.74 49.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -112.96 137.92 50.62 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -150.93 -154.51 0.55 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.71 1.604 . . . . 0.0 108.96 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.1 m -127.31 -55.58 1.34 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.604 1.962 . . . . 0.0 107.101 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -60.83 -26.29 67.23 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.752 1.221 . . . . 0.0 113.312 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -113.93 -41.98 3.47 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.75 -96.72 1.02 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.068 0.842 . . . . 0.0 112.339 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -149.28 108.35 3.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 117.609 0.705 . . . . 0.0 109.567 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -125.22 176.77 6.51 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 109.726 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -131.25 156.9 44.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 123.702 0.801 . . . . 0.0 110.239 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 98.5 t -139.34 142.59 32.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.506 1.122 . . . . 0.0 108.783 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -106.19 115.04 29.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.548 2.339 . . . . 0.0 105.096 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -79.55 -17.1 54.74 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.51 0.724 . . . . 0.0 112.773 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -79.98 -45.11 19.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.214 1.405 . . . . 0.0 109.33 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -95.32 -15.12 23.35 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.188 0.995 . . . . 0.0 111.54 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 58.48 53.41 6.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 127.454 2.302 . . . . 0.0 109.312 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -134.66 153.61 51.91 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.967 0.507 . . . . 0.0 111.291 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.08 145.78 36.52 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.831 1.253 . . . . 0.0 110.524 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -147.23 150.87 35.7 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.682 0.793 . . . . 0.0 109.277 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.54 19.2 11.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.815 1.646 . . . . 0.0 112.613 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.8 159.69 41.67 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.41 -1.431 . . . . 0.0 109.037 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.63 152.09 76.06 Favored Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 123.956 0.902 . . . . 0.0 112.588 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.11 77.31 3.86 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.32 2.68 . . . . 0.0 116.047 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.9 162.03 26.31 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.579 -0.701 . . . . 0.0 109.227 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.91 164.52 10.9 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.91 0.767 . . . . 0.0 113.739 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.47 150.75 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 106.451 -2.173 . . . . 0.0 106.451 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -141.53 63.63 1.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.764 0.792 . . . . 0.0 109.177 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 4.3 m -73.42 -13.01 61.0 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.642 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.793 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 p -132.65 155.55 48.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.502 1.151 . . . . 0.0 109.967 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -133.3 149.01 51.94 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.991 2.117 . . . . 0.0 108.313 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.64 -19.92 2.99 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.073 0.844 . . . . 0.0 112.5 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m -79.09 175.31 10.7 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.546 1.173 . . . . 0.0 110.985 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -37.96 109.15 0.09 Allowed 'General case' 0 C--N 1.344 0.346 0 C-N-CA 126.419 1.888 . . . . 0.0 110.865 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.45 171.63 30.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.835 1.207 . . . . 0.0 112.085 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -61.4 -38.88 60.76 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.918 2.412 . . . . 0.0 113.534 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.84 -171.0 2.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.268 1.827 . . . . 0.0 109.639 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -54.0 158.23 2.2 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.84 1.656 . . . . 0.0 112.628 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -130.43 68.12 1.47 Allowed 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 125.371 1.468 . . . . 0.0 107.075 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -139.02 165.95 25.77 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.248 1.019 . . . . 0.0 108.963 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.77 -10.39 0.11 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 118.25 -1.305 . . . . 0.0 114.203 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.2 mt -123.38 160.17 51.64 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.747 1.619 . . . . 0.0 110.568 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -71.05 163.7 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.458 2.105 . . . . 0.0 110.614 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 140.49 64.31 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.954 1.77 . . . . 0.0 108.747 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.12 -12.6 63.84 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.057 -1.413 . . . . 0.0 113.23 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.449 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 5.9 m95 -90.59 164.14 14.31 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 120.657 2.229 . . . . 0.0 109.112 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -147.43 155.27 41.78 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.804 0.812 . . . . 0.0 109.847 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -124.87 140.81 52.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 103.93 -2.619 . . . . 0.0 103.93 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.99 139.19 50.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.8 121.53 37.43 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 126.212 1.805 . . . . 0.0 106.474 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.0 p -131.53 172.25 12.44 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 112.012 -178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -95.64 -28.21 14.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.791 1.236 . . . . 0.0 110.674 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -95.93 -28.14 14.82 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -107.97 -34.79 6.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.88 -98.23 0.98 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.33 0.968 . . . . 0.0 112.762 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 m -148.16 121.83 9.23 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.521 0.728 . . . . 0.0 109.202 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -140.14 176.44 8.75 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.206 -0.934 . . . . 0.0 109.67 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -129.42 150.09 50.92 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.814 0.734 . . . . 0.0 110.373 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -121.5 131.85 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.747 0.819 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.3 t0 -98.78 116.98 32.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -86.84 -20.46 27.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.774 -1.108 . . . . 0.0 113.115 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 m -76.97 -31.71 56.75 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.591 1.087 . . . . 0.0 110.118 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -109.96 -12.01 14.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.893 1.677 . . . . 0.0 111.959 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HE2' ' CE2' ' B' ' 40' ' ' TYR . 42.5 mmtm 54.11 56.91 6.44 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.476 1.51 . . . . 0.0 110.782 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -130.58 169.6 15.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.24 1.016 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.37 142.74 51.42 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.896 1.679 . . . . 0.0 108.923 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -151.77 161.01 43.37 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.432 1.493 . . . . 0.0 110.522 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -107.57 25.78 11.06 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.906 1.282 . . . . 0.0 112.142 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.61 160.03 40.81 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.704 -1.248 . . . . 0.0 110.059 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.97 153.41 55.23 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.981 0.913 . . . . 0.0 110.481 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.49 83.8 1.94 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.636 2.891 . . . . 0.0 114.509 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 p -50.95 -55.41 17.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.332 1.453 . . . . 0.0 112.786 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -175.44 32.98 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.96 -16.28 16.1 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.512 2.808 . . . . 0.0 113.949 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 p -139.34 175.87 9.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.518 1.127 . . . . 0.0 110.37 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 p -147.87 -176.44 5.27 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 127.415 2.286 . . . . 0.0 106.385 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.699 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.603 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -145.43 179.14 7.6 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.773 1.229 . . . . 0.0 109.102 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -157.74 179.37 9.28 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.639 1.576 . . . . 0.0 108.343 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.2 -13.27 0.59 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.529 1.061 . . . . 0.0 113.274 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.7 m -82.79 166.58 18.9 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 119.007 1.403 . . . . 0.0 110.257 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -47.98 137.7 9.89 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.146 1.378 . . . . 0.0 111.922 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.22 166.51 35.11 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.776 0.703 . . . . 0.0 112.568 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.41 -39.14 10.19 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.814 2.343 . . . . 0.0 110.102 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.67 178.97 7.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.263 2.625 . . . . 0.0 107.069 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.17 168.92 2.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.985 0.898 . . . . 0.0 111.132 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -130.16 12.88 5.64 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.086 1.354 . . . . 0.0 112.479 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -83.5 141.9 31.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.99 0.916 . . . . 0.0 109.66 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -115.83 -86.97 1.34 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 123.036 0.351 . . . . 0.0 113.294 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -50.5 153.26 2.77 Favored Pre-proline 0 N--CA 1.465 0.294 0 C-N-CA 126.15 1.78 . . . . 0.0 114.302 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.78 160.51 49.34 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.108 1.872 . . . . 0.0 111.764 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.62 99.21 0.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.797 2.998 . . . . 0.0 109.769 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.59 -1.62 5.22 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.645 1.593 . . . . 0.0 112.235 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -117.37 153.75 32.5 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.651 1.225 . . . . 0.0 109.479 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -143.01 168.47 19.64 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -130.8 125.54 33.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.643 2.377 . . . . 0.0 105.408 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.54 145.73 15.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -124.5 138.9 54.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.477 1.111 . . . . 0.0 108.276 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.7 p -154.66 177.66 10.98 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.363 1.865 . . . . 0.0 111.479 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -105.52 -33.47 8.1 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -64.62 -35.57 81.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.908 1.683 . . . . 0.0 110.865 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.05 -35.96 3.22 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.811 0.844 . . . . 0.0 113.006 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.05 -100.37 1.3 Allowed Glycine 0 C--O 1.224 -0.521 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 22.9 m -147.36 127.56 13.83 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 120.225 -1.75 . . . . 0.0 108.818 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -142.37 173.99 11.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.641 0.776 . . . . 0.0 111.329 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -122.62 148.04 45.72 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.168 0.987 . . . . 0.0 112.944 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -126.49 140.0 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 108.66 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -107.94 115.61 30.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 127.862 2.465 . . . . 0.0 108.418 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -77.27 -30.31 54.26 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 87.3 m -67.61 -39.07 84.75 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.55 1.14 . . . . 0.0 110.783 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -106.9 -6.77 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.094 0.558 . . . . 0.0 112.441 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp 51.74 52.94 13.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.854 1.662 . . . . 0.0 110.633 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -126.48 166.46 17.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.846 1.258 . . . . 0.0 109.954 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.47 140.63 52.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.351 1.461 . . . . 0.0 107.727 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -147.06 171.67 14.93 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.607 1.163 . . . . 0.0 108.743 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.472 ' CE2' ' HE2' ' A' ' 36' ' ' LYS . 84.3 m-85 -112.79 -2.08 14.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.66 0.664 . . . . 0.0 112.429 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 160.89 14.84 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.964 0.906 . . . . 0.0 109.37 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -71.72 143.72 87.49 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.81 147.68 50.69 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.51 2.14 . . . . 0.0 114.155 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -114.12 -89.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.117 1.767 . . . . 0.0 107.534 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.94 -177.37 20.03 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.457 1.98 . . . . 0.0 109.519 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.6 -8.43 19.36 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.778 2.986 . . . . 0.0 112.836 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.8 p -151.73 168.48 24.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.104 1.362 . . . . 0.0 109.226 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.2 p -172.75 160.52 4.51 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.897 1.679 . . . . 0.0 108.127 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.756 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -68.02 168.8 11.22 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.043 0.921 . . . . 0.0 110.407 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.59 143.24 32.35 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.6 135.25 8.78 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.8 p -165.91 170.43 13.76 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.067 0.947 . . . . 0.0 110.599 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.7 t -153.72 172.39 17.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.857 1.663 . . . . 0.0 107.01 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.7 -176.54 14.46 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.839 2.161 . . . . 0.0 109.142 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -64.2 -47.02 6.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.79 1.66 . . . . 0.0 109.626 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp -157.17 177.84 11.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.953 2.501 . . . . 0.0 107.482 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -125.97 169.56 12.58 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.699 1.2 . . . . 0.0 108.545 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -130.17 44.42 2.97 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.557 1.543 . . . . 0.0 110.522 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -105.92 171.83 7.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.797 0.839 . . . . 0.0 110.491 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.47 -164.58 10.82 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.196 2.808 . . . . 0.0 108.834 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt -138.56 157.89 71.34 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 118.977 1.389 . . . . 0.0 111.438 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.91 163.56 35.23 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.058 1.172 . . . . 0.0 110.949 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.27 133.11 36.35 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.042 1.828 . . . . 0.0 109.006 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.1 -14.96 61.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.72 1.629 . . . . 0.0 111.644 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -105.9 142.54 35.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.394 1.097 . . . . 0.0 108.884 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -135.94 160.19 39.36 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.475 1.51 . . . . 0.0 107.705 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -120.26 120.7 36.84 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.16 149.72 11.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.43 148.38 52.4 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.72 1.208 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.6 t -160.82 153.88 21.42 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.784 1.634 . . . . 0.0 112.819 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -80.44 -29.75 37.57 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -80.58 -27.1 37.55 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.918 1.687 . . . . 0.0 112.41 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -117.26 -38.13 3.41 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.95 -109.83 2.3 Favored Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 107.204 -2.358 . . . . 0.0 107.204 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.25 126.98 20.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -138.48 170.04 16.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.508 0.67 . . . . 0.0 109.665 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -130.27 148.45 52.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.225 1.01 . . . . 0.0 109.0 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' B' ' 31' ' ' VAL . 58.6 t -134.42 139.68 47.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 109.355 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -103.34 116.1 31.8 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 126.734 2.014 . . . . 0.0 108.319 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -72.23 -17.55 61.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.581 178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 m -71.21 -51.22 25.92 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.877 0.871 . . . . 0.0 111.665 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -110.4 4.75 20.92 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 123.516 0.727 . . . . 0.0 112.776 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 51.87 41.69 29.59 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.97 1.308 . . . . 0.0 111.387 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -105.74 156.34 18.39 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.31 148.21 49.58 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.942 1.297 . . . . 0.0 107.952 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -160.44 168.31 25.43 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.865 -1.147 . . . . 0.0 110.647 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -104.85 15.73 27.28 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 112.302 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -117.22 153.95 31.99 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.047 -1.033 . . . . 0.0 109.977 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -71.18 136.63 84.42 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.88 118.0 5.3 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.781 1.654 . . . . 0.0 108.197 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 t -116.58 54.15 0.86 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.559 1.544 . . . . 0.0 111.511 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 163.85 26.1 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 120.822 -1.174 . . . . 0.0 114.396 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.0 160.75 45.78 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.099 3.2 . . . . 0.0 111.473 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.3 m -86.09 114.51 23.01 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.806 0.843 . . . . 0.0 108.822 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.73 -45.83 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.865 0.866 . . . . 0.0 109.352 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.906 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.641 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.95 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -71.09 168.58 16.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -128.83 173.61 10.21 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 128.069 2.548 . . . . 0.0 107.048 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.26 165.28 12.16 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p -173.9 169.52 4.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.14 1.776 . . . . 0.0 108.51 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.7 t -147.43 134.99 20.92 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.17 169.62 40.17 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.97 -31.32 8.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.557 2.171 . . . . 0.0 111.423 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 pp -170.76 173.82 5.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 129.493 3.117 . . . . 0.0 106.523 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -147.9 178.99 8.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.31 1.044 . . . . 0.0 110.989 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -126.37 17.09 7.68 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.933 2.493 . . . . 0.0 110.681 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.55 173.83 11.07 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.475 -0.765 . . . . 0.0 110.869 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.9 -163.92 13.31 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 49.1 mt -130.32 156.12 79.93 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.627 1.571 . . . . 0.0 109.766 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 18.8 Cg_endo -63.78 160.21 37.93 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.786 1.657 . . . . 0.0 111.368 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.86 91.05 0.52 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 124.534 3.489 . . . . 0.0 110.149 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.49 -3.28 2.93 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.477 1.513 . . . . 0.0 111.734 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.433 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.5 m95 -110.36 156.73 20.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.487 1.144 . . . . 0.0 108.195 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -148.95 158.56 44.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.21 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -112.04 144.95 40.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.787 1.635 . . . . 0.0 106.949 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 90.6 t -124.44 118.82 54.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -110.28 130.78 55.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 t -154.77 148.72 25.7 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.745 1.218 . . . . 0.0 110.804 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 28.5 m -76.16 -23.34 54.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.494 1.043 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -81.22 -22.67 38.63 Favored 'General case' 0 C--O 1.23 0.05 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -120.69 -43.97 2.46 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.52 -113.29 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 7.1 m -141.05 111.99 7.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -131.71 -179.96 5.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -131.35 155.9 46.43 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.89 0.876 . . . . 0.0 111.345 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 31' ' ' VAL . 44.9 t -131.66 138.7 52.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.795 1.238 . . . . 0.0 109.301 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 22.1 t0 -106.68 118.96 38.03 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.474 1.91 . . . . 0.0 109.258 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -77.88 -20.9 52.15 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -69.28 -49.98 51.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.5 1.046 . . . . 0.0 110.49 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -105.85 -0.06 25.55 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt 53.87 53.49 11.21 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.008 1.323 . . . . 0.0 109.919 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtp85 -119.27 162.48 18.66 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.466 0.706 . . . . 0.0 109.578 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.93 142.68 50.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.861 1.264 . . . . 0.0 108.856 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -154.9 164.81 38.33 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.349 1.059 . . . . 0.0 108.372 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -103.71 -6.56 21.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.63 142.5 34.55 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.0 t-80 -56.12 146.69 49.42 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.807 1.243 . . . . 0.0 110.572 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 56.4 Cg_endo -67.73 158.53 56.8 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.469 2.113 . . . . 0.0 112.492 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.37 125.21 3.81 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.785 1.234 . . . . 0.0 108.531 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.75 -177.64 21.98 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.918 1.247 . . . . 0.0 111.688 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -83.03 -169.88 0.81 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 124.996 3.797 . . . . 0.0 109.858 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 49.5 m -109.65 112.44 24.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.607 1.163 . . . . 0.0 109.357 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 3.1 m -145.73 -81.53 0.15 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.145 1.378 . . . . 0.0 107.514 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.505 0 N-CA-C 107.052 -2.419 . . . . 0.0 107.052 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 t -70.86 146.47 49.61 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.849 1.325 . . . . 0.0 108.932 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.9 m -149.22 170.74 17.79 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.688 1.995 . . . . 0.0 109.152 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.39 167.5 20.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p -161.45 178.34 9.23 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.08 0.552 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -164.31 -163.82 0.79 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.303 1.841 . . . . 0.0 106.787 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.66 176.34 44.48 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.16 -39.18 2.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.291 1.994 . . . . 0.0 112.057 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.6 mt -148.47 145.04 27.78 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 128.014 2.526 . . . . 0.0 107.994 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -121.74 168.64 11.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.187 1.395 . . . . 0.0 108.497 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.33 21.32 1.71 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.933 1.293 . . . . 0.0 113.038 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -82.21 -177.18 6.54 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.567 1.147 . . . . 0.0 112.752 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.65 122.66 27.04 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.41 157.64 63.13 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 163.27 39.2 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.863 2.375 . . . . 0.0 110.921 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.52 123.92 11.02 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.391 2.061 . . . . 0.0 107.991 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.71 -17.75 22.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.527 -1.152 . . . . 0.0 112.176 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 24.5 m95 -100.77 164.07 12.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -143.52 151.33 40.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.883 0.373 . . . . 0.0 111.851 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -112.82 121.16 43.88 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -105.79 146.28 12.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -131.8 111.83 11.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.98 1.712 . . . . 0.0 106.902 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m -129.11 174.68 9.34 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.43 1.492 . . . . 0.0 111.427 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -106.85 -22.13 12.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.584 0.754 . . . . 0.0 112.205 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.39 -12.96 47.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.724 0.693 . . . . 0.0 111.314 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -134.59 -63.41 0.71 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.192 0.997 . . . . 0.0 109.673 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.36 -109.47 0.71 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.627 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.1 m -131.37 112.05 12.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.757 1.279 . . . . 0.0 109.257 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -134.07 146.1 50.01 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.496 1.518 . . . . 0.0 108.255 178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.11 146.87 26.29 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.859 1.264 . . . . 0.0 111.204 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.08 138.34 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.303 1.041 . . . . 0.0 110.15 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 36.3 t70 -105.92 110.48 22.77 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 127.044 2.137 . . . . 0.0 108.032 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -75.81 -18.08 59.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.2 m -71.72 -28.98 64.06 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 120.751 1.614 . . . . 0.0 111.807 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -126.18 -7.75 6.5 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 124.555 1.142 . . . . 0.0 112.536 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.6 mtmm 58.66 60.03 2.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.472 1.909 . . . . 0.0 109.047 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -124.33 168.79 12.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.54 1.136 . . . . 0.0 108.974 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.15 147.92 52.08 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -155.1 167.82 29.07 Favored 'General case' 0 C--N 1.333 -0.115 0 O-C-N 121.09 -1.006 . . . . 0.0 110.978 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -108.15 10.9 27.89 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.041 0.937 . . . . 0.0 112.927 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.97 153.27 46.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.327 1.051 . . . . 0.0 110.39 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.58 136.74 89.49 Favored Pre-proline 0 N--CA 1.451 -0.415 0 O-C-N 124.398 1.061 . . . . 0.0 109.946 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 88.4 Cg_endo -75.5 92.12 1.03 Allowed 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.312 2.675 . . . . 0.0 110.564 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.0 m -143.02 140.22 30.91 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.698 0.799 . . . . 0.0 109.149 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.28 173.13 22.91 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.264 0.935 . . . . 0.0 111.351 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.36 125.21 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.286 2.657 . . . . 0.0 108.701 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.4 m -125.67 98.06 5.41 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.127 1.371 . . . . 0.0 108.641 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 t -70.7 -62.1 1.52 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.803 0.841 . . . . 0.0 109.124 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -179.205 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.079 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -65.35 157.51 28.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.545 1.172 . . . . 0.0 108.898 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.1 m -147.68 161.37 41.31 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.859 1.264 . . . . 0.0 109.118 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.5 -175.85 31.26 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.421 1.486 . . . . 0.0 110.571 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -162.77 133.49 4.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.09 0.445 . . . . 0.0 111.037 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 68.5 m -155.95 139.03 15.48 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 129.201 3.0 . . . . 0.0 107.198 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 174.62 40.91 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.3 -49.2 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.148 2.565 . . . . 0.0 116.941 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 62.5 mt -147.67 79.89 1.49 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.403 1.881 . . . . 0.0 110.922 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.05 165.59 15.46 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -142.3 67.44 1.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 125.299 1.44 . . . . 0.0 107.554 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -128.0 -170.03 2.17 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.99 167.67 10.98 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -115.27 157.23 44.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 121.341 -1.093 . . . . 0.0 112.038 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.474 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 42.6 Cg_endo -67.44 165.49 26.91 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.51 2.14 . . . . 0.0 109.841 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.81 128.05 22.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.273 1.982 . . . . 0.0 108.367 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.07 -17.41 58.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.15 1.357 . . . . 0.0 114.28 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.474 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 6.8 m95 -83.96 153.79 23.71 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.955 1.877 . . . . 0.0 109.498 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -138.25 151.54 47.74 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.362 0.665 . . . . 0.0 109.72 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.51 134.54 54.62 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.94 134.24 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 123.802 0.841 . . . . 0.0 109.055 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.18 140.71 52.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -159.9 133.52 7.11 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.222 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.4 m -60.06 -14.95 19.14 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -89.3 -20.73 23.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.011 0.823 . . . . 0.0 112.128 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.33 -16.4 3.95 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.03 -99.1 2.24 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.829 -2.109 . . . . 0.0 107.829 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 25.4 m -152.03 142.49 22.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.466 0.706 . . . . 0.0 109.497 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.09 -179.42 7.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.842 1.657 . . . . 0.0 109.017 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -131.66 151.9 51.27 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.623 1.569 . . . . 0.0 106.898 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.93 145.97 34.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 123.556 0.743 . . . . 0.0 109.108 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -107.34 102.54 11.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 128.975 2.91 . . . . 0.0 105.918 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -23.84 61.65 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 24.2 m -74.95 -16.89 60.63 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.762 2.025 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -132.84 -12.45 2.94 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.253 1.421 . . . . 0.0 112.35 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm 57.61 56.78 4.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.346 2.258 . . . . 0.0 109.095 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 63.6 mtm-85 -133.22 155.7 48.87 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.525 1.13 . . . . 0.0 109.589 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.49 153.7 29.51 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.497 1.119 . . . . 0.0 110.865 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -153.78 147.82 25.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.34 10.62 12.13 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.24 166.78 23.83 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.207 1.367 . . . . 0.0 112.983 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -55.81 144.7 55.53 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 126.406 1.882 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.91 68.89 3.83 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.791 3.66 . . . . 0.0 113.866 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 18.3 m -81.91 -173.15 4.31 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.835 1.254 . . . . 0.0 110.847 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.19 158.71 17.64 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.129 1.347 . . . . 0.0 113.093 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.99 167.35 22.11 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 124.335 3.357 . . . . 0.0 112.287 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 66.9 m -138.35 167.02 22.76 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.591 1.956 . . . . 0.0 110.532 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 9.2 t -134.31 -63.56 0.72 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.567 1.947 . . . . 0.0 108.232 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.666 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p -86.39 169.36 12.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.273 1.037 . . . . 0.0 110.589 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -77.51 31.45 0.15 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.482 1.913 . . . . 0.0 112.734 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.45 -87.78 0.18 Allowed Glycine 0 C--N 1.338 0.677 0 O-C-N 120.837 -1.164 . . . . 0.0 112.616 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m -103.22 -172.25 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.561 1.145 . . . . 0.0 110.379 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m -59.06 131.56 51.4 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.234 0.614 . . . . 0.0 109.384 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.91 -174.95 40.98 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.13 -54.33 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.302 2.668 . . . . 0.0 112.677 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -176.33 165.01 2.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.578 2.351 . . . . 0.0 109.024 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.53 175.81 9.04 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.057 1.343 . . . . 0.0 111.81 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -121.63 -8.1 9.05 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.796 1.238 . . . . 0.0 114.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.97 180.0 4.6 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.235 1.014 . . . . 0.0 112.605 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.88 174.8 51.0 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.522 1.058 . . . . 0.0 110.834 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.42 154.55 63.27 Favored Pre-proline 0 C--O 1.238 0.448 0 O-C-N 121.788 -0.831 . . . . 0.0 112.446 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -72.41 163.43 38.61 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 N-CA-C 107.409 -1.804 . . . . 0.0 107.409 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.29 151.39 82.7 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.56 -20.72 4.95 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.068 -1.407 . . . . 0.0 113.593 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.477 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 19.5 m95 -86.06 157.99 19.93 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.956 1.878 . . . . 0.0 109.124 178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -143.14 152.48 41.85 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 122.091 -0.38 . . . . 0.0 110.092 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -117.73 121.87 41.97 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.338 1.855 . . . . 0.0 108.939 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.34 138.78 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.65 105.08 8.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.411 1.484 . . . . 0.0 109.023 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.0 m -137.83 128.15 26.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 127.681 2.392 . . . . 0.0 108.491 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.3 m -63.79 -21.54 66.47 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.095 1.316 . . . . 0.0 112.045 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.88 -21.29 66.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.913 1.685 . . . . 0.0 112.651 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -134.24 -29.28 1.26 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.63 -108.21 2.15 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 127.351 2.405 . . . . 0.0 107.432 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -145.13 125.12 13.54 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.442 0.697 . . . . 0.0 110.274 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.32 176.92 8.25 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -128.39 153.4 47.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.894 1.278 . . . . 0.0 110.64 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.64 135.03 61.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.216 1.006 . . . . 0.0 108.985 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 62.1 t0 -99.8 102.71 14.22 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 126.578 1.951 . . . . 0.0 108.582 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -70.4 -20.36 62.94 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.245 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.8 m -75.81 -31.44 59.42 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 120.806 -1.184 . . . . 0.0 110.582 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -117.79 -2.6 11.34 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 53.56 46.24 26.5 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.549 2.339 . . . . 0.0 110.252 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -119.49 167.45 11.94 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 148.78 51.89 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 125.089 1.355 . . . . 0.0 108.571 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -156.78 152.94 27.56 Favored 'General case' 0 C--O 1.225 -0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 110.526 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -86.23 0.07 54.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -118.23 162.92 17.45 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 119.287 0.949 . . . . 0.0 112.314 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -65.11 143.94 98.96 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 124.557 1.161 . . . . 0.0 109.09 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 89.9 Cg_endo -73.36 -168.3 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.021 3.147 . . . . 0.0 113.462 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 t -137.79 160.16 40.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.378 1.871 . . . . 0.0 107.919 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.94 170.51 22.46 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.22 -155.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.283 3.322 . . . . 0.0 109.395 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.4 m -137.44 159.23 42.52 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 121.413 -0.804 . . . . 0.0 111.249 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.93 -38.93 2.14 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.031 2.132 . . . . 0.0 110.502 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.905 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.786 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.9 p -72.75 148.2 44.85 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.655 1.228 . . . . 0.0 111.334 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.6 m -69.72 98.43 1.19 Allowed 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.425 1.09 . . . . 0.0 111.236 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.12 -88.85 1.18 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 124.55 1.071 . . . . 0.0 111.056 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.7 m -63.43 168.65 4.36 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.852 0.861 . . . . 0.0 111.668 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.4 m -72.79 -12.45 61.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.177 1.791 . . . . 0.0 113.626 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.42 163.01 28.33 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.947 1.261 . . . . 0.0 110.946 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.64 -58.38 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.169 2.579 . . . . 0.0 110.79 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.79 144.96 5.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.635 1.574 . . . . 0.0 108.957 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.34 172.83 13.02 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -129.02 -9.47 4.84 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.416 1.486 . . . . 0.0 113.976 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -75.11 177.46 6.41 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.547 1.539 . . . . 0.0 111.244 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.29 176.71 26.51 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 123.862 0.744 . . . . 0.0 111.359 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 72.7 mt -74.45 156.23 87.19 Favored Pre-proline 0 N--CA 1.468 0.45 0 O-C-N 120.933 -1.334 . . . . 0.0 111.49 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.65 165.17 33.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.86 1.707 . . . . 0.0 109.029 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.16 146.03 93.95 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.286 1.991 . . . . 0.0 110.518 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.1 -17.7 9.2 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.886 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' B' ' 43' ' ' PRO . 11.3 m95 -83.59 156.53 22.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 120.159 1.98 . . . . 0.0 109.414 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -140.54 153.44 46.16 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.947 -0.471 . . . . 0.0 110.651 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -121.35 121.43 37.62 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.8 112.42 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -110.58 130.99 55.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.673 1.189 . . . . 0.0 107.812 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -153.44 -162.61 1.49 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.175 2.59 . . . . 0.0 107.95 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -124.95 -24.09 4.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.948 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -69.83 -25.31 63.69 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.334 0.97 . . . . 0.0 109.895 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -127.89 -15.62 4.81 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.151 1.78 . . . . 0.0 111.873 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.95 -83.64 1.59 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 118.424 0.556 . . . . 0.0 113.436 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 87.6 m -156.63 129.12 7.58 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.159 -1.2 . . . . 0.0 110.665 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -142.44 171.15 14.45 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.83 149.46 48.62 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.378 1.471 . . . . 0.0 107.748 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.9 t -132.68 131.93 59.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 123.608 0.763 . . . . 0.0 108.956 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -94.73 107.41 19.42 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.095 1.358 . . . . 0.0 109.307 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -65.05 -19.03 65.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.7 m -76.02 -38.39 57.32 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.333 1.453 . . . . 0.0 113.414 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -121.0 2.07 10.43 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp 49.92 39.92 19.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.898 2.079 . . . . 0.0 112.316 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -105.86 156.98 17.81 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.23 143.07 48.48 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.68 1.192 . . . . 0.0 109.031 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -155.08 161.55 41.27 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.656 -0.652 . . . . 0.0 110.967 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -101.66 19.16 18.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.626 1.17 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.63 152.41 45.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 119.889 -1.757 . . . . 0.0 109.821 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.84 147.7 98.52 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.065 0.946 . . . . 0.0 109.612 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.497 ' HB3' ' CE2' ' B' ' 18' ' ' TRP . 59.8 Cg_endo -69.78 166.63 26.95 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.5 2.8 . . . . 0.0 115.05 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -138.47 161.32 37.31 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.141 1.776 . . . . 0.0 108.796 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.49 -178.11 39.44 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.657 2.075 . . . . 0.0 108.73 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.75 161.59 36.34 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.757 2.971 . . . . 0.0 111.94 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 16.4 m -78.84 -175.33 4.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.387 1.075 . . . . 0.0 109.273 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -106.55 -49.83 3.25 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.425 1.09 . . . . 0.0 109.34 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 N-CA-C 105.139 -3.185 . . . . 0.0 105.139 -179.816 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.558 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.08 161.1 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.973 1.309 . . . . 0.0 109.368 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -142.29 153.65 44.07 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.125 1.37 . . . . 0.0 107.654 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.18 177.77 43.6 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.829 1.68 . . . . 0.0 108.976 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -148.53 91.62 1.91 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.615 1.208 . . . . 0.0 110.33 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 p -156.6 146.2 20.76 Favored 'General case' 0 C--O 1.239 0.525 0 O-C-N 120.952 -1.093 . . . . 0.0 110.541 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.25 169.6 54.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.367 0.984 . . . . 0.0 112.862 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -58.07 -74.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 125.245 3.963 . . . . 0.0 113.592 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pp -155.46 -177.34 6.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.523 1.529 . . . . 0.0 109.1 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -133.16 -176.27 4.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.856 2.063 . . . . 0.0 107.495 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -138.82 19.94 2.67 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.468 1.107 . . . . 0.0 111.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -76.0 -177.73 4.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.595 0.758 . . . . 0.0 109.903 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.36 178.25 10.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.686 1.136 . . . . 0.0 110.934 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.7 mt -135.78 153.49 77.31 Favored Pre-proline 0 N--CA 1.464 0.266 0 O-C-N 121.071 -1.252 . . . . 0.0 112.538 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 36.6 Cg_endo -70.38 166.34 28.68 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.14 1.894 . . . . 0.0 110.214 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.55 140.63 82.54 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 N-CA-C 106.966 -1.974 . . . . 0.0 106.966 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.82 -9.63 73.41 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.291 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.9 m95 -104.11 156.17 18.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 121.196 2.498 . . . . 0.0 110.161 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -145.2 157.69 44.01 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.033 0.933 . . . . 0.0 108.958 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -127.23 121.56 31.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.727 2.411 . . . . 0.0 106.534 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.7 t -104.33 149.21 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 125.789 1.636 . . . . 0.0 109.116 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.28 130.44 38.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.371 1.468 . . . . 0.0 110.036 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.9 m -147.88 170.45 17.63 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.091 1.356 . . . . 0.0 110.56 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.1 m -91.15 -42.58 10.37 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 120.315 -1.49 . . . . 0.0 107.027 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -64.54 -23.84 67.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.984 1.714 . . . . 0.0 112.374 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -129.07 -12.18 4.66 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.29 -86.4 1.21 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.58 136.78 13.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.461 0.704 . . . . 0.0 110.678 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.81 161.59 41.51 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.604 1.093 . . . . 0.0 109.571 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -116.34 148.09 40.93 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.575 0.75 . . . . 0.0 109.109 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 31' ' ' VAL . 57.4 t -127.38 142.21 44.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 50.3 t0 -107.35 102.48 11.77 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.042 1.737 . . . . 0.0 110.342 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -66.04 -18.05 65.09 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.93 -0.481 . . . . 0.0 111.658 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.3 m -73.28 -29.75 62.94 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.284 0.947 . . . . 0.0 111.924 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -127.32 -0.96 6.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.63 0.772 . . . . 0.0 112.832 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm 56.75 45.32 22.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.683 1.993 . . . . 0.0 109.899 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm180 -121.79 153.41 38.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.846 0.858 . . . . 0.0 110.684 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.6 143.79 44.44 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.946 1.299 . . . . 0.0 108.881 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -140.01 170.85 15.1 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.909 1.684 . . . . 0.0 109.778 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.6 6.88 20.3 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.22 161.03 34.42 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.586 0.63 . . . . 0.0 109.723 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.45 138.91 89.09 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.07 167.65 26.79 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.372 2.715 . . . . 0.0 114.902 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.6 m -80.05 -73.72 0.34 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.49 175.66 36.94 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -82.55 -174.66 2.15 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 124.304 3.336 . . . . 0.0 110.424 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.7 t -99.59 -96.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 102.451 -3.166 . . . . 0.0 102.451 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.1 m -146.19 171.85 14.32 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.567 1.076 . . . . 0.0 110.284 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 117.989 -1.451 . . . . 0.0 110.928 179.719 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.54 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.22 174.24 6.66 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.678 1.191 . . . . 0.0 109.018 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.33 165.01 33.26 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.122 0.969 . . . . 0.0 109.304 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.89 -170.3 26.43 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.839 2.162 . . . . 0.0 108.288 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.8 t -155.57 103.76 2.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 57.7 p -139.28 156.63 46.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.057 0.543 . . . . 0.0 111.156 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.88 166.6 53.13 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.77 -51.42 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.507 2.138 . . . . 0.0 107.82 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 pp -167.96 178.86 4.93 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 130.324 3.45 . . . . 0.0 105.621 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -135.67 174.99 10.0 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.236 2.614 . . . . 0.0 106.068 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -136.69 7.94 3.03 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -71.63 179.66 2.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.2 175.86 8.21 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.205 0.907 . . . . 0.0 112.171 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -132.24 159.9 70.27 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.428 -1.042 . . . . 0.0 113.487 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.73 168.3 24.89 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.939 1.759 . . . . 0.0 109.441 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.26 151.11 86.75 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 107.239 -1.87 . . . . 0.0 107.239 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.75 -8.11 45.13 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.259 -1.3 . . . . 0.0 112.659 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 20.4 m95 -106.42 153.56 22.08 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 121.375 2.587 . . . . 0.0 110.039 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -139.07 157.87 45.2 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.513 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -118.32 131.83 56.31 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.976 2.11 . . . . 0.0 105.676 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.22 144.0 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -132.86 147.49 52.3 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m -158.57 158.49 34.03 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 126.898 2.079 . . . . 0.0 109.949 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -76.78 -43.41 37.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.685 1.13 . . . . 0.0 111.509 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.47 ' HG3' ' CE1' ' B' ' 26' ' ' PHE . 9.8 pt-20 -67.36 -34.66 77.77 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.47 ' CE1' ' HG3' ' B' ' 25' ' ' GLU . 15.1 m-85 -98.71 -34.38 10.56 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.93 -98.32 1.98 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -147.32 132.09 17.96 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.627 -0.925 . . . . 0.0 110.892 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -140.97 158.03 44.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.546 0.689 . . . . 0.0 109.212 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -115.21 145.43 42.43 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.601 HG21 HG21 ' A' ' 31' ' ' VAL . 46.3 t -121.21 137.88 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 122.662 1.22 . . . . 0.0 110.342 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.484 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 26.2 t0 -103.08 102.37 12.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.088 2.955 . . . . 0.0 109.758 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -75.68 -22.95 56.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.62 0.768 . . . . 0.0 109.643 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 71.6 m -67.24 -18.14 65.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.871 1.269 . . . . 0.0 113.101 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -143.58 -12.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.537 1.135 . . . . 0.0 111.59 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm 65.07 60.42 0.8 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.826 2.05 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -128.61 164.5 22.74 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.468 1.507 . . . . 0.0 108.036 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.21 146.36 50.75 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -150.55 136.96 18.76 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.545 0.738 . . . . 0.0 109.313 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -80.08 20.3 0.66 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.757 1.623 . . . . 0.0 112.501 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 169.79 17.02 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.207 1.403 . . . . 0.0 110.282 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.23 149.59 97.46 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 0.0 110.461 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -68.79 157.75 60.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.307 2.005 . . . . 0.0 112.073 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 7.5 t -77.59 -48.44 16.89 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.92 162.12 9.92 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.761 0.696 . . . . 0.0 112.494 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.49 -174.85 2.41 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.21 3.273 . . . . 0.0 110.363 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.3 t -110.92 -109.65 0.34 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -144.2 158.84 43.5 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 120.282 1.401 . . . . 0.0 109.127 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 117.644 -1.642 . . . . 0.0 109.486 179.653 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.442 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 m -60.94 161.94 7.62 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.621 1.568 . . . . 0.0 109.211 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 m -141.94 159.1 42.91 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.86 -4.42 9.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.541 1.543 . . . . 0.0 112.623 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -77.02 -168.99 1.19 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.112 1.765 . . . . 0.0 112.555 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 p -62.59 174.19 1.07 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.539 1.936 . . . . 0.0 111.857 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.33 164.32 6.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.627 1.108 . . . . 0.0 115.462 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.51 -49.67 0.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.338 2.025 . . . . 0.0 110.245 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -169.07 -166.97 0.68 Allowed 'General case' 0 C--O 1.239 0.531 0 C-N-CA 129.224 3.01 . . . . 0.0 106.953 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.41 177.8 2.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.881 1.672 . . . . 0.0 112.008 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.44 -10.97 5.13 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.758 1.623 . . . . 0.0 111.849 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -65.92 -1.89 3.41 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 114.336 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.78 -174.57 34.66 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 119.851 -1.781 . . . . 0.0 110.733 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.1 mt -135.42 157.19 77.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 126.105 1.762 . . . . 0.0 108.681 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 14.9 Cg_endo -71.32 155.08 60.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 N-CA-C 109.908 -0.843 . . . . 0.0 109.908 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.48 117.03 4.82 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 103.789 -3.197 . . . . 0.0 103.789 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.36 -0.41 8.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.391 1.472 . . . . 0.0 110.398 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 19.1 m95 -121.08 144.15 48.7 Favored 'General case' 0 CA--C 1.527 0.065 0 CA-C-N 119.293 1.546 . . . . 0.0 109.69 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -116.68 150.69 37.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.153 0.981 . . . . 0.0 109.391 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.0 ttp-105 -111.03 136.73 49.6 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.0 t -119.24 124.37 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -117.49 110.91 18.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.637 1.975 . . . . 0.0 108.554 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 p -125.76 171.52 10.59 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.856 1.663 . . . . 0.0 109.958 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -108.47 -23.09 12.01 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.991 -0.443 . . . . 0.0 110.948 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -83.51 -18.74 37.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 118.056 0.389 . . . . 0.0 111.327 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.82 -61.35 1.51 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.935 1.294 . . . . 0.0 109.078 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.05 -95.4 0.25 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 m -152.31 132.68 13.71 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 117.933 0.866 . . . . 0.0 111.735 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -147.77 169.54 19.53 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -119.11 152.37 36.63 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.3 t -117.95 131.76 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.082 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 27.9 t0 -98.0 103.6 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.017 1.727 . . . . 0.0 109.976 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -18.4 65.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -77.84 -35.65 50.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.194 0.906 . . . . 0.0 112.788 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -118.86 4.4 11.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.033 0.833 . . . . 0.0 113.177 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm 53.72 47.31 24.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.642 1.177 . . . . 0.0 110.854 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 -120.2 142.59 48.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.493 1.117 . . . . 0.0 111.365 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.72 138.88 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -149.33 146.49 27.55 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 120.063 1.301 . . . . 0.0 113.547 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -86.85 3.21 46.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.833 1.653 . . . . 0.0 112.098 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.03 143.57 48.98 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.327 1.451 . . . . 0.0 108.319 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -62.08 142.13 95.57 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 125.71 1.604 . . . . 0.0 110.7 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.49 178.25 6.93 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.907 2.405 . . . . 0.0 111.434 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 m -133.39 168.83 17.89 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.314 1.046 . . . . 0.0 109.982 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.63 154.83 19.72 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.902 -2.079 . . . . 0.0 107.902 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.87 -18.61 21.63 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.368 2.712 . . . . 0.0 114.945 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 t -131.13 168.85 16.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.164 1.347 . . . . 0.0 109.574 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 m -159.24 -17.04 0.06 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 N-CA-C 106.271 -2.731 . . . . 0.0 106.271 -178.683 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.514 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.7 m -150.65 149.15 29.49 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.294 1.038 . . . . 0.0 110.126 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -128.62 -169.14 2.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.712 2.405 . . . . 0.0 108.997 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.19 24.89 74.74 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -112.9 -176.03 2.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.307 2.643 . . . . 0.0 111.972 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -178.43 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.268 2.227 . . . . 0.0 110.246 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.62 161.26 53.74 Favored Glycine 0 CA--C 1.541 1.658 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.12 -48.94 1.53 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.994 3.129 . . . . 0.0 112.903 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.57 168.38 3.18 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 128.484 2.714 . . . . 0.0 107.091 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.0 167.59 4.68 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.506 0.67 . . . . 0.0 111.178 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -123.97 -1.02 8.36 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.27 -14.98 30.45 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.39 -175.3 23.07 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.757 2.122 . . . . 0.0 109.949 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 38.7 mt -140.44 157.95 67.27 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 125.741 1.616 . . . . 0.0 110.948 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 67.5 Cg_endo -73.29 168.15 25.5 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 121.944 1.763 . . . . 0.0 110.334 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.72 133.21 35.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.899 2.399 . . . . 0.0 108.768 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.63 -18.91 56.19 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.628 1.109 . . . . 0.0 111.96 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.471 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 21.9 m95 -93.06 132.55 37.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 119.199 1.5 . . . . 0.0 108.39 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.8 159.77 35.51 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.54 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -121.16 120.96 36.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 67.7 t -102.04 133.68 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.62 150.08 46.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 77.3 p -149.29 175.52 11.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 59.2 m -108.1 -12.85 15.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -93.9 -19.65 20.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.99 -53.16 0.8 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 147.14 -134.81 5.38 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 105.993 -2.843 . . . . 0.0 105.993 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.7 m -130.78 138.28 49.85 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.299 1.04 . . . . 0.0 110.19 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -147.18 178.75 8.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.131 0.972 . . . . 0.0 110.022 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -118.19 155.39 30.58 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.102 0.961 . . . . 0.0 110.371 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.53 135.26 63.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 C-N-CA 124.002 0.921 . . . . 0.0 108.566 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.443 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.2 t0 -103.98 105.52 15.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.67 -20.21 64.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.892 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 39.9 m -74.31 -34.89 63.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.629 0.772 . . . . 0.0 111.793 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.87 -9.92 11.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm 60.72 49.93 5.9 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.177 1.791 . . . . 0.0 109.195 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -121.65 160.7 23.88 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.81 1.244 . . . . 0.0 109.109 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.95 139.98 50.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -149.73 137.78 20.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -77.97 -2.83 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -108.65 156.62 19.35 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.458 1.103 . . . . 0.0 109.78 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . 0.455 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 52.2 t-80 -69.76 149.33 96.7 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.931 0.893 . . . . 0.0 108.751 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 72.4 Cg_endo -73.12 -176.95 2.65 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.709 3.606 . . . . 0.0 115.813 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 35.7 m -134.22 153.17 52.01 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.38 2.272 . . . . 0.0 108.455 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.91 171.9 47.28 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.444 0.545 . . . . 0.0 113.794 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.05 -34.85 3.47 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.568 2.845 . . . . 0.0 111.164 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 19.5 t -140.39 163.62 32.3 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.38 2.672 . . . . 0.0 105.344 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.5 m -143.91 12.48 1.64 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 110.379 -179.281 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.187 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.53 11.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.225 2.61 . . . . 0.0 117.181 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -81.45 72.05 8.48 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.749 -1.22 . . . . 0.0 108.116 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.62 174.0 46.58 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.4 t -72.37 158.36 35.94 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.1 t -152.48 -63.07 0.16 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.44 169.26 42.39 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.75 -44.96 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.412 2.075 . . . . 0.0 112.191 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.08 -179.75 7.15 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.112 2.165 . . . . 0.0 109.091 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -93.83 -174.33 3.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.116 0.966 . . . . 0.0 112.035 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -144.5 54.47 1.26 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.877 1.671 . . . . 0.0 109.451 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -71.92 -175.93 1.57 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.67 0.788 . . . . 0.0 111.34 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.98 160.29 30.68 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.24 155.84 89.63 Favored Pre-proline 0 C--O 1.233 0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 111.798 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -68.24 157.98 59.49 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.437 1.425 . . . . 0.0 109.91 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.86 116.52 4.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.347 2.698 . . . . 0.0 107.359 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.18 -9.75 10.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.592 1.567 . . . . 0.0 111.582 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.466 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 23.1 m95 -107.36 163.8 12.73 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.531 1.166 . . . . 0.0 109.878 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -147.49 153.28 39.32 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.07 0.948 . . . . 0.0 109.775 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -118.43 121.01 39.28 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.15 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -128.15 92.12 3.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.1 m -127.87 151.96 48.42 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.788 1.235 . . . . 0.0 110.304 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 m -89.34 -29.53 19.06 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.769 0.827 . . . . 0.0 111.225 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -62.01 -38.45 88.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.289 0.636 . . . . 0.0 111.74 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -117.27 -40.61 3.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 -170.74 15.47 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 106.782 -2.527 . . . . 0.0 106.782 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.8 m -84.48 117.48 23.7 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.191 1.796 . . . . 0.0 107.892 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -136.36 -179.91 5.97 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.781 0.832 . . . . 0.0 109.976 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -131.51 156.15 46.19 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 121.181 -0.95 . . . . 0.0 111.322 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.96 143.5 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.622 1.169 . . . . 0.0 109.106 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 23.8 t0 -106.17 118.78 37.51 Favored 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 127.39 2.276 . . . . 0.0 110.064 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -74.68 -21.73 59.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.915 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 m -65.24 -41.56 94.2 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.181 1.392 . . . . 0.0 112.579 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -122.97 -1.87 8.78 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.278 1.431 . . . . 0.0 113.971 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 57.78 46.78 16.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.523 1.129 . . . . 0.0 110.453 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -116.2 139.7 50.07 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.92 152.17 23.64 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.74 163.38 39.32 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 121.018 -1.051 . . . . 0.0 110.981 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -105.39 18.95 21.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.458 1.903 . . . . 0.0 111.846 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.99 154.12 51.84 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 120.246 -1.533 . . . . 0.0 110.948 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -65.65 136.67 96.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.403 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 68.2 Cg_endo -73.01 67.54 4.05 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.918 3.079 . . . . 0.0 114.289 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.37 176.86 10.7 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.292 0.637 . . . . 0.0 111.067 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.19 168.44 44.67 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.076 0.845 . . . . 0.0 111.298 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -82.23 -12.34 10.53 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.201 3.267 . . . . 0.0 111.856 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.2 p -158.94 -177.18 6.33 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 129.428 3.091 . . . . 0.0 106.392 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 t 60.69 19.41 9.45 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.629 0.772 . . . . 0.0 111.832 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.28 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.94 0.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.864 2.466 . . . . 0.0 116.919 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -76.66 80.65 3.3 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.9 -175.31 36.93 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 5.8 t -67.22 122.53 18.06 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 10.7 t -142.44 164.75 29.29 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.506 1.523 . . . . 0.0 107.242 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.46 169.11 53.39 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -66.98 -33.26 32.97 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.035 2.49 . . . . 0.0 112.131 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.39 162.27 39.33 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 128.553 2.741 . . . . 0.0 107.708 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -80.63 169.04 18.17 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.18 0.592 . . . . 0.0 109.971 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -110.9 37.55 2.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.674 1.19 . . . . 0.0 111.899 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -59.91 171.37 0.95 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.129 1.371 . . . . 0.0 112.157 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.71 173.17 34.6 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 121.509 -0.744 . . . . 0.0 112.479 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.61 160.74 80.64 Favored Pre-proline 0 C--O 1.235 0.301 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 60.1 Cg_endo -71.54 155.76 58.95 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.627 2.218 . . . . 0.0 109.084 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.13 94.53 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 124.379 3.386 . . . . 0.0 109.356 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 145.57 -7.56 1.53 Allowed Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.334 1.445 . . . . 0.0 111.509 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.456 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 14.1 m95 -108.56 156.46 19.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.895 0.878 . . . . 0.0 109.293 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.91 155.74 45.55 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.595 0.758 . . . . 0.0 109.641 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -129.39 121.66 27.83 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 97.9 t -107.92 142.76 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.16 111.3 10.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 57.7 m -134.01 141.82 47.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.462 1.505 . . . . 0.0 111.407 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 66.8 m -70.01 -25.5 63.61 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.536 1.062 . . . . 0.0 111.104 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.41 -26.72 63.81 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.199 -0.905 . . . . 0.0 113.176 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.18 -23.68 2.41 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.67 -107.74 1.66 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.383 1.944 . . . . 0.0 111.82 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 54.5 m -141.85 132.43 25.41 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 126.488 1.915 . . . . 0.0 109.362 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -150.83 174.82 12.64 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.95 0.795 . . . . 0.0 109.771 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -124.93 154.34 41.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.06 0.944 . . . . 0.0 110.511 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -134.94 143.08 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 124.601 1.16 . . . . 0.0 109.446 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.403 ' HB2' ' CZ2' ' B' ' 18' ' ' TRP . 12.0 t0 -106.91 143.21 35.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.951 1.7 . . . . 0.0 108.256 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -105.87 2.21 27.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.136 1.374 . . . . 0.0 111.26 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -91.62 -38.5 12.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.04 1.736 . . . . 0.0 112.658 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -132.25 6.06 4.15 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.945 2.098 . . . . 0.0 113.145 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt 51.03 52.05 15.78 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.703 1.601 . . . . 0.0 111.822 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -110.57 150.51 28.85 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.46 146.85 49.45 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -155.49 172.42 18.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.725 1.148 . . . . 0.0 112.084 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -113.54 13.23 18.75 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.083 1.353 . . . . 0.0 111.589 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.86 161.11 23.35 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . 0.426 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 1.8 t-80 -70.06 150.84 96.18 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.102 0.864 . . . . 0.0 110.298 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 73.3 Cg_endo -79.01 51.26 3.79 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.874 2.383 . . . . 0.0 111.827 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 30.8 t -141.54 161.06 38.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.371 1.868 . . . . 0.0 109.674 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.71 -176.65 50.99 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.66 -26.82 22.93 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.806 2.337 . . . . 0.0 112.34 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -76.69 -170.31 1.53 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.709 1.604 . . . . 0.0 109.528 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -56.92 -9.85 0.93 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.312 0 CA-C-N 120.454 1.479 . . . . 0.0 109.416 179.345 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -117.87 166.7 12.16 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.979 1.712 . . . . 0.0 110.245 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -144.24 -8.65 0.68 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.493 0.717 . . . . 0.0 112.885 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.8 -163.32 52.08 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.797 1.181 . . . . 0.0 110.923 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 m -128.31 163.2 25.31 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.854 1.662 . . . . 0.0 110.043 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 p -157.17 173.98 16.16 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.485 0.584 . . . . 0.0 109.691 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.5 177.72 52.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.871 -0.518 . . . . 0.0 113.105 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.68 -47.67 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.016 2.477 . . . . 0.0 112.318 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 9' ' ' LEU . 3.6 pp -164.61 173.42 11.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.4 1.88 . . . . 0.0 109.627 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -158.75 152.32 23.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -81.01 -0.25 38.74 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.3 155.68 31.39 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 119.375 0.989 . . . . 0.0 110.933 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.47 173.03 33.95 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.8 mt -114.7 151.02 44.95 Favored Pre-proline 0 C--O 1.234 0.25 0 C-N-CA 122.962 0.505 . . . . 0.0 112.116 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.94 164.11 31.06 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.696 2.264 . . . . 0.0 110.894 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.02 127.97 19.65 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.119 1.879 . . . . 0.0 108.057 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.38 -20.98 31.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.294 0.949 . . . . 0.0 111.567 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 17.9 m95 -91.98 154.97 18.45 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.278 1.539 . . . . 0.0 108.171 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -142.07 146.24 35.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -107.25 126.86 52.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.303 1.841 . . . . 0.0 107.293 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -111.71 117.19 54.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -102.3 137.45 40.54 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.457 1.503 . . . . 0.0 107.829 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 m -149.44 178.96 8.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.911 0.884 . . . . 0.0 111.688 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.9 m -106.0 -11.05 16.29 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 0.0 111.412 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -104.41 -47.45 4.1 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.35 0.595 . . . . 0.0 110.669 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -91.93 -8.27 46.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.078 1.351 . . . . 0.0 113.108 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.17 -88.56 1.19 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -156.74 134.27 10.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -145.33 176.48 9.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -134.56 159.79 40.08 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.2 t -131.85 133.41 61.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 123.331 0.652 . . . . 0.0 110.284 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 14.9 t0 -92.56 108.37 19.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 127.893 2.477 . . . . 0.0 107.275 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -68.98 -28.15 66.36 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 122.12 -0.362 . . . . 0.0 111.948 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.5 m -69.6 -44.76 70.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.113 0.965 . . . . 0.0 111.892 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -103.45 -8.2 20.34 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.389 1.076 . . . . 0.0 113.696 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt 55.74 60.81 3.09 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.653 1.581 . . . . 0.0 108.901 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -136.44 154.65 50.71 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.842 1.257 . . . . 0.0 110.124 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.46 149.51 36.2 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -153.29 160.1 42.66 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.652 0.781 . . . . 0.0 111.413 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -108.0 13.66 25.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.009 1.324 . . . . 0.0 113.219 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.04 160.38 29.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.931 1.292 . . . . 0.0 108.753 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -68.7 139.93 91.58 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.95 -75.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.964 3.776 . . . . 0.0 114.858 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.5 t -63.67 -43.65 96.06 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.51 -178.03 47.27 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.968 0.794 . . . . 0.0 112.427 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.78 102.46 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 124.764 3.643 . . . . 0.0 112.289 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.8 t -75.41 164.8 26.02 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -136.16 50.42 2.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.378 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.553 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -134.0 161.38 34.99 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.754 0.777 . . . . 0.0 109.62 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -125.89 -1.91 7.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.356 1.062 . . . . 0.0 112.217 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.95 -171.34 22.94 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -121.88 134.23 54.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -139.68 166.82 23.57 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.872 0.76 . . . . 0.0 112.296 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.59 -168.2 43.12 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.953 1.74 . . . . 0.0 112.758 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.35 -41.99 3.12 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.109 2.539 . . . . 0.0 112.903 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 pp 167.4 -172.67 0.02 OUTLIER 'General case' 0 C--O 1.238 0.457 0 C-N-CA 131.184 3.793 . . . . 0.0 106.853 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -157.76 168.32 27.55 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.22 1.808 . . . . 0.0 107.071 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -83.47 2.29 37.5 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.462 -0.774 . . . . 0.0 112.929 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.36 149.76 19.78 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.314 1.446 . . . . 0.0 110.558 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.77 -179.46 28.55 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.31 160.44 50.24 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.806 0.803 . . . . 0.0 112.044 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.4 Cg_endo -64.37 158.06 51.17 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.235 1.956 . . . . 0.0 109.764 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.13 103.64 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.376 3.384 . . . . 0.0 109.983 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.99 3.52 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.004 1.764 . . . . 0.0 110.577 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.476 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 7.4 m95 -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.181 -1.188 . . . . 0.0 109.151 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -143.24 155.07 44.42 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.233 0.54 . . . . 0.0 110.559 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -116.99 136.82 52.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 128.071 2.549 . . . . 0.0 105.365 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.38 143.95 27.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -128.16 137.18 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.0 m -154.44 -172.64 4.28 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.111 1.764 . . . . 0.0 110.508 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 67.2 m -105.21 -59.22 1.78 Allowed 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -60.69 -18.04 51.56 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 114.192 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -126.72 -12.77 5.98 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.584 1.154 . . . . 0.0 114.06 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.64 -92.02 0.78 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.463 1.982 . . . . 0.0 111.461 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.19 127.5 10.61 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.133 -0.627 . . . . 0.0 111.61 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -141.85 174.07 10.93 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.376 0.67 . . . . 0.0 111.616 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.82 146.87 50.8 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.383 -1.448 . . . . 0.0 110.768 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.86 136.79 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.024 1.329 . . . . 0.0 111.766 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -97.44 112.82 24.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.471 1.908 . . . . 0.0 106.328 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.63 -22.57 53.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.899 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -67.08 -53.18 33.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.01 1.277 . . . . 0.0 111.746 -177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -99.78 -4.04 31.44 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.353 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm 56.55 58.14 4.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.533 1.533 . . . . 0.0 107.072 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -119.66 169.6 9.95 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.175 1.39 . . . . 0.0 109.693 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.65 146.39 50.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.245 1.018 . . . . 0.0 110.43 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.45 167.67 21.64 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.937 1.295 . . . . 0.0 109.487 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.7 4.88 18.85 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.045 0.938 . . . . 0.0 113.153 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.08 176.36 8.14 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.885 -1.134 . . . . 0.0 109.96 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -71.54 141.54 85.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.85 -73.45 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.16 2.573 . . . . 0.0 114.733 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.8 m -66.58 -21.76 66.14 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.123 1.328 . . . . 0.0 110.967 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.38 -166.52 52.72 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.85 151.32 84.57 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.615 2.21 . . . . 0.0 109.894 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 4.8 t -134.37 170.37 15.84 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.451 . . . . 0.0 107.769 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -131.77 88.45 2.57 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.1 1.36 . . . . 0.0 108.489 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.02 -1.433 . . . . 0.0 109.58 -179.761 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -87.02 88.73 7.77 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p -116.06 148.12 40.55 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.722 1.209 . . . . 0.0 110.408 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.99 64.53 0.17 Allowed Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.5 m -78.18 89.83 4.27 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.23 -177.85 6.29 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 127.343 2.257 . . . . 0.0 107.718 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.95 176.46 25.6 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.74 -75.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.015 1.81 . . . . 0.0 111.752 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 87.7 mt -122.77 111.17 16.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.992 1.717 . . . . 0.0 106.978 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -136.29 174.16 10.92 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.408 1.483 . . . . 0.0 107.113 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.4 ptp85 -123.72 20.32 9.37 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.625 1.57 . . . . 0.0 109.357 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -129.84 151.33 50.53 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.84 -74.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 106.994 -2.442 . . . . 0.0 106.994 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.15 160.85 27.89 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 125.306 1.442 . . . . 0.0 112.585 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.67 159.51 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.066 2.511 . . . . 0.0 110.773 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.79 117.6 5.12 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.971 2.448 . . . . 0.0 107.038 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.58 -20.76 8.75 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 125.317 1.437 . . . . 0.0 112.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 43' ' ' PRO . 13.5 m95 -90.99 157.43 17.29 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 119.793 1.796 . . . . 0.0 110.005 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -135.03 145.15 47.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -118.53 130.53 55.97 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.57 139.4 47.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -116.65 140.29 49.57 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.594 1.958 . . . . 0.0 106.761 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.45 150.87 20.05 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.26 1.024 . . . . 0.0 108.374 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -74.27 -24.1 59.21 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.743 1.156 . . . . 0.0 110.35 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -80.43 -39.03 28.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.418 1.087 . . . . 0.0 113.732 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -109.55 -9.23 14.91 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.106 . . . . 0.0 113.528 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.32 -88.82 1.1 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 126.404 1.954 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.4 m -152.98 119.77 5.71 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -129.54 168.13 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.948 0.899 . . . . 0.0 110.361 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -125.48 139.54 53.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.364 1.066 . . . . 0.0 109.695 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' B' ' 31' ' ' VAL . 93.5 t -122.12 131.87 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.02 0.928 . . . . 0.0 110.08 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 10.6 t0 -91.24 121.85 33.36 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 127.144 2.178 . . . . 0.0 108.836 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -85.97 -9.87 56.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.988 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -73.07 -43.56 61.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 119.794 1.179 . . . . 0.0 110.016 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -120.49 2.92 10.76 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.96 1.304 . . . . 0.0 112.871 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 56.59 45.84 21.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.967 1.307 . . . . 0.0 110.973 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -117.21 138.6 51.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.28 20.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -151.91 164.95 36.04 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.322 1.058 . . . . 0.0 110.482 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 51.7 m-85 -107.76 26.4 10.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.8 1.64 . . . . 0.0 111.204 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -140.55 160.96 38.86 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -74.61 141.5 76.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.586 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 72.6 Cg_endo -71.32 164.05 37.03 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.438 2.092 . . . . 0.0 112.444 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m -134.36 -47.45 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.358 0.663 . . . . 0.0 111.943 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.91 174.91 5.57 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.817 -0.552 . . . . 0.0 112.359 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.12 177.84 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.081 2.521 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.0 p -140.44 159.55 41.94 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.612 1.565 . . . . 0.0 106.809 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -144.47 3.21 1.14 Allowed 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.081 . . . . 0.0 111.888 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.637 0 N-CA-C 105.591 -3.004 . . . . 0.0 105.591 179.739 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -78.67 143.43 36.3 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.681 1.24 . . . . 0.0 110.59 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -167.52 172.15 9.74 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.693 1.197 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.59 84.31 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 105.59 -3.004 . . . . 0.0 105.59 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 53.8 m -65.13 88.49 0.07 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.703 1.201 . . . . 0.0 107.873 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 14.6 p -140.44 173.95 10.99 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.932 2.093 . . . . 0.0 111.791 -177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.89 172.41 54.13 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.92 -66.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.421 2.081 . . . . 0.0 113.621 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 93.9 mt -133.26 102.93 5.75 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.082 0.953 . . . . 0.0 110.441 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -134.88 177.37 7.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.173 2.589 . . . . 0.0 107.878 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -116.83 9.83 14.0 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.978 1.311 . . . . 0.0 111.902 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -120.16 141.37 49.93 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.941 0.896 . . . . 0.0 111.0 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.74 -3.8 11.88 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.53 1.538 . . . . 0.0 114.35 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.3 mt -134.07 157.23 78.14 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 120.283 2.042 . . . . 0.0 110.044 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 61.2 Cg_endo -71.04 157.53 57.6 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.234 1.29 . . . . 0.0 110.373 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.12 125.25 13.78 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.648 2.232 . . . . 0.0 106.349 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.92 -10.84 27.34 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.779 1.657 . . . . 0.0 110.75 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 27.7 m95 -113.04 148.98 34.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.897 1.349 . . . . 0.0 109.695 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -139.3 155.83 47.46 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.927 0.767 . . . . 0.0 109.779 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -116.15 138.69 51.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.731 1.612 . . . . 0.0 108.257 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 t -116.59 139.58 42.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.43 133.26 46.21 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.7 m -149.02 172.03 15.42 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.885 1.274 . . . . 0.0 113.685 -175.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 23.1 m -84.93 -32.48 23.07 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.541 1.137 . . . . 0.0 113.921 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -100.89 -12.03 19.31 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.464 1.106 . . . . 0.0 112.667 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -116.86 -21.08 9.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.315 1.046 . . . . 0.0 111.57 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.61 -89.97 1.34 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 24.1 m -156.74 129.16 7.52 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.082 -1.246 . . . . 0.0 109.856 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -138.45 174.75 10.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -130.53 143.03 50.49 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.595 HG21 HG21 ' A' ' 31' ' ' VAL . 22.2 t -119.19 131.78 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.49 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 12.2 t0 -92.66 109.32 20.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -74.57 -11.83 60.3 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.111 -1.035 . . . . 0.0 110.662 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.7 m -66.84 -41.25 87.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.498 1.499 . . . . 0.0 110.572 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.02 1.73 8.62 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 46.1 mmtm 59.39 51.75 6.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.756 1.222 . . . . 0.0 109.466 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -122.68 146.05 47.82 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.57 131.36 54.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -134.68 157.89 45.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.492 1.117 . . . . 0.0 108.291 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -104.26 3.21 32.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.481 1.112 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -105.04 156.04 18.42 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.826 1.65 . . . . 0.0 109.107 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -69.13 149.61 97.6 Favored Pre-proline 0 C--O 1.242 0.7 0 CA-C-O 117.541 -1.219 . . . . 0.0 107.966 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -71.49 160.43 48.5 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 121.352 1.519 . . . . 0.0 110.276 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.2 m -130.42 -66.32 0.77 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.833 0.853 . . . . 0.0 110.829 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.01 177.02 28.22 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 118.211 0.459 . . . . 0.0 113.749 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.17 178.93 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.202 3.268 . . . . 0.0 110.436 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 66.3 p -147.74 166.62 26.93 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.779 0.832 . . . . 0.0 109.587 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.0 m -138.2 14.57 2.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.945 1.698 . . . . 0.0 110.611 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.477 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.565 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.903 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.59 177.04 4.3 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.195 1.398 . . . . 0.0 109.746 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 t -153.7 173.35 15.94 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.083 0.953 . . . . 0.0 108.873 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 38.98 2.95 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.492 1.52 . . . . 0.0 110.882 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.3 m -132.32 139.12 48.05 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.404 1.081 . . . . 0.0 111.58 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 p -77.82 167.14 22.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.15 179.81 31.77 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.46 -39.37 2.8 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.315 2.01 . . . . 0.0 110.991 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.9 mt -142.73 152.13 42.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.685 1.594 . . . . 0.0 110.05 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.2 -169.04 1.9 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.9 mtm-85 -138.61 -32.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.804 1.242 . . . . 0.0 110.164 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.43 170.72 11.37 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.433 1.493 . . . . 0.0 110.575 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.72 170.9 54.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 122.404 1.002 . . . . 0.0 110.782 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.6 mt -82.82 162.71 54.33 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 125.835 1.654 . . . . 0.0 110.738 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.21 164.97 31.95 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.601 1.534 . . . . 0.0 109.982 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.69 149.03 78.78 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 N-CA-C 105.698 -2.462 . . . . 0.0 105.698 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.72 -11.43 70.32 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -111.7 136.18 51.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.431 1.615 . . . . 0.0 107.405 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -119.6 152.09 37.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.097 0.959 . . . . 0.0 110.388 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.7 ttp180 -115.68 120.51 39.6 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.1 t -104.53 138.53 28.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -123.98 129.09 50.35 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.965 1.306 . . . . 0.0 107.816 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -147.76 169.22 20.22 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.812 2.045 . . . . 0.0 108.213 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.9 m -105.7 -23.89 12.64 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -78.16 -35.1 49.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -96.5 -69.65 0.75 Allowed 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.978 1.311 . . . . 0.0 108.851 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.97 -132.75 6.27 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 104.316 -3.514 . . . . 0.0 104.316 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.97 132.14 54.46 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 109.421 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -141.71 166.51 24.52 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.512 0.725 . . . . 0.0 109.682 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -122.55 139.64 53.68 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.848 0.859 . . . . 0.0 111.035 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' B' ' 31' ' ' VAL . 55.4 t -121.61 148.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -108.08 113.03 25.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.214 1.806 . . . . 0.0 111.963 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -21.08 64.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.695 0.679 . . . . 0.0 111.748 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 m -73.63 -30.85 63.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.17 0.988 . . . . 0.0 113.045 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -129.13 -1.09 5.17 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' CE ' ' CE2' ' B' ' 40' ' ' TYR . 17.6 mmtp 59.06 46.7 12.99 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.679 1.192 . . . . 0.0 110.616 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -125.35 146.41 49.59 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.635 -0.665 . . . . 0.0 110.78 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -106.19 142.11 36.42 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 107.858 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -148.83 161.48 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 108.833 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -106.99 14.17 26.74 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.948 0.899 . . . . 0.0 111.002 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -118.51 160.29 22.01 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 120.97 -1.081 . . . . 0.0 110.744 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -69.88 133.83 88.09 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.947 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.06 24.32 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 124.362 3.374 . . . . 0.0 115.398 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.9 p -63.67 -38.67 92.01 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.948 1.249 . . . . 0.0 109.98 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.34 -173.48 46.14 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.55 167.3 27.61 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.815 2.343 . . . . 0.0 110.221 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 t -120.95 161.45 21.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -147.72 105.78 3.74 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.94 -1.1 . . . . 0.0 108.605 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.657 0 N-CA-C 105.121 -3.192 . . . . 0.0 105.121 -178.884 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.495 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -71.18 -177.02 1.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.037 2.135 . . . . 0.0 110.779 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -158.45 169.91 23.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.631 1.172 . . . . 0.0 108.469 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.72 95.98 1.14 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -176.17 144.45 0.57 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.583 1.953 . . . . 0.0 108.392 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 3.8 p -74.94 175.52 8.02 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.094 1.357 . . . . 0.0 109.654 178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.27 166.53 39.31 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.205 -0.934 . . . . 0.0 111.732 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.28 -35.25 63.81 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.399 2.733 . . . . 0.0 113.097 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 pp -142.52 -173.48 3.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.837 2.455 . . . . 0.0 108.403 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -134.02 143.98 48.42 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -95.69 27.16 3.6 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.39 -178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.02 177.38 8.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.033 0.921 . . . . 0.0 113.016 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.48 171.81 51.16 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 125.167 1.365 . . . . 0.0 112.207 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' B' ' 20' ' ' ARG . 74.8 mt -90.54 160.13 39.75 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.594 1.158 . . . . 0.0 111.842 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.409 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 48.2 Cg_endo -67.2 157.19 62.94 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.042 1.828 . . . . 0.0 109.407 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.18 93.34 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 124.573 3.515 . . . . 0.0 111.64 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.36 -19.65 2.26 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.279 1.419 . . . . 0.0 111.153 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.436 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 18.6 m95 -94.43 149.89 20.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -131.74 141.09 49.43 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.07 0.548 . . . . 0.0 109.788 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.411 ' HB2' HD11 ' B' ' 14' ' ' LEU . 42.0 ttp180 -107.48 121.83 45.41 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.0 t -110.91 141.53 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -130.18 150.23 51.52 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.0 0.818 . . . . 0.0 109.445 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.5 m -154.87 -165.63 2.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.115 1.366 . . . . 0.0 109.435 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 73.0 m -115.43 -45.16 2.93 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.07 0.948 . . . . 0.0 108.957 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.79 -14.73 62.53 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.989 0.516 . . . . 0.0 110.559 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -123.61 -25.63 4.32 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.69 1.596 . . . . 0.0 113.192 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.79 -86.61 1.55 Allowed Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.9 m -159.61 140.06 12.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.121 1.46 . . . . 0.0 110.577 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -146.64 176.34 9.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.414 -0.804 . . . . 0.0 109.689 176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.34 151.9 50.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 108.931 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 31' ' ' VAL . 42.5 t -128.32 136.6 59.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 124.217 1.007 . . . . 0.0 109.136 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.436 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 63.3 t0 -101.53 104.08 14.96 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.978 1.311 . . . . 0.0 108.879 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.24 -19.89 66.18 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.795 -0.565 . . . . 0.0 111.26 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 2.0 m -71.45 -33.16 69.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.682 1.593 . . . . 0.0 112.661 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -126.78 0.75 6.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 54.57 36.99 27.17 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.359 1.864 . . . . 0.0 111.01 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 25.1 mtm180 -111.75 161.16 16.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.37 148.44 48.77 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.986 0.914 . . . . 0.0 108.587 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -154.42 168.51 26.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.82 1.248 . . . . 0.0 110.118 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.502 ' CE2' ' CE ' ' A' ' 36' ' ' LYS . 69.2 m-85 -105.36 -1.02 25.62 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.8 167.88 9.5 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.064 -1.023 . . . . 0.0 111.233 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.29 149.89 89.35 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 177.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.44 45.49 1.43 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.447 2.765 . . . . 0.0 115.436 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 45.5 p -69.22 -58.41 4.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.196 0.907 . . . . 0.0 111.756 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.85 -175.28 43.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.64 170.87 19.34 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.82 2.347 . . . . 0.0 110.311 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 8.4 m -135.41 176.6 8.52 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.94 0.896 . . . . 0.0 110.675 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 22.7 t -149.36 163.12 38.62 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 128.595 2.758 . . . . 0.0 104.326 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 N-CA-C 105.262 -3.135 . . . . 0.0 105.262 -178.89 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.0 m -89.37 113.67 25.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.936 0.894 . . . . 0.0 108.759 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 p -100.04 113.28 25.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.45 -171.42 26.35 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m -164.94 175.49 9.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.903 1.681 . . . . 0.0 109.399 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.9 m -128.49 24.42 5.83 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.805 2.042 . . . . 0.0 111.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.9 -178.82 16.4 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.014 0.816 . . . . 0.0 112.453 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.31 -36.79 3.77 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.357 2.704 . . . . 0.0 112.331 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.42 163.13 33.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 127.573 2.349 . . . . 0.0 107.77 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -130.49 173.55 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.936 1.295 . . . . 0.0 110.673 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -132.39 69.36 1.48 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.61 1.564 . . . . 0.0 107.02 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -142.7 174.67 10.44 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.021 0.929 . . . . 0.0 109.961 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.58 -163.69 38.8 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 20' ' ' ARG . 36.6 mt -125.4 155.05 72.28 Favored Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 118.65 1.225 . . . . 0.0 111.917 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 57.8 Cg_endo -71.56 162.39 42.36 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.119 1.879 . . . . 0.0 110.705 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 121.22 9.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.12 2.546 . . . . 0.0 110.41 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.08 -15.42 47.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.315 1.435 . . . . 0.0 112.904 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 32' ' ' ASP . 13.2 m95 -92.2 151.09 20.54 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.454 1.627 . . . . 0.0 108.151 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -131.02 154.74 47.87 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.557 1.143 . . . . 0.0 109.919 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HB2' HD11 ' A' ' 14' ' ' LEU . 51.8 ttp180 -125.87 124.86 41.82 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t -108.33 115.03 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 124.438 1.095 . . . . 0.0 108.426 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.67 128.27 44.89 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.5 m -139.94 -173.72 3.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.575 1.15 . . . . 0.0 109.885 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -116.45 -43.96 2.9 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.853 1.261 . . . . 0.0 108.801 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -70.55 -18.81 62.92 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.928 0.891 . . . . 0.0 112.695 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -128.17 -19.28 3.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.3 -100.24 1.79 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -157.95 139.58 13.8 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.493 0.717 . . . . 0.0 109.641 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -146.31 170.57 16.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -119.33 152.79 36.15 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.576 1.55 . . . . 0.0 107.59 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.44 135.33 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.204 0.601 . . . . 0.0 110.321 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' HB2' ' CH2' ' A' ' 18' ' ' TRP . 20.4 t0 -101.53 106.19 17.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.248 1.419 . . . . 0.0 108.176 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -71.94 -13.87 61.76 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.561 -0.712 . . . . 0.0 111.233 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.5 m -75.11 -39.12 60.88 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 119.88 1.218 . . . . 0.0 112.528 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -124.25 8.12 8.5 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm 54.18 53.72 10.61 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.421 1.488 . . . . 0.0 109.414 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -121.97 134.93 54.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.792 1.637 . . . . 0.0 110.84 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.99 135.35 39.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.318 1.447 . . . . 0.0 107.621 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -139.07 153.63 48.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.848 1.204 . . . . 0.0 113.227 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -96.96 15.81 21.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.891 1.276 . . . . 0.0 113.085 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 158.44 43.99 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 119.955 -1.716 . . . . 0.0 109.742 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -58.37 141.71 82.71 Favored Pre-proline 0 C--O 1.238 0.487 0 O-C-N 124.391 1.057 . . . . 0.0 110.726 -179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.97 94.47 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.743 2.295 . . . . 0.0 109.306 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 73.2 m -47.08 -33.64 5.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 0.0 113.128 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.05 158.16 28.6 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.3 0.955 . . . . 0.0 112.142 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.87 -13.45 21.72 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.671 2.914 . . . . 0.0 111.478 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 m -166.87 177.86 6.16 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 130.477 3.511 . . . . 0.0 105.754 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.46 -25.63 8.29 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.923 0.889 . . . . 0.0 112.386 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 N-CA-C 108.121 -1.992 . . . . 0.0 108.121 -179.687 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -150.53 171.0 17.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.728 1.611 . . . . 0.0 108.39 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.1 p -162.41 121.63 2.29 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.68 170.47 41.43 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 123.857 0.741 . . . . 0.0 111.306 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.8 m -148.12 -179.36 6.87 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.322 1.849 . . . . 0.0 108.423 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 19.3 t -128.02 -33.96 2.17 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.519 1.128 . . . . 0.0 110.86 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.31 169.39 35.45 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 119.216 0.917 . . . . 0.0 111.882 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.32 -37.75 0.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.781 2.321 . . . . 0.0 111.576 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -142.61 106.35 4.67 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.58 1.952 . . . . 0.0 108.644 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.39 172.25 13.9 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -133.14 -19.98 2.18 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.62 169.97 17.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.54 175.35 21.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.272 0.939 . . . . 0.0 112.122 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' B' ' 20' ' ' ARG . 86.4 mt -107.02 160.73 25.31 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 125.643 1.577 . . . . 0.0 111.887 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 28.4 Cg_endo -69.06 163.35 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.914 1.742 . . . . 0.0 109.336 177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.0 137.79 49.99 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 105.845 -2.406 . . . . 0.0 105.845 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.31 74.24 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.635 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.445 ' CD1' ' HG2' ' B' ' 15' ' ' PRO . 9.8 m95 -114.3 142.03 46.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 121.171 2.486 . . . . 0.0 109.094 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -125.32 157.68 36.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.647 0.779 . . . . 0.0 110.553 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.421 ' HB2' HD11 ' B' ' 14' ' ' LEU . 38.0 ttp180 -128.05 125.04 38.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 127.469 2.308 . . . . 0.0 106.906 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.51 133.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -113.96 119.06 35.94 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 65.1 m -138.51 158.46 44.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.462 1.105 . . . . 0.0 109.738 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -84.81 -39.55 18.22 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.695 -1.253 . . . . 0.0 110.458 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -76.26 -16.24 59.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -124.83 -13.04 7.01 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.91 -94.66 1.99 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.998 1.761 . . . . 0.0 110.543 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.7 m -151.91 135.83 16.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.037 -0.684 . . . . 0.0 110.47 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -148.54 167.79 24.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -123.22 155.05 37.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 108.337 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.9 139.31 51.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.889 0.852 . . . . 0.0 109.236 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -100.61 102.47 13.62 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 128.533 2.733 . . . . 0.0 106.938 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.9 -20.19 64.24 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.535 0.607 . . . . 0.0 112.413 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -71.86 -36.88 70.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.375 0.989 . . . . 0.0 110.7 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -116.82 -1.47 12.03 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 58.02 53.52 6.72 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.027 1.331 . . . . 0.0 108.285 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -123.41 147.38 47.17 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.702 0.401 . . . . 0.0 110.016 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.85 136.23 48.76 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 150.41 40.74 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 118.856 0.753 . . . . 0.0 110.376 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -88.73 1.32 55.35 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.21 156.5 33.61 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.583 1.153 . . . . 0.0 110.169 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -64.48 146.42 98.09 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.21 144.51 90.45 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m -87.06 -13.65 43.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.781 1.232 . . . . 0.0 113.151 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.83 162.91 10.97 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.773 1.178 . . . . 0.0 111.878 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.55 -57.33 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.865 3.043 . . . . 0.0 112.625 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 3.6 m -133.22 149.48 52.0 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.249 0.931 . . . . 0.0 111.471 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.73 -17.95 58.78 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.773 0.829 . . . . 0.0 111.329 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.633 2.54 . . . . 0.0 106.777 -179.989 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 m -141.48 88.93 2.18 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -167.27 162.69 15.1 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.265 1.426 . . . . 0.0 108.334 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.69 58.6 0.5 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.7 p -138.7 162.24 35.17 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.646 1.579 . . . . 0.0 108.516 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 p -85.19 -169.28 2.57 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.726 0.811 . . . . 0.0 110.054 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.09 -179.98 21.79 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.6 -32.39 79.39 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.069 2.513 . . . . 0.0 112.15 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.48 167.18 30.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.729 2.011 . . . . 0.0 108.727 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -73.79 31.95 0.08 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.366 2.266 . . . . 0.0 110.465 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 56.22 36.75 27.99 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.318 1.847 . . . . 0.0 111.286 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.98 84.9 2.88 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 129.495 3.118 . . . . 0.0 104.744 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.67 74.14 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 O-C-N 121.078 -1.014 . . . . 0.0 111.579 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.35 157.59 63.03 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.41 0.684 . . . . 0.0 112.542 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 74.2 Cg_endo -76.62 168.66 23.27 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.575 2.184 . . . . 0.0 109.105 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.9 149.88 72.73 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.211 -1.496 . . . . 0.0 108.211 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.38 -11.44 44.51 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.391 -0.672 . . . . 0.0 111.554 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.462 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 16.2 m95 -99.68 151.8 20.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.475 1.638 . . . . 0.0 106.619 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -135.63 151.98 50.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.922 0.489 . . . . 0.0 110.004 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -111.14 129.72 55.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.31 143.97 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -133.33 149.88 51.88 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.9 t -155.31 148.96 25.28 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.401 1.08 . . . . 0.0 109.942 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.1 m -76.23 -19.48 58.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -85.37 -20.09 30.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.337 1.055 . . . . 0.0 113.209 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.53 -46.0 1.77 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.67 -109.39 1.1 Allowed Glycine 0 C--O 1.224 -0.471 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -138.56 129.23 26.37 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -144.69 163.21 34.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 110.874 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.75 149.03 39.12 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 111.444 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.14 142.49 43.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.492 0.717 . . . . 0.0 109.744 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 119.44 39.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 127.907 2.483 . . . . 0.0 108.844 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -84.61 -20.97 30.54 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -76.84 -31.98 57.25 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.284 1.034 . . . . 0.0 110.085 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -117.38 -9.42 10.9 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp 56.86 50.46 12.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.07 1.348 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -126.05 160.19 30.74 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.661 0.785 . . . . 0.0 110.287 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.77 139.5 53.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.376 1.471 . . . . 0.0 109.37 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -153.9 144.68 22.57 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.631 1.173 . . . . 0.0 108.688 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' B' ' 36' ' ' LYS . 62.8 m-85 -91.25 24.41 2.92 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.46 0.704 . . . . 0.0 109.845 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.56 154.28 47.99 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.573 -1.329 . . . . 0.0 111.036 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.95 143.99 98.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-O 119.005 -0.521 . . . . 0.0 110.328 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 18' ' ' TRP . 59.6 Cg_endo -74.92 -23.78 13.64 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.845 2.364 . . . . 0.0 116.658 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t 61.72 18.75 9.92 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.935 1.698 . . . . 0.0 112.861 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.08 168.46 41.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.459 1.028 . . . . 0.0 112.0 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.33 -34.45 15.99 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.563 2.175 . . . . 0.0 112.524 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -157.75 179.04 9.59 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.371 2.269 . . . . 0.0 106.384 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 t -143.9 152.69 41.46 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.935 0.874 . . . . 0.0 109.286 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.819 0 C-N-CA 126.805 2.145 . . . . 0.0 107.865 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -71.77 80.4 0.86 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.301 1.041 . . . . 0.0 109.143 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 12.9 m -153.4 157.51 40.08 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.901 1.28 . . . . 0.0 107.905 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.54 82.43 0.18 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -147.0 163.42 36.27 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.405 1.482 . . . . 0.0 108.263 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 30.7 p -78.02 -174.5 3.62 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.467 0.707 . . . . 0.0 111.061 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.67 175.28 23.71 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.299 1.428 . . . . 0.0 110.703 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.34 -32.54 20.08 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.917 3.078 . . . . 0.0 113.373 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.06 163.06 18.22 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.013 2.925 . . . . 0.0 105.271 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.64 154.02 40.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.785 0.802 . . . . 0.0 111.832 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -74.72 56.84 0.73 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.823 2.449 . . . . 0.0 109.137 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.91 -28.75 17.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -15.44 90.68 0.01 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 129.38 3.372 . . . . 0.0 114.185 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 75.4 mt -75.63 154.37 85.47 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.48 166.91 27.89 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.923 2.415 . . . . 0.0 110.291 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.67 118.63 5.74 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.703 2.268 . . . . 0.0 109.975 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.5 -11.96 33.12 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.058 -1.412 . . . . 0.0 113.181 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 32.2 m95 -100.54 150.43 22.68 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 119.303 1.551 . . . . 0.0 108.373 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -135.02 168.03 19.85 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.257 1.423 . . . . 0.0 108.669 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -133.06 121.34 22.55 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.116 1.366 . . . . 0.0 108.585 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -92.76 107.98 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 124.168 0.917 . . . . 0.0 109.221 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -95.48 133.36 39.55 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.3 m -155.78 -177.64 6.71 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.006 -1.684 . . . . 0.0 110.833 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -102.68 -44.75 5.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.806 0.843 . . . . 0.0 111.896 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.74 -11.85 59.9 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.69 -19.86 3.29 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.17 -105.33 3.26 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -144.96 124.19 12.95 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.909 0.484 . . . . 0.0 110.905 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.45 178.51 7.04 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.373 1.069 . . . . 0.0 108.838 178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -131.35 155.57 47.01 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.557 1.143 . . . . 0.0 109.767 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.4 131.58 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 51.7 t0 -98.82 104.66 16.72 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -70.06 -21.95 63.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.843 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 90.3 m -67.7 -45.19 75.83 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.837 1.653 . . . . 0.0 110.823 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -106.63 1.11 24.93 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.81 0.844 . . . . 0.0 112.424 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 40' ' ' TYR . 2.4 mmtp 49.85 54.73 10.54 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.756 2.022 . . . . 0.0 110.611 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -119.62 167.39 12.05 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.089 0.956 . . . . 0.0 109.168 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.0 143.32 50.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -155.05 149.43 26.17 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.896 0.878 . . . . 0.0 108.968 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -90.98 -8.76 48.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.226 1.01 . . . . 0.0 110.14 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -93.56 152.4 19.06 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 124.539 1.136 . . . . 0.0 108.584 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . 0.441 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 42.5 t-80 -67.26 151.33 97.26 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 118.202 -0.904 . . . . 0.0 108.61 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 92.0 Cg_endo -84.21 -31.86 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 N-CA-C 117.357 2.022 . . . . 0.0 117.357 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 7.2 t 63.67 3.27 1.48 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.135 0.88 . . . . 0.0 113.239 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.23 166.77 42.68 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 120.807 1.64 . . . . 0.0 114.059 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.4 -35.39 23.72 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.797 2.998 . . . . 0.0 113.753 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 75.0 m -146.21 -173.9 4.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 112.473 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.1 t -132.99 121.08 22.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.325 -2.31 . . . . 0.0 107.325 -179.626 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.97 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 m -163.15 169.99 18.52 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.358 1.863 . . . . 0.0 107.68 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -61.89 147.08 47.85 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.04 85.89 0.14 Allowed Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.9 t -60.56 110.29 1.24 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -157.91 155.36 29.43 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -121.75 170.35 14.86 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.583 1.087 . . . . 0.0 110.573 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.44 -42.82 44.96 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.032 2.488 . . . . 0.0 113.611 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.95 131.79 13.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.202 1.801 . . . . 0.0 106.212 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -144.94 157.86 44.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.49 1.916 . . . . 0.0 106.55 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -103.23 13.62 33.51 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.19 -179.84 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.518 1.127 . . . . 0.0 110.507 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.57 -165.7 31.15 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.563 1.554 . . . . 0.0 110.442 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.9 mt -123.84 162.88 38.47 Favored Pre-proline 0 N--CA 1.466 0.363 0 C-N-CA 124.934 1.294 . . . . 0.0 111.695 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 40.5 Cg_endo -72.09 164.55 35.31 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.405 1.403 . . . . 0.0 109.304 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.18 134.65 40.17 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.57 1.513 . . . . 0.0 108.919 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.68 -10.8 72.19 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 117.615 -1.659 . . . . 0.0 114.216 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.459 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 13.2 m95 -93.91 168.18 11.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.147 1.973 . . . . 0.0 109.181 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -140.95 156.27 46.1 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.608 0.763 . . . . 0.0 109.986 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -125.04 129.99 51.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.5 t -121.68 132.74 70.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -107.32 139.61 41.52 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -142.84 -172.41 3.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.8 2.44 . . . . 0.0 109.819 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -126.28 -38.86 2.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.535 1.934 . . . . 0.0 107.594 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.19 -34.8 71.24 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -113.33 -17.11 12.37 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.76 -85.7 1.51 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -157.63 146.03 19.2 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.343 1.072 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -154.63 166.99 31.64 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.296 0.638 . . . . 0.0 109.606 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.0 144.98 45.09 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.032 0.933 . . . . 0.0 109.838 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' B' ' 31' ' ' VAL . 85.3 t -123.78 142.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.823 0.849 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -107.43 112.55 25.4 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 127.255 2.222 . . . . 0.0 109.498 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -74.22 -22.37 59.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.767 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.4 m -69.53 -34.1 73.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.59 1.086 . . . . 0.0 112.148 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -121.92 1.84 9.9 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.341 0.656 . . . . 0.0 112.734 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HE3' ' CE1' ' B' ' 40' ' ' TYR . 34.9 mmtm 51.15 52.5 14.78 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.983 1.713 . . . . 0.0 108.446 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -121.75 154.84 36.4 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.664 0.786 . . . . 0.0 108.984 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.83 140.95 51.03 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.67 1.188 . . . . 0.0 108.371 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -150.22 147.28 27.51 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.522 -0.736 . . . . 0.0 110.527 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -84.31 -13.28 52.87 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.365 1.466 . . . . 0.0 112.965 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.69 144.01 27.1 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.481 1.912 . . . . 0.0 107.158 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -68.05 142.14 94.91 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -70.2 -169.09 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.822 3.015 . . . . 0.0 112.591 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.1 t -129.05 -31.88 2.09 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.222 1.009 . . . . 0.0 110.512 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.58 -170.59 2.66 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 119.336 0.971 . . . . 0.0 113.807 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.15 -69.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.44 2.76 . . . . 0.0 110.621 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.8 m -155.91 -174.46 4.97 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 128.831 2.853 . . . . 0.0 107.773 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -63.32 168.03 4.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.129 0.971 . . . . 0.0 109.426 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 N-CA-C 105.644 -2.982 . . . . 0.0 105.644 179.372 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.081 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -134.97 167.84 20.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.183 0.992 . . . . 0.0 110.5 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m 54.2 80.98 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 126.672 1.989 . . . . 0.0 108.483 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.83 80.86 0.22 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -61.87 106.67 0.72 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.517 1.527 . . . . 0.0 109.25 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.9 t -142.61 154.64 44.58 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.07 172.41 14.32 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.843 1.201 . . . . 0.0 113.382 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.7 -37.18 81.03 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.609 2.206 . . . . 0.0 109.465 178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 pp -176.85 134.32 0.21 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 130.81 3.644 . . . . 0.0 105.516 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 -167.06 2.05 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 131.457 3.903 . . . . 0.0 106.325 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -140.44 15.56 2.38 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.947 1.249 . . . . 0.0 113.935 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -73.31 -178.29 2.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.821 1.248 . . . . 0.0 112.007 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.35 -165.63 24.73 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.092 1.329 . . . . 0.0 111.611 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 36.3 mt -129.61 157.69 75.76 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 124.034 0.933 . . . . 0.0 111.007 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 43.6 Cg_endo -74.25 164.0 35.18 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.59 2.194 . . . . 0.0 112.773 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.74 130.69 26.95 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 N-CA-C 105.282 -2.622 . . . . 0.0 105.282 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.2 -1.83 56.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 117.532 -1.705 . . . . 0.0 113.283 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 16.0 m95 -117.18 165.98 12.79 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.226 2.013 . . . . 0.0 111.467 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -152.1 150.89 30.41 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.116 0.966 . . . . 0.0 109.153 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -104.59 149.46 25.49 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.04 114.43 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -105.9 145.94 30.61 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -156.22 -168.14 2.65 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.639 1.175 . . . . 0.0 109.364 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 13.3 m -120.6 -44.07 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 126.478 1.911 . . . . 0.0 107.954 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -63.88 -25.12 68.01 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.325 1.05 . . . . 0.0 113.263 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -123.01 -33.15 3.38 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.2 -104.51 1.35 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -150.24 136.47 18.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -151.09 -175.3 5.1 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.234 1.014 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -132.35 155.77 47.81 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.093 1.357 . . . . 0.0 109.43 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.611 HG21 HG21 ' A' ' 31' ' ' VAL . 57.7 t -131.61 133.63 61.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.462 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 57.2 t0 -97.06 111.51 23.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 126.166 1.787 . . . . 0.0 110.587 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -70.75 -18.75 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.436 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 1.9 m -67.52 -37.03 82.16 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 125.947 1.699 . . . . 0.0 112.377 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -127.13 3.96 6.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.585 0.754 . . . . 0.0 112.724 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 53.4 42.85 31.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.216 1.806 . . . . 0.0 110.878 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mtm180 -113.97 161.37 17.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -122.03 146.92 46.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.641 1.176 . . . . 0.0 107.959 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -158.06 155.6 29.55 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.321 1.048 . . . . 0.0 109.126 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . 0.447 ' CE1' ' HE3' ' A' ' 36' ' ' LYS . 75.5 m-85 -95.04 -4.2 46.89 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.568 1.147 . . . . 0.0 112.574 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -102.85 140.5 37.05 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . 0.507 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 61.1 t-80 -59.24 151.89 55.77 Favored Pre-proline 0 C--N 1.319 -0.738 0 C-N-CA 124.411 1.085 . . . . 0.0 109.672 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 87.0 Cg_endo -70.43 -158.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.169 0 C-N-CA 122.121 1.88 . . . . 0.0 110.283 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.18 -58.12 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.595 1.558 . . . . 0.0 107.523 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.55 159.43 23.67 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.14 -35.59 6.72 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.398 2.066 . . . . 0.0 110.099 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 36.9 m -168.12 172.02 9.05 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 131.546 3.938 . . . . 0.0 107.128 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.0 t -69.75 161.63 29.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.855 -1.525 . . . . 0.0 109.396 179.753 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.449 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -78.95 170.64 16.37 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.511 0.655 . . . . 0.0 111.928 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 128.77 56.56 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 127.818 2.447 . . . . 0.0 105.913 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.11 -8.02 0.56 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.294 -1.281 . . . . 0.0 115.411 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -130.94 153.31 49.32 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 119.524 1.662 . . . . 0.0 110.75 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.7 t -107.36 152.29 24.36 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 126.33 1.852 . . . . 0.0 107.52 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.04 168.97 41.95 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.51 -42.36 7.27 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.373 2.049 . . . . 0.0 113.628 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -161.22 179.27 8.49 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.903 1.281 . . . . 0.0 108.687 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.13 162.11 35.05 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.674 0.79 . . . . 0.0 111.341 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.14 -9.47 4.78 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.83 1.252 . . . . 0.0 111.478 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.25 -178.15 1.96 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.164 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.82 158.67 49.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 54.5 mt -80.8 160.94 65.38 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 121.107 -1.231 . . . . 0.0 110.755 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.65 163.54 36.59 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 107.965 -1.59 . . . . 0.0 107.965 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.1 149.99 88.3 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.23 -21.47 10.18 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.83 1.205 . . . . 0.0 112.64 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -88.12 143.54 27.0 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.759 1.78 . . . . 0.0 107.74 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -117.33 151.6 36.66 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.609 0.764 . . . . 0.0 111.011 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -117.71 119.42 34.89 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.32 145.12 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.15 139.79 52.29 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.5 m -157.48 132.27 8.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 117.842 -1.075 . . . . 0.0 109.216 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 m -59.64 -33.74 71.91 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 120.166 1.348 . . . . 0.0 112.512 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -16.5 61.64 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.96 -30.72 1.35 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.05 -94.15 0.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 126.647 2.07 . . . . 0.0 108.575 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.64 133.78 16.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -143.5 143.65 31.65 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.659 1.118 . . . . 0.0 109.739 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -96.87 156.48 16.33 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.261 -0.899 . . . . 0.0 109.806 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.1 t -131.16 142.17 44.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -105.2 108.69 20.34 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 127.344 2.258 . . . . 0.0 107.426 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -25.54 62.03 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.7 m -70.8 -41.43 71.62 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.235 1.014 . . . . 0.0 110.815 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -105.97 -10.01 16.8 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.935 0.894 . . . . 0.0 113.003 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 56.24 59.4 3.7 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 126.26 1.824 . . . . 0.0 107.198 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -126.4 166.69 16.72 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.895 1.678 . . . . 0.0 109.238 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.13 145.66 50.89 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 125.1 1.36 . . . . 0.0 107.414 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -149.14 163.79 36.57 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.268 -0.895 . . . . 0.0 112.448 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' CZ ' ' HE3' ' B' ' 36' ' ' LYS . 78.6 m-85 -103.6 19.07 20.5 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.915 1.686 . . . . 0.0 112.878 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 152.28 43.7 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.737 -1.227 . . . . 0.0 109.911 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.37 140.63 91.7 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.843 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.21 99.45 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.629 2.886 . . . . 0.0 111.852 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.0 p -79.11 1.43 24.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.657 1.183 . . . . 0.0 112.686 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.3 48.38 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 108.724 -1.751 . . . . 0.0 108.724 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.94 39.2 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 125.071 3.848 . . . . 0.0 110.897 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.2 p -138.8 169.34 17.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.757 1.623 . . . . 0.0 110.102 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 p -59.73 -45.31 92.59 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 N-CA-C 106.576 -2.61 . . . . 0.0 106.576 -179.387 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.14 124.0 2.77 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -64.02 159.92 19.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.143 0.977 . . . . 0.0 110.542 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.36 -5.86 0.02 OUTLIER Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.693 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -117.2 -173.54 2.43 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.457 1.629 . . . . 0.0 110.054 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 33.8 t -144.65 124.74 13.62 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.57 163.35 31.16 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.49 -38.36 19.75 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 112.455 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -165.42 173.6 10.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.144 2.578 . . . . 0.0 107.596 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -143.24 -176.83 5.08 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.141 1.376 . . . . 0.0 109.538 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -139.17 -7.44 1.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.58 176.81 2.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 111.593 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.95 175.0 3.01 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.71 1.624 . . . . 0.0 114.631 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 76.3 mt -99.95 155.44 36.45 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 124.557 1.143 . . . . 0.0 112.893 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 40.1 Cg_endo -69.89 162.32 42.59 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.204 1.936 . . . . 0.0 109.131 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.53 139.77 72.06 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 N-CA-C 107.574 -1.741 . . . . 0.0 107.574 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.14 73.05 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-O 117.413 -1.77 . . . . 0.0 112.588 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.444 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 11.4 m95 -101.62 157.49 16.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 120.434 2.117 . . . . 0.0 108.396 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -146.01 147.39 31.6 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.83 -0.544 . . . . 0.0 110.296 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -103.67 135.95 44.28 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.5 120.67 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.302 1.041 . . . . 0.0 109.1 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -111.76 136.93 50.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -143.44 135.65 26.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.606 1.562 . . . . 0.0 108.901 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 18.9 m -66.8 -28.52 68.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 120.61 1.55 . . . . 0.0 111.422 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -75.69 -21.5 57.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.76 -22.6 4.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.13 -98.37 1.22 Allowed Glycine 0 CA--C 1.519 0.339 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 55.2 m -158.17 145.55 18.11 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.232 1.013 . . . . 0.0 108.501 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -152.51 178.28 9.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.16 1.784 . . . . 0.0 106.623 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -128.26 158.08 39.13 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 66.1 t -132.08 131.43 61.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 59.7 t0 -91.61 103.86 16.41 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 127.435 2.294 . . . . 0.0 107.669 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.07 -27.14 67.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.87 0.759 . . . . 0.0 111.877 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 63.1 m -69.13 -24.48 64.11 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.113 0.965 . . . . 0.0 112.535 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -126.72 -2.47 6.65 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.53 0.732 . . . . 0.0 112.752 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.404 ' HE3' ' CZ ' ' A' ' 40' ' ' TYR . 40.1 mmtm 51.06 52.22 15.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.946 2.098 . . . . 0.0 110.301 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 23.3 mtt180 -127.5 160.72 30.63 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 121.66 -0.65 . . . . 0.0 109.724 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -117.36 139.93 50.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.352 1.061 . . . . 0.0 110.179 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -144.15 159.78 42.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.459 1.104 . . . . 0.0 109.977 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -100.25 15.15 28.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.085 1.354 . . . . 0.0 114.071 -178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.07 151.7 51.52 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.21 -1.556 . . . . 0.0 110.829 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . 0.414 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 59.4 t-80 -60.41 143.73 89.2 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.883 0.873 . . . . 0.0 109.891 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 42' ' ' HIS . 42.4 Cg_endo -65.68 119.01 5.97 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.809 2.339 . . . . 0.0 112.55 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.8 p -111.41 5.35 19.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.227 2.211 . . . . 0.0 111.55 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.4 -171.75 13.81 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.177 0.894 . . . . 0.0 112.551 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -74.06 78.4 2.57 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 124.027 3.151 . . . . 0.0 109.443 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -158.19 175.14 14.15 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.655 1.982 . . . . 0.0 107.691 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -104.61 8.13 35.22 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.983 1.713 . . . . 0.0 112.09 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 -179.487 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.633 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.9 t -83.94 -8.14 59.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.454 1.101 . . . . 0.0 112.255 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.9 m -125.43 165.24 18.78 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.59 1.156 . . . . 0.0 108.739 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.86 -5.91 7.35 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 118.678 -1.068 . . . . 0.0 114.018 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.9 m -70.55 170.08 12.88 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.516 1.158 . . . . 0.0 111.424 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.8 m -59.73 128.06 35.08 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.72 1.208 . . . . 0.0 107.878 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.26 175.56 48.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.83 -67.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.562 2.175 . . . . 0.0 112.429 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.8 179.91 4.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.07 1.748 . . . . 0.0 111.339 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.94 -174.56 3.61 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.048 0.939 . . . . 0.0 110.868 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.0 ptt-85 -128.67 22.92 5.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.472 1.509 . . . . 0.0 109.684 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.64 138.22 36.14 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.159 0.984 . . . . 0.0 108.567 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.72 91.05 0.58 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.72 158.61 85.21 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 117.622 0.711 . . . . 0.0 109.622 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.2 164.42 35.69 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 121.794 1.663 . . . . 0.0 109.727 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.02 117.26 4.93 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.175 2.583 . . . . 0.0 109.906 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.01 -22.81 7.92 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.158 1.837 . . . . 0.0 111.134 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.418 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 31.6 m95 -88.95 136.66 32.9 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.397 -1.06 . . . . 0.0 109.705 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -119.68 139.95 51.42 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.284 1.033 . . . . 0.0 110.19 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -108.75 120.75 43.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -95.9 140.12 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -125.97 118.17 24.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 104.114 -2.551 . . . . 0.0 104.114 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.0 m -140.86 170.62 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.526 1.131 . . . . 0.0 111.176 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 m -85.03 -65.14 1.04 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -60.43 -16.51 36.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.508 1.923 . . . . 0.0 114.911 -178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.15 -14.59 7.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.509 1.124 . . . . 0.0 112.45 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.38 -85.66 0.93 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 125.242 1.401 . . . . 0.0 111.759 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.83 136.43 12.32 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.249 -1.148 . . . . 0.0 109.497 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -149.03 175.21 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.565 1.075 . . . . 0.0 110.057 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -123.99 149.21 46.27 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.878 0.871 . . . . 0.0 109.82 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.3 t -126.79 143.06 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.683 1.193 . . . . 0.0 109.073 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -106.71 112.95 26.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.862 2.065 . . . . 0.0 105.599 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' ND1' ' HE3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -74.17 -23.67 59.28 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -68.66 -36.83 79.06 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.854 0.862 . . . . 0.0 112.307 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -117.73 -3.57 11.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.501 1.121 . . . . 0.0 112.317 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HE3' ' ND1' ' A' ' 33' ' ' HIS . 6.9 mmtp 58.17 51.99 8.0 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.943 1.697 . . . . 0.0 109.78 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -118.23 161.86 19.2 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.463 0.705 . . . . 0.0 110.497 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.62 148.72 46.17 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.45 155.86 37.09 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.216 0.607 . . . . 0.0 111.223 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -95.58 27.28 3.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.594 1.558 . . . . 0.0 111.538 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -142.78 146.69 34.49 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 119.799 -1.813 . . . . 0.0 109.682 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -61.72 141.75 94.92 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 18' ' ' TRP . 19.6 Cg_endo -55.54 -56.78 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.956 2.437 . . . . 0.0 116.476 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 -69.7 0.12 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.609 0.763 . . . . 0.0 112.557 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.2 -170.69 51.93 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.97 125.91 13.16 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.359 2.039 . . . . 0.0 107.511 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.35 -176.31 5.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.3 t -150.32 -82.68 0.1 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.142 0 C-N-CA 124.662 1.125 . . . . 0.0 110.644 179.653 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 CA-C-O 121.233 0.352 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t -128.9 -147.14 0.34 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 0.0 109.603 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 4.9 m -4.96 101.08 0.01 OUTLIER 'General case' 0 C--O 1.237 0.427 1 C-N-CA 131.862 4.065 . . . . 0.0 113.686 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.9 9.13 5.37 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.308 1.432 . . . . 0.0 115.18 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.6 m -71.49 175.27 5.66 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.835 1.254 . . . . 0.0 111.607 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.9 m -58.81 133.3 55.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.753 1.221 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.05 174.62 54.88 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.14 -46.86 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.404 2.069 . . . . 0.0 112.829 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.49 -159.46 0.98 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.099 1.36 . . . . 0.0 110.844 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -61.35 165.0 4.96 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.428 1.109 . . . . 0.0 110.816 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 83.6 mtm-85 -124.79 46.98 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.231 1.413 . . . . 0.0 108.409 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -140.04 -178.57 5.52 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.018 1.727 . . . . 0.0 111.074 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.65 88.04 0.1 OUTLIER Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.853 1.692 . . . . 0.0 110.617 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 57.0 mt -69.57 147.19 96.6 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 118.374 1.087 . . . . 0.0 110.311 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.68 160.09 50.96 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.304 2.003 . . . . 0.0 112.553 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 84.95 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.784 3.656 . . . . 0.0 110.07 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.7 4.73 0.28 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.837 2.16 . . . . 0.0 112.162 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -124.71 157.78 34.84 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.27 155.9 44.05 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 122.047 -0.408 . . . . 0.0 109.933 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -109.17 121.84 46.01 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.538 1.535 . . . . 0.0 107.547 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.83 131.71 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -122.84 126.5 47.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.729 1.612 . . . . 0.0 109.143 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.1 m -147.88 -176.0 5.1 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 110.767 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m -112.55 -29.88 7.32 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.124 -0.985 . . . . 0.0 110.004 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -79.07 -14.57 59.07 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.793 -0.567 . . . . 0.0 109.669 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -130.71 -19.5 2.97 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.97 -92.74 1.71 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 124.613 1.101 . . . . 0.0 111.093 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -151.41 131.2 13.22 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.811 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -148.75 172.57 14.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -120.73 156.6 31.46 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.919 -0.488 . . . . 0.0 110.606 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.51 140.04 49.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -101.37 112.75 25.37 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.572 2.349 . . . . 0.0 108.733 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . 0.409 ' ND1' ' HE2' ' B' ' 36' ' ' LYS . 1.8 m-70 -76.54 -13.09 60.11 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.7 m -88.96 -22.88 22.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 111.66 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -123.79 -5.62 8.03 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.505 0.722 . . . . 0.0 111.461 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.409 ' HE2' ' ND1' ' B' ' 33' ' ' HIS . 21.6 mmtp 51.76 52.73 13.97 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.23 1.812 . . . . 0.0 111.724 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -132.75 153.55 51.09 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.504 0.722 . . . . 0.0 109.459 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -105.91 153.97 21.22 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 108.584 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -158.96 151.91 22.16 Favored 'General case' 0 C--N 1.334 -0.071 0 O-C-N 121.608 -0.682 . . . . 0.0 111.107 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -95.45 27.63 3.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.002 1.321 . . . . 0.0 112.082 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.35 147.05 34.09 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 119.891 -1.755 . . . . 0.0 108.432 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -64.95 142.19 98.58 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 119.036 -0.507 . . . . 0.0 109.765 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.76 -37.78 34.06 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.256 2.638 . . . . 0.0 114.056 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 17.0 t -63.69 -77.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.09 0.956 . . . . 0.0 108.777 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.66 -175.68 43.73 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.06 138.75 63.71 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.312 2.008 . . . . 0.0 109.454 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 58.1 m -165.98 175.68 8.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.139 2.576 . . . . 0.0 107.492 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -148.78 -36.36 0.18 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.109 0.964 . . . . 0.0 110.196 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.288 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.135 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.438 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.8 p -150.37 170.54 18.78 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 110.459 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.45 172.26 13.06 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 127.453 2.301 . . . . 0.0 107.971 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.98 167.27 36.85 Favored Glycine 0 CA--C 1.521 0.431 0 O-C-N 120.781 -1.2 . . . . 0.0 111.217 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t 55.6 21.62 4.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.781 1.632 . . . . 0.0 112.721 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.49 151.11 20.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.398 1.079 . . . . 0.0 111.145 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.76 -173.51 45.79 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.87 -63.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.065 1.843 . . . . 0.0 108.509 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.5 pp -145.3 153.7 41.55 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 129.115 2.966 . . . . 0.0 107.748 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -166.64 56.8 0.09 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 126.401 1.88 . . . . 0.0 106.801 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 51.85 7.13 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 128.169 2.588 . . . . 0.0 115.373 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -66.76 5.56 0.61 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -178.047 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -25.72 103.53 0.01 OUTLIER Glycine 0 N--CA 1.471 0.969 0 C-N-CA 128.287 2.851 . . . . 0.0 112.193 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.1 mt -48.81 154.62 1.19 Allowed Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 128.254 2.622 . . . . 0.0 115.177 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 51.7 Cg_endo -71.83 164.86 34.34 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.282 1.988 . . . . 0.0 110.205 178.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.98 124.04 11.36 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.543 2.162 . . . . 0.0 108.457 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.17 -12.08 33.96 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.723 1.154 . . . . 0.0 111.736 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.411 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 37.3 m95 -104.13 150.93 23.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.646 1.223 . . . . 0.0 108.608 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -144.09 156.8 44.5 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.105 0.962 . . . . 0.0 108.613 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -116.04 122.0 43.89 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.561 1.545 . . . . 0.0 107.055 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.8 t -95.78 127.34 47.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -124.03 116.03 22.16 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.9 m -140.46 155.23 46.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.825 1.25 . . . . 0.0 111.709 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.5 m -76.71 -20.25 56.77 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 120.85 -1.157 . . . . 0.0 112.937 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -83.09 -53.63 5.66 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.8 0.727 . . . . 0.0 111.405 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -93.74 -11.85 30.5 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.74 -91.34 1.62 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 m -155.68 147.99 23.69 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.213 0.506 . . . . 0.0 111.851 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -161.16 179.64 8.21 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.74 1.616 . . . . 0.0 108.099 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -125.67 158.91 33.57 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.085 -1.009 . . . . 0.0 110.416 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.25 140.86 47.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.555 1.142 . . . . 0.0 108.027 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -109.7 117.59 34.29 Favored 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 127.239 2.216 . . . . 0.0 109.512 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -82.35 -14.13 55.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.584 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.7 m -70.82 -47.83 57.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 120.217 1.371 . . . . 0.0 110.277 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -108.08 -3.41 18.69 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.25 1.42 . . . . 0.0 111.864 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp 56.89 53.15 8.45 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.525 1.53 . . . . 0.0 110.073 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -120.86 165.64 14.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.41 138.34 53.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -150.99 151.64 32.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.19 0.905 . . . . 0.0 110.6 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' B' ' 36' ' ' LYS . 54.6 m-85 -83.06 8.2 13.6 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.25 153.26 44.99 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.295 1.407 . . . . 0.0 113.221 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -62.31 139.93 96.37 Favored Pre-proline 0 C--O 1.24 0.57 0 O-C-N 124.99 1.431 . . . . 0.0 109.345 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.13 178.99 3.12 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.308 2.672 . . . . 0.0 114.572 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 t -126.92 -79.1 0.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.22 1.408 . . . . 0.0 110.532 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.46 174.58 37.98 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 119.521 1.055 . . . . 0.0 112.441 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.37 -25.08 3.38 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.245 3.296 . . . . 0.0 113.657 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.8 p 178.82 166.61 0.9 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 128.865 2.866 . . . . 0.0 106.737 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 p -129.66 -53.66 1.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.771 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -154.51 167.75 29.0 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.523 1.529 . . . . 0.0 107.223 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.5 p -158.94 -179.04 7.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.784 0.834 . . . . 0.0 111.093 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.15 -173.36 41.74 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.673 1.606 . . . . 0.0 109.263 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.8 t -48.54 123.89 7.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.185 1.394 . . . . 0.0 109.388 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 25.9 m -100.26 177.81 4.95 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.163 1.785 . . . . 0.0 110.722 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.85 164.79 10.19 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 123.799 0.714 . . . . 0.0 112.481 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.06 -39.06 52.43 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.83 2.353 . . . . 0.0 112.225 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -145.03 148.18 33.42 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.723 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -160.45 35.11 0.16 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.894 0.878 . . . . 0.0 111.052 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.37 24.59 6.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.509 1.924 . . . . 0.0 112.882 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.38 37.29 1.12 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.628 2.771 . . . . 0.0 112.581 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -44.63 113.9 0.96 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.561 1.553 . . . . 0.0 111.502 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -58.75 154.94 33.54 Favored Pre-proline 0 C--O 1.233 0.222 0 C-N-CA 123.87 0.868 . . . . 0.0 112.662 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 20.0 Cg_endo -70.24 155.96 63.2 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 108.79 -1.273 . . . . 0.0 108.79 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.38 140.07 62.2 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 105.385 -2.583 . . . . 0.0 105.385 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.81 70.53 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.639 -1.089 . . . . 0.0 112.071 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.462 ' CZ2' ' HB3' ' B' ' 43' ' ' PRO . 6.7 m95 -107.01 167.62 9.76 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 119.954 1.877 . . . . 0.0 106.58 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -144.43 154.45 42.97 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -119.06 133.34 55.87 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -124.87 136.96 59.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -127.17 134.94 50.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 2.2 m -150.94 179.1 8.53 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.522 2.329 . . . . 0.0 110.281 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 69.4 m -110.77 -25.05 10.11 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.099 -1.001 . . . . 0.0 111.7 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -75.08 -23.13 57.98 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 110.527 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -122.46 -53.65 1.9 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.243 1.417 . . . . 0.0 112.036 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.21 -104.36 0.64 Allowed Glycine 0 N--CA 1.469 0.84 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.7 m -144.13 131.01 20.32 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.506 1.653 . . . . 0.0 108.536 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -139.54 175.33 9.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.211 1.004 . . . . 0.0 109.829 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -127.18 142.94 51.37 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.035 1.334 . . . . 0.0 108.086 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.53 135.22 59.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.81 0.814 . . . . 0.0 110.11 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -100.63 104.26 15.57 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -72.94 -24.94 60.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 119.158 -0.448 . . . . 0.0 111.826 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 18.2 m -71.0 -37.21 72.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.363 1.465 . . . . 0.0 111.615 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -115.25 1.89 13.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.575 1.15 . . . . 0.0 112.574 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 40' ' ' TYR . 4.9 mmtp 48.19 62.17 2.65 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.554 1.942 . . . . 0.0 109.901 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 21.6 mtm-85 -128.62 160.17 33.27 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.821 0.848 . . . . 0.0 110.018 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.8 131.41 47.76 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.356 1.462 . . . . 0.0 108.447 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -146.34 148.93 32.89 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 118.227 0.467 . . . . 0.0 110.538 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -91.44 25.7 2.52 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.04 1.736 . . . . 0.0 111.055 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -137.77 153.5 49.69 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . 0.454 ' CG ' ' HD2' ' B' ' 43' ' ' PRO . 4.7 t-80 -68.71 147.0 97.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 111.799 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . 0.462 ' HB3' ' CZ2' ' B' ' 18' ' ' TRP . 73.2 Cg_endo -71.44 -174.01 1.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 124.122 3.215 . . . . 0.0 113.449 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t -125.66 -38.72 2.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.131 0.972 . . . . 0.0 111.444 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.3 178.8 15.53 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.314 1.435 . . . . 0.0 111.43 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.01 -42.15 2.29 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.736 2.958 . . . . 0.0 110.534 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 33.1 p -158.79 -162.43 1.09 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 127.832 2.453 . . . . 0.0 105.927 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.3 p -141.22 -78.04 0.28 Allowed 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.581 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -164.45 125.02 2.08 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.435 1.117 . . . . 0.0 110.403 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.8 t -136.59 128.19 28.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.1 169.88 42.43 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 m -77.41 167.34 21.84 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.168 -1.195 . . . . 0.0 111.348 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 t -151.69 162.63 40.69 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.422 1.489 . . . . 0.0 108.05 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.08 169.63 45.72 Favored Glycine 0 CA--C 1.536 1.353 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.1 -59.8 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.251 2.634 . . . . 0.0 110.036 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.71 142.94 5.57 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 128.526 2.73 . . . . 0.0 104.627 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -121.13 177.43 5.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.37 1.468 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -124.34 6.63 8.39 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -58.34 165.82 1.91 Allowed 'General case' 0 C--O 1.239 0.53 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.57 121.41 20.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.157 1.36 . . . . 0.0 110.402 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.0 mt -82.85 157.61 66.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 125.209 1.403 . . . . 0.0 113.986 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.81 161.73 40.96 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.536 2.157 . . . . 0.0 110.328 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.36 123.71 11.18 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.851 2.368 . . . . 0.0 108.545 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.45 5.58 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.673 1.13 . . . . 0.0 110.669 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.458 ' CZ2' ' HB2' ' A' ' 32' ' ' ASP . 24.2 m95 -81.33 151.82 27.83 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.397 1.098 . . . . 0.0 108.993 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -135.43 140.87 45.24 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.468 0.707 . . . . 0.0 109.534 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -103.11 132.24 49.52 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.6 136.02 55.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -121.23 142.55 49.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -154.24 146.36 23.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.315 -0.866 . . . . 0.0 111.033 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.4 m -74.82 -12.82 60.48 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.559 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -101.27 -45.71 5.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 110.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -93.85 -18.1 22.36 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.11 -92.54 1.79 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.704 1.621 . . . . 0.0 111.544 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 m -153.75 124.44 7.18 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -139.43 177.15 8.13 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.806 0.442 . . . . 0.0 109.995 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.14 148.04 51.94 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.769 1.227 . . . . 0.0 108.923 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.46 137.12 57.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 123.226 0.61 . . . . 0.0 110.271 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 9.2 t0 -99.14 115.74 29.74 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 128.597 2.759 . . . . 0.0 108.941 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -82.94 -10.04 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.598 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 84.9 m -75.45 -43.43 49.63 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 120.747 1.612 . . . . 0.0 110.164 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -117.74 0.41 11.99 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.157 0.983 . . . . 0.0 112.176 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm 57.17 60.71 2.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.595 1.558 . . . . 0.0 108.509 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -129.47 143.63 50.91 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.789 0.835 . . . . 0.0 109.441 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -107.79 145.84 33.02 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.676 1.19 . . . . 0.0 109.288 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -148.86 162.86 38.99 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.461 1.104 . . . . 0.0 110.276 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -101.78 8.91 41.26 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.75 160.56 32.15 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.819 1.19 . . . . 0.0 111.007 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -61.88 134.83 94.29 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HB3' ' CH2' ' A' ' 18' ' ' TRP . 89.8 Cg_endo -74.08 -6.66 18.82 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.29 3.327 . . . . 0.0 116.028 -179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.73 -74.76 0.47 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.88 -178.11 18.38 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.496 -2.241 . . . . 0.0 107.496 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.73 -14.65 44.14 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.431 2.754 . . . . 0.0 113.378 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 p -148.92 151.99 35.61 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.964 1.706 . . . . 0.0 108.007 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -109.21 -5.0 16.09 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.884 0 N-CA-C 106.009 -2.836 . . . . 0.0 106.009 -179.155 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -127.54 153.11 46.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.841 0.856 . . . . 0.0 109.384 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -158.8 159.74 35.46 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 105.585 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 51.53 -135.77 32.74 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.743 0.687 . . . . 0.0 112.064 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 50.7 m -134.81 170.98 15.02 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.667 1.587 . . . . 0.0 108.38 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 12.3 t -145.6 170.44 16.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 126.157 1.783 . . . . 0.0 106.555 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.8 -167.3 39.08 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.374 1.464 . . . . 0.0 111.062 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -74.88 -72.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.681 2.92 . . . . 0.0 104.998 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 pp -159.69 158.33 31.2 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.608 1.563 . . . . 0.0 109.324 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -137.57 171.34 14.59 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 126.704 2.002 . . . . 0.0 106.356 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -133.55 9.86 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.7 172.77 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.745 1.157 . . . . 0.0 112.036 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -50.36 159.0 1.63 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.746 2.117 . . . . 0.0 113.348 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 48.6 mt -128.44 155.9 77.89 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.437 1.095 . . . . 0.0 112.865 -178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.9 158.53 52.61 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.283 1.989 . . . . 0.0 110.567 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.8 123.61 10.26 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.558 2.172 . . . . 0.0 106.87 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.96 -26.41 6.8 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.643 1.592 . . . . 0.0 110.789 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 25.6 m95 -90.0 157.01 18.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.381 1.091 . . . . 0.0 110.172 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -141.19 150.5 42.8 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.802 0.841 . . . . 0.0 108.761 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -115.48 128.55 56.09 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 t -117.77 120.3 64.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 123.879 0.872 . . . . 0.0 109.509 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -107.31 146.28 31.74 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -150.11 170.77 18.14 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.754 1.622 . . . . 0.0 110.914 -178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 70.8 m -96.24 -34.23 11.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -74.87 -27.01 60.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.133 0.973 . . . . 0.0 110.756 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.93 -19.42 5.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.65 -86.5 1.28 Allowed Glycine 0 N--CA 1.461 0.331 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -159.67 134.23 7.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.902 1.351 . . . . 0.0 111.307 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -143.76 158.11 43.91 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.352 1.461 . . . . 0.0 107.417 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -110.87 159.58 17.55 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.821 -1.174 . . . . 0.0 108.587 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 38.8 t -131.11 135.23 60.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 122.817 0.447 . . . . 0.0 109.955 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.447 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 42.9 t0 -99.06 113.18 25.25 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.912 1.285 . . . . 0.0 108.689 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -72.92 -16.89 61.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.508 -0.758 . . . . 0.0 112.687 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 79.4 m -79.78 -28.91 40.27 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.996 0.919 . . . . 0.0 112.857 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -121.76 -4.79 9.17 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.893 0.769 . . . . 0.0 111.537 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp 56.21 47.66 18.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.829 1.652 . . . . 0.0 109.7 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -118.81 160.85 21.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 124.153 0.981 . . . . 0.0 111.175 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.61 140.59 51.32 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.972 1.309 . . . . 0.0 109.111 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -150.9 156.05 40.4 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.438 1.095 . . . . 0.0 110.169 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -97.47 -7.63 31.11 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.917 0.887 . . . . 0.0 111.67 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -100.1 142.43 31.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.06 1.344 . . . . 0.0 108.825 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -58.66 143.57 81.7 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 118.828 -0.606 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.37 -29.78 16.38 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.575 2.183 . . . . 0.0 116.734 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 13.9 t -78.75 -84.92 0.08 Allowed 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.697 1.135 . . . . 0.0 108.578 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.0 -174.07 23.82 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 119.384 0.993 . . . . 0.0 112.512 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.53 -5.42 16.63 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.483 2.788 . . . . 0.0 112.613 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 18.3 p -160.23 167.26 27.98 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.813 1.245 . . . . 0.0 109.342 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.4 m -135.04 29.89 3.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.878 1.271 . . . . 0.0 109.645 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -178.789 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -78.52 171.46 15.07 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.01 -167.5 2.75 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 109.617 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.86 82.1 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 CA-C-O 119.293 -0.726 . . . . 0.0 112.086 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.9 m -94.94 89.26 5.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 p -70.03 171.18 9.94 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.554 1.142 . . . . 0.0 110.533 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.22 164.92 16.03 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.543 1.068 . . . . 0.0 111.675 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.45 -62.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.187 2.592 . . . . 0.0 108.728 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.4 mt -140.56 163.69 32.17 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.738 1.615 . . . . 0.0 108.396 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -126.6 172.67 10.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.729 1.612 . . . . 0.0 108.723 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 48.3 mtt85 -133.16 40.11 3.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 0.0 109.81 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -125.22 -176.79 3.67 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.221 1.409 . . . . 0.0 107.296 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 -78.15 0.34 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 119.217 0.917 . . . . 0.0 112.22 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.0 mt -144.74 159.77 49.58 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 109.475 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 18' ' ' TRP . 33.1 Cg_endo -66.9 158.87 54.43 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 121.43 1.42 . . . . 0.0 110.454 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.04 95.55 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.528 2.819 . . . . 0.0 107.589 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 139.98 -2.04 2.33 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.347 0.975 . . . . 0.0 112.982 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.4 ' CD1' ' HG2' ' A' ' 15' ' ' PRO . 19.8 m95 -118.24 151.47 37.58 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -137.18 153.53 50.42 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.265 0.626 . . . . 0.0 109.964 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -114.49 127.62 55.91 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 126.23 1.812 . . . . 0.0 107.789 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.25 117.76 56.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -87.83 152.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.103 -2.554 . . . . 0.0 104.103 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -151.2 177.39 10.27 Favored 'General case' 0 C--O 1.239 0.508 0 O-C-N 120.647 -1.283 . . . . 0.0 111.622 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.2 m -114.07 -18.08 11.78 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.81 -10.97 12.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.701 0.801 . . . . 0.0 110.087 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -123.69 -12.36 7.64 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.466 1.906 . . . . 0.0 112.563 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.87 -77.04 1.15 Allowed Glycine 0 CA--C 1.524 0.635 0 C-N-CA 126.11 1.814 . . . . 0.0 110.329 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -161.24 138.43 8.87 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.628 1.714 . . . . 0.0 110.357 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -143.17 171.74 13.67 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -124.93 153.1 43.22 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.911 0.885 . . . . 0.0 109.686 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -128.92 141.5 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.885 0.874 . . . . 0.0 110.846 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -104.55 111.07 23.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 129.729 3.212 . . . . 0.0 108.477 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -76.56 -18.53 58.63 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 96.6 m -78.26 -32.45 49.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.98 0.809 . . . . 0.0 110.313 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -116.44 -4.97 11.75 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 38' ' ' ALA . 6.4 mmmm 55.29 52.52 11.33 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.989 2.116 . . . . 0.0 109.886 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.9 mtm180 -124.52 165.69 17.37 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 124.454 1.102 . . . . 0.0 110.311 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.68 151.52 47.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.158 1.383 . . . . 0.0 108.57 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -152.43 159.98 43.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.828 0.823 . . . . 0.0 111.643 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' B' ' 36' ' ' LYS . 14.2 m-30 -93.8 17.28 12.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.411 1.484 . . . . 0.0 113.837 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.36 150.84 38.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 120.464 -1.398 . . . . 0.0 110.072 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -59.92 142.33 88.87 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-O 117.831 -1.081 . . . . 0.0 108.907 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.96 44.84 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 125.747 4.298 . . . . 0.0 116.083 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.64 131.09 34.64 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.69 164.41 19.38 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.287 1.899 . . . . 0.0 113.628 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.72 151.06 45.84 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.022 2.481 . . . . 0.0 109.024 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 p -75.22 135.56 41.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.059 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.43 -55.7 2.95 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 105.767 -2.933 . . . . 0.0 105.767 178.501 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.865 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -61.44 160.63 10.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.912 1.685 . . . . 0.0 114.154 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -141.24 162.16 36.16 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 107.951 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.14 109.34 0.39 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.0 m -123.87 66.59 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.05 1.34 . . . . 0.0 108.595 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.7 133.66 47.08 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.74 0.816 . . . . 0.0 110.184 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.67 175.62 54.83 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.74 -71.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 124.069 3.179 . . . . 0.0 110.912 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 72.3 mt -146.4 123.83 11.68 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.884 2.074 . . . . 0.0 107.118 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -85.27 162.42 19.14 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 54.4 mtt-85 -98.54 -18.83 17.95 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.041 -0.412 . . . . 0.0 109.96 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -70.0 176.48 3.73 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.952 0.901 . . . . 0.0 112.32 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.59 -68.72 1.55 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.657 1.122 . . . . 0.0 112.804 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 mt -150.85 160.58 32.06 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 125.179 1.392 . . . . 0.0 109.585 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . 0.412 ' HG2' ' CD1' ' B' ' 18' ' ' TRP . 55.8 Cg_endo -66.28 162.57 35.55 Favored 'Trans proline' 0 CA--C 1.547 1.147 0 C-N-CA 122.12 1.88 . . . . 0.0 110.336 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.95 108.62 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.423 2.749 . . . . 0.0 110.17 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.41 -26.19 6.73 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.674 1.131 . . . . 0.0 112.706 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 32' ' ' ASP . 9.6 m95 -80.85 148.99 29.7 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 119.428 1.614 . . . . 0.0 108.867 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -131.24 152.19 50.76 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.722 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -111.65 138.84 47.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.6 136.15 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -124.58 141.19 52.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 17.0 p -154.25 -166.57 2.39 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.657 2.383 . . . . 0.0 109.209 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m -121.15 -47.69 2.26 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.71 -50.99 70.22 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -80.61 -59.02 2.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.83 -98.49 0.53 Allowed Glycine 0 C--N 1.338 0.648 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.6 m -150.96 136.34 17.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 119.446 1.623 . . . . 0.0 107.673 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -150.52 178.08 9.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.07 152.75 43.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.397 0.679 . . . . 0.0 109.409 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -122.66 139.0 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.464 ' HB2' ' CH2' ' B' ' 18' ' ' TRP . 55.0 t0 -100.01 104.91 16.54 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.051 1.74 . . . . 0.0 107.753 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -27.77 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.89 0.768 . . . . 0.0 112.386 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 94.6 m -64.2 -39.37 93.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 111.573 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -118.57 -1.33 11.19 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 40' ' ' TYR . 34.5 mmtm 52.63 50.71 17.57 Favored 'General case' 0 C--O 1.23 0.063 0 C-N-CA 125.019 1.328 . . . . 0.0 111.069 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -125.41 164.77 19.71 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . 0.4 ' O ' ' HE2' ' A' ' 36' ' ' LYS . . . -122.2 151.52 40.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.717 0.807 . . . . 0.0 109.104 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -146.14 152.25 38.97 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.271 0.941 . . . . 0.0 111.419 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -95.2 26.21 3.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.61 1.564 . . . . 0.0 112.622 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.86 167.52 28.05 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 120.15 -1.594 . . . . 0.0 109.011 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.11 154.84 91.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.619 -0.705 . . . . 0.0 110.159 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.82 42.19 1.09 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.651 2.901 . . . . 0.0 110.605 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 6.9 t -73.3 122.41 21.95 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.467 1.107 . . . . 0.0 110.739 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.59 169.53 5.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.322 1.439 . . . . 0.0 112.216 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.16 142.15 72.57 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 107.866 -1.628 . . . . 0.0 107.866 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.57 103.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.092 1.357 . . . . 0.0 110.766 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -58.62 -16.52 16.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.954 1.302 . . . . 0.0 112.893 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.321 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 179.369 . . . . . . . . 0 0 . 1 stop_ save_